*********** PTASSAMj00 ******** FILEIN user.vek ../../CSA/PIK_SPRITE/ ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 1 3 # 1 A 49 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 86 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 250 ALA A 91 ALA.? 11.21 ZN ZN A 119 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -7.50 39.92 51.50 -8.68 39.00 51.45 ULMN 3 2wwt_o00 INTRACELLULAR SUBTILISIN PROTEASE user 2 3 # 2 A 49 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 86 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 250 ALA B 91 ALA.? 11.25 ZN ZN B 118 coo 18.89 -28.09 25.11 19.05 -26.61 23.60 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 21.50 -24.76 21.11 19.82 -23.58 21.50 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 16.40 -19.57 19.82 17.00 -20.87 19.22 -5.13 -2.73 40.48 -6.21 -1.76 40.05 2wwt_o00 source 2WWT INTRACELLULAR SUBTILISIN PROTEASE : 2 hits 2wwt_o00 naa= 3 ULMN 5 1gdh_c00 D-GLYCERATE DEHYDROGENASE (APO FORM)user 1 5 # 1 A 240 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 242 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 264 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 269 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 287 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 17.36 8.35 16.57 16.96 6.04 18.54 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 21.36 6.05 14.95 19.24 5.81 14.80 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 21.49 19.11 18.39 20.81 19.66 20.29 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 23.48 10.69 22.39 22.24 12.31 21.83 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 20.16 15.49 22.94 18.67 14.36 21.99 -11.17 33.63 46.78 -12.74 33.06 45.52 1gdh_c00 source 1gdh D-GLYCERATE DEHYDROGENASE (APO FORM) (E.C.1.1.: 1 hits 1gdh_c00 naa= 5 ULMN 5 1gdh_c01 D-GLYCERATE DEHYDROGENASE (APO FORM)user 1 5 # 1 B 240 ARG B 35 ARG.? 5.03 ZN ZN B 118 B 242 ASP A 15 ASP~? 8.61 ZN ZN B 118 B 264 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 269 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 287 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 32.06 52.83 17.17 34.90 53.72 17.93 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 33.52 53.25 23.28 32.78 54.06 21.46 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 29.98 41.40 17.79 31.11 40.78 16.13 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 37.72 45.90 19.85 36.33 45.31 18.40 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 34.65 43.41 15.42 33.80 45.28 15.03 -10.33 3.56 43.54 -12.07 4.44 44.29 1gdh_c01 source 1gdh D-GLYCERATE DEHYDROGENASE (APO FORM) (E.C.1.1.: 1 hits 1gdh_c01 naa= 5 ULMN 5 1j49_c00 D-LACTATE DEHYDROGENASE user 1 5 # 1 A 209 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 236 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 260 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 265 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 297 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 49.94 38.64 112.59 48.72 39.54 111.21 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 51.23 35.28 110.82 48.57 36.20 109.45 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 56.31 32.31 102.69 55.56 30.36 102.87 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 47.07 34.33 103.36 48.88 33.52 104.12 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 51.04 30.36 104.92 51.06 31.23 106.83 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 5 1j49_c00 D-LACTATE DEHYDROGENASE user 2 5 # 2 A 209 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 236 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 260 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 265 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 297 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 49.94 38.64 112.59 48.72 39.54 111.21 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 51.23 35.28 110.82 48.57 36.20 109.45 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 56.31 32.31 102.69 55.56 30.36 102.87 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 47.07 34.33 103.36 48.88 33.52 104.12 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 51.04 30.36 104.92 51.06 31.23 106.83 -11.17 33.63 46.78 -12.74 33.06 45.52 1j49_c00 source 1j49 D-LACTATE DEHYDROGENASE : 2 hits 1j49_c00 naa= 5 ULMN 4 1avf_c06 GASTRICSIN user 1 4 # 1 J 32 ASP A 15 ASP~? 8.61 ZN ZN B 118 J 35 SER A 14 SER~? 11.41 CH3 ACY A 120 J 75 TYR A 79 TYR^? -4.35 CH3 ACY A 120s J 217 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -8.58 16.80 48.15 -8.42 16.11 45.83 coo -41.81 -30.90 17.10 -43.71 -28.85 16.83 -8.40 22.97 58.06 -7.77 20.89 56.30 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 4 1avf_c06 GASTRICSIN user 2 4 # 2 J 32 ASP B 15 ASP~? 8.50 ZN ZN A 119 J 35 SER B 14 SER~? 11.46 CH3 ACY B 120 J 75 TYR B 79 TYR^? -4.21 CH3 ACY B 120s J 217 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -7.60 20.35 43.19 -8.11 21.15 45.47 coo -41.81 -30.90 17.10 -43.71 -28.85 16.83 -4.08 14.27 33.90 -4.00 16.42 35.66 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -12.98 14.88 47.28 -12.40 12.90 47.92 1avf_c06 source 1avf GASTRICSIN : 2 hits 1avf_c06 naa= 4 ULMN 4 1dae_c00 DETHIOBIOTIN SYNTHETASE user 1 4 # 1 11 THR A 5 THR.? 10.24 ZN ZN B 118 15 LYS A 16 LYS~? -3.27 O ACY A 120s 37 LYS B 40 LYS.? 4.59 ZN ZN A 118 41 SER B 46 SER^? 14.91 OXT ACY A 120 coo 0.09 24.25 7.43 -1.97 23.87 6.88 -11.20 6.24 51.51 -9.77 5.38 52.87 coo 7.11 25.15 11.60 2.05 27.82 12.68 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 1.91 29.06 21.41 0.93 26.02 16.70 -0.91 15.74 55.76 -5.29 12.34 58.61 coo -6.12 22.99 17.90 -6.59 23.98 15.67 1.20 11.37 47.30 1.64 9.60 48.90 1dae_c00 source 1dae DETHIOBIOTIN SYNTHETASE : 1 hits 1dae_c00 naa= 4 ULMN 4 1e6e_c00 ADRENODOXIN user 1 4 # 1 A 55 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 159 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 376 ILE A 33 ILE^? 8.64 CH3 ACY A 120 A 377 THR A 20 THR.? 4.16 CH3 ACY A 120 coo 17.95 58.52 112.81 17.29 59.41 111.03 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 11.32 57.46 110.35 12.85 58.48 111.39 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 15.00 65.23 121.40 15.42 63.95 122.00 -10.52 24.52 52.33 -9.35 25.29 52.28 coo 15.65 69.77 121.40 17.38 70.64 120.41 -13.83 21.70 55.31 -12.29 20.44 56.16 ULMN 4 1e6e_c00 ADRENODOXIN user 2 4 # 2 A 55 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 159 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 376 ILE B 33 ILE^? 8.52 CH3 ACY B 120 A 377 THR B 20 THR.? 4.10 CH3 ACY B 120 coo 17.95 58.52 112.81 17.29 59.41 111.03 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 11.32 57.46 110.35 12.85 58.48 111.39 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 15.00 65.23 121.40 15.42 63.95 122.00 -8.17 12.63 38.56 -7.01 11.89 38.90 coo 15.65 69.77 121.40 17.38 70.64 120.41 -10.29 15.42 34.68 -8.60 16.74 34.44 1e6e_c00 source 1e6e ADRENODOXIN : 2 hits 1e6e_c00 naa= 4 ULMN 4 1e6e_c01 ADRENODOXIN user 1 4 # 1 C 55 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 159 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 376 ILE A 33 ILE^? 8.64 CH3 ACY A 120 C 377 THR A 20 THR.? 4.16 CH3 ACY A 120 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -10.52 24.52 52.33 -9.35 25.29 52.28 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -13.83 21.70 55.31 -12.29 20.44 56.16 ULMN 4 1e6e_c01 ADRENODOXIN user 2 4 # 2 C 55 HIS B 62 HIS^? -3.22 ZN ZN B 118s C 159 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 376 ILE B 33 ILE^? 8.52 CH3 ACY B 120 C 377 THR B 20 THR.? 4.10 CH3 ACY B 120 coo -29.07 40.56 142.27 -27.79 41.91 141.29 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -23.44 38.39 138.46 -25.44 39.03 138.64 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -37.08 37.01 134.95 -37.09 36.11 136.10 -8.17 12.63 38.56 -7.01 11.89 38.90 coo -39.65 39.67 132.35 -40.33 41.62 133.03 -10.29 15.42 34.68 -8.60 16.74 34.44 1e6e_c01 source 1e6e ADRENODOXIN : 2 hits 1e6e_c01 naa= 4 ULMN 4 1els_c01 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-user 1 4 # 1 168 GLU B 4 GLU.? -2.30 ZN ZN A 119s 211 GLU A 34 GLU^? -2.26 ZN ZN A 119s 345 LYS A 93 LYS.? 17.16 ZN ZN A 119 373 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 93.43 51.01 30.24 95.07 49.77 29.67 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 91.65 44.62 30.04 93.01 45.95 29.66 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 103.59 43.46 23.85 98.61 47.18 23.58 -8.24 41.47 45.26 -7.63 47.05 46.72 coo 97.00 42.72 29.81 95.87 44.35 30.62 -11.17 33.63 46.78 -12.74 33.06 45.52 1els_c01 source 1els ENOLASE (E.C.4.2.1.11) (2-PHOSPHO-D-GLYCERATE : 1 hits 1els_c01 naa= 4 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 1 4 # 1 A 481 GLU A 39 GLU^? 13.07 O ACY A 121 A 485 LYS B 10 LYS.? 9.83 CH3 ACY A 121 A 488 GLU B 7 GLU.? -2.20 ZN ZN B 119s A 603 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo -7.79 3.39 10.29 -9.01 4.74 9.32 3.97 24.42 42.90 6.03 24.50 43.46 coo -9.44 10.08 8.58 -11.94 6.98 8.10 2.14 27.03 37.15 7.00 28.76 35.76 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -4.86 25.89 35.02 -5.24 24.36 33.68 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -10.13 21.11 38.47 -9.52 22.58 33.19 ULMN 4 1jxa_c01 GLUCOSAMINE 6-PHOSPHATE SYNTHASE user 2 4 # 2 A 481 GLU B 39 GLU.? 14.67 OXT ACY A 120 A 485 LYS A 10 LYS.? 12.65 OXT ACY A 120 A 488 GLU A 7 GLU.? 2.09 ZN ZN A 118s A 603 LYS A 16 LYS~? -3.27 O ACY A 120s coo -7.79 3.39 10.29 -9.01 4.74 9.32 2.54 12.93 51.58 4.67 12.91 51.32 coo -9.44 10.08 8.58 -11.94 6.98 8.10 -0.98 10.25 56.97 2.99 9.65 58.52 coo -13.30 11.40 4.76 -13.95 9.40 5.16 -8.44 11.27 56.65 -9.19 12.79 57.99 coo -21.26 6.97 3.81 -20.43 4.23 9.21 -12.18 15.96 51.84 -12.69 14.73 56.98 1jxa_c01 source 1jxa GLUCOSAMINE 6-PHOSPHATE SYNTHASE : 2 hits 1jxa_c01 naa= 4 ULMN 4 1mdr_c00 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 4 # 1 166 LYS B 16 LYS~? -4.10 OXT ACY B 120s 270 ASP A 60 ASP.? -2.37 ZN ZN A 119s 297 HIS A 62 HIS^? -3.21 ZN ZN A 119s 317 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 27.27 1.43 25.09 29.18 5.25 22.89 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 29.40 9.25 9.79 31.51 9.14 10.05 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 29.05 8.65 14.00 30.25 7.04 14.30 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 29.25 11.66 19.43 29.42 9.79 18.51 -14.65 30.41 41.31 -14.31 31.08 43.33 1mdr_c00 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 1 hits 1mdr_c00 naa= 4 ULMN 3 1a0j_c12 TRYPSIN user 1 3 # 1 A 57 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 102 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 193 GLY A 95 GLY.? 11.34 ZN ZN A 119 coo 25.57 41.22 61.68 24.18 39.98 62.50 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 22.33 45.48 59.73 23.35 43.67 60.06 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 22.57 32.23 64.13 21.98 32.82 64.22 -4.39 36.14 43.27 -4.07 36.89 43.24 1a0j_c12 source 1a0j TRYPSIN : 1 hits 1a0j_c12 naa= 3 ULMN 3 1a0j_c13 TRYPSIN user 1 3 # 1 B 57 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 102 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 193 GLY A 95 GLY.? 11.34 ZN ZN A 119 coo 44.08 45.58 52.81 45.86 46.55 52.85 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 43.04 44.75 47.18 43.31 45.51 49.13 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 50.46 51.91 56.90 50.65 51.62 56.14 -4.39 36.14 43.27 -4.07 36.89 43.24 1a0j_c13 source 1a0j TRYPSIN : 1 hits 1a0j_c13 naa= 3 ULMN 3 1a0j_c14 TRYPSIN user 1 3 # 1 C 57 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 102 ASP A 60 ASP.? -2.37 ZN ZN A 119s C 193 GLY A 95 GLY.? 11.34 ZN ZN A 119 coo 34.37 41.18 73.21 34.04 43.09 73.87 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 34.89 38.34 78.12 35.11 39.59 76.42 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 35.43 51.03 72.12 35.20 50.72 72.87 -4.39 36.14 43.27 -4.07 36.89 43.24 1a0j_c14 source 1a0j TRYPSIN : 1 hits 1a0j_c14 naa= 3 ULMN 3 1a0j_c15 TRYPSIN user 1 3 # 1 D 57 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 102 ASP A 60 ASP.? -2.37 ZN ZN A 119s D 193 GLY A 95 GLY.? 11.34 ZN ZN A 119 coo 8.19 15.01 95.72 7.78 16.53 97.01 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 13.53 16.28 93.98 11.45 16.21 94.40 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 1.80 21.25 100.04 2.61 21.42 100.18 -4.39 36.14 43.27 -4.07 36.89 43.24 1a0j_c15 source 1a0j TRYPSIN : 1 hits 1a0j_c15 naa= 3 ULMN 3 1a50_c03 TRYPTOPHAN SYNTHASE user 1 3 # 1 A 49 GLU A 7 GLU.? 2.09 ZN ZN A 118s A 60 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 175 TYR A 72 TYR^? -3.77 O ACY A 120s coo 46.10 28.27 19.27 45.48 26.99 20.84 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 56.42 28.06 12.93 55.01 27.92 14.50 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 45.02 22.04 15.38 46.16 24.00 13.76 -8.74 18.57 61.24 -11.39 17.69 61.31 1a50_c03 source 1a50 TRYPTOPHAN SYNTHASE : 1 hits 1a50_c03 naa= 3 ULMN 3 1a79_c00 TRNA ENDONUCLEASE user 1 3 # 1 A 115 TYR A 63 TYR^? 13.00 ZN ZN A 119 A 125 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 156 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 37.11 -19.03 58.81 39.12 -18.07 60.48 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 44.53 -22.25 60.75 45.90 -22.66 62.28 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 46.42 -20.06 51.80 44.79 -19.05 56.86 -8.24 41.47 45.26 -7.63 47.05 46.72 1a79_c00 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c00 naa= 3 ULMN 3 1a79_c01 TRNA ENDONUCLEASE user 1 3 # 1 B 115 TYR A 63 TYR^? 13.00 ZN ZN A 119 B 125 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 156 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 52.78 -23.08 19.46 51.79 -21.72 17.22 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 45.10 -24.12 17.42 43.96 -24.36 15.67 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 43.97 -19.59 26.02 45.10 -20.27 21.16 -8.24 41.47 45.26 -7.63 47.05 46.72 1a79_c01 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c01 naa= 3 ULMN 3 1a79_c02 TRNA ENDONUCLEASE user 1 3 # 1 C 115 TYR A 63 TYR^? 13.00 ZN ZN A 119 C 125 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 156 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 72.53 -8.86 48.33 70.89 -10.65 46.92 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 69.12 -16.18 50.82 68.25 -17.99 50.22 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 64.47 -11.13 56.60 66.23 -12.62 51.81 -8.24 41.47 45.26 -7.63 47.05 46.72 1a79_c02 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c02 naa= 3 ULMN 3 1a79_c03 TRNA ENDONUCLEASE user 1 3 # 1 D 115 TYR A 63 TYR^? 13.00 ZN ZN A 119 D 125 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 156 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 54.10 1.42 85.16 54.14 4.17 85.62 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 61.27 5.43 85.32 62.73 6.38 86.49 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 60.28 4.62 76.00 58.35 6.41 80.65 -8.24 41.47 45.26 -7.63 47.05 46.72 1a79_c03 source 1a79 TRNA ENDONUCLEASE : 1 hits 1a79_c03 naa= 3 ULMN 3 1am5_c04 PEPSIN user 1 3 # 1 32 ASP A 15 ASP~? 8.61 ZN ZN B 118 35 SER A 14 SER~? 11.41 CH3 ACY A 120 215 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -8.58 16.80 48.15 -8.42 16.11 45.83 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1am5_c04 PEPSIN user 2 3 # 2 32 ASP B 15 ASP~? 8.50 ZN ZN A 119 35 SER B 14 SER~? 11.46 CH3 ACY B 120 215 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -7.18 8.92 145.10 -8.77 8.81 143.59 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -12.30 10.35 145.24 -10.75 8.55 145.88 -7.60 20.35 43.19 -8.11 21.15 45.47 coo -8.20 12.64 138.30 -8.86 10.97 139.38 -12.98 14.88 47.28 -12.40 12.90 47.92 1am5_c04 source 1am5 PEPSIN : 2 hits 1am5_c04 naa= 3 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 1 3 # 1 E 33 ASP A 15 ASP~? 8.61 ZN ZN B 118 E 36 SER A 14 SER~? 11.41 CH3 ACY A 120 E 213 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 26.30 12.96 16.78 25.46 12.99 18.72 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 28.33 15.15 21.27 28.70 13.12 19.97 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 20.15 16.04 19.79 21.65 14.49 19.86 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1apt_c04 ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET user 2 3 # 2 E 33 ASP B 15 ASP~? 8.50 ZN ZN A 119 E 36 SER B 14 SER~? 11.46 CH3 ACY B 120 E 213 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 26.30 12.96 16.78 25.46 12.99 18.72 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 28.33 15.15 21.27 28.70 13.12 19.97 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 20.15 16.04 19.79 21.65 14.49 19.86 -12.98 14.88 47.28 -12.40 12.90 47.92 1apt_c04 source 1apt ISOVALERYL (IVA)-VAL-VAL-LYSTA-O-ET (LYSTA IS : 2 hits 1apt_c04 naa= 3 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 A 194 SER A 14 SER~? 11.41 CH3 ACY A 120 A 292 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 322 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 36.34 32.23 39.60 36.43 34.62 39.93 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 19.73 19.18 41.39 21.50 18.65 40.34 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 41.69 45.14 46.60 41.78 47.19 46.18 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 A 194 SER A 14 SER~? 11.41 CH3 ACY A 120 A 292 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 322 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 36.34 32.23 39.60 36.43 34.62 39.93 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 19.73 19.18 41.39 21.50 18.65 40.34 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 41.69 45.14 46.60 41.78 47.19 46.18 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 A 194 SER B 14 SER~? 11.46 CH3 ACY B 120 A 292 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 322 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 36.34 32.23 39.60 36.43 34.62 39.93 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 19.73 19.18 41.39 21.50 18.65 40.34 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 41.69 45.14 46.60 41.78 47.19 46.18 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 3 1aql_c02 BILE-SALT ACTIVATED LIPASE user 4 3 # 4 A 194 SER B 14 SER~? 11.46 CH3 ACY B 120 A 292 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 322 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 36.34 32.23 39.60 36.43 34.62 39.93 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 19.73 19.18 41.39 21.50 18.65 40.34 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 41.69 45.14 46.60 41.78 47.19 46.18 -11.17 33.63 46.78 -12.74 33.06 45.52 1aql_c02 source 1aql BILE-SALT ACTIVATED LIPASE : 4 hits 1aql_c02 naa= 3 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 1 3 # 1 B 194 SER A 14 SER~? 11.41 CH3 ACY A 120 B 292 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 322 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 35.42 71.28 22.94 36.24 69.06 22.37 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 24.74 78.07 5.59 24.32 79.03 7.46 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 48.81 64.16 26.34 49.30 62.16 26.73 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 2 3 # 2 B 194 SER A 14 SER~? 11.41 CH3 ACY A 120 B 292 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 322 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 35.42 71.28 22.94 36.24 69.06 22.37 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 24.74 78.07 5.59 24.32 79.03 7.46 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 48.81 64.16 26.34 49.30 62.16 26.73 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 3 1aql_c03 BILE-SALT ACTIVATED LIPASE user 3 3 # 3 B 194 SER B 14 SER~? 11.46 CH3 ACY B 120 B 292 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 322 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 35.42 71.28 22.94 36.24 69.06 22.37 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 24.74 78.07 5.59 24.32 79.03 7.46 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 48.81 64.16 26.34 49.30 62.16 26.73 -11.17 33.63 46.78 -12.74 33.06 45.52 1aql_c03 source 1aql BILE-SALT ACTIVATED LIPASE : 3 hits 1aql_c03 naa= 3 ULMN 3 1avf_c04 GASTRICSIN user 1 3 # 1 A 32 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 35 SER A 14 SER~? 11.41 CH3 ACY A 120 A 217 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -8.58 16.80 48.15 -8.42 16.11 45.83 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1avf_c04 GASTRICSIN user 2 3 # 2 A 32 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 35 SER B 14 SER~? 11.46 CH3 ACY B 120 A 217 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -10.06 2.54 49.69 -8.83 3.73 50.96 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -11.96 5.74 52.90 -10.55 6.74 51.22 -7.60 20.35 43.19 -8.11 21.15 45.47 coo -5.22 1.43 56.08 -5.36 2.84 54.49 -12.98 14.88 47.28 -12.40 12.90 47.92 1avf_c04 source 1avf GASTRICSIN : 2 hits 1avf_c04 naa= 3 ULMN 3 1avf_c05 GASTRICSIN user 1 3 # 1 J 32 ASP A 15 ASP~? 8.61 ZN ZN B 118 J 35 SER A 14 SER~? 11.41 CH3 ACY A 120 J 217 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -8.58 16.80 48.15 -8.42 16.11 45.83 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1avf_c05 GASTRICSIN user 2 3 # 2 J 32 ASP B 15 ASP~? 8.50 ZN ZN A 119 J 35 SER B 14 SER~? 11.46 CH3 ACY B 120 J 217 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -37.57 -17.54 20.53 -38.55 -18.66 19.00 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -40.93 -20.91 21.81 -38.85 -21.36 20.65 -7.60 20.35 43.19 -8.11 21.15 45.47 coo -43.00 -16.46 14.92 -41.37 -17.71 15.28 -12.98 14.88 47.28 -12.40 12.90 47.92 1avf_c05 source 1avf GASTRICSIN : 2 hits 1avf_c05 naa= 3 ULMN 3 1bbs_c06 RENIN user 1 3 # 1 32 ASP A 15 ASP~? 8.61 ZN ZN B 118 35 SER A 14 SER~? 11.41 CH3 ACY A 120 215 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 61.19 45.85 78.73 62.86 45.48 77.48 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 66.00 46.17 80.29 64.31 47.92 79.91 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 63.61 40.10 74.06 64.05 42.07 74.70 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1bbs_c06 RENIN user 2 3 # 2 32 ASP B 15 ASP~? 8.50 ZN ZN A 119 35 SER B 14 SER~? 11.46 CH3 ACY B 120 215 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 61.19 45.85 78.73 62.86 45.48 77.48 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 66.00 46.17 80.29 64.31 47.92 79.91 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 63.61 40.10 74.06 64.05 42.07 74.70 -12.98 14.88 47.28 -12.40 12.90 47.92 1bbs_c06 source 1bbs RENIN : 2 hits 1bbs_c06 naa= 3 ULMN 3 1bbs_c07 RENIN user 1 3 # 1 32 ASP A 15 ASP~? 8.61 ZN ZN B 118 35 SER A 14 SER~? 11.41 CH3 ACY A 120 215 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 61.19 45.85 78.73 62.86 45.48 77.48 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 66.00 46.17 80.29 64.31 47.92 79.91 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 63.61 40.10 74.06 64.05 42.07 74.70 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1bbs_c07 RENIN user 2 3 # 2 32 ASP B 15 ASP~? 8.50 ZN ZN A 119 35 SER B 14 SER~? 11.46 CH3 ACY B 120 215 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 61.19 45.85 78.73 62.86 45.48 77.48 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 66.00 46.17 80.29 64.31 47.92 79.91 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 63.61 40.10 74.06 64.05 42.07 74.70 -12.98 14.88 47.28 -12.40 12.90 47.92 1bbs_c07 source 1bbs RENIN : 2 hits 1bbs_c07 naa= 3 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 A 137 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 141 THR B 8 THR.? 9.69 CH3 ACY A 121 A 235 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 6.21 93.81 36.58 4.58 96.33 37.17 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 -2.71 29.36 36.26 -2.04 29.94 38.25 coo 12.98 90.36 47.57 11.26 89.62 46.62 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 A 137 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 141 THR B 8 THR.? 9.69 CH3 ACY A 121 A 235 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 6.21 93.81 36.58 4.58 96.33 37.17 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 -2.71 29.36 36.26 -2.04 29.94 38.25 coo 12.98 90.36 47.57 11.26 89.62 46.62 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 A 137 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 141 THR B 8 THR.? 9.69 CH3 ACY A 121 A 235 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 6.21 93.81 36.58 4.58 96.33 37.17 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 6.80 92.87 28.33 4.91 92.74 27.40 -2.71 29.36 36.26 -2.04 29.94 38.25 coo 12.98 90.36 47.57 11.26 89.62 46.62 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 A 137 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 141 THR A 8 THR.? 9.96 ZN ZN A 118 A 235 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 6.21 93.81 36.58 4.58 96.33 37.17 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 6.80 92.87 28.33 4.91 92.74 27.40 -5.91 7.98 55.94 -4.35 7.02 54.82 coo 12.98 90.36 47.57 11.26 89.62 46.62 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 A 137 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 141 THR A 8 THR.? 9.96 ZN ZN A 118 A 235 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 6.21 93.81 36.58 4.58 96.33 37.17 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 6.80 92.87 28.33 4.91 92.74 27.40 -5.91 7.98 55.94 -4.35 7.02 54.82 coo 12.98 90.36 47.57 11.26 89.62 46.62 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 3 1bd3_c00 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 A 137 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 141 THR A 8 THR.? 9.96 ZN ZN A 118 A 235 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 6.21 93.81 36.58 4.58 96.33 37.17 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 6.80 92.87 28.33 4.91 92.74 27.40 -5.91 7.98 55.94 -4.35 7.02 54.82 coo 12.98 90.36 47.57 11.26 89.62 46.62 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1bd3_c00 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 6 hits 1bd3_c00 naa= 3 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 D 137 ARG A 35 ARG^? 4.87 ZN ZN A 119 D 141 THR B 8 THR.? 9.69 CH3 ACY A 121 D 235 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -2.71 29.36 36.26 -2.04 29.94 38.25 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 D 137 ARG A 35 ARG^? 4.87 ZN ZN A 119 D 141 THR B 8 THR.? 9.69 CH3 ACY A 121 D 235 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -8.33 92.80 100.06 -7.71 95.33 98.44 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -2.71 29.36 36.26 -2.04 29.94 38.25 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 D 137 ARG A 35 ARG^? 4.87 ZN ZN A 119 D 141 THR B 8 THR.? 9.69 CH3 ACY A 121 D 235 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -2.71 29.36 36.26 -2.04 29.94 38.25 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 D 137 ARG B 35 ARG.? 5.03 ZN ZN B 118 D 141 THR A 8 THR.? 9.96 ZN ZN A 118 D 235 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -5.91 7.98 55.94 -4.35 7.02 54.82 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 D 137 ARG B 35 ARG.? 5.03 ZN ZN B 118 D 141 THR A 8 THR.? 9.96 ZN ZN A 118 D 235 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -8.33 92.80 100.06 -7.71 95.33 98.44 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -5.91 7.98 55.94 -4.35 7.02 54.82 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 3 1bd3_c01 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 D 137 ARG B 35 ARG.? 5.03 ZN ZN B 118 D 141 THR A 8 THR.? 9.96 ZN ZN A 118 D 235 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo -8.33 92.80 100.06 -7.71 95.33 98.44 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -9.24 93.49 108.77 -7.37 94.21 109.61 -5.91 7.98 55.94 -4.35 7.02 54.82 coo -14.64 87.74 89.51 -12.89 87.43 90.65 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1bd3_c01 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 6 hits 1bd3_c01 naa= 3 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 C 137 ARG A 35 ARG^? 4.87 ZN ZN A 119 C 141 THR B 8 THR.? 9.69 CH3 ACY A 121 C 235 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -2.71 29.36 36.26 -2.04 29.94 38.25 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 C 137 ARG A 35 ARG^? 4.87 ZN ZN A 119 C 141 THR B 8 THR.? 9.69 CH3 ACY A 121 C 235 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -2.71 29.36 36.26 -2.04 29.94 38.25 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 C 137 ARG A 35 ARG^? 4.87 ZN ZN A 119 C 141 THR B 8 THR.? 9.69 CH3 ACY A 121 C 235 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -2.71 29.36 36.26 -2.04 29.94 38.25 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 C 137 ARG B 35 ARG.? 5.03 ZN ZN B 118 C 141 THR A 8 THR.? 9.96 ZN ZN A 118 C 235 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -5.91 7.98 55.94 -4.35 7.02 54.82 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 5 3 # 5 C 137 ARG B 35 ARG.? 5.03 ZN ZN B 118 C 141 THR A 8 THR.? 9.96 ZN ZN A 118 C 235 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -5.79 67.26 36.83 -4.57 64.58 37.74 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -5.91 7.98 55.94 -4.35 7.02 54.82 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 3 1bd3_c02 URACIL PHOSPHORIBOSYLTRANSFERASE user 6 3 # 6 C 137 ARG B 35 ARG.? 5.03 ZN ZN B 118 C 141 THR A 8 THR.? 9.96 ZN ZN A 118 C 235 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo -5.79 67.26 36.83 -4.57 64.58 37.74 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -6.81 68.31 28.28 -4.82 68.47 27.57 -5.91 7.98 55.94 -4.35 7.02 54.82 coo -13.01 70.96 47.58 -11.44 71.65 46.34 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1bd3_c02 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 6 hits 1bd3_c02 naa= 3 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 1 3 # 1 B 137 ARG A 35 ARG^? 4.87 ZN ZN A 119 B 141 THR B 8 THR.? 9.69 CH3 ACY A 121 B 235 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 8.13 67.41 100.27 7.18 68.35 97.45 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 -2.71 29.36 36.26 -2.04 29.94 38.25 coo 14.55 73.52 89.47 12.81 73.95 90.56 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 2 3 # 2 B 137 ARG A 35 ARG^? 4.87 ZN ZN A 119 B 141 THR B 8 THR.? 9.69 CH3 ACY A 121 B 235 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 8.13 67.41 100.27 7.18 68.35 97.45 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 8.28 67.78 108.81 6.22 67.65 109.43 -2.71 29.36 36.26 -2.04 29.94 38.25 coo 14.55 73.52 89.47 12.81 73.95 90.56 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 3 3 # 3 B 137 ARG B 35 ARG.? 5.03 ZN ZN B 118 B 141 THR A 8 THR.? 9.96 ZN ZN A 118 B 235 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 8.13 67.41 100.27 7.18 68.35 97.45 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 8.28 67.78 108.81 6.22 67.65 109.43 -5.91 7.98 55.94 -4.35 7.02 54.82 coo 14.55 73.52 89.47 12.81 73.95 90.56 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1bd3_c03 URACIL PHOSPHORIBOSYLTRANSFERASE user 4 3 # 4 B 137 ARG B 35 ARG.? 5.03 ZN ZN B 118 B 141 THR A 8 THR.? 9.96 ZN ZN A 118 B 235 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 8.13 67.41 100.27 7.18 68.35 97.45 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 8.28 67.78 108.81 6.22 67.65 109.43 -5.91 7.98 55.94 -4.35 7.02 54.82 coo 14.55 73.52 89.47 12.81 73.95 90.56 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1bd3_c03 source 1bd3 URACIL PHOSPHORIBOSYLTRANSFERASE : 4 hits 1bd3_c03 naa= 3 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 1 3 # 1 14 ASP A 60 ASP.? -2.37 ZN ZN A 119s 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s 67 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 2 3 # 2 14 ASP A 60 ASP.? -2.37 ZN ZN A 119s 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s 67 GLY A 77 GLY.? 7.71 O ACY A 120 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -14.40 19.56 63.33 -14.08 20.34 63.32 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 3 3 # 3 14 ASP A 60 ASP.? -2.37 ZN ZN A 119s 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s 67 GLY B 19 GLY.? 9.20 CH3 ACY B 120 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -13.06 15.01 37.28 -12.27 15.10 37.18 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 4 3 # 4 14 ASP A 60 ASP.? -2.37 ZN ZN A 119s 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s 67 GLY B 43 GLY.? 11.77 OXT ACY A 120 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 1.41 19.22 51.53 1.94 18.61 51.36 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 5 3 # 5 14 ASP A 61 ASP^? 8.97 ZN ZN A 119 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s 67 GLY A 77 GLY.? 7.71 O ACY A 120 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -14.40 19.56 63.33 -14.08 20.34 63.32 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 6 3 # 6 14 ASP A 61 ASP^? 8.97 ZN ZN A 119 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s 67 GLY B 43 GLY.? 11.77 OXT ACY A 120 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 1.41 19.22 51.53 1.94 18.61 51.36 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 7 3 # 7 14 ASP B 60 ASP.? -2.30 ZN ZN B 118s 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s 67 GLY A 19 GLY.? 9.19 CH3 ACY A 120 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -15.53 22.05 51.92 -14.82 21.95 52.30 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 8 3 # 8 14 ASP B 60 ASP.? -2.30 ZN ZN B 118s 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s 67 GLY A 43 GLY.? 10.93 O ACY A 121 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 2.67 18.14 42.78 3.17 18.66 43.17 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 9 3 # 9 14 ASP B 60 ASP.? -2.30 ZN ZN B 118s 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s 67 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 10 3 # 10 14 ASP B 60 ASP.? -2.30 ZN ZN B 118s 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s 67 GLY B 27 GLY.? 15.88 CH3 ACY B 120 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -5.69 8.07 23.28 -5.94 7.34 23.49 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 11 3 # 11 14 ASP B 60 ASP.? -2.30 ZN ZN B 118s 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s 67 GLY B 77 GLY.? 7.77 OXT ACY B 120 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.24 17.31 26.84 -7.89 16.59 26.97 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 12 3 # 12 14 ASP B 61 ASP^? 9.02 ZN ZN B 118 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s 67 GLY A 43 GLY.? 10.93 O ACY A 121 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 2.67 18.14 42.78 3.17 18.66 43.17 ULMN 3 1be1_c02 GLUTAMATE MUTASE user 13 3 # 13 14 ASP B 61 ASP^? 9.02 ZN ZN B 118 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s 67 GLY B 77 GLY.? 7.77 OXT ACY B 120 coo -11.04 -6.46 -7.27 -10.57 -4.40 -7.48 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -6.73 -11.42 -7.86 -5.41 -11.61 -6.26 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 10.06 -0.59 -9.79 9.66 -0.34 -9.05 -8.24 17.31 26.84 -7.89 16.59 26.97 1be1_c02 source 1be1 GLUTAMATE MUTASE : 13 hits 1be1_c02 naa= 3 ULMN 3 1bp2_c00 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSuser 1 3 # 1 30 GLY A 95 GLY.? 11.34 ZN ZN A 119 48 HIS A 62 HIS^? -3.21 ZN ZN A 119s 99 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 12.38 5.55 24.25 13.27 5.59 24.39 -4.39 36.14 43.27 -4.07 36.89 43.24 coo 18.80 12.68 24.53 17.69 13.54 26.08 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 17.07 18.51 26.62 16.67 17.07 28.09 -16.84 33.62 48.35 -16.08 32.62 46.63 1bp2_c00 source 1bp2 PHOSPHOLIPASE A2 (E.C.3.1.1.4) (PHOSPHATIDE AC: 1 hits 1bp2_c00 naa= 3 ULMN 3 1bqc_c01 BETA-MANNANASE user 1 3 # 1 A 50 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 128 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 225 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 38.56 19.11 14.83 37.12 21.00 16.76 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 36.48 24.43 22.02 36.86 26.34 21.13 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 40.16 23.71 17.01 38.52 24.96 17.40 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 1bqc_c01 BETA-MANNANASE user 2 3 # 2 A 50 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 128 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 225 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 38.56 19.11 14.83 37.12 21.00 16.76 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 36.48 24.43 22.02 36.86 26.34 21.13 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 40.16 23.71 17.01 38.52 24.96 17.40 -13.07 9.82 43.01 -13.89 7.88 43.30 1bqc_c01 source 1bqc BETA-MANNANASE : 2 hits 1bqc_c01 naa= 3 ULMN 3 1bs4_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 80 GLN^? 13.44 O ACY A 121 A 91 LEU B 76 LEU.? 12.13 CH3 ACY B 120 A 133 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 43.58 43.67 66.73 42.32 42.78 68.15 -1.66 10.00 27.14 -1.43 10.41 25.06 coo 38.58 45.09 70.44 38.28 45.21 72.59 -6.47 13.63 24.78 -5.64 11.86 23.83 coo 44.05 36.87 70.65 43.15 38.64 69.97 -8.23 3.75 25.31 -7.96 1.78 24.56 1bs4_c00 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c00 naa= 3 ULMN 3 1bs4_c01 PEPTIDE DEFORMYLASE user 1 3 # 1 B 550 GLN B 80 GLN^? 13.44 O ACY A 121 B 591 LEU B 76 LEU.? 12.13 CH3 ACY B 120 B 633 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 88.06 44.34 57.19 89.06 45.53 55.74 -1.66 10.00 27.14 -1.43 10.41 25.06 coo 86.70 48.66 52.61 87.15 48.69 50.51 -6.47 13.63 24.78 -5.64 11.86 23.83 coo 95.42 44.52 54.43 93.46 45.31 54.70 -8.23 3.75 25.31 -7.96 1.78 24.56 1bs4_c01 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c01 naa= 3 ULMN 3 1bs4_c02 PEPTIDE DEFORMYLASE user 1 3 # 1 C1050 GLN B 80 GLN^? 13.44 O ACY A 121 C1091 LEU B 76 LEU.? 12.13 CH3 ACY B 120 C1133 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 68.29 34.44 43.03 66.67 34.74 44.37 -1.66 10.00 27.14 -1.43 10.41 25.06 coo 65.83 38.95 47.05 65.46 38.90 49.20 -6.47 13.63 24.78 -5.64 11.86 23.83 coo 63.14 29.39 46.25 63.84 31.31 45.74 -8.23 3.75 25.31 -7.96 1.78 24.56 1bs4_c02 source 1bs4 PEPTIDE DEFORMYLASE : 1 hits 1bs4_c02 naa= 3 ULMN 3 1bsj_c00 PEPTIDE DEFORMYLASE user 1 3 # 1 A 50 GLN B 80 GLN^? 13.44 O ACY A 121 A 91 LEU B 76 LEU.? 12.13 CH3 ACY B 120 A 133 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 38.23 53.34 67.59 38.84 53.87 69.56 -1.66 10.00 27.14 -1.43 10.41 25.06 coo 35.40 53.22 73.30 35.37 54.87 74.74 -6.47 13.63 24.78 -5.64 11.86 23.83 coo 45.08 56.04 70.60 43.15 55.19 70.77 -8.23 3.75 25.31 -7.96 1.78 24.56 1bsj_c00 source 1bsj PEPTIDE DEFORMYLASE : 1 hits 1bsj_c00 naa= 3 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 1 3 # 1 A 325 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 354 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 421 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 31.05 49.37 64.51 31.97 51.11 63.85 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 29.07 50.42 58.36 29.02 52.18 59.49 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 30.82 59.76 58.47 31.12 59.02 60.40 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 2 3 # 2 A 325 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 354 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 421 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 31.05 49.37 64.51 31.97 51.11 63.85 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 29.07 50.42 58.36 29.02 52.18 59.49 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 30.82 59.76 58.47 31.12 59.02 60.40 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 3 1bvz_c08 ALPHA-AMYLASE II user 3 3 # 3 A 325 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 354 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 421 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 31.05 49.37 64.51 31.97 51.11 63.85 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 29.07 50.42 58.36 29.02 52.18 59.49 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 30.82 59.76 58.47 31.12 59.02 60.40 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1bvz_c08 source 1bvz ALPHA-AMYLASE II : 3 hits 1bvz_c08 naa= 3 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 1 3 # 1 B 325 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 354 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 421 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 25.90 8.19 53.87 25.36 6.97 52.29 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 27.87 10.66 47.95 27.82 8.60 48.27 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 26.02 1.87 43.38 25.90 1.97 45.49 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 2 3 # 2 B 325 ASP A 86 ASP~? 22.55 ZN ZN A 119 B 354 GLU A 89 GLU~? 19.37 ZN ZN A 119 B 421 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 25.90 8.19 53.87 25.36 6.97 52.29 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 27.87 10.66 47.95 27.82 8.60 48.27 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 26.02 1.87 43.38 25.90 1.97 45.49 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 3 3 # 3 B 325 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 354 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 421 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 25.90 8.19 53.87 25.36 6.97 52.29 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 27.87 10.66 47.95 27.82 8.60 48.27 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 26.02 1.87 43.38 25.90 1.97 45.49 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 3 1bvz_c09 ALPHA-AMYLASE II user 4 3 # 4 B 325 ASP B 86 ASP~? 22.13 ZN ZN B 118 B 354 GLU B 89 GLU~? 19.03 ZN ZN B 118 B 421 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 25.90 8.19 53.87 25.36 6.97 52.29 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 27.87 10.66 47.95 27.82 8.60 48.27 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 26.02 1.87 43.38 25.90 1.97 45.49 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1bvz_c09 source 1bvz ALPHA-AMYLASE II : 4 hits 1bvz_c09 naa= 3 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 1 3 # 1 104 ASN A 6 ASN.? 7.96 O ACY A 120 192 ASP B 60 ASP.? -2.30 ZN ZN B 118s 195 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -11.99 10.76 51.07 -13.19 11.09 52.81 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 2 3 # 2 104 ASN B 6 ASN.? 8.30 OXT ACY B 120 192 ASP A 60 ASP.? -2.37 ZN ZN A 119s 195 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -9.87 26.28 39.29 -10.81 26.02 37.42 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 3 1bwp_c01 PLATELET-ACTIVATING FACTOR ACETYLHYDuser 3 3 # 3 104 ASN B 6 ASN.? 8.30 OXT ACY B 120 192 ASP A 61 ASP^? 8.97 ZN ZN A 119 195 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 48.26 -8.64 25.32 50.17 -7.72 25.52 -9.87 26.28 39.29 -10.81 26.02 37.42 coo 56.18 0.19 32.76 56.16 -1.23 31.19 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 56.71 -3.36 28.21 54.80 -3.08 27.37 -11.17 33.63 46.78 -12.74 33.06 45.52 1bwp_c01 source 1bwp PLATELET-ACTIVATING FACTOR ACETYLHYDROLASE : 3 hits 1bwp_c01 naa= 3 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 1 3 # 1 A 14 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 67 GLY A 31 GLY^? 10.46 ZN ZN A 119 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -15.56 30.08 55.93 -15.09 29.60 56.48 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 2 3 # 2 A 14 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 67 GLY A 31 GLY^? 10.46 ZN ZN A 119 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -15.56 30.08 55.93 -15.09 29.60 56.48 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 3 3 # 3 A 14 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 67 GLY A 54 GLY.? 9.09 ZN ZN A 119 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -21.24 35.01 50.29 -20.80 34.52 50.80 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 4 3 # 4 A 14 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 67 GLY B 31 GLY^? 10.38 ZN ZN B 118 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -11.44 6.93 33.52 -10.95 7.47 33.07 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 5 3 # 5 A 14 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 67 GLY B 31 GLY^? 10.38 ZN ZN B 118 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -11.44 6.93 33.52 -10.95 7.47 33.07 ULMN 3 1cb7_c06 GLUTAMATE MUTASE user 6 3 # 6 A 14 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 67 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo 11.02 -13.08 77.25 10.70 -11.13 76.52 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 7.44 -8.54 76.22 7.57 -7.67 78.12 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 18.64 -11.26 77.99 18.99 -11.13 78.72 -18.56 1.34 36.85 -18.13 1.88 36.45 1cb7_c06 source 1cb7 GLUTAMATE MUTASE : 6 hits 1cb7_c06 naa= 3 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 1 3 # 1 C 14 ASP A 60 ASP.? -2.37 ZN ZN A 119s C 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 67 GLY A 31 GLY^? 10.46 ZN ZN A 119 coo 10.04 44.27 88.44 9.47 42.32 89.03 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 6.38 39.80 88.71 6.88 38.89 86.87 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 17.63 42.50 89.25 18.11 42.29 88.64 -15.56 30.08 55.93 -15.09 29.60 56.48 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 2 3 # 2 C 14 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 67 GLY A 31 GLY^? 10.46 ZN ZN A 119 coo 10.04 44.27 88.44 9.47 42.32 89.03 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 6.38 39.80 88.71 6.88 38.89 86.87 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 17.63 42.50 89.25 18.11 42.29 88.64 -15.56 30.08 55.93 -15.09 29.60 56.48 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 3 3 # 3 C 14 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 16 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 67 GLY A 54 GLY.? 9.09 ZN ZN A 119 coo 10.04 44.27 88.44 9.47 42.32 89.03 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 6.38 39.80 88.71 6.88 38.89 86.87 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 17.63 42.50 89.25 18.11 42.29 88.64 -21.24 35.01 50.29 -20.80 34.52 50.80 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 4 3 # 4 C 14 ASP B 60 ASP.? -2.30 ZN ZN B 118s C 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s C 67 GLY B 31 GLY^? 10.38 ZN ZN B 118 coo 10.04 44.27 88.44 9.47 42.32 89.03 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 6.38 39.80 88.71 6.88 38.89 86.87 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 17.63 42.50 89.25 18.11 42.29 88.64 -11.44 6.93 33.52 -10.95 7.47 33.07 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 5 3 # 5 C 14 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s C 67 GLY B 31 GLY^? 10.38 ZN ZN B 118 coo 10.04 44.27 88.44 9.47 42.32 89.03 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 6.38 39.80 88.71 6.88 38.89 86.87 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 17.63 42.50 89.25 18.11 42.29 88.64 -11.44 6.93 33.52 -10.95 7.47 33.07 ULMN 3 1cb7_c07 GLUTAMATE MUTASE user 6 3 # 6 C 14 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 16 HIS B 62 HIS^? -3.22 ZN ZN B 118s C 67 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo 10.04 44.27 88.44 9.47 42.32 89.03 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 6.38 39.80 88.71 6.88 38.89 86.87 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 17.63 42.50 89.25 18.11 42.29 88.64 -18.56 1.34 36.85 -18.13 1.88 36.45 1cb7_c07 source 1cb7 GLUTAMATE MUTASE : 6 hits 1cb7_c07 naa= 3 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 1 3 # 1 229 ASP A 15 ASP~? 8.61 ZN ZN B 118 264 GLU A 39 GLU^? 13.07 O ACY A 121 328 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 45.62 80.42 43.69 45.65 82.01 45.07 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 59.69 92.71 39.85 58.53 92.03 41.47 3.97 24.42 42.90 6.03 24.50 43.46 coo 45.39 90.72 40.63 45.07 89.14 41.90 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1cdg_c00 CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.user 2 3 # 2 229 ASP B 15 ASP~? 8.50 ZN ZN A 119 264 GLU B 39 GLU.? 14.67 OXT ACY A 120 328 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 45.62 80.42 43.69 45.65 82.01 45.07 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 59.69 92.71 39.85 58.53 92.03 41.47 2.54 12.93 51.58 4.67 12.91 51.32 coo 45.39 90.72 40.63 45.07 89.14 41.90 -12.98 14.88 47.28 -12.40 12.90 47.92 1cdg_c00 source 1cdg CYCLODEXTRIN GLYCOSYLTRANSFERASE (E.C.2.4.1.19: 2 hits 1cdg_c00 naa= 3 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 A 198 GLY A 31 GLY^? 10.46 ZN ZN A 119 A 228 SER A 51 SER^? 4.15 ZN ZN A 119 A 549 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -15.56 30.08 55.93 -15.09 29.60 56.48 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 A 198 GLY A 31 GLY^? 10.46 ZN ZN A 119 A 228 SER A 51 SER^? 4.15 ZN ZN A 119 A 549 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -15.56 30.08 55.93 -15.09 29.60 56.48 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 A 198 GLY A 54 GLY.? 9.09 ZN ZN A 119 A 228 SER A 51 SER^? 4.15 ZN ZN A 119 A 549 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -21.24 35.01 50.29 -20.80 34.52 50.80 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 A 198 GLY A 57 GLY.? 4.30 ZN ZN A 119 A 228 SER A 51 SER^? 4.15 ZN ZN A 119 A 549 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -18.19 30.32 43.90 -18.50 30.85 44.43 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 A 198 GLY B 31 GLY^? 10.38 ZN ZN B 118 A 228 SER B 51 SER^? 4.27 ZN ZN B 118 A 549 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -11.44 6.93 33.52 -10.95 7.47 33.07 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 A 198 GLY B 31 GLY^? 10.38 ZN ZN B 118 A 228 SER B 51 SER^? 4.27 ZN ZN B 118 A 549 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -11.44 6.93 33.52 -10.95 7.47 33.07 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -11.52 -0.56 39.66 -12.44 -2.44 39.86 ULMN 3 1cjy_c00 CYTOSOLIC PHOSPHOLIPASE A2 user 7 3 # 7 A 198 GLY B 57 GLY.? -3.44 ZN ZN B 118s A 228 SER B 51 SER^? 4.27 ZN ZN B 118 A 549 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 43.62 -9.31 54.06 43.04 -9.29 54.58 -17.31 6.32 43.48 -17.60 5.82 42.91 coo 45.99 -4.81 58.63 47.02 -6.84 57.75 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 51.69 -5.84 58.91 49.67 -6.52 58.93 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1cjy_c00 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 7 hits 1cjy_c00 naa= 3 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 1 3 # 1 B1198 GLY A 31 GLY^? 10.46 ZN ZN A 119 B1228 SER A 51 SER^? 4.15 ZN ZN A 119 B1549 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 126.34 72.75 125.66 125.95 73.27 126.11 -15.56 30.08 55.93 -15.09 29.60 56.48 coo 131.65 74.68 129.41 130.31 72.73 128.82 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 134.72 69.43 130.42 133.03 70.65 130.08 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 2 3 # 2 B1198 GLY A 31 GLY^? 10.46 ZN ZN A 119 B1228 SER A 51 SER^? 4.15 ZN ZN A 119 B1549 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 126.34 72.75 125.66 125.95 73.27 126.11 -15.56 30.08 55.93 -15.09 29.60 56.48 coo 131.65 74.68 129.41 130.31 72.73 128.82 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 134.72 69.43 130.42 133.03 70.65 130.08 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 3 3 # 3 B1198 GLY A 57 GLY.? 4.30 ZN ZN A 119 B1228 SER A 51 SER^? 4.15 ZN ZN A 119 B1549 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 126.34 72.75 125.66 125.95 73.27 126.11 -18.19 30.32 43.90 -18.50 30.85 44.43 coo 131.65 74.68 129.41 130.31 72.73 128.82 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 134.72 69.43 130.42 133.03 70.65 130.08 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 4 3 # 4 B1198 GLY B 31 GLY^? 10.38 ZN ZN B 118 B1228 SER B 51 SER^? 4.27 ZN ZN B 118 B1549 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 126.34 72.75 125.66 125.95 73.27 126.11 -11.44 6.93 33.52 -10.95 7.47 33.07 coo 131.65 74.68 129.41 130.31 72.73 128.82 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 134.72 69.43 130.42 133.03 70.65 130.08 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 5 3 # 5 B1198 GLY B 31 GLY^? 10.38 ZN ZN B 118 B1228 SER B 51 SER^? 4.27 ZN ZN B 118 B1549 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 126.34 72.75 125.66 125.95 73.27 126.11 -11.44 6.93 33.52 -10.95 7.47 33.07 coo 131.65 74.68 129.41 130.31 72.73 128.82 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 134.72 69.43 130.42 133.03 70.65 130.08 -11.52 -0.56 39.66 -12.44 -2.44 39.86 ULMN 3 1cjy_c01 CYTOSOLIC PHOSPHOLIPASE A2 user 6 3 # 6 B1198 GLY B 57 GLY.? -3.44 ZN ZN B 118s B1228 SER B 51 SER^? 4.27 ZN ZN B 118 B1549 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 126.34 72.75 125.66 125.95 73.27 126.11 -17.31 6.32 43.48 -17.60 5.82 42.91 coo 131.65 74.68 129.41 130.31 72.73 128.82 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 134.72 69.43 130.42 133.03 70.65 130.08 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1cjy_c01 source 1cjy CYTOSOLIC PHOSPHOLIPASE A2 : 6 hits 1cjy_c01 naa= 3 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 1 3 # 1 34 ASP A 15 ASP~? 8.61 ZN ZN B 118 37 SER A 14 SER~? 11.41 CH3 ACY A 120 216 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 16.90 26.20 29.49 16.22 24.50 28.41 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 12.23 24.31 30.40 14.55 23.96 31.03 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 13.93 25.52 22.10 14.75 24.44 23.75 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1cms_c04 CHYMOSIN B (FORMERLY KNOWN AS RENNINuser 2 3 # 2 34 ASP B 15 ASP~? 8.50 ZN ZN A 119 37 SER B 14 SER~? 11.46 CH3 ACY B 120 216 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 16.90 26.20 29.49 16.22 24.50 28.41 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 12.23 24.31 30.40 14.55 23.96 31.03 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 13.93 25.52 22.10 14.75 24.44 23.75 -12.98 14.88 47.28 -12.40 12.90 47.92 1cms_c04 source 1cms CHYMOSIN B (FORMERLY KNOWN AS RENNIN) (E.C.3.4: 2 hits 1cms_c04 naa= 3 ULMN 3 1cns_c00 CHITINASE user 1 3 # 1 A 67 GLU A 39 GLU^? 13.07 O ACY A 121 A 89 GLU B 7 GLU.? -2.20 ZN ZN B 119s A 120 SER B 14 SER~? 11.46 CH3 ACY B 120 coo -24.35 9.53 67.64 -25.07 11.29 68.60 3.97 24.42 42.90 6.03 24.50 43.46 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -4.86 25.89 35.02 -5.24 24.36 33.68 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -7.60 20.35 43.19 -8.11 21.15 45.47 ULMN 3 1cns_c00 CHITINASE user 2 3 # 2 A 67 GLU B 39 GLU.? 14.67 OXT ACY A 120 A 89 GLU A 7 GLU.? 2.09 ZN ZN A 118s A 120 SER A 14 SER~? 11.41 CH3 ACY A 120 coo -24.35 9.53 67.64 -25.07 11.29 68.60 2.54 12.93 51.58 4.67 12.91 51.32 coo -31.18 6.91 75.60 -32.39 8.51 74.91 -8.44 11.27 56.65 -9.19 12.79 57.99 coo -34.73 8.57 68.21 -33.63 9.08 70.28 -8.58 16.80 48.15 -8.42 16.11 45.83 1cns_c00 source 1cns CHITINASE : 2 hits 1cns_c00 naa= 3 ULMN 3 1cns_c01 CHITINASE user 1 3 # 1 B 67 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 89 GLU A 7 GLU.? 2.09 ZN ZN A 118s B 120 SER A 14 SER~? 11.41 CH3 ACY A 120 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -8.58 16.80 48.15 -8.42 16.11 45.83 ULMN 3 1cns_c01 CHITINASE user 2 3 # 2 B 67 GLU A 39 GLU^? 13.07 O ACY A 121 B 89 GLU B 7 GLU.? -2.20 ZN ZN B 119s B 120 SER B 14 SER~? 11.46 CH3 ACY B 120 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 3.97 24.42 42.90 6.03 24.50 43.46 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -7.60 20.35 43.19 -8.11 21.15 45.47 ULMN 3 1cns_c01 CHITINASE user 3 3 # 3 B 67 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 89 GLU B 7 GLU.? -2.20 ZN ZN B 119s B 120 SER B 14 SER~? 11.46 CH3 ACY B 120 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -7.60 20.35 43.19 -8.11 21.15 45.47 ULMN 3 1cns_c01 CHITINASE user 4 3 # 4 B 67 GLU B 39 GLU.? 14.67 OXT ACY A 120 B 89 GLU A 7 GLU.? 2.09 ZN ZN A 118s B 120 SER A 14 SER~? 11.41 CH3 ACY A 120 coo 9.89 -17.65 45.79 9.28 -17.39 43.77 2.54 12.93 51.58 4.67 12.91 51.32 coo 19.53 -19.89 39.46 19.21 -18.09 38.37 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 18.32 -11.51 42.26 16.65 -12.32 40.69 -8.58 16.80 48.15 -8.42 16.11 45.83 1cns_c01 source 1cns CHITINASE : 4 hits 1cns_c01 naa= 3 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 101 TYR A 63 TYR^? 13.00 ZN ZN A 119 A 173 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 48 ARG A 90 ARG~? 21.28 ZN ZN A 119 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 24.35 4.55 25.11 25.94 3.23 25.53 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -4.89 45.59 55.49 -2.75 44.62 57.47 ULMN 3 1cs1_c00 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 101 TYR B 63 TYR^? 12.86 ZN ZN B 118 A 173 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 48 ARG B 90 ARG~? 22.74 ZN ZN B 118 coo 25.00 -3.03 25.68 27.14 -4.51 26.75 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 24.35 4.55 25.11 25.94 3.23 25.53 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 29.84 -5.31 33.83 28.87 -5.97 30.97 -1.29 -8.08 37.25 0.33 -10.46 36.18 1cs1_c00 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c00 naa= 3 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 48 ARG A 90 ARG~? 21.28 ZN ZN A 119 C 101 TYR A 63 TYR^? 13.00 ZN ZN A 119 C 173 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 32.27 5.62 48.15 31.93 6.48 51.06 -4.89 45.59 55.49 -2.75 44.62 57.47 coo 29.64 3.64 57.39 31.22 5.14 55.65 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1cs1_c01 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 48 ARG B 90 ARG~? 22.74 ZN ZN B 118 C 101 TYR B 63 TYR^? 12.86 ZN ZN B 118 C 173 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 32.27 5.62 48.15 31.93 6.48 51.06 -1.29 -8.08 37.25 0.33 -10.46 36.18 coo 29.64 3.64 57.39 31.22 5.14 55.65 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 28.89 -3.78 58.23 30.38 -2.57 57.33 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1cs1_c01 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c01 naa= 3 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 48 ARG A 90 ARG~? 21.28 ZN ZN A 119 D 101 TYR A 63 TYR^? 13.00 ZN ZN A 119 D 173 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 69.08 8.58 32.60 69.70 10.81 30.58 -4.89 45.59 55.49 -2.75 44.62 57.47 coo 71.77 11.86 24.26 70.23 12.22 26.56 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 71.60 6.14 19.25 70.26 6.87 20.69 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1cs1_c02 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 48 ARG B 90 ARG~? 22.74 ZN ZN B 118 D 101 TYR B 63 TYR^? 12.86 ZN ZN B 118 D 173 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 69.08 8.58 32.60 69.70 10.81 30.58 -1.29 -8.08 37.25 0.33 -10.46 36.18 coo 71.77 11.86 24.26 70.23 12.22 26.56 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 71.60 6.14 19.25 70.26 6.87 20.69 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1cs1_c02 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c02 naa= 3 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 101 TYR A 63 TYR^? 13.00 ZN ZN A 119 B 173 ASP A 61 ASP^? 8.97 ZN ZN A 119 D 48 ARG A 90 ARG~? 21.28 ZN ZN A 119 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -4.89 45.59 55.49 -2.75 44.62 57.47 ULMN 3 1cs1_c03 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 101 TYR B 63 TYR^? 12.86 ZN ZN B 118 B 173 ASP B 61 ASP^? 9.02 ZN ZN B 118 D 48 ARG B 90 ARG~? 22.74 ZN ZN B 118 coo 74.59 -12.57 45.75 72.37 -12.96 44.12 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 76.00 -6.96 50.63 74.29 -7.61 49.57 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 69.39 -8.90 38.17 70.70 -11.19 39.77 -1.29 -8.08 37.25 0.33 -10.46 36.18 1cs1_c03 source 1cs1 CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1cs1_c03 naa= 3 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 1 3 # 1 313 ASP A 15 ASP~? 8.61 ZN ZN B 118 315 GLU B 34 GLU.? -2.23 ZN ZN B 118s 390 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 32.46 99.13 19.34 30.94 100.38 20.07 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 32.04 94.22 18.23 30.57 94.75 16.88 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 21.10 94.74 18.36 23.09 96.71 18.59 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 2 3 # 2 313 ASP A 86 ASP~? 22.55 ZN ZN A 119 315 GLU A 89 GLU~? 19.37 ZN ZN A 119 390 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 32.46 99.13 19.34 30.94 100.38 20.07 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 32.04 94.22 18.23 30.57 94.75 16.88 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 21.10 94.74 18.36 23.09 96.71 18.59 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 3 3 # 3 313 ASP B 15 ASP~? 8.50 ZN ZN A 119 315 GLU A 34 GLU^? -2.26 ZN ZN A 119s 390 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 32.46 99.13 19.34 30.94 100.38 20.07 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 32.04 94.22 18.23 30.57 94.75 16.88 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 21.10 94.74 18.36 23.09 96.71 18.59 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 3 1ctn_c00 CHITINASE A (E.C.3.2.1.14) (PH 5.5, user 4 3 # 4 313 ASP B 86 ASP~? 22.13 ZN ZN B 118 315 GLU B 89 GLU~? 19.03 ZN ZN B 118 390 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 32.46 99.13 19.34 30.94 100.38 20.07 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 32.04 94.22 18.23 30.57 94.75 16.88 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 21.10 94.74 18.36 23.09 96.71 18.59 -4.17 2.05 38.57 -1.76 0.81 38.01 1ctn_c00 source 1ctn CHITINASE A (E.C.3.2.1.14) (PH 5.5, 4 DEGREES : 4 hits 1ctn_c00 naa= 3 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 1 3 # 1 A 37 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 56 ILE A 30 ILE^? 13.25 ZN ZN A 119 A 82 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -13.24 32.30 58.68 -12.02 32.74 58.71 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 3 1d6o_c00 FK506-BINDING PROTEIN user 2 3 # 2 A 37 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 56 ILE B 30 ILE^? 13.34 ZN ZN B 118 A 82 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 57.53 -0.59 -5.76 57.73 0.50 -3.97 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 60.23 -10.38 -0.25 59.76 -9.69 -1.44 -8.41 4.82 31.53 -7.21 4.23 31.91 coo 54.60 -10.25 -2.46 55.96 -7.94 -1.62 -7.61 10.49 27.32 -9.94 11.99 27.12 1d6o_c00 source 1d6o FK506-BINDING PROTEIN : 2 hits 1d6o_c00 naa= 3 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 1 3 # 1 B 37 ASP A 26 ASP.? 19.54 CH3 ACY A 120 B 56 ILE A 30 ILE^? 13.25 ZN ZN A 119 B 82 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -13.24 32.30 58.68 -12.02 32.74 58.71 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 3 1d6o_c01 FK506-BINDING PROTEIN user 2 3 # 2 B 37 ASP B 26 ASP.? 19.38 CH3 ACY B 120 B 56 ILE B 30 ILE^? 13.34 ZN ZN B 118 B 82 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 60.36 -17.02 -33.28 60.59 -15.91 -31.49 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 63.12 -26.85 -28.11 62.65 -26.16 -29.29 -8.41 4.82 31.53 -7.21 4.23 31.91 coo 57.53 -26.71 -30.24 58.93 -24.39 -29.50 -7.61 10.49 27.32 -9.94 11.99 27.12 1d6o_c01 source 1d6o FK506-BINDING PROTEIN : 2 hits 1d6o_c01 naa= 3 ULMN 3 1d7r_c02 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYuser 1 3 # 1 A 173 TYR A 72 TYR^? -3.77 O ACY A 120s A 243 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 272 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 2.03 68.31 21.46 0.66 68.36 23.90 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 16.93 55.67 9.65 17.16 54.23 11.19 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 14.13 45.79 13.40 14.25 49.41 18.30 -8.24 41.47 45.26 -7.63 47.05 46.72 1d7r_c02 source 1d7r 2,2-DIALKYLGLYCINE DECARBOXYLASE (PYRUVATE) : 1 hits 1d7r_c02 naa= 3 ULMN 3 1daa_c01 D-AMINO ACID AMINOTRANSFERASE user 1 3 # 1 B 145 LYS B 40 LYS.? 4.59 ZN ZN A 118 B 177 GLU A 7 GLU.? 2.09 ZN ZN A 118s B 201 LEU A 11 LEU^? 10.57 OXT ACY A 120 coo 25.29 -4.12 49.41 22.68 -2.48 54.25 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 27.00 6.35 51.01 26.30 4.53 50.18 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 23.74 1.68 49.50 22.87 -0.24 49.97 -2.89 10.27 52.74 -1.16 9.35 51.85 1daa_c01 source 1daa D-AMINO ACID AMINOTRANSFERASE : 1 hits 1daa_c01 naa= 3 ULMN 3 1ddj_c12 PLASMINOGEN user 1 3 # 1 A 603 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 646 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 739 GLY A 19 GLY.? 9.19 CH3 ACY A 120 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 11.37 50.89 2.29 11.05 51.63 2.25 -15.53 22.05 51.92 -14.82 21.95 52.30 ULMN 3 1ddj_c12 PLASMINOGEN user 2 3 # 2 A 603 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 646 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 739 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 11.37 50.89 2.29 11.05 51.63 2.25 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 3 1ddj_c12 PLASMINOGEN user 3 3 # 3 A 603 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 646 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 739 GLY A 19 GLY.? 9.19 CH3 ACY A 120 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 11.37 50.89 2.29 11.05 51.63 2.25 -15.53 22.05 51.92 -14.82 21.95 52.30 ULMN 3 1ddj_c12 PLASMINOGEN user 4 3 # 4 A 603 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 646 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 739 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 11.37 50.89 2.29 11.05 51.63 2.25 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 3 1ddj_c12 PLASMINOGEN user 5 3 # 5 A 603 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 646 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 739 GLY B 19 GLY.? 9.20 CH3 ACY B 120 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 11.37 50.89 2.29 11.05 51.63 2.25 -13.06 15.01 37.28 -12.27 15.10 37.18 ULMN 3 1ddj_c12 PLASMINOGEN user 6 3 # 6 A 603 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 646 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 739 GLY B 19 GLY.? 9.20 CH3 ACY B 120 coo 17.92 60.45 -3.51 16.63 61.88 -2.68 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 18.60 56.26 -8.31 18.53 57.26 -6.47 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 11.37 50.89 2.29 11.05 51.63 2.25 -13.06 15.01 37.28 -12.27 15.10 37.18 1ddj_c12 source 1ddj PLASMINOGEN : 6 hits 1ddj_c12 naa= 3 ULMN 3 1ddj_c13 PLASMINOGEN user 1 3 # 1 B 603 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 646 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 739 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 3 1ddj_c13 PLASMINOGEN user 2 3 # 2 B 603 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 646 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 739 GLY A 19 GLY.? 9.19 CH3 ACY A 120 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -15.53 22.05 51.92 -14.82 21.95 52.30 ULMN 3 1ddj_c13 PLASMINOGEN user 3 3 # 3 B 603 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 646 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 739 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 3 1ddj_c13 PLASMINOGEN user 4 3 # 4 B 603 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 646 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 739 GLY B 19 GLY.? 9.20 CH3 ACY B 120 coo -28.76 37.11 -20.75 -29.48 38.32 -19.19 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -23.42 34.83 -23.78 -25.09 36.03 -23.31 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -24.60 49.24 -23.60 -24.80 48.99 -22.86 -13.06 15.01 37.28 -12.27 15.10 37.18 1ddj_c13 source 1ddj PLASMINOGEN : 4 hits 1ddj_c13 naa= 3 ULMN 3 1ddj_c14 PLASMINOGEN user 1 3 # 1 C 603 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 646 ASP A 60 ASP.? -2.37 ZN ZN A 119s C 739 GLY A 19 GLY.? 9.19 CH3 ACY A 120 coo 15.33 59.81 59.60 13.98 60.99 60.69 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 16.06 55.72 54.73 15.97 56.49 56.70 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 9.38 49.29 65.28 9.01 50.03 65.31 -15.53 22.05 51.92 -14.82 21.95 52.30 ULMN 3 1ddj_c14 PLASMINOGEN user 2 3 # 2 C 603 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 646 ASP A 60 ASP.? -2.37 ZN ZN A 119s C 739 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo 15.33 59.81 59.60 13.98 60.99 60.69 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 16.06 55.72 54.73 15.97 56.49 56.70 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 9.38 49.29 65.28 9.01 50.03 65.31 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 3 1ddj_c14 PLASMINOGEN user 3 3 # 3 C 603 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 646 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 739 GLY A 19 GLY.? 9.19 CH3 ACY A 120 coo 15.33 59.81 59.60 13.98 60.99 60.69 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 16.06 55.72 54.73 15.97 56.49 56.70 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 9.38 49.29 65.28 9.01 50.03 65.31 -15.53 22.05 51.92 -14.82 21.95 52.30 ULMN 3 1ddj_c14 PLASMINOGEN user 4 3 # 4 C 603 HIS B 62 HIS^? -3.22 ZN ZN B 118s C 646 ASP B 60 ASP.? -2.30 ZN ZN B 118s C 739 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo 15.33 59.81 59.60 13.98 60.99 60.69 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 16.06 55.72 54.73 15.97 56.49 56.70 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 9.38 49.29 65.28 9.01 50.03 65.31 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 3 1ddj_c14 PLASMINOGEN user 5 3 # 5 C 603 HIS B 62 HIS^? -3.22 ZN ZN B 118s C 646 ASP B 60 ASP.? -2.30 ZN ZN B 118s C 739 GLY B 19 GLY.? 9.20 CH3 ACY B 120 coo 15.33 59.81 59.60 13.98 60.99 60.69 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 16.06 55.72 54.73 15.97 56.49 56.70 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 9.38 49.29 65.28 9.01 50.03 65.31 -13.06 15.01 37.28 -12.27 15.10 37.18 ULMN 3 1ddj_c14 PLASMINOGEN user 6 3 # 6 C 603 HIS B 62 HIS^? -3.22 ZN ZN B 118s C 646 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 739 GLY B 19 GLY.? 9.20 CH3 ACY B 120 coo 15.33 59.81 59.60 13.98 60.99 60.69 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 16.06 55.72 54.73 15.97 56.49 56.70 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 9.38 49.29 65.28 9.01 50.03 65.31 -13.06 15.01 37.28 -12.27 15.10 37.18 1ddj_c14 source 1ddj PLASMINOGEN : 6 hits 1ddj_c14 naa= 3 ULMN 3 1ddj_c15 PLASMINOGEN user 1 3 # 1 D 603 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 646 ASP A 60 ASP.? -2.37 ZN ZN A 119s D 739 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 3 1ddj_c15 PLASMINOGEN user 2 3 # 2 D 603 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 646 ASP A 61 ASP^? 8.97 ZN ZN A 119 D 739 GLY A 19 GLY.? 9.19 CH3 ACY A 120 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -15.53 22.05 51.92 -14.82 21.95 52.30 ULMN 3 1ddj_c15 PLASMINOGEN user 3 3 # 3 D 603 HIS B 62 HIS^? -3.22 ZN ZN B 118s D 646 ASP B 60 ASP.? -2.30 ZN ZN B 118s D 739 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 3 1ddj_c15 PLASMINOGEN user 4 3 # 4 D 603 HIS B 62 HIS^? -3.22 ZN ZN B 118s D 646 ASP B 61 ASP^? 9.02 ZN ZN B 118 D 739 GLY B 19 GLY.? 9.20 CH3 ACY B 120 coo -30.51 33.83 43.05 -30.50 33.12 45.03 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -25.73 33.05 39.28 -27.50 34.05 39.88 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -27.66 47.32 40.66 -27.81 47.01 41.41 -13.06 15.01 37.28 -12.27 15.10 37.18 1ddj_c15 source 1ddj PLASMINOGEN : 4 hits 1ddj_c15 naa= 3 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 A 57 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 226 THR A 20 THR.? 4.16 CH3 ACY A 120 A 229 LYS A 16 LYS~? -3.27 O ACY A 120s coo 9.66 102.78 70.07 9.79 101.18 71.42 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 7.24 97.46 49.60 8.11 95.69 48.80 -13.83 21.70 55.31 -12.29 20.44 56.16 coo 10.53 97.56 43.71 9.33 93.71 47.17 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 3 1dfo_c04 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 A 57 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 226 THR B 20 THR.? 4.10 CH3 ACY B 120 A 229 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 9.66 102.78 70.07 9.79 101.18 71.42 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 7.24 97.46 49.60 8.11 95.69 48.80 -10.29 15.42 34.68 -8.60 16.74 34.44 coo 10.53 97.56 43.71 9.33 93.71 47.17 -10.13 21.11 38.47 -9.52 22.58 33.19 1dfo_c04 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c04 naa= 3 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 B 57 GLU A 89 GLU~? 19.37 ZN ZN A 119 B 226 THR A 20 THR.? 4.16 CH3 ACY A 120 B 229 LYS A 16 LYS~? -3.27 O ACY A 120s coo 15.90 87.61 49.61 13.92 86.96 49.36 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 20.74 95.78 68.68 19.29 96.84 69.83 -13.83 21.70 55.31 -12.29 20.44 56.16 coo 22.32 101.61 71.64 17.89 98.63 71.55 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 3 1dfo_c05 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 B 57 GLU B 89 GLU~? 19.03 ZN ZN B 118 B 226 THR B 20 THR.? 4.10 CH3 ACY B 120 B 229 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 15.90 87.61 49.61 13.92 86.96 49.36 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 20.74 95.78 68.68 19.29 96.84 69.83 -10.29 15.42 34.68 -8.60 16.74 34.44 coo 22.32 101.61 71.64 17.89 98.63 71.55 -10.13 21.11 38.47 -9.52 22.58 33.19 1dfo_c05 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c05 naa= 3 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 C 57 GLU A 89 GLU~? 19.37 ZN ZN A 119 C 226 THR A 20 THR.? 4.16 CH3 ACY A 120 C 229 LYS A 16 LYS~? -3.27 O ACY A 120s coo 5.43 40.40 61.63 4.27 41.99 60.90 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 22.16 45.88 73.63 23.23 47.70 73.25 -13.83 21.70 55.31 -12.29 20.44 56.16 coo 28.90 45.91 73.55 25.22 49.72 72.97 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 3 1dfo_c06 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 C 57 GLU B 89 GLU~? 19.03 ZN ZN B 118 C 226 THR B 20 THR.? 4.10 CH3 ACY B 120 C 229 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 5.43 40.40 61.63 4.27 41.99 60.90 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 22.16 45.88 73.63 23.23 47.70 73.25 -10.29 15.42 34.68 -8.60 16.74 34.44 coo 28.90 45.91 73.55 25.22 49.72 72.97 -10.13 21.11 38.47 -9.52 22.58 33.19 1dfo_c06 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c06 naa= 3 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 1 3 # 1 D 57 GLU A 89 GLU~? 19.37 ZN ZN A 119 D 226 THR A 20 THR.? 4.16 CH3 ACY A 120 D 229 LYS A 16 LYS~? -3.27 O ACY A 120s coo 26.07 55.89 66.14 25.33 56.50 68.01 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 11.79 47.62 52.67 10.10 46.51 53.39 -13.83 21.70 55.31 -12.29 20.44 56.16 coo 10.05 41.79 49.80 7.94 44.71 53.76 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 3 1dfo_c07 SERINE HYDROXYMETHYLTRANSFERASE user 2 3 # 2 D 57 GLU B 89 GLU~? 19.03 ZN ZN B 118 D 226 THR B 20 THR.? 4.10 CH3 ACY B 120 D 229 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 26.07 55.89 66.14 25.33 56.50 68.01 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 11.79 47.62 52.67 10.10 46.51 53.39 -10.29 15.42 34.68 -8.60 16.74 34.44 coo 10.05 41.79 49.80 7.94 44.71 53.76 -10.13 21.11 38.47 -9.52 22.58 33.19 1dfo_c07 source 1dfo SERINE HYDROXYMETHYLTRANSFERASE : 2 hits 1dfo_c07 naa= 3 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 1 3 # 1 146 TYR A 72 TYR^? -3.77 O ACY A 120s 150 LYS A 71 LYS^? 11.96 OXT ACY A 120 186 ASN A 6 ASN.? 7.96 O ACY A 120 coo 32.88 50.55 24.33 31.89 51.78 26.65 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 27.04 52.42 22.30 26.88 49.99 27.00 -4.35 22.91 61.78 1.12 23.33 62.25 coo 36.98 50.30 37.29 35.85 50.29 35.50 -11.99 10.76 51.07 -13.19 11.09 52.81 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 2 3 # 2 146 TYR A 79 TYR^? -4.35 CH3 ACY A 120s 150 LYS A 71 LYS^? 11.96 OXT ACY A 120 186 ASN A 6 ASN.? 7.96 O ACY A 120 coo 32.88 50.55 24.33 31.89 51.78 26.65 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 27.04 52.42 22.30 26.88 49.99 27.00 -4.35 22.91 61.78 1.12 23.33 62.25 coo 36.98 50.30 37.29 35.85 50.29 35.50 -11.99 10.76 51.07 -13.19 11.09 52.81 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 3 3 # 3 146 TYR B 72 TYR^? 3.72 OXT ACY B 120s 150 LYS B 71 LYS^? 12.90 O ACY A 121 186 ASN B 6 ASN.? 8.30 OXT ACY B 120 coo 32.88 50.55 24.33 31.89 51.78 26.65 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 27.04 52.42 22.30 26.88 49.99 27.00 0.91 14.36 31.66 5.84 10.91 29.66 coo 36.98 50.30 37.29 35.85 50.29 35.50 -9.87 26.28 39.29 -10.81 26.02 37.42 ULMN 3 1dhr_c00 DIHYDROPTERIDINE REDUCTASE (DHPR) (Euser 4 3 # 4 146 TYR B 79 TYR^? -4.21 CH3 ACY B 120s 150 LYS B 71 LYS^? 12.90 O ACY A 121 186 ASN B 6 ASN.? 8.30 OXT ACY B 120 coo 32.88 50.55 24.33 31.89 51.78 26.65 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 27.04 52.42 22.30 26.88 49.99 27.00 0.91 14.36 31.66 5.84 10.91 29.66 coo 36.98 50.30 37.29 35.85 50.29 35.50 -9.87 26.28 39.29 -10.81 26.02 37.42 1dhr_c00 source 1dhr DIHYDROPTERIDINE REDUCTASE (DHPR) (E.C.1.6.99.: 4 hits 1dhr_c00 naa= 3 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 1 3 # 1 E 57 HIS A 62 HIS^? -3.21 ZN ZN A 119s E 102 ASP A 60 ASP.? -2.37 ZN ZN A 119s E 193 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo 11.39 26.86 25.95 9.85 26.64 27.36 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 10.90 32.83 25.96 10.83 30.68 25.98 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 4.57 20.60 30.29 4.74 21.36 30.66 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 3 1ds2_c02 PROTEINASE B (SGPB user 2 3 # 2 E 57 HIS B 62 HIS^? -3.22 ZN ZN B 118s E 102 ASP B 60 ASP.? -2.30 ZN ZN B 118s E 193 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo 11.39 26.86 25.95 9.85 26.64 27.36 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 10.90 32.83 25.96 10.83 30.68 25.98 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 4.57 20.60 30.29 4.74 21.36 30.66 -8.10 13.52 49.98 -8.09 14.12 50.54 1ds2_c02 source 1ds2 PROTEINASE B (SGPB : 2 hits 1ds2_c02 naa= 3 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 1 3 # 1 B 141 GLY A 57 GLY.? 4.30 ZN ZN A 119 B 144 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 164 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 88.87 114.43 152.30 88.45 115.15 152.32 -18.19 30.32 43.90 -18.50 30.85 44.43 coo 85.20 111.99 152.05 86.60 110.89 150.91 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 88.14 113.46 145.73 86.79 113.92 147.30 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 1dub_c13 2-ENOYL-COA HYDRATASE user 2 3 # 2 B 141 GLY B 57 GLY.? -3.44 ZN ZN B 118s B 144 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 164 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 88.87 114.43 152.30 88.45 115.15 152.32 -17.31 6.32 43.48 -17.60 5.82 42.91 coo 85.20 111.99 152.05 86.60 110.89 150.91 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 88.14 113.46 145.73 86.79 113.92 147.30 -13.07 9.82 43.01 -13.89 7.88 43.30 1dub_c13 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c13 naa= 3 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 1 3 # 1 C 141 GLY A 57 GLY.? 4.30 ZN ZN A 119 C 144 GLU B 4 GLU.? -2.30 ZN ZN A 119s C 164 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 56.28 104.55 135.84 56.09 105.34 136.05 -18.19 30.32 43.90 -18.50 30.85 44.43 coo 58.46 103.90 139.48 57.57 102.00 139.16 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 51.71 102.03 140.09 53.02 103.62 140.54 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 1dub_c14 2-ENOYL-COA HYDRATASE user 2 3 # 2 C 141 GLY B 57 GLY.? -3.44 ZN ZN B 118s C 144 GLU A 4 GLU.? -2.10 ZN ZN B 118s C 164 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 56.28 104.55 135.84 56.09 105.34 136.05 -17.31 6.32 43.48 -17.60 5.82 42.91 coo 58.46 103.90 139.48 57.57 102.00 139.16 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 51.71 102.03 140.09 53.02 103.62 140.54 -13.07 9.82 43.01 -13.89 7.88 43.30 1dub_c14 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c14 naa= 3 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 1 3 # 1 D 141 GLY A 57 GLY.? 4.30 ZN ZN A 119 D 144 GLU B 4 GLU.? -2.30 ZN ZN A 119s D 164 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 86.19 80.64 132.77 86.38 79.85 132.93 -18.19 30.32 43.90 -18.50 30.85 44.43 coo 84.75 81.24 136.88 85.62 83.14 136.43 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 91.47 83.05 136.24 90.35 81.38 136.84 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 1dub_c15 2-ENOYL-COA HYDRATASE user 2 3 # 2 D 141 GLY B 57 GLY.? -3.44 ZN ZN B 118s D 144 GLU A 4 GLU.? -2.10 ZN ZN B 118s D 164 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 86.19 80.64 132.77 86.38 79.85 132.93 -17.31 6.32 43.48 -17.60 5.82 42.91 coo 84.75 81.24 136.88 85.62 83.14 136.43 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 91.47 83.05 136.24 90.35 81.38 136.84 -13.07 9.82 43.01 -13.89 7.88 43.30 1dub_c15 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c15 naa= 3 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 1 3 # 1 E 141 GLY A 57 GLY.? 4.30 ZN ZN A 119 E 144 GLU B 4 GLU.? -2.30 ZN ZN A 119s E 164 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 90.07 81.07 170.50 90.23 80.26 170.38 -18.19 30.32 43.90 -18.50 30.85 44.43 coo 87.05 81.30 167.53 86.38 82.74 168.94 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 84.40 80.02 173.80 85.08 79.06 172.03 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 1dub_c16 2-ENOYL-COA HYDRATASE user 2 3 # 2 E 141 GLY B 57 GLY.? -3.44 ZN ZN B 118s E 144 GLU A 4 GLU.? -2.10 ZN ZN B 118s E 164 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 90.07 81.07 170.50 90.23 80.26 170.38 -17.31 6.32 43.48 -17.60 5.82 42.91 coo 87.05 81.30 167.53 86.38 82.74 168.94 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 84.40 80.02 173.80 85.08 79.06 172.03 -13.07 9.82 43.01 -13.89 7.88 43.30 1dub_c16 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c16 naa= 3 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 1 3 # 1 F 141 GLY A 57 GLY.? 4.30 ZN ZN A 119 F 144 GLU B 4 GLU.? -2.30 ZN ZN A 119s F 164 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 57.12 70.68 155.10 57.52 69.95 155.02 -18.19 30.32 43.90 -18.50 30.85 44.43 coo 60.62 73.13 154.21 59.05 74.26 153.35 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 56.75 71.71 148.46 58.44 71.01 149.54 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 1dub_c17 2-ENOYL-COA HYDRATASE user 2 3 # 2 F 141 GLY B 57 GLY.? -3.44 ZN ZN B 118s F 144 GLU A 4 GLU.? -2.10 ZN ZN B 118s F 164 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 57.12 70.68 155.10 57.52 69.95 155.02 -17.31 6.32 43.48 -17.60 5.82 42.91 coo 60.62 73.13 154.21 59.05 74.26 153.35 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 56.75 71.71 148.46 58.44 71.01 149.54 -13.07 9.82 43.01 -13.89 7.88 43.30 1dub_c17 source 1dub 2-ENOYL-COA HYDRATASE : 2 hits 1dub_c17 naa= 3 ULMN 3 1e19_c01 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPuser 1 3 # 1 B 131 LYS B 16 LYS~? -4.10 OXT ACY B 120s B 215 LYS A 40 LYS.? -3.18 C ACY A 121s B 277 LYS B 71 LYS^? 12.90 O ACY A 121 coo 6.78 45.91 16.15 7.82 40.81 15.84 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 17.88 38.77 19.81 16.38 34.23 17.24 1.80 21.48 38.21 -1.61 24.69 34.09 coo 20.33 37.78 11.20 16.77 34.53 13.47 0.91 14.36 31.66 5.84 10.91 29.66 1e19_c01 source 1e19 CARBAMATE KINASE-LIKE CARBAMOYLPHOSPHATE SYNTH: 1 hits 1e19_c01 naa= 3 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 1 3 # 1 A 107 ALA A 69 ALA~? 13.19 CH3 ACY A 120 A 136 TYR A 79 TYR^? -4.35 CH3 ACY A 120s A 140 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 55.90 7.49 23.83 56.71 8.23 22.76 -1.21 27.00 58.54 -1.45 28.33 57.91 coo 59.38 10.02 17.51 59.95 9.89 20.21 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 59.52 3.69 18.67 62.31 6.19 22.58 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 3 1e7q_c01 GDP-FUCOSE SYNTHETASE user 2 3 # 2 A 107 ALA B 69 ALA~? 13.11 CH3 ACY B 120 A 136 TYR B 79 TYR^? -4.21 CH3 ACY B 120s A 140 LYS B 71 LYS^? 12.90 O ACY A 121 coo 55.90 7.49 23.83 56.71 8.23 22.76 2.84 10.11 35.92 2.27 8.90 36.60 coo 59.38 10.02 17.51 59.95 9.89 20.21 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 59.52 3.69 18.67 62.31 6.19 22.58 0.91 14.36 31.66 5.84 10.91 29.66 1e7q_c01 source 1e7q GDP-FUCOSE SYNTHETASE : 2 hits 1e7q_c01 naa= 3 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 1 3 # 1 A 32 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 35 SER A 14 SER~? 11.41 CH3 ACY A 120 A 218 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 47.22 22.34 8.57 45.16 22.02 9.13 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 43.58 20.85 5.15 44.62 23.01 5.76 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 44.05 16.99 12.67 44.05 18.89 11.74 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1eag_c04 PEPTIDE INHIBITOR user 2 3 # 2 A 32 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 35 SER B 14 SER~? 11.46 CH3 ACY B 120 A 218 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 47.22 22.34 8.57 45.16 22.02 9.13 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 43.58 20.85 5.15 44.62 23.01 5.76 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 44.05 16.99 12.67 44.05 18.89 11.74 -12.98 14.88 47.28 -12.40 12.90 47.92 1eag_c04 source 1eag PEPTIDE INHIBITOR : 2 hits 1eag_c04 naa= 3 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 1 3 # 1 P 32 ASP A 15 ASP~? 8.61 ZN ZN B 118 P 35 SER A 14 SER~? 11.41 CH3 ACY A 120 P 215 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 10.15 33.41 11.98 7.98 33.66 12.07 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 7.57 37.60 10.00 8.86 37.02 12.03 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 4.04 29.97 8.82 4.78 31.15 10.46 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1eed_c04 ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLuser 2 3 # 2 P 32 ASP B 15 ASP~? 8.50 ZN ZN A 119 P 35 SER B 14 SER~? 11.46 CH3 ACY B 120 P 215 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 10.15 33.41 11.98 7.98 33.66 12.07 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 7.57 37.60 10.00 8.86 37.02 12.03 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 4.04 29.97 8.82 4.78 31.15 10.46 -12.98 14.88 47.28 -12.40 12.90 47.92 1eed_c04 source 1eed ENDOTHIAPEPSIN (E.C.3.4.23.22) COMPLEX WITH TH: 2 hits 1eed_c04 naa= 3 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 B 107 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 246 ASP B 15 ASP~? 8.50 ZN ZN A 119 B 275 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 34.84 56.77 81.62 34.95 54.74 82.03 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 43.18 49.30 68.39 44.75 49.87 69.78 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 38.73 55.10 77.62 36.80 55.01 78.46 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 3 1ehy_c01 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 B 107 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 246 ASP A 15 ASP~? 8.61 ZN ZN B 118 B 275 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 34.84 56.77 81.62 34.95 54.74 82.03 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 43.18 49.30 68.39 44.75 49.87 69.78 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 38.73 55.10 77.62 36.80 55.01 78.46 -10.33 3.56 43.54 -12.07 4.44 44.29 1ehy_c01 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 2 hits 1ehy_c01 naa= 3 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 C 107 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 246 ASP B 15 ASP~? 8.50 ZN ZN A 119 C 275 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 1.90 35.26 72.76 3.20 35.74 71.18 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 12.03 20.33 71.56 10.48 19.25 70.56 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 3.92 29.96 71.75 4.22 31.96 72.31 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 3 1ehy_c02 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 C 107 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 246 ASP A 15 ASP~? 8.61 ZN ZN B 118 C 275 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 1.90 35.26 72.76 3.20 35.74 71.18 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 12.03 20.33 71.56 10.48 19.25 70.56 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 3.92 29.96 71.75 4.22 31.96 72.31 -10.33 3.56 43.54 -12.07 4.44 44.29 1ehy_c02 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 2 hits 1ehy_c02 naa= 3 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 1 3 # 1 D 107 ASP A 61 ASP^? 8.97 ZN ZN A 119 D 246 ASP B 15 ASP~? 8.50 ZN ZN A 119 D 275 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 37.41 19.89 81.58 37.64 21.98 81.53 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 23.50 26.43 88.52 24.76 26.47 90.29 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 33.16 21.44 85.29 34.07 21.53 83.40 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 3 1ehy_c03 SOLUBLE EPOXIDE HYDROLASE user 2 3 # 2 D 107 ASP B 61 ASP^? 9.02 ZN ZN B 118 D 246 ASP A 15 ASP~? 8.61 ZN ZN B 118 D 275 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 37.41 19.89 81.58 37.64 21.98 81.53 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 23.50 26.43 88.52 24.76 26.47 90.29 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 33.16 21.44 85.29 34.07 21.53 83.40 -10.33 3.56 43.54 -12.07 4.44 44.29 1ehy_c03 source 1ehy SOLUBLE EPOXIDE HYDROLASE : 2 hits 1ehy_c03 naa= 3 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 1 3 # 1 A 38 THR A 8 THR.? 9.96 ZN ZN A 118 A 159 LYS A 16 LYS~? -3.27 O ACY A 120s A 193 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo -2.58 16.31 54.79 -4.02 14.93 55.64 -5.91 7.98 55.94 -4.35 7.02 54.82 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -12.18 15.96 51.84 -12.69 14.73 56.98 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 2 3 # 2 A 38 THR A 20 THR.? 4.16 CH3 ACY A 120 A 159 LYS A 71 LYS^? 11.96 OXT ACY A 120 A 193 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -13.83 21.70 55.31 -12.29 20.44 56.16 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -4.35 22.91 61.78 1.12 23.33 62.25 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 3 3 # 3 A 38 THR B 8 THR.? 9.69 CH3 ACY A 121 A 159 LYS B 16 LYS~? -4.10 OXT ACY B 120s A 193 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo -2.58 16.31 54.79 -4.02 14.93 55.64 -2.71 29.36 36.26 -2.04 29.94 38.25 coo 2.10 10.68 61.44 -2.14 13.16 60.61 -10.13 21.11 38.47 -9.52 22.58 33.19 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 1et0_c02 4-AMINO-4-DEOXYCHORISMATE LYASE user 4 3 # 4 A 38 THR B 20 THR.? 4.10 CH3 ACY B 120 A 159 LYS B 71 LYS^? 12.90 O ACY A 121 A 193 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo -2.58 16.31 54.79 -4.02 14.93 55.64 -10.29 15.42 34.68 -8.60 16.74 34.44 coo 2.10 10.68 61.44 -2.14 13.16 60.61 0.91 14.36 31.66 5.84 10.91 29.66 coo -5.33 11.71 69.72 -4.62 11.92 67.73 -3.38 17.56 20.48 -2.28 16.44 19.03 1et0_c02 source 1et0 4-AMINO-4-DEOXYCHORISMATE LYASE : 4 hits 1et0_c02 naa= 3 ULMN 3 1euy_c00 GLUTAMINYL-TRNA SYNTHETASE user 1 3 # 1 A 34 GLU B 7 GLU.? -2.20 ZN ZN B 119s A 260 ARG A 44 ARG.? 16.49 O ACY A 121 A 270 LYS A 40 LYS.? -3.18 C ACY A 121s coo 50.99 29.43 12.86 52.11 29.45 14.65 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 39.80 27.50 22.98 42.20 26.56 21.34 6.31 22.16 46.81 4.95 24.70 47.95 coo 48.83 21.70 19.50 47.44 24.99 15.25 1.80 21.48 38.21 -1.61 24.69 34.09 1euy_c00 source 1euy GLUTAMINYL-TRNA SYNTHETASE : 1 hits 1euy_c00 naa= 3 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 A 112 PHE A 55 PHE.? 11.31 ZN ZN A 119 A 210 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 244 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 9.23 46.77 25.11 11.48 48.39 24.76 -23.76 31.53 49.05 -25.99 32.30 50.52 coo 10.51 37.86 19.71 9.07 39.38 20.04 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -1.20 42.34 17.67 3.19 45.13 19.06 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 3 1fc4_c02 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 A 112 PHE B 55 PHE.? 11.31 ZN ZN B 118 A 210 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 244 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 9.23 46.77 25.11 11.48 48.39 24.76 -21.82 4.67 37.54 -23.75 3.88 35.71 coo 10.51 37.86 19.71 9.07 39.38 20.04 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -1.20 42.34 17.67 3.19 45.13 19.06 -10.40 7.25 27.78 -14.86 10.45 31.09 1fc4_c02 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c02 naa= 3 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 1 3 # 1 B 112 PHE A 55 PHE.? 11.31 ZN ZN A 119 B 210 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 244 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 8.76 47.85 34.91 11.08 46.36 35.41 -23.76 31.53 49.05 -25.99 32.30 50.52 coo 9.06 56.85 40.30 7.71 55.27 39.90 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -2.38 51.82 41.62 2.07 49.19 40.42 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 3 1fc4_c03 2-AMINO-3-KETOBUTYRATE CONENZYME A Luser 2 3 # 2 B 112 PHE B 55 PHE.? 11.31 ZN ZN B 118 B 210 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 244 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 8.76 47.85 34.91 11.08 46.36 35.41 -21.82 4.67 37.54 -23.75 3.88 35.71 coo 9.06 56.85 40.30 7.71 55.27 39.90 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -2.38 51.82 41.62 2.07 49.19 40.42 -10.40 7.25 27.78 -14.86 10.45 31.09 1fc4_c03 source 1fc4 2-AMINO-3-KETOBUTYRATE CONENZYME A LIGASE : 2 hits 1fc4_c03 naa= 3 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 137 TYR A 79 TYR^? -4.35 CH3 ACY A 120s A 142 LEU A 50 LEU^? 9.64 ZN ZN A 119 A 165 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -8.40 22.97 58.06 -7.77 20.89 56.30 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -9.53 30.58 53.36 -10.77 31.04 55.17 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 3 1fdy_c00 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 137 TYR B 79 TYR^? -4.21 CH3 ACY B 120s A 142 LEU B 50 LEU^? 9.59 ZN ZN B 118 A 165 LYS B 71 LYS^? 12.90 O ACY A 121 coo -38.10 -88.84 -25.29 -37.86 -86.12 -24.64 -4.08 14.27 33.90 -4.00 16.42 35.66 coo -32.09 -82.74 -22.70 -32.91 -80.79 -22.33 -6.85 6.47 37.85 -7.39 6.15 35.74 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 0.91 14.36 31.66 5.84 10.91 29.66 1fdy_c00 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c00 naa= 3 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 137 TYR A 79 TYR^? -4.35 CH3 ACY A 120s B 142 LEU A 50 LEU^? 9.64 ZN ZN A 119 B 165 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -8.40 22.97 58.06 -7.77 20.89 56.30 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -9.53 30.58 53.36 -10.77 31.04 55.17 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 3 1fdy_c01 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 137 TYR B 79 TYR^? -4.21 CH3 ACY B 120s B 142 LEU B 50 LEU^? 9.59 ZN ZN B 118 B 165 LYS B 71 LYS^? 12.90 O ACY A 121 coo 1.63 -78.98 -34.99 0.64 -76.54 -34.02 -4.08 14.27 33.90 -4.00 16.42 35.66 coo -5.98 -74.54 -33.87 -5.92 -72.62 -32.92 -6.85 6.47 37.85 -7.39 6.15 35.74 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 0.91 14.36 31.66 5.84 10.91 29.66 1fdy_c01 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c01 naa= 3 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 137 TYR A 79 TYR^? -4.35 CH3 ACY A 120s C 142 LEU A 50 LEU^? 9.64 ZN ZN A 119 C 165 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -8.40 22.97 58.06 -7.77 20.89 56.30 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -9.53 30.58 53.36 -10.77 31.04 55.17 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 3 1fdy_c02 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 137 TYR B 79 TYR^? -4.21 CH3 ACY B 120s C 142 LEU B 50 LEU^? 9.59 ZN ZN B 118 C 165 LYS B 71 LYS^? 12.90 O ACY A 121 coo -19.42 -69.79 -47.15 -19.24 -72.58 -47.52 -4.08 14.27 33.90 -4.00 16.42 35.66 coo -15.96 -76.69 -42.83 -16.62 -78.73 -42.99 -6.85 6.47 37.85 -7.39 6.15 35.74 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 0.91 14.36 31.66 5.84 10.91 29.66 1fdy_c02 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c02 naa= 3 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 D 137 TYR A 79 TYR^? -4.35 CH3 ACY A 120s D 142 LEU A 50 LEU^? 9.64 ZN ZN A 119 D 165 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -8.40 22.97 58.06 -7.77 20.89 56.30 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -9.53 30.58 53.36 -10.77 31.04 55.17 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 3 1fdy_c03 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 D 137 TYR B 79 TYR^? -4.21 CH3 ACY B 120s D 142 LEU B 50 LEU^? 9.59 ZN ZN B 118 D 165 LYS B 71 LYS^? 12.90 O ACY A 121 coo -19.43 -82.92 -7.62 -19.06 -85.28 -9.04 -4.08 14.27 33.90 -4.00 16.42 35.66 coo -21.22 -86.47 -15.56 -20.39 -88.44 -15.62 -6.85 6.47 37.85 -7.39 6.15 35.74 coo -14.17 -80.73 -6.25 -16.63 -86.38 -7.08 0.91 14.36 31.66 5.84 10.91 29.66 1fdy_c03 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c03 naa= 3 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 A 47 SER A 32 SER^? 8.89 ZN ZN A 119 A 48 THR A 20 THR.? 4.16 CH3 ACY A 120 A 165 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -14.23 26.97 54.31 -16.02 26.35 52.81 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -13.83 21.70 55.31 -12.29 20.44 56.16 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 3 1fdy_c04 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 A 47 SER B 32 SER^? 8.58 ZN ZN B 118 A 48 THR B 20 THR.? 4.10 CH3 ACY B 120 A 165 LYS B 71 LYS^? 12.90 O ACY A 121 coo -39.09 -83.21 -19.79 -37.33 -83.94 -21.38 -11.02 10.19 35.41 -13.14 10.52 36.50 coo -41.85 -80.60 -20.11 -42.94 -79.78 -21.77 -10.29 15.42 34.68 -8.60 16.74 34.44 coo -39.97 -88.99 -30.53 -40.75 -85.40 -25.70 0.91 14.36 31.66 5.84 10.91 29.66 1fdy_c04 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c04 naa= 3 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 B 47 SER A 32 SER^? 8.89 ZN ZN A 119 B 48 THR A 20 THR.? 4.16 CH3 ACY A 120 B 165 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -13.83 21.70 55.31 -12.29 20.44 56.16 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 3 1fdy_c05 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 B 47 SER B 32 SER^? 8.58 ZN ZN B 118 B 48 THR B 20 THR.? 4.10 CH3 ACY B 120 B 165 LYS B 71 LYS^? 12.90 O ACY A 121 coo 0.74 -71.26 -35.87 -0.36 -73.34 -35.30 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 2.65 -68.72 -33.78 3.66 -68.93 -31.87 -10.29 15.42 34.68 -8.60 16.74 34.44 coo 4.26 -81.75 -30.55 3.40 -75.83 -32.08 0.91 14.36 31.66 5.84 10.91 29.66 1fdy_c05 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c05 naa= 3 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 1 3 # 1 C 47 SER A 32 SER^? 8.89 ZN ZN A 119 C 48 THR A 20 THR.? 4.16 CH3 ACY A 120 C 165 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -14.23 26.97 54.31 -16.02 26.35 52.81 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -13.83 21.70 55.31 -12.29 20.44 56.16 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 3 1fdy_c06 N-ACETYLNEURAMINATE LYASE user 2 3 # 2 C 47 SER B 32 SER^? 8.58 ZN ZN B 118 C 48 THR B 20 THR.? 4.10 CH3 ACY B 120 C 165 LYS B 71 LYS^? 12.90 O ACY A 121 coo -15.18 -75.37 -50.42 -16.12 -74.55 -48.34 -11.02 10.19 35.41 -13.14 10.52 36.50 coo -16.57 -77.65 -53.15 -18.61 -78.18 -53.63 -10.29 15.42 34.68 -8.60 16.74 34.44 coo -25.12 -68.79 -47.79 -21.06 -72.76 -50.30 0.91 14.36 31.66 5.84 10.91 29.66 1fdy_c06 source 1fdy N-ACETYLNEURAMINATE LYASE : 2 hits 1fdy_c06 naa= 3 ULMN 3 1fgj_c01 HYDROXYLAMINE OXIDOREDUCTASE user 1 3 # 1 B 267 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 268 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 334 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 34.92 32.34 -16.78 33.96 30.63 -15.98 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 34.35 32.52 -12.02 33.62 30.54 -12.18 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 31.28 36.97 -17.45 31.29 34.40 -16.38 -4.17 2.05 38.57 -1.76 0.81 38.01 1fgj_c01 source 1fgj HYDROXYLAMINE OXIDOREDUCTASE : 1 hits 1fgj_c01 naa= 3 ULMN 3 1foh_c00 PHENOL HYDROXYLASE user 1 3 # 1 A 54 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 281 ARG B 90 ARG~? 22.74 ZN ZN B 118 A 289 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 54.86 40.00 47.23 55.57 38.60 48.67 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 52.08 40.18 50.14 50.83 38.93 47.73 -1.29 -8.08 37.25 0.33 -10.46 36.18 coo 57.82 31.70 50.73 57.94 34.00 49.17 -4.17 2.05 38.57 -1.76 0.81 38.01 1foh_c00 source 1foh PHENOL HYDROXYLASE : 1 hits 1foh_c00 naa= 3 ULMN 3 1foh_c01 PHENOL HYDROXYLASE user 1 3 # 1 B 54 ASP B 86 ASP~? 22.13 ZN ZN B 118 B 281 ARG B 90 ARG~? 22.74 ZN ZN B 118 B 289 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 90.56 80.24 98.04 90.36 81.53 96.34 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 86.62 80.67 97.51 87.37 82.00 100.10 -1.29 -8.08 37.25 0.33 -10.46 36.18 coo 91.83 88.28 92.88 92.60 85.93 94.14 -4.17 2.05 38.57 -1.76 0.81 38.01 1foh_c01 source 1foh PHENOL HYDROXYLASE : 1 hits 1foh_c01 naa= 3 ULMN 3 1foh_c02 PHENOL HYDROXYLASE user 1 3 # 1 C 54 ASP B 86 ASP~? 22.13 ZN ZN B 118 C 281 ARG B 90 ARG~? 22.74 ZN ZN B 118 C 289 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 42.34 76.83 49.10 43.06 78.59 50.01 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 46.12 77.15 48.13 44.44 77.61 45.70 -1.29 -8.08 37.25 0.33 -10.46 36.18 coo 42.69 86.18 51.69 41.59 83.63 51.54 -4.17 2.05 38.57 -1.76 0.81 38.01 1foh_c02 source 1foh PHENOL HYDROXYLASE : 1 hits 1foh_c02 naa= 3 ULMN 3 1fuq_c00 FUMARASE C user 1 3 # 1 A 324 LYS A 93 LYS.? 17.16 ZN ZN A 119 A 331 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 188 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 130.22 155.23 83.49 125.21 153.71 84.04 -8.24 41.47 45.26 -7.63 47.05 46.72 coo 120.90 152.23 75.28 120.94 153.09 77.19 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 122.04 152.80 81.06 120.71 154.37 81.46 -11.17 33.63 46.78 -12.74 33.06 45.52 1fuq_c00 source 1fuq FUMARASE C : 1 hits 1fuq_c00 naa= 3 ULMN 3 1gns_c00 SUBTILISIN BPN' user 1 3 # 1 A 32 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 64 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 155 ASN B 6 ASN.? 8.30 OXT ACY B 120 coo 3.12 38.70 24.20 3.24 38.59 26.33 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 1.90 38.00 29.77 3.91 38.35 29.95 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 9.89 36.55 37.38 9.27 37.99 36.08 -9.87 26.28 39.29 -10.81 26.02 37.42 ULMN 3 1gns_c00 SUBTILISIN BPN' user 2 3 # 2 A 32 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 64 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 155 ASN B 6 ASN.? 8.30 OXT ACY B 120 coo 3.12 38.70 24.20 3.24 38.59 26.33 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 1.90 38.00 29.77 3.91 38.35 29.95 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 9.89 36.55 37.38 9.27 37.99 36.08 -9.87 26.28 39.29 -10.81 26.02 37.42 ULMN 3 1gns_c00 SUBTILISIN BPN' user 3 3 # 3 A 32 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 64 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 155 ASN A 6 ASN.? 7.96 O ACY A 120 coo 3.12 38.70 24.20 3.24 38.59 26.33 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 1.90 38.00 29.77 3.91 38.35 29.95 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 9.89 36.55 37.38 9.27 37.99 36.08 -11.99 10.76 51.07 -13.19 11.09 52.81 ULMN 3 1gns_c00 SUBTILISIN BPN' user 4 3 # 4 A 32 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 64 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 155 ASN A 6 ASN.? 7.96 O ACY A 120 coo 3.12 38.70 24.20 3.24 38.59 26.33 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 1.90 38.00 29.77 3.91 38.35 29.95 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 9.89 36.55 37.38 9.27 37.99 36.08 -11.99 10.76 51.07 -13.19 11.09 52.81 1gns_c00 source 1gns SUBTILISIN BPN' : 4 hits 1gns_c00 naa= 3 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 1 3 # 1 160 LYS A 71 LYS^? 11.96 OXT ACY A 120 210 ARG A 44 ARG.? 16.49 O ACY A 121 225 ARG B 44 ARG.? 18.52 O ACY A 121 coo 17.51 28.50 73.42 17.24 23.02 75.86 -4.35 22.91 61.78 1.12 23.33 62.25 coo 24.74 11.56 73.05 25.29 14.32 71.80 6.31 22.16 46.81 4.95 24.70 47.95 coo 27.81 15.44 77.10 25.66 16.50 75.19 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 2 3 # 2 160 LYS A 71 LYS^? 11.96 OXT ACY A 120 210 ARG B 44 ARG.? 18.52 O ACY A 121 225 ARG A 44 ARG.? 16.49 O ACY A 121 coo 17.51 28.50 73.42 17.24 23.02 75.86 -4.35 22.91 61.78 1.12 23.33 62.25 coo 24.74 11.56 73.05 25.29 14.32 71.80 6.69 16.72 49.11 8.85 18.83 48.43 coo 27.81 15.44 77.10 25.66 16.50 75.19 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 3 3 # 3 160 LYS B 16 LYS~? -4.10 OXT ACY B 120s 210 ARG B 44 ARG.? 18.52 O ACY A 121 225 ARG A 44 ARG.? 16.49 O ACY A 121 coo 17.51 28.50 73.42 17.24 23.02 75.86 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 24.74 11.56 73.05 25.29 14.32 71.80 6.69 16.72 49.11 8.85 18.83 48.43 coo 27.81 15.44 77.10 25.66 16.50 75.19 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 4 3 # 4 160 LYS B 71 LYS^? 12.90 O ACY A 121 210 ARG A 44 ARG.? 16.49 O ACY A 121 225 ARG B 44 ARG.? 18.52 O ACY A 121 coo 17.51 28.50 73.42 17.24 23.02 75.86 0.91 14.36 31.66 5.84 10.91 29.66 coo 24.74 11.56 73.05 25.29 14.32 71.80 6.31 22.16 46.81 4.95 24.70 47.95 coo 27.81 15.44 77.10 25.66 16.50 75.19 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1gsa_c00 GLUTATHIONE SYNTHETASE user 5 3 # 5 160 LYS B 71 LYS^? 12.90 O ACY A 121 210 ARG B 44 ARG.? 18.52 O ACY A 121 225 ARG A 44 ARG.? 16.49 O ACY A 121 coo 17.51 28.50 73.42 17.24 23.02 75.86 0.91 14.36 31.66 5.84 10.91 29.66 coo 24.74 11.56 73.05 25.29 14.32 71.80 6.69 16.72 49.11 8.85 18.83 48.43 coo 27.81 15.44 77.10 25.66 16.50 75.19 6.31 22.16 46.81 4.95 24.70 47.95 1gsa_c00 source 1gsa GLUTATHIONE SYNTHETASE : 5 hits 1gsa_c00 naa= 3 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 1 3 # 1 A 271 GLN A 18 GLN.? 11.66 ZN ZN A 119 A 296 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 383 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -11.72 21.08 47.54 -11.51 20.01 45.71 coo 40.93 4.45 2.36 38.91 3.75 2.26 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 30.54 7.22 6.23 31.38 5.79 3.97 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 3 1h19_c00 LEUKOTRIENE A-4 HYDROLASE user 2 3 # 2 A 271 GLN B 18 GLN~? 11.75 ZN ZN B 118 A 296 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 383 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 38.07 -1.37 3.28 36.21 -0.34 2.92 -10.66 16.34 42.67 -11.39 17.08 44.58 coo 40.93 4.45 2.36 38.91 3.75 2.26 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 30.54 7.22 6.23 31.38 5.79 3.97 -1.77 7.84 45.62 -3.44 6.86 47.62 1h19_c00 source 1h19 LEUKOTRIENE A-4 HYDROLASE : 2 hits 1h19_c00 naa= 3 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 1 3 # 1 A 50 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 327 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 339 ARG B 90 ARG~? 22.74 ZN ZN B 118 coo 85.81 57.99 116.01 86.03 55.86 115.89 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 75.11 41.01 160.30 76.65 40.06 161.41 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 82.23 40.35 159.87 85.09 40.67 161.01 -1.29 -8.08 37.25 0.33 -10.46 36.18 ULMN 3 1hto_c00 GLUTAMINE SYNTHETASE user 2 3 # 2 A 50 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 327 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 339 ARG A 90 ARG~? 21.28 ZN ZN A 119 coo 85.81 57.99 116.01 86.03 55.86 115.89 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 75.11 41.01 160.30 76.65 40.06 161.41 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 82.23 40.35 159.87 85.09 40.67 161.01 -4.89 45.59 55.49 -2.75 44.62 57.47 1hto_c00 source 1hto GLUTAMINE SYNTHETASE : 2 hits 1hto_c00 naa= 3 ULMN 3 1i19_c00 CHOLESTEROL OXIDASE user 1 3 # 1 A 311 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 475 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 477 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 13.27 46.15 59.96 13.96 44.19 59.76 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 9.69 44.01 59.12 10.58 42.11 58.89 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 13.49 45.17 55.56 13.84 42.22 54.75 -8.90 26.62 43.60 -11.56 28.13 43.24 1i19_c00 source 1i19 CHOLESTEROL OXIDASE : 1 hits 1i19_c00 naa= 3 ULMN 3 1i29_c03 CSDB user 1 3 # 1 A 128 VAL A 22 VAL^? 9.76 CH3 ACY A 120 A 200 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 226 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 19.13 38.05 1.41 19.72 38.80 -0.53 -12.07 26.86 58.76 -10.55 27.60 57.34 coo 24.51 43.28 11.18 25.17 44.50 9.58 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 34.47 51.09 7.19 28.58 51.18 7.53 -8.24 41.47 45.26 -7.63 47.05 46.72 1i29_c03 source 1i29 CSDB : 1 hits 1i29_c03 naa= 3 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 1 3 # 1 54 ASP A 15 ASP~? 8.61 ZN ZN B 118 158 THR A 5 THR.? 10.24 ZN ZN B 118 317 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -11.20 6.24 51.51 -9.77 5.38 52.87 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 3 1inp_c02 INOSITOL POLYPHOSPHATE 1-PHOSPHATASEuser 2 3 # 2 54 ASP B 15 ASP~? 8.50 ZN ZN A 119 158 THR B 5 THR.? 9.07 ZN ZN A 119 317 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -2.63 8.40 35.07 -3.66 9.81 36.17 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -5.30 12.75 41.86 -4.34 13.05 39.99 -9.78 30.84 38.74 -8.10 32.14 39.13 coo -12.63 17.64 33.66 -10.65 17.90 34.40 -16.84 33.62 48.35 -16.08 32.62 46.63 1inp_c02 source 1inp INOSITOL POLYPHOSPHATE 1-PHOSPHATASE (1-PTASE): 2 hits 1inp_c02 naa= 3 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 1 3 # 1 A 202 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 204 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 279 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 5.85 5.60 30.32 5.00 7.49 29.88 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 7.79 1.83 27.81 9.08 3.25 26.92 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 8.22 7.77 18.64 7.58 8.47 21.28 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 2 3 # 2 A 202 ASP A 86 ASP~? 22.55 ZN ZN A 119 A 204 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 279 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 5.85 5.60 30.32 5.00 7.49 29.88 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 7.79 1.83 27.81 9.08 3.25 26.92 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 8.22 7.77 18.64 7.58 8.47 21.28 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 3 3 # 3 A 202 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 204 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 279 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 5.85 5.60 30.32 5.00 7.49 29.88 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 7.79 1.83 27.81 9.08 3.25 26.92 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 8.22 7.77 18.64 7.58 8.47 21.28 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 3 1itx_c00 GLYCOSYL HYDROLASE user 4 3 # 4 A 202 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 204 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 279 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 5.85 5.60 30.32 5.00 7.49 29.88 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 7.79 1.83 27.81 9.08 3.25 26.92 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 8.22 7.77 18.64 7.58 8.47 21.28 -4.17 2.05 38.57 -1.76 0.81 38.01 1itx_c00 source 1itx GLYCOSYL HYDROLASE : 4 hits 1itx_c00 naa= 3 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 1 3 # 1 A 55 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 58 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 424 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 58.42 47.76 20.67 58.01 49.10 19.12 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 58.59 41.80 18.81 58.94 43.89 18.94 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 52.85 46.34 13.34 54.09 44.97 14.42 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 2 3 # 2 A 55 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 58 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 424 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 58.42 47.76 20.67 58.01 49.10 19.12 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 58.59 41.80 18.81 58.94 43.89 18.94 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 52.85 46.34 13.34 54.09 44.97 14.42 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 3 3 # 3 A 55 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 58 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 424 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 58.42 47.76 20.67 58.01 49.10 19.12 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 58.59 41.80 18.81 58.94 43.89 18.94 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 52.85 46.34 13.34 54.09 44.97 14.42 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 4 3 # 4 A 55 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 58 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 424 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 58.42 47.76 20.67 58.01 49.10 19.12 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 58.59 41.80 18.81 58.94 43.89 18.94 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 52.85 46.34 13.34 54.09 44.97 14.42 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 5 3 # 5 A 55 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 58 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 424 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 58.42 47.76 20.67 58.01 49.10 19.12 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 58.59 41.80 18.81 58.94 43.89 18.94 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 52.85 46.34 13.34 54.09 44.97 14.42 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 6 3 # 6 A 55 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 58 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 424 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 58.42 47.76 20.67 58.01 49.10 19.12 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 58.59 41.80 18.81 58.94 43.89 18.94 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 52.85 46.34 13.34 54.09 44.97 14.42 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 3 1js4_c00 ENDO-EXOCELLULASE E4 user 7 3 # 7 A 55 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 58 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 424 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 58.42 47.76 20.67 58.01 49.10 19.12 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 58.59 41.80 18.81 58.94 43.89 18.94 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 52.85 46.34 13.34 54.09 44.97 14.42 -13.07 9.82 43.01 -13.89 7.88 43.30 1js4_c00 source 1js4 ENDO-EXOCELLULASE E4 : 7 hits 1js4_c00 naa= 3 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 A 2 GLU A 39 GLU^? 13.07 O ACY A 121 A 56 LYS B 10 LYS.? 9.83 CH3 ACY A 121 A 258 ARG B 44 ARG.? 18.52 O ACY A 121 coo 42.33 1.56 26.99 42.38 2.91 28.66 3.97 24.42 42.90 6.03 24.50 43.46 coo 38.45 -0.44 19.89 37.36 0.90 25.90 2.14 27.03 37.15 7.00 28.76 35.76 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1k82_c00 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 A 2 GLU B 39 GLU.? 14.67 OXT ACY A 120 A 56 LYS A 10 LYS.? 12.65 OXT ACY A 120 A 258 ARG A 44 ARG.? 16.49 O ACY A 121 coo 42.33 1.56 26.99 42.38 2.91 28.66 2.54 12.93 51.58 4.67 12.91 51.32 coo 38.45 -0.44 19.89 37.36 0.90 25.90 -0.98 10.25 56.97 2.99 9.65 58.52 coo 36.54 -1.79 35.54 37.68 -1.44 32.69 6.31 22.16 46.81 4.95 24.70 47.95 1k82_c00 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c00 naa= 3 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 B 2 GLU A 39 GLU^? 13.07 O ACY A 121 B 56 LYS B 10 LYS.? 9.83 CH3 ACY A 121 B 258 ARG B 44 ARG.? 18.52 O ACY A 121 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 3.97 24.42 42.90 6.03 24.50 43.46 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 2.14 27.03 37.15 7.00 28.76 35.76 coo 2.64 1.83 34.81 1.56 1.13 32.02 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1k82_c01 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 B 2 GLU B 39 GLU.? 14.67 OXT ACY A 120 B 56 LYS A 10 LYS.? 12.65 OXT ACY A 120 B 258 ARG A 44 ARG.? 16.49 O ACY A 121 coo -2.88 -2.27 26.18 -2.94 -3.40 27.96 2.54 12.93 51.58 4.67 12.91 51.32 coo 1.37 -0.44 19.19 2.21 -1.48 25.26 -0.98 10.25 56.97 2.99 9.65 58.52 coo 2.64 1.83 34.81 1.56 1.13 32.02 6.31 22.16 46.81 4.95 24.70 47.95 1k82_c01 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c01 naa= 3 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 C 2 GLU A 39 GLU^? 13.07 O ACY A 121 C 56 LYS B 10 LYS.? 9.83 CH3 ACY A 121 C 258 ARG B 44 ARG.? 18.52 O ACY A 121 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 3.97 24.42 42.90 6.03 24.50 43.46 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 2.14 27.03 37.15 7.00 28.76 35.76 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1k82_c02 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 C 2 GLU B 39 GLU.? 14.67 OXT ACY A 120 C 56 LYS A 10 LYS.? 12.65 OXT ACY A 120 C 258 ARG A 44 ARG.? 16.49 O ACY A 121 coo 43.38 -1.09 -22.48 43.25 -2.24 -24.24 2.54 12.93 51.58 4.67 12.91 51.32 coo 39.00 0.70 -15.53 38.30 -0.73 -21.58 -0.98 10.25 56.97 2.99 9.65 58.52 coo 37.62 2.54 -31.11 38.78 1.93 -28.33 6.31 22.16 46.81 4.95 24.70 47.95 1k82_c02 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c02 naa= 3 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 1 3 # 1 D 2 GLU A 39 GLU^? 13.07 O ACY A 121 D 56 LYS B 10 LYS.? 9.83 CH3 ACY A 121 D 258 ARG B 44 ARG.? 18.52 O ACY A 121 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 3.97 24.42 42.90 6.03 24.50 43.46 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 2.14 27.03 37.15 7.00 28.76 35.76 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1k82_c03 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE user 2 3 # 2 D 2 GLU B 39 GLU.? 14.67 OXT ACY A 120 D 56 LYS A 10 LYS.? 12.65 OXT ACY A 120 D 258 ARG A 44 ARG.? 16.49 O ACY A 121 coo -2.14 0.68 -23.29 -2.02 1.93 -25.00 2.54 12.93 51.58 4.67 12.91 51.32 coo 2.02 -1.43 -16.27 3.11 0.23 -22.16 -0.98 10.25 56.97 2.99 9.65 58.52 coo 4.06 -2.42 -31.79 2.79 -2.18 -28.99 6.31 22.16 46.81 4.95 24.70 47.95 1k82_c03 source 1k82 FORMAMIDOPYRIMIDINE-DNA GLYCOSYLASE : 2 hits 1k82_c03 naa= 3 ULMN 3 1lam_c00 LEUCINE AMINOPEPTIDASE user 1 3 # 1 255 ASP A 61 ASP^? 8.97 ZN ZN A 119 262 LYS A 93 LYS.? 17.16 ZN ZN A 119 336 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 61.88 50.78 12.96 63.84 50.60 13.71 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 63.59 44.40 18.32 63.20 49.74 17.95 -8.24 41.47 45.26 -7.63 47.05 46.72 coo 72.60 57.42 15.86 71.61 56.68 18.70 -8.90 26.62 43.60 -11.56 28.13 43.24 1lam_c00 source 1lam LEUCINE AMINOPEPTIDASE : 1 hits 1lam_c00 naa= 3 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 1 3 # 1 A 123 LYS A 29 LYS^? 13.52 CH3 ACY A 120 A 202 SER A 32 SER^? 8.89 ZN ZN A 119 A 226 SER A 51 SER^? 4.15 ZN ZN A 119 coo 1.62 6.10 69.30 3.81 1.25 65.91 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 4.43 1.89 61.79 4.31 0.09 63.40 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1m21_c00 PEPTIDE AMIDASE user 2 3 # 2 A 123 LYS B 29 LYS^? 13.36 ZN ZN B 118 A 202 SER B 32 SER^? 8.58 ZN ZN B 118 A 226 SER B 51 SER^? 4.27 ZN ZN B 118 coo 1.62 6.10 69.30 3.81 1.25 65.91 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 4.43 1.89 61.79 4.31 0.09 63.40 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 8.52 -0.27 63.61 6.46 -1.15 62.94 -11.41 5.84 39.04 -13.87 6.10 39.28 1m21_c00 source 1m21 PEPTIDE AMIDASE : 2 hits 1m21_c00 naa= 3 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 1 3 # 1 B 123 LYS A 29 LYS^? 13.52 CH3 ACY A 120 B 202 SER A 32 SER^? 8.89 ZN ZN A 119 B 226 SER A 51 SER^? 4.15 ZN ZN A 119 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 32.81 4.27 10.70 32.87 6.07 12.31 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 28.77 6.36 12.44 30.83 7.25 11.75 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1m21_c01 PEPTIDE AMIDASE user 2 3 # 2 B 123 LYS B 29 LYS^? 13.36 ZN ZN B 118 B 202 SER B 32 SER^? 8.58 ZN ZN B 118 B 226 SER B 51 SER^? 4.27 ZN ZN B 118 coo 35.67 -0.01 18.11 33.47 4.84 14.73 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 32.81 4.27 10.70 32.87 6.07 12.31 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 28.77 6.36 12.44 30.83 7.25 11.75 -11.41 5.84 39.04 -13.87 6.10 39.28 1m21_c01 source 1m21 PEPTIDE AMIDASE : 2 hits 1m21_c01 naa= 3 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 1 3 # 1 A 241 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 265 GLU B 39 GLU.? 14.67 OXT ACY A 120 A 369 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 11.74 38.14 80.19 10.63 36.40 80.65 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 17.36 23.57 72.04 18.68 21.92 71.98 2.54 12.93 51.58 4.67 12.91 51.32 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1m53_c05 ISOMALTULOSE SYNTHASE user 2 3 # 2 A 241 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 265 GLU B 39 GLU.? 14.67 OXT ACY A 120 A 369 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 11.74 38.14 80.19 10.63 36.40 80.65 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 17.36 23.57 72.04 18.68 21.92 71.98 2.54 12.93 51.58 4.67 12.91 51.32 coo 12.19 31.08 87.29 11.13 32.66 86.38 -12.98 14.88 47.28 -12.40 12.90 47.92 1m53_c05 source 1m53 ISOMALTULOSE SYNTHASE : 2 hits 1m53_c05 naa= 3 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 1 3 # 1 159 ARG A 35 ARG^? 4.87 ZN ZN A 119 229 SER A 51 SER^? 4.15 ZN ZN A 119 325 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 2.54 15.84 18.57 3.24 17.85 16.30 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 10.17 13.48 15.92 9.61 15.76 15.27 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 5.42 13.04 19.75 5.74 13.81 17.79 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 2 3 # 2 159 ARG B 35 ARG.? 5.03 ZN ZN B 118 229 SER B 51 SER^? 4.27 ZN ZN B 118 325 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 2.54 15.84 18.57 3.24 17.85 16.30 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 10.17 13.48 15.92 9.61 15.76 15.27 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 5.42 13.04 19.75 5.74 13.81 17.79 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 3 1mbb_c00 URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYuser 3 3 # 3 159 ARG B 44 ARG.? 18.52 O ACY A 121 229 SER B 46 SER^? 14.91 OXT ACY A 120 325 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 2.54 15.84 18.57 3.24 17.85 16.30 6.69 16.72 49.11 8.85 18.83 48.43 coo 10.17 13.48 15.92 9.61 15.76 15.27 1.20 11.37 47.30 1.64 9.60 48.90 coo 5.42 13.04 19.75 5.74 13.81 17.79 2.54 12.93 51.58 4.67 12.91 51.32 1mbb_c00 source 1mbb URIDINE DIPHOSPHO-N-ACETYLENOLPYRUVYLGLUCOSAMI: 3 hits 1mbb_c00 naa= 3 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 1 3 # 1 164 LYS A 10 LYS.? 12.65 OXT ACY A 120 166 LYS B 40 LYS.? 4.59 ZN ZN A 118 324 SER B 32 SER^? 8.58 ZN ZN B 118 coo 25.93 8.11 25.51 26.40 7.80 19.66 -0.98 10.25 56.97 2.99 9.65 58.52 coo 27.27 1.43 25.09 29.18 5.25 22.89 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 46.32 14.55 19.93 45.95 12.72 21.27 -11.02 10.19 35.41 -13.14 10.52 36.50 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 2 3 # 2 164 LYS A 10 LYS.? 12.65 OXT ACY A 120 166 LYS B 40 LYS.? 4.59 ZN ZN A 118 324 SER B 51 SER^? 4.27 ZN ZN B 118 coo 25.93 8.11 25.51 26.40 7.80 19.66 -0.98 10.25 56.97 2.99 9.65 58.52 coo 27.27 1.43 25.09 29.18 5.25 22.89 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 46.32 14.55 19.93 45.95 12.72 21.27 -11.41 5.84 39.04 -13.87 6.10 39.28 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 3 3 # 3 164 LYS A 40 LYS.? -3.18 C ACY A 121s 166 LYS B 10 LYS.? 9.83 CH3 ACY A 121 324 SER A 32 SER^? 8.89 ZN ZN A 119 coo 25.93 8.11 25.51 26.40 7.80 19.66 1.80 21.48 38.21 -1.61 24.69 34.09 coo 27.27 1.43 25.09 29.18 5.25 22.89 2.14 27.03 37.15 7.00 28.76 35.76 coo 46.32 14.55 19.93 45.95 12.72 21.27 -14.23 26.97 54.31 -16.02 26.35 52.81 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 4 3 # 4 164 LYS A 40 LYS.? -3.18 C ACY A 121s 166 LYS B 10 LYS.? 9.83 CH3 ACY A 121 324 SER B 51 SER^? 4.27 ZN ZN B 118 coo 25.93 8.11 25.51 26.40 7.80 19.66 1.80 21.48 38.21 -1.61 24.69 34.09 coo 27.27 1.43 25.09 29.18 5.25 22.89 2.14 27.03 37.15 7.00 28.76 35.76 coo 46.32 14.55 19.93 45.95 12.72 21.27 -11.41 5.84 39.04 -13.87 6.10 39.28 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 5 3 # 5 164 LYS B 10 LYS.? 9.83 CH3 ACY A 121 166 LYS A 40 LYS.? -3.18 C ACY A 121s 324 SER A 32 SER^? 8.89 ZN ZN A 119 coo 25.93 8.11 25.51 26.40 7.80 19.66 2.14 27.03 37.15 7.00 28.76 35.76 coo 27.27 1.43 25.09 29.18 5.25 22.89 1.80 21.48 38.21 -1.61 24.69 34.09 coo 46.32 14.55 19.93 45.95 12.72 21.27 -14.23 26.97 54.31 -16.02 26.35 52.81 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 6 3 # 6 164 LYS B 10 LYS.? 9.83 CH3 ACY A 121 166 LYS A 40 LYS.? -3.18 C ACY A 121s 324 SER A 51 SER^? 4.15 ZN ZN A 119 coo 25.93 8.11 25.51 26.40 7.80 19.66 2.14 27.03 37.15 7.00 28.76 35.76 coo 27.27 1.43 25.09 29.18 5.25 22.89 1.80 21.48 38.21 -1.61 24.69 34.09 coo 46.32 14.55 19.93 45.95 12.72 21.27 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 7 3 # 7 164 LYS B 40 LYS.? 4.59 ZN ZN A 118 166 LYS A 10 LYS.? 12.65 OXT ACY A 120 324 SER A 51 SER^? 4.15 ZN ZN A 119 coo 25.93 8.11 25.51 26.40 7.80 19.66 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 27.27 1.43 25.09 29.18 5.25 22.89 -0.98 10.25 56.97 2.99 9.65 58.52 coo 46.32 14.55 19.93 45.95 12.72 21.27 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mdr_c01 MANDELATE RACEMASE (E.C.5.1.2.2) user 8 3 # 8 164 LYS B 40 LYS.? 4.59 ZN ZN A 118 166 LYS A 10 LYS.? 12.65 OXT ACY A 120 324 SER B 32 SER^? 8.58 ZN ZN B 118 coo 25.93 8.11 25.51 26.40 7.80 19.66 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 27.27 1.43 25.09 29.18 5.25 22.89 -0.98 10.25 56.97 2.99 9.65 58.52 coo 46.32 14.55 19.93 45.95 12.72 21.27 -11.02 10.19 35.41 -13.14 10.52 36.50 1mdr_c01 source 1mdr MANDELATE RACEMASE (E.C.5.1.2.2) : 8 hits 1mdr_c01 naa= 3 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 1 3 # 1 32 ASP A 15 ASP~? 8.61 ZN ZN B 118 35 SER A 14 SER~? 11.41 CH3 ACY A 120 215 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 20.97 14.47 32.28 19.66 15.96 31.62 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 16.04 14.72 33.82 17.27 13.71 31.95 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 20.65 22.00 33.80 20.06 20.56 32.39 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1mpp_c04 PEPSIN (RENIN) (E.C.3.4.23.23) user 2 3 # 2 32 ASP B 15 ASP~? 8.50 ZN ZN A 119 35 SER B 14 SER~? 11.46 CH3 ACY B 120 215 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 20.97 14.47 32.28 19.66 15.96 31.62 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 16.04 14.72 33.82 17.27 13.71 31.95 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 20.65 22.00 33.80 20.06 20.56 32.39 -12.98 14.88 47.28 -12.40 12.90 47.92 1mpp_c04 source 1mpp PEPSIN (RENIN) (E.C.3.4.23.23) : 2 hits 1mpp_c04 naa= 3 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 1 3 # 1 A 465 GLY A 43 GLY.? 10.93 O ACY A 121 A 501 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 367 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 2.67 18.14 42.78 3.17 18.66 43.17 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 3 1mro_c00 METHYL-COENZYME M REDUCTASE user 2 3 # 2 A 465 GLY B 43 GLY.? 11.77 OXT ACY A 120 A 501 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 367 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 4.40 25.46 -23.33 5.00 25.87 -23.68 1.41 19.22 51.53 1.94 18.61 51.36 coo 13.82 6.17 -29.83 11.78 5.87 -29.33 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 27.05 35.80 -12.24 28.72 34.05 -10.85 -7.61 10.49 27.32 -9.94 11.99 27.12 1mro_c00 source 1mro METHYL-COENZYME M REDUCTASE : 2 hits 1mro_c00 naa= 3 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 1 3 # 1 D 465 GLY A 43 GLY.? 10.93 O ACY A 121 D 501 ASP B 61 ASP^? 9.02 ZN ZN B 118 E 367 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 2.67 18.14 42.78 3.17 18.66 43.17 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 3 1mro_c01 METHYL-COENZYME M REDUCTASE user 2 3 # 2 D 465 GLY B 43 GLY.? 11.77 OXT ACY A 120 D 501 ASP A 61 ASP^? 8.97 ZN ZN A 119 E 367 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 21.60 60.44 -42.77 21.61 59.72 -42.40 1.41 19.22 51.53 1.94 18.61 51.36 coo 42.23 65.30 -35.49 41.21 67.05 -36.13 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 28.27 36.08 -52.91 30.75 35.88 -54.18 -7.61 10.49 27.32 -9.94 11.99 27.12 1mro_c01 source 1mro METHYL-COENZYME M REDUCTASE : 2 hits 1mro_c01 naa= 3 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 A 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 A 217 SER A 32 SER^? 8.89 ZN ZN A 119 A 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c00 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 A 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 A 217 SER B 32 SER^? 8.58 ZN ZN B 118 A 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo 12.59 -31.89 29.79 15.18 -27.54 26.08 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 19.52 -27.28 27.04 17.55 -25.93 26.56 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 18.91 -27.35 22.36 18.66 -25.43 23.90 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c00 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c00 naa= 3 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 B 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 B 217 SER A 32 SER^? 8.89 ZN ZN A 119 B 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -16.25 29.91 61.58 -19.73 26.30 57.65 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -14.23 26.97 54.31 -16.02 26.35 52.81 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c01 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 B 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 B 217 SER B 32 SER^? 8.58 ZN ZN B 118 B 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo -7.04 -5.02 -4.87 -7.61 -4.05 1.23 -10.40 7.25 27.78 -14.86 10.45 31.09 coo -9.93 -0.90 2.43 -7.82 -1.91 3.00 -11.02 10.19 35.41 -13.14 10.52 36.50 coo -11.06 -4.56 5.15 -9.38 -2.84 5.46 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c01 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c01 naa= 3 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 C 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 C 217 SER A 32 SER^? 8.89 ZN ZN A 119 C 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -16.25 29.91 61.58 -19.73 26.30 57.65 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -14.23 26.97 54.31 -16.02 26.35 52.81 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c02 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 C 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 C 217 SER B 32 SER^? 8.58 ZN ZN B 118 C 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo -12.07 2.83 63.52 -8.95 7.56 61.01 -10.40 7.25 27.78 -14.86 10.45 31.09 coo -11.64 10.12 58.62 -9.34 9.31 58.79 -11.02 10.19 35.41 -13.14 10.52 36.50 coo -9.31 12.91 61.58 -8.56 11.90 59.50 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c02 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c02 naa= 3 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 D 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 D 217 SER A 32 SER^? 8.89 ZN ZN A 119 D 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo 32.93 17.78 71.88 30.89 13.50 67.83 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 34.38 11.17 66.10 32.18 12.14 65.65 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 31.34 7.96 67.74 31.44 9.08 65.62 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c03 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 D 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 D 217 SER B 32 SER^? 8.58 ZN ZN B 118 D 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo 32.93 17.78 71.88 30.89 13.50 67.83 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 34.38 11.17 66.10 32.18 12.14 65.65 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 31.34 7.96 67.74 31.44 9.08 65.62 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c03 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c03 naa= 3 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 E 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 E 217 SER A 32 SER^? 8.89 ZN ZN A 119 E 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c04 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 E 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 E 217 SER B 32 SER^? 8.58 ZN ZN B 118 E 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo 75.33 -22.06 34.43 71.44 -18.39 37.56 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 67.33 -19.20 36.79 68.69 -17.23 37.19 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 67.84 -18.40 41.49 67.44 -16.90 39.59 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c04 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c04 naa= 3 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 F 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 F 217 SER A 32 SER^? 8.89 ZN ZN A 119 F 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo 85.78 13.19 64.96 85.47 13.47 58.63 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 87.43 17.13 57.15 85.84 15.39 56.76 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 89.69 13.60 54.86 87.60 14.67 54.46 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c05 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 F 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 F 217 SER B 32 SER^? 8.58 ZN ZN B 118 F 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo 85.78 13.19 64.96 85.47 13.47 58.63 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 87.43 17.13 57.15 85.84 15.39 56.76 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 89.69 13.60 54.86 87.60 14.67 54.46 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c05 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c05 naa= 3 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 G 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 G 217 SER A 32 SER^? 8.89 ZN ZN A 119 G 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c06 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 G 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 G 217 SER B 32 SER^? 8.58 ZN ZN B 118 G 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo 89.44 13.59 -3.79 85.15 17.81 -2.15 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 86.84 21.07 -0.09 84.89 19.68 -0.05 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 83.77 22.72 -3.25 83.41 21.94 -0.96 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c06 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c06 naa= 3 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 H 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 H 217 SER A 32 SER^? 8.89 ZN ZN A 119 H 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c07 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 H 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 H 217 SER B 32 SER^? 8.58 ZN ZN B 118 H 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo 42.27 12.37 -13.24 45.60 9.85 -8.67 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 42.97 6.75 -6.56 44.94 8.04 -6.19 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 46.96 4.33 -7.53 46.37 5.62 -5.61 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c07 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c07 naa= 3 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 I 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 I 217 SER A 32 SER^? 8.89 ZN ZN A 119 I 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 2.83 88.63 29.54 1.30 86.82 30.03 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 2.37 88.32 34.25 2.82 86.58 32.61 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c08 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 I 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 I 217 SER B 32 SER^? 8.58 ZN ZN B 118 I 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo -5.05 91.11 27.04 -1.24 87.39 30.21 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 2.83 88.63 29.54 1.30 86.82 30.03 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 2.37 88.32 34.25 2.82 86.58 32.61 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c08 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c08 naa= 3 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 J 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 J 217 SER A 32 SER^? 8.89 ZN ZN A 119 J 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -16.25 29.91 61.58 -19.73 26.30 57.65 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -14.23 26.97 54.31 -16.02 26.35 52.81 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c09 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 J 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 J 217 SER B 32 SER^? 8.58 ZN ZN B 118 J 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo -16.11 59.78 61.53 -15.92 58.68 55.43 -10.40 7.25 27.78 -14.86 10.45 31.09 coo -17.65 54.92 54.17 -15.81 56.46 53.79 -11.02 10.19 35.41 -13.14 10.52 36.50 coo -19.92 58.10 51.57 -17.75 57.08 51.34 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c09 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c09 naa= 3 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 K 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 K 217 SER A 32 SER^? 8.89 ZN ZN A 119 K 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -16.25 29.91 61.58 -19.73 26.30 57.65 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -14.23 26.97 54.31 -16.02 26.35 52.81 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c10 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 K 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 K 217 SER B 32 SER^? 8.58 ZN ZN B 118 K 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo -19.03 51.36 -6.94 -15.20 46.99 -4.75 -10.40 7.25 27.78 -14.86 10.45 31.09 coo -16.83 44.30 -2.14 -14.73 45.44 -2.29 -11.02 10.19 35.41 -13.14 10.52 36.50 coo -13.82 42.19 -5.17 -13.38 43.30 -3.07 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c10 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c10 naa= 3 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 L 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 L 217 SER A 32 SER^? 8.89 ZN ZN A 119 L 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c11 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 L 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 L 217 SER B 32 SER^? 8.58 ZN ZN B 118 L 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo 28.16 48.07 -15.34 25.35 51.49 -11.15 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 28.02 54.76 -9.49 26.01 53.53 -9.27 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 24.20 57.36 -11.16 24.62 56.31 -9.00 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c11 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c11 naa= 3 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 M 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 M 217 SER A 32 SER^? 8.89 ZN ZN A 119 M 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo 57.83 99.61 24.25 54.90 95.14 20.60 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 51.07 94.66 21.52 53.18 93.49 22.20 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 51.67 94.23 16.93 51.60 92.47 18.57 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c12 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 M 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 M 217 SER B 32 SER^? 8.58 ZN ZN B 118 M 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo 57.83 99.61 24.25 54.90 95.14 20.60 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 51.07 94.66 21.52 53.18 93.49 22.20 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 51.67 94.23 16.93 51.60 92.47 18.57 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c12 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c12 naa= 3 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 N 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 N 217 SER A 32 SER^? 8.89 ZN ZN A 119 N 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 82.47 71.15 2.07 80.82 69.44 2.28 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c13 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 N 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 N 217 SER B 32 SER^? 8.58 ZN ZN B 118 N 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo 79.06 71.19 -8.17 79.37 70.55 -1.89 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 81.67 67.31 -0.58 79.53 68.28 0.00 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 82.47 71.15 2.07 80.82 69.44 2.28 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c13 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c13 naa= 3 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 O 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 O 217 SER A 32 SER^? 8.89 ZN ZN A 119 O 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo 81.67 70.12 58.71 78.82 64.87 57.22 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 81.62 62.23 55.05 79.32 62.93 55.20 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 79.39 59.54 58.42 78.72 60.00 56.11 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c14 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 O 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 O 217 SER B 32 SER^? 8.58 ZN ZN B 118 O 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo 81.67 70.12 58.71 78.82 64.87 57.22 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 81.62 62.23 55.05 79.32 62.93 55.20 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 79.39 59.54 58.42 78.72 60.00 56.11 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c14 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c14 naa= 3 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 1 3 # 1 P 142 LYS A 29 LYS^? 13.52 CH3 ACY A 120 P 217 SER A 32 SER^? 8.89 ZN ZN A 119 P 241 SER A 51 SER^? 4.15 ZN ZN A 119 coo 37.29 55.72 69.54 38.73 59.85 65.07 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 35.55 61.40 62.96 37.72 60.41 62.66 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 38.60 64.77 64.10 38.63 63.28 62.26 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 3 1mt5_c15 FATTY-ACID AMIDE HYDROLASE user 2 3 # 2 P 142 LYS B 29 LYS^? 13.36 ZN ZN B 118 P 217 SER B 32 SER^? 8.58 ZN ZN B 118 P 241 SER B 51 SER^? 4.27 ZN ZN B 118 coo 37.29 55.72 69.54 38.73 59.85 65.07 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 35.55 61.40 62.96 37.72 60.41 62.66 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 38.60 64.77 64.10 38.63 63.28 62.26 -11.41 5.84 39.04 -13.87 6.10 39.28 1mt5_c15 source 1mt5 FATTY-ACID AMIDE HYDROLASE : 2 hits 1mt5_c15 naa= 3 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 A 114 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 197 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 223 ALA A 21 ALA^? 9.29 CH3 ACY A 120 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -14.76 24.38 57.77 -15.72 24.16 58.96 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 A 114 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 197 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 223 ALA B 21 ALA^? 9.36 CH3 ACY B 120 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -10.37 12.66 32.04 -10.93 12.80 30.64 ULMN 3 1n2t_c02 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 A 114 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 197 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 223 ALA B 21 ALA^? 9.36 CH3 ACY B 120 coo -61.68 -8.94 -28.01 -61.87 -7.73 -26.31 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -57.09 -14.53 -30.28 -57.60 -13.32 -28.61 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -56.49 -13.76 -16.93 -57.17 -13.93 -18.30 -10.37 12.66 32.04 -10.93 12.80 30.64 1n2t_c02 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 3 hits 1n2t_c02 naa= 3 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 1 3 # 1 B 114 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 197 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 223 ALA A 21 ALA^? 9.29 CH3 ACY A 120 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -14.76 24.38 57.77 -15.72 24.16 58.96 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 2 3 # 2 B 114 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 197 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 223 ALA B 21 ALA^? 9.36 CH3 ACY B 120 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -10.37 12.66 32.04 -10.93 12.80 30.64 ULMN 3 1n2t_c03 L-CYSTEINE-CYSTINE LYASE C-DES user 3 3 # 3 B 114 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 197 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 223 ALA B 21 ALA^? 9.36 CH3 ACY B 120 coo -32.24 6.73 -26.90 -32.01 5.24 -25.44 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -36.83 12.62 -28.19 -36.31 11.10 -26.78 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -37.23 9.70 -15.15 -36.60 10.10 -16.48 -10.37 12.66 32.04 -10.93 12.80 30.64 1n2t_c03 source 1n2t L-CYSTEINE-CYSTINE LYASE C-DES : 3 hits 1n2t_c03 naa= 3 ULMN 3 1nsf_c00 N-ETHYLMALEIMIDE SENSITIVE FACTOR user 1 3 # 1 549 LYS A 40 LYS.? -3.18 C ACY A 121s 631 LYS A 93 LYS.? 17.16 ZN ZN A 119 708 LYS B 71 LYS^? 12.90 O ACY A 121 coo 8.61 33.06 11.15 10.12 29.19 8.82 1.80 21.48 38.21 -1.61 24.69 34.09 coo -11.99 27.40 17.14 -13.60 24.52 11.71 -8.24 41.47 45.26 -7.63 47.05 46.72 coo 18.16 32.86 9.85 16.06 28.20 13.56 0.91 14.36 31.66 5.84 10.91 29.66 1nsf_c00 source 1nsf N-ETHYLMALEIMIDE SENSITIVE FACTOR : 1 hits 1nsf_c00 naa= 3 ULMN 3 1ohh_c06 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 A 175 LYS A 16 LYS~? -3.27 O ACY A 120s A 208 GLN B 18 GLN~? 11.75 ZN ZN B 118 A 209 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 98.39 14.31 -19.34 101.13 12.36 -14.91 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 107.44 7.66 -20.60 106.37 8.45 -22.25 -10.66 16.34 42.67 -11.39 17.08 44.58 coo 109.03 2.06 -20.49 104.00 -1.36 -18.88 -10.13 21.11 38.47 -9.52 22.58 33.19 1ohh_c06 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 1 hits 1ohh_c06 naa= 3 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 1 3 # 1 B 175 LYS A 16 LYS~? -3.27 O ACY A 120s B 208 GLN B 18 GLN~? 11.75 ZN ZN B 118 B 209 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 105.03 46.01 19.55 106.59 42.35 15.55 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 113.93 46.99 13.56 113.37 48.52 14.95 -10.66 16.34 42.67 -11.39 17.08 44.58 coo 115.66 49.12 8.60 111.19 49.52 4.73 -10.13 21.11 38.47 -9.52 22.58 33.19 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 2 3 # 2 B 175 LYS A 29 LYS^? 13.52 CH3 ACY A 120 B 208 GLN A 80 GLN^? 13.49 CH3 ACY A 120 B 209 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 105.03 46.01 19.55 106.59 42.35 15.55 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 113.93 46.99 13.56 113.37 48.52 14.95 -8.25 27.21 65.12 -8.76 26.74 67.12 coo 115.66 49.12 8.60 111.19 49.52 4.73 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 3 3 # 3 B 175 LYS B 16 LYS~? -4.10 OXT ACY B 120s B 208 GLN A 18 GLN.? 11.66 ZN ZN A 119 B 209 LYS A 16 LYS~? -3.27 O ACY A 120s coo 105.03 46.01 19.55 106.59 42.35 15.55 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 113.93 46.99 13.56 113.37 48.52 14.95 -11.72 21.08 47.54 -11.51 20.01 45.71 coo 115.66 49.12 8.60 111.19 49.52 4.73 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 3 1ohh_c07 ATP SYNTHASE ALPHA CHAIN HEART ISOFOuser 4 3 # 4 B 175 LYS B 29 LYS^? 13.36 ZN ZN B 118 B 208 GLN B 80 GLN^? 13.44 O ACY A 121 B 209 LYS B 71 LYS^? 12.90 O ACY A 121 coo 105.03 46.01 19.55 106.59 42.35 15.55 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 113.93 46.99 13.56 113.37 48.52 14.95 -1.66 10.00 27.14 -1.43 10.41 25.06 coo 115.66 49.12 8.60 111.19 49.52 4.73 0.91 14.36 31.66 5.84 10.91 29.66 1ohh_c07 source 1ohh ATP SYNTHASE ALPHA CHAIN HEART ISOFORM, MITOCH: 4 hits 1ohh_c07 naa= 3 ULMN 3 1p7m_c00 DNA-3-METHYLADENINE GLYCOSYLASE I user 1 3 # 1 A 16 TYR A 94 TYR.? 14.61 ZN ZN A 119 A 38 GLU A 99 GLU.? 20.42 CH3 ACY A 121 A 46 TRP A 100 TRP.? 19.43 ZN ZN A 119 coo 141.05 24.62 -1.85 142.62 22.60 -2.97 -5.97 41.42 41.15 -7.10 43.78 40.18 coo 142.20 14.40 -6.46 142.04 16.49 -6.62 4.40 42.94 40.00 4.87 41.71 38.33 coo 137.32 22.45 -5.52 140.17 20.39 -3.63 -2.26 47.11 41.70 -4.68 47.32 44.78 1p7m_c00 source 1p7m DNA-3-METHYLADENINE GLYCOSYLASE I : 1 hits 1p7m_c00 naa= 3 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 A 70 ALA A 91 ALA.? 11.21 ZN ZN A 119 A 126 LEU A 88 LEU~? 13.45 ZN ZN A 119 A 158 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -7.50 39.92 51.50 -8.68 39.00 51.45 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -10.40 38.33 56.93 -10.60 36.17 57.15 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 3 1pjh_c00 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 A 70 ALA B 91 ALA.? 11.25 ZN ZN B 118 A 126 LEU B 88 LEU~? 13.53 ZN ZN B 118 A 158 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo -2.29 37.66 144.73 -1.46 37.12 145.87 -5.13 -2.73 40.48 -6.21 -1.76 40.05 coo -4.62 32.83 147.14 -5.50 32.85 149.12 -6.19 -1.12 34.28 -6.06 1.03 33.84 coo -0.83 29.57 149.77 -0.39 31.47 148.95 -7.13 -6.28 33.53 -6.83 -7.93 32.24 1pjh_c00 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c00 naa= 3 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 B 70 ALA A 91 ALA.? 11.21 ZN ZN A 119 B 126 LEU A 88 LEU~? 13.45 ZN ZN A 119 B 158 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -7.50 39.92 51.50 -8.68 39.00 51.45 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -10.40 38.33 56.93 -10.60 36.17 57.15 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 3 1pjh_c01 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 B 70 ALA B 91 ALA.? 11.25 ZN ZN B 118 B 126 LEU B 88 LEU~? 13.53 ZN ZN B 118 B 158 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo -39.79 4.61 147.27 -39.61 5.56 148.47 -5.13 -2.73 40.48 -6.21 -1.76 40.05 coo -34.22 5.06 149.25 -33.65 4.24 151.15 -6.19 -1.12 34.28 -6.06 1.03 33.84 coo -33.03 9.93 151.71 -34.98 9.38 151.11 -7.13 -6.28 33.53 -6.83 -7.93 32.24 1pjh_c01 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c01 naa= 3 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 1 3 # 1 C 70 ALA A 91 ALA.? 11.21 ZN ZN A 119 C 126 LEU A 88 LEU~? 13.45 ZN ZN A 119 C 158 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -7.50 39.92 51.50 -8.68 39.00 51.45 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -10.40 38.33 56.93 -10.60 36.17 57.15 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 3 1pjh_c02 ENOYL-COA ISOMERASE; ECI1P user 2 3 # 2 C 70 ALA B 91 ALA.? 11.25 ZN ZN B 118 C 126 LEU B 88 LEU~? 13.53 ZN ZN B 118 C 158 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 7.77 -11.41 146.15 6.88 -11.77 147.32 -5.13 -2.73 40.48 -6.21 -1.76 40.05 coo 4.88 -6.81 148.13 5.33 -5.89 150.06 -6.19 -1.12 34.28 -6.06 1.03 33.84 coo 0.03 -8.25 150.96 1.55 -9.64 150.41 -7.13 -6.28 33.53 -6.83 -7.93 32.24 1pjh_c02 source 1pjh ENOYL-COA ISOMERASE; ECI1P : 2 hits 1pjh_c02 naa= 3 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 1 3 # 1 111 GLN A 18 GLN.? 11.66 ZN ZN A 119 294 GLU B 34 GLU.? -2.23 ZN ZN B 118s 304 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 15.89 18.45 46.53 15.82 16.91 48.02 -11.72 21.08 47.54 -11.51 20.01 45.71 coo 22.84 13.44 52.91 20.84 13.18 52.38 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 8.71 17.11 46.51 7.23 17.64 49.20 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 3 1pmi_c00 PHOSPHOMANNOSE ISOMERASE user 2 3 # 2 111 GLN B 18 GLN~? 11.75 ZN ZN B 118 294 GLU A 34 GLU^? -2.26 ZN ZN A 119s 304 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo 15.89 18.45 46.53 15.82 16.91 48.02 -10.66 16.34 42.67 -11.39 17.08 44.58 coo 22.84 13.44 52.91 20.84 13.18 52.38 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 8.71 17.11 46.51 7.23 17.64 49.20 -9.55 10.54 47.29 -12.21 9.06 46.81 1pmi_c00 source 1pmi PHOSPHOMANNOSE ISOMERASE : 2 hits 1pmi_c00 naa= 3 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 A 74 ASN A 6 ASN.? 7.96 O ACY A 120 A 192 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 195 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -11.99 10.76 51.07 -13.19 11.09 52.81 coo 2.03 47.14 19.75 1.72 46.26 21.64 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 3 1pp4_c02 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 A 74 ASN B 6 ASN.? 8.30 OXT ACY B 120 A 192 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 195 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo -4.84 51.77 30.37 -3.89 50.12 29.46 -9.87 26.28 39.29 -10.81 26.02 37.42 coo 2.03 47.14 19.75 1.72 46.26 21.64 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 1.41 44.84 24.92 -0.49 45.70 25.19 -11.17 33.63 46.78 -12.74 33.06 45.52 1pp4_c02 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 2 hits 1pp4_c02 naa= 3 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 1 3 # 1 B 74 ASN A 6 ASN.? 7.96 O ACY A 120 B 192 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 195 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo -1.08 51.41 10.34 0.65 52.62 10.17 -11.99 10.76 51.07 -13.19 11.09 52.81 coo 11.36 52.33 5.59 10.18 53.87 6.47 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 7.99 56.74 7.55 6.88 55.39 8.70 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 3 1pp4_c03 RHAMNOGALACTURONAN ACETYLESTERASE user 2 3 # 2 B 74 ASN B 6 ASN.? 8.30 OXT ACY B 120 B 192 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 195 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo -1.08 51.41 10.34 0.65 52.62 10.17 -9.87 26.28 39.29 -10.81 26.02 37.42 coo 11.36 52.33 5.59 10.18 53.87 6.47 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 7.99 56.74 7.55 6.88 55.39 8.70 -11.17 33.63 46.78 -12.74 33.06 45.52 1pp4_c03 source 1pp4 RHAMNOGALACTURONAN ACETYLESTERASE : 2 hits 1pp4_c03 naa= 3 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 1 3 # 1 A 189 SER A 51 SER^? 4.15 ZN ZN A 119 A 310 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 399 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 2.67 37.96 55.23 1.78 40.01 56.16 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 6.61 38.44 63.61 6.69 38.31 61.50 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 4.95 41.82 59.53 3.85 40.70 58.14 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 3 1qe3_c00 PARA-NITROBENZYL ESTERASE user 2 3 # 2 A 189 SER B 51 SER^? 4.27 ZN ZN B 118 A 310 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 399 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 2.67 37.96 55.23 1.78 40.01 56.16 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 6.61 38.44 63.61 6.69 38.31 61.50 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 4.95 41.82 59.53 3.85 40.70 58.14 -10.33 3.56 43.54 -12.07 4.44 44.29 1qe3_c00 source 1qe3 PARA-NITROBENZYL ESTERASE : 2 hits 1qe3_c00 naa= 3 ULMN 3 1qgn_c08 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 A 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 261 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 55.48 26.51 40.65 55.39 23.99 39.43 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 48.87 29.19 44.63 49.10 27.34 43.63 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 47.58 17.35 41.83 51.40 20.85 40.83 -16.25 29.91 61.58 -19.73 26.30 57.65 1qgn_c08 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c08 naa= 3 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 B 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 261 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 3 1qgn_c09 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 B 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 261 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 34.76 -4.30 11.09 34.67 -9.53 11.78 -10.40 7.25 27.78 -14.86 10.45 31.09 1qgn_c09 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c09 naa= 3 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 C 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 C 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 261 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 39.51 34.34 13.63 37.63 32.61 14.79 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 45.78 31.11 9.51 44.25 30.06 10.53 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 37.54 22.37 12.10 37.83 27.55 13.24 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 3 1qgn_c10 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 C 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 C 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 261 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 39.51 34.34 13.63 37.63 32.61 14.79 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 45.78 31.11 9.51 44.25 30.06 10.53 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 37.54 22.37 12.10 37.83 27.55 13.24 -10.40 7.25 27.78 -14.86 10.45 31.09 1qgn_c10 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c10 naa= 3 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 D 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 D 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 D 261 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 3 1qgn_c11 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 D 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 D 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 D 261 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 29.23 -2.19 42.26 25.35 -5.68 41.50 -10.40 7.25 27.78 -14.86 10.45 31.09 1qgn_c11 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c11 naa= 3 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 E 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 E 261 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 3 1qgn_c12 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 E 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 E 261 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 47.72 -17.32 -35.69 50.97 -21.34 -36.71 -10.40 7.25 27.78 -14.86 10.45 31.09 1qgn_c12 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c12 naa= 3 ULMN 3 1qgn_c13 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 F 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 F 261 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 26.66 -3.59 -66.44 21.49 -3.17 -65.71 -16.25 29.91 61.58 -19.73 26.30 57.65 1qgn_c13 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 1 hits 1qgn_c13 naa= 3 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 G 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 G 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 G 261 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 3 1qgn_c14 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 G 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 G 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 G 261 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 53.04 -8.15 -65.60 58.23 -8.69 -64.55 -10.40 7.25 27.78 -14.86 10.45 31.09 1qgn_c14 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c14 naa= 3 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 H 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 H 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 H 261 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 3 1qgn_c15 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 H 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 H 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 H 261 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 29.54 2.32 -35.34 26.33 6.41 -36.17 -10.40 7.25 27.78 -14.86 10.45 31.09 1qgn_c15 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c15 naa= 3 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 110 ARG A 90 ARG~? 21.28 ZN ZN A 119 C 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 C 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 39.01 29.77 22.02 37.48 31.30 19.84 -4.89 45.59 55.49 -2.75 44.62 57.47 coo 39.51 34.34 13.63 37.63 32.61 14.79 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 45.78 31.11 9.51 44.25 30.06 10.53 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1qgn_c16 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 110 ARG B 90 ARG~? 22.74 ZN ZN B 118 C 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 C 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 39.01 29.77 22.02 37.48 31.30 19.84 -1.29 -8.08 37.25 0.33 -10.46 36.18 coo 39.51 34.34 13.63 37.63 32.61 14.79 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 45.78 31.11 9.51 44.25 30.06 10.53 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1qgn_c16 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c16 naa= 3 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 110 ARG A 90 ARG~? 21.28 ZN ZN A 119 D 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 D 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -4.89 45.59 55.49 -2.75 44.62 57.47 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1qgn_c17 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 110 ARG B 90 ARG~? 22.74 ZN ZN B 118 D 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 D 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 23.05 -7.35 32.81 21.30 -7.38 35.33 -1.29 -8.08 37.25 0.33 -10.46 36.18 coo 21.28 -11.43 41.42 21.14 -8.83 40.39 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 28.41 -14.31 44.14 27.98 -12.36 43.41 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1qgn_c17 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c17 naa= 3 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 A 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 A 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 110 ARG A 90 ARG~? 21.28 ZN ZN A 119 coo 55.48 26.51 40.65 55.39 23.99 39.43 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 48.87 29.19 44.63 49.10 27.34 43.63 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 52.39 23.42 32.10 54.51 23.27 34.29 -4.89 45.59 55.49 -2.75 44.62 57.47 ULMN 3 1qgn_c18 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 A 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 A 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 110 ARG B 90 ARG~? 22.74 ZN ZN B 118 coo 55.48 26.51 40.65 55.39 23.99 39.43 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 48.87 29.19 44.63 49.10 27.34 43.63 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 52.39 23.42 32.10 54.51 23.27 34.29 -1.29 -8.08 37.25 0.33 -10.46 36.18 1qgn_c18 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c18 naa= 3 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 B 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 B 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 D 110 ARG A 90 ARG~? 21.28 ZN ZN A 119 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -4.89 45.59 55.49 -2.75 44.62 57.47 ULMN 3 1qgn_c19 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 B 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 B 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 D 110 ARG B 90 ARG~? 22.74 ZN ZN B 118 coo 32.99 -16.32 11.66 35.01 -14.70 12.72 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 26.18 -12.82 8.91 27.87 -11.87 9.77 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 34.79 -12.60 20.34 35.97 -13.92 17.84 -1.29 -8.08 37.25 0.33 -10.46 36.18 1qgn_c19 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c19 naa= 3 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 110 ARG A 90 ARG~? 21.28 ZN ZN A 119 G 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 G 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -4.89 45.59 55.49 -2.75 44.62 57.47 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1qgn_c20 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 110 ARG B 90 ARG~? 22.74 ZN ZN B 118 G 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 G 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 60.40 -9.85 -55.76 62.00 -8.48 -58.01 -1.29 -8.08 37.25 0.33 -10.46 36.18 coo 64.84 -10.79 -64.16 63.27 -8.78 -63.00 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 61.22 -16.97 -68.13 60.30 -15.38 -67.08 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1qgn_c20 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c20 naa= 3 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 110 ARG A 90 ARG~? 21.28 ZN ZN A 119 H 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 H 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -4.89 45.59 55.49 -2.75 44.62 57.47 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1qgn_c21 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 110 ARG B 90 ARG~? 22.74 ZN ZN B 118 H 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 H 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 24.62 8.71 -44.89 24.77 10.53 -42.42 -1.29 -8.08 37.25 0.33 -10.46 36.18 coo 20.90 10.83 -36.23 23.51 10.75 -37.23 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 17.57 3.99 -33.38 19.51 4.24 -34.16 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1qgn_c21 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c21 naa= 3 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 E 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 E 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 G 110 ARG A 90 ARG~? 21.28 ZN ZN A 119 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -4.89 45.59 55.49 -2.75 44.62 57.47 ULMN 3 1qgn_c22 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 E 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 E 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 G 110 ARG B 90 ARG~? 22.74 ZN ZN B 118 coo 56.39 -25.68 -36.91 53.88 -25.46 -38.13 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 59.54 -19.27 -32.99 57.70 -19.44 -33.97 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 53.35 -22.70 -45.35 52.95 -24.81 -43.16 -1.29 -8.08 37.25 0.33 -10.46 36.18 1qgn_c22 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c22 naa= 3 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 1 3 # 1 F 163 TYR A 63 TYR^? 13.00 ZN ZN A 119 F 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 H 110 ARG A 90 ARG~? 21.28 ZN ZN A 119 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -4.89 45.59 55.49 -2.75 44.62 57.47 ULMN 3 1qgn_c23 CYSTATHIONINE GAMMA-SYNTHASE user 2 3 # 2 F 163 TYR B 63 TYR^? 12.86 ZN ZN B 118 F 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 H 110 ARG B 90 ARG~? 22.74 ZN ZN B 118 coo 14.88 -1.19 -65.80 16.37 -3.30 -64.72 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 18.75 5.49 -68.65 19.58 3.75 -67.80 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 18.56 -3.01 -57.11 17.14 -4.14 -59.58 -1.29 -8.08 37.25 0.33 -10.46 36.18 1qgn_c23 source 1qgn CYSTATHIONINE GAMMA-SYNTHASE : 2 hits 1qgn_c23 naa= 3 ULMN 3 1qho_c05 ALPHA-AMYLASE user 1 3 # 1 A 228 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 261 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 329 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 34.02 79.89 42.60 34.73 78.01 41.86 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1qho_c05 ALPHA-AMYLASE user 2 3 # 2 A 228 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 261 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 329 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 34.02 79.89 42.60 34.73 78.01 41.86 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 37.87 70.12 31.80 36.61 69.74 30.15 -12.98 14.88 47.28 -12.40 12.90 47.92 1qho_c05 source 1qho ALPHA-AMYLASE : 2 hits 1qho_c05 naa= 3 ULMN 3 1qz9_c02 KYNURENINASE user 1 3 # 1 A 129 PHE A 52 PHE^? 9.40 ZN ZN A 119 A 201 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 227 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 23.39 49.81 32.16 21.33 51.68 32.26 -13.64 35.13 53.79 -11.95 37.28 53.18 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 12.68 46.83 36.69 18.26 48.67 34.51 -8.24 41.47 45.26 -7.63 47.05 46.72 1qz9_c02 source 1qz9 KYNURENINASE : 1 hits 1qz9_c02 naa= 3 ULMN 3 1rgq_c01 NS4A PEPTIDE user 1 3 # 1 B 60 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 84 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 140 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 3 1rgq_c01 NS4A PEPTIDE user 2 3 # 2 B 60 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 84 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 140 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo 20.71 17.85 -18.47 19.91 19.62 -17.68 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 23.40 21.01 -22.79 22.72 19.65 -21.32 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 11.52 20.17 -13.15 11.93 20.87 -13.16 -8.10 13.52 49.98 -8.09 14.12 50.54 1rgq_c01 source 1rgq NS4A PEPTIDE : 2 hits 1rgq_c01 naa= 3 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 1 3 # 1 32 ASP A 15 ASP~? 8.61 ZN ZN B 118 35 SER A 14 SER~? 11.41 CH3 ACY A 120 215 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 11.85 17.24 72.81 11.09 15.37 72.36 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 12.20 12.71 75.45 13.69 13.84 74.03 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 5.22 15.03 71.43 7.19 14.88 70.83 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 2 3 # 2 32 ASP A 60 ASP.? -2.37 ZN ZN A 119s 35 SER A 51 SER^? 4.15 ZN ZN A 119 215 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 11.85 17.24 72.81 11.09 15.37 72.36 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 12.20 12.71 75.45 13.69 13.84 74.03 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 5.22 15.03 71.43 7.19 14.88 70.83 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 3 3 # 3 32 ASP B 15 ASP~? 8.50 ZN ZN A 119 35 SER B 14 SER~? 11.46 CH3 ACY B 120 215 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 11.85 17.24 72.81 11.09 15.37 72.36 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 12.20 12.71 75.45 13.69 13.84 74.03 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 5.22 15.03 71.43 7.19 14.88 70.83 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 3 1rne_c04 RENIN (ACTIVATED, GLYCOSYLATED, INHIuser 4 3 # 4 32 ASP B 60 ASP.? -2.30 ZN ZN B 118s 35 SER B 51 SER^? 4.27 ZN ZN B 118 215 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 11.85 17.24 72.81 11.09 15.37 72.36 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 12.20 12.71 75.45 13.69 13.84 74.03 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 5.22 15.03 71.43 7.19 14.88 70.83 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1rne_c04 source 1rne RENIN (ACTIVATED, GLYCOSYLATED, INHIBITED) (E.: 4 hits 1rne_c04 naa= 3 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 1 3 # 1 D 129 ARG A 35 ARG^? 4.87 ZN ZN A 119 D 156 TYR A 63 TYR^? 13.00 ZN ZN A 119 D 188 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 -6.95 35.16 53.71 -4.78 36.23 55.09 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 3 1ro7_c03 ALPHA-2,3/8-SIALYLTRANSFERASE user 2 3 # 2 D 129 ARG B 35 ARG.? 5.03 ZN ZN B 118 D 156 TYR B 63 TYR^? 12.86 ZN ZN B 118 D 188 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo -19.99 -38.81 30.91 -19.99 -39.90 28.04 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -32.96 -44.88 30.49 -32.31 -42.65 28.92 -4.17 2.05 38.57 -1.76 0.81 38.01 coo -25.33 -42.26 31.79 -24.77 -40.56 30.70 -10.33 3.56 43.54 -12.07 4.44 44.29 1ro7_c03 source 1ro7 ALPHA-2,3/8-SIALYLTRANSFERASE : 2 hits 1ro7_c03 naa= 3 ULMN 3 1rtf_c06 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 3 # 1 B 57 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 102 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 193 GLY A 95 GLY.? 11.34 ZN ZN A 119 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -6.81 22.81 34.74 -6.42 23.54 34.62 -4.39 36.14 43.27 -4.07 36.89 43.24 1rtf_c06 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 1 hits 1rtf_c06 naa= 3 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 1 3 # 1 32 ASP A 60 ASP.? -2.37 ZN ZN A 119s 64 HIS A 62 HIS^? -3.21 ZN ZN A 119s 155 ASN B 6 ASN.? 8.30 OXT ACY B 120 coo 80.16 73.25 62.48 80.01 71.25 61.82 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 78.27 67.69 61.83 79.58 67.76 60.19 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 80.34 61.88 52.75 81.25 63.19 54.35 -9.87 26.28 39.29 -10.81 26.02 37.42 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 2 3 # 2 32 ASP A 61 ASP^? 8.97 ZN ZN A 119 64 HIS A 62 HIS^? -3.21 ZN ZN A 119s 155 ASN B 6 ASN.? 8.30 OXT ACY B 120 coo 80.16 73.25 62.48 80.01 71.25 61.82 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 78.27 67.69 61.83 79.58 67.76 60.19 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 80.34 61.88 52.75 81.25 63.19 54.35 -9.87 26.28 39.29 -10.81 26.02 37.42 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 3 3 # 3 32 ASP B 60 ASP.? -2.30 ZN ZN B 118s 64 HIS B 62 HIS^? -3.22 ZN ZN B 118s 155 ASN A 6 ASN.? 7.96 O ACY A 120 coo 80.16 73.25 62.48 80.01 71.25 61.82 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 78.27 67.69 61.83 79.58 67.76 60.19 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 80.34 61.88 52.75 81.25 63.19 54.35 -11.99 10.76 51.07 -13.19 11.09 52.81 ULMN 3 1sca_c01 SUBTILISIN CARLSBERG (E.C.3.4.21.62)user 4 3 # 4 32 ASP B 61 ASP^? 9.02 ZN ZN B 118 64 HIS B 62 HIS^? -3.22 ZN ZN B 118s 155 ASN A 6 ASN.? 7.96 O ACY A 120 coo 80.16 73.25 62.48 80.01 71.25 61.82 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 78.27 67.69 61.83 79.58 67.76 60.19 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 80.34 61.88 52.75 81.25 63.19 54.35 -11.99 10.76 51.07 -13.19 11.09 52.81 1sca_c01 source 1sca SUBTILISIN CARLSBERG (E.C.3.4.21.62) (AQUEOUS : 4 hits 1sca_c01 naa= 3 ULMN 3 1sme_c04 PLASMEPSIN II user 1 3 # 1 A 34 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 37 SER A 14 SER~? 11.41 CH3 ACY A 120 A 214 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 51.75 60.57 19.10 52.05 60.90 21.19 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 51.10 65.11 20.73 52.62 63.74 19.42 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 48.59 58.89 25.78 50.13 59.74 24.61 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1sme_c04 PLASMEPSIN II user 2 3 # 2 A 34 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 37 SER B 14 SER~? 11.46 CH3 ACY B 120 A 214 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 51.75 60.57 19.10 52.05 60.90 21.19 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 51.10 65.11 20.73 52.62 63.74 19.42 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 48.59 58.89 25.78 50.13 59.74 24.61 -12.98 14.88 47.28 -12.40 12.90 47.92 1sme_c04 source 1sme PLASMEPSIN II : 2 hits 1sme_c04 naa= 3 ULMN 3 1sme_c05 PLASMEPSIN II user 1 3 # 1 B 34 ASP A 15 ASP~? 8.61 ZN ZN B 118 B 37 SER A 14 SER~? 11.41 CH3 ACY A 120 B 214 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 17.69 97.58 52.73 17.33 97.19 54.77 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 20.67 100.44 55.84 20.21 98.51 54.45 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 12.41 98.71 58.47 14.37 98.17 58.05 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 1sme_c05 PLASMEPSIN II user 2 3 # 2 B 34 ASP B 15 ASP~? 8.50 ZN ZN A 119 B 37 SER B 14 SER~? 11.46 CH3 ACY B 120 B 214 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 17.69 97.58 52.73 17.33 97.19 54.77 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 20.67 100.44 55.84 20.21 98.51 54.45 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 12.41 98.71 58.47 14.37 98.17 58.05 -12.98 14.88 47.28 -12.40 12.90 47.92 1sme_c05 source 1sme PLASMEPSIN II : 2 hits 1sme_c05 naa= 3 ULMN 3 1ssx_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 102 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 193 GLY A 95 GLY.? 11.34 ZN ZN A 119 coo 15.02 29.17 19.44 15.63 29.96 17.60 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 19.67 30.58 22.61 18.30 29.87 21.17 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 14.52 29.10 10.01 15.08 29.66 10.19 -4.39 36.14 43.27 -4.07 36.89 43.24 1ssx_c02 source 1ssx ALPHA-LYTIC PROTEASE : 1 hits 1ssx_c02 naa= 3 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 1 3 # 1 A 88 SER A 51 SER^? 4.15 ZN ZN A 119 A 90 SER A 32 SER^? 8.89 ZN ZN A 119 A 145 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 1.47 40.03 18.48 2.45 41.37 16.68 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 7.35 44.71 16.29 4.71 40.98 14.52 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 3 1t7d_c00 SIGNAL PEPTIDASE I user 2 3 # 2 A 88 SER B 51 SER^? 4.27 ZN ZN B 118 A 90 SER B 32 SER^? 8.58 ZN ZN B 118 A 145 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo -3.31 40.95 15.56 -0.94 40.79 14.97 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 1.47 40.03 18.48 2.45 41.37 16.68 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 7.35 44.71 16.29 4.71 40.98 14.52 -10.40 7.25 27.78 -14.86 10.45 31.09 1t7d_c00 source 1t7d SIGNAL PEPTIDASE I : 2 hits 1t7d_c00 naa= 3 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 1 3 # 1 B 88 SER A 51 SER^? 4.15 ZN ZN A 119 B 90 SER A 32 SER^? 8.89 ZN ZN A 119 B 145 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 61.01 10.03 12.97 58.78 10.97 12.69 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 56.85 12.22 16.37 55.62 11.34 14.45 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 49.80 9.51 14.88 53.14 11.99 12.77 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 3 1t7d_c01 SIGNAL PEPTIDASE I user 2 3 # 2 B 88 SER B 51 SER^? 4.27 ZN ZN B 118 B 90 SER B 32 SER^? 8.58 ZN ZN B 118 B 145 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 61.01 10.03 12.97 58.78 10.97 12.69 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 56.85 12.22 16.37 55.62 11.34 14.45 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 49.80 9.51 14.88 53.14 11.99 12.77 -10.40 7.25 27.78 -14.86 10.45 31.09 1t7d_c01 source 1t7d SIGNAL PEPTIDASE I : 2 hits 1t7d_c01 naa= 3 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 1 3 # 1 217 SER A 51 SER^? 4.15 ZN ZN A 119 354 GLU B 4 GLU.? -2.30 ZN ZN A 119s 463 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 48.87 13.74 2.81 48.49 11.54 3.93 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 39.95 14.43 3.01 41.55 14.10 1.63 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 43.90 10.50 2.81 45.63 11.48 3.27 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 3 1thg_c00 LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROLuser 2 3 # 2 217 SER B 51 SER^? 4.27 ZN ZN B 118 354 GLU A 4 GLU.? -2.10 ZN ZN B 118s 463 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 48.87 13.74 2.81 48.49 11.54 3.93 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 39.95 14.43 3.01 41.55 14.10 1.63 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 43.90 10.50 2.81 45.63 11.48 3.27 -10.33 3.56 43.54 -12.07 4.44 44.29 1thg_c00 source 1thg LIPASE (E.C.3.1.1.3) TRIACYLGLYCEROL HYDROLASE: 2 hits 1thg_c00 naa= 3 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 1 3 # 1 A 581 GLU A 39 GLU^? 13.07 O ACY A 121 A 596 ARG A 44 ARG.? 16.49 O ACY A 121 A 647 ARG B 44 ARG.? 18.52 O ACY A 121 coo 69.13 32.20 28.58 68.39 32.96 30.44 3.97 24.42 42.90 6.03 24.50 43.46 coo 70.89 37.31 29.70 69.54 36.29 32.39 6.31 22.16 46.81 4.95 24.70 47.95 coo 66.09 40.54 34.70 66.92 37.69 35.49 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1v0e_c00 ENDO-ALPHA-SIALIDASE user 2 3 # 2 A 581 GLU B 39 GLU.? 14.67 OXT ACY A 120 A 596 ARG B 44 ARG.? 18.52 O ACY A 121 A 647 ARG A 44 ARG.? 16.49 O ACY A 121 coo 69.13 32.20 28.58 68.39 32.96 30.44 2.54 12.93 51.58 4.67 12.91 51.32 coo 70.89 37.31 29.70 69.54 36.29 32.39 6.69 16.72 49.11 8.85 18.83 48.43 coo 66.09 40.54 34.70 66.92 37.69 35.49 6.31 22.16 46.81 4.95 24.70 47.95 1v0e_c00 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c00 naa= 3 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 1 3 # 1 B 581 GLU A 39 GLU^? 13.07 O ACY A 121 B 596 ARG A 44 ARG.? 16.49 O ACY A 121 B 647 ARG B 44 ARG.? 18.52 O ACY A 121 coo 38.22 57.83 70.36 36.82 56.74 69.18 3.97 24.42 42.90 6.03 24.50 43.46 coo 34.24 60.89 68.08 33.31 57.93 67.63 6.31 22.16 46.81 4.95 24.70 47.95 coo 31.43 57.38 61.97 31.90 55.58 64.41 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1v0e_c01 ENDO-ALPHA-SIALIDASE user 2 3 # 2 B 581 GLU B 39 GLU.? 14.67 OXT ACY A 120 B 596 ARG B 44 ARG.? 18.52 O ACY A 121 B 647 ARG A 44 ARG.? 16.49 O ACY A 121 coo 38.22 57.83 70.36 36.82 56.74 69.18 2.54 12.93 51.58 4.67 12.91 51.32 coo 34.24 60.89 68.08 33.31 57.93 67.63 6.69 16.72 49.11 8.85 18.83 48.43 coo 31.43 57.38 61.97 31.90 55.58 64.41 6.31 22.16 46.81 4.95 24.70 47.95 1v0e_c01 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c01 naa= 3 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 1 3 # 1 C 581 GLU A 39 GLU^? 13.07 O ACY A 121 C 596 ARG A 44 ARG.? 16.49 O ACY A 121 C 647 ARG B 44 ARG.? 18.52 O ACY A 121 coo 11.31 31.26 27.00 13.31 30.71 26.58 3.97 24.42 42.90 6.03 24.50 43.46 coo 13.44 32.78 22.07 15.56 30.91 23.37 6.31 22.16 46.81 4.95 24.70 47.95 coo 21.00 33.35 22.82 19.83 30.82 24.09 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1v0e_c02 ENDO-ALPHA-SIALIDASE user 2 3 # 2 C 581 GLU B 39 GLU.? 14.67 OXT ACY A 120 C 596 ARG B 44 ARG.? 18.52 O ACY A 121 C 647 ARG A 44 ARG.? 16.49 O ACY A 121 coo 11.31 31.26 27.00 13.31 30.71 26.58 2.54 12.93 51.58 4.67 12.91 51.32 coo 13.44 32.78 22.07 15.56 30.91 23.37 6.69 16.72 49.11 8.85 18.83 48.43 coo 21.00 33.35 22.82 19.83 30.82 24.09 6.31 22.16 46.81 4.95 24.70 47.95 1v0e_c02 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c02 naa= 3 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 1 3 # 1 D 581 GLU A 39 GLU^? 13.07 O ACY A 121 D 596 ARG A 44 ARG.? 16.49 O ACY A 121 D 647 ARG B 44 ARG.? 18.52 O ACY A 121 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 3.97 24.42 42.90 6.03 24.50 43.46 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 6.31 22.16 46.81 4.95 24.70 47.95 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1v0e_c03 ENDO-ALPHA-SIALIDASE user 2 3 # 2 D 581 GLU B 39 GLU.? 14.67 OXT ACY A 120 D 596 ARG B 44 ARG.? 18.52 O ACY A 121 D 647 ARG A 44 ARG.? 16.49 O ACY A 121 coo -44.60 -18.05 21.23 -43.91 -19.28 22.81 2.54 12.93 51.58 4.67 12.91 51.32 coo -46.27 -23.29 20.77 -45.12 -23.03 23.65 6.69 16.72 49.11 8.85 18.83 48.43 coo -41.59 -27.81 24.72 -42.43 -25.21 26.20 6.31 22.16 46.81 4.95 24.70 47.95 1v0e_c03 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c03 naa= 3 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 1 3 # 1 E 581 GLU A 39 GLU^? 13.07 O ACY A 121 E 596 ARG A 44 ARG.? 16.49 O ACY A 121 E 647 ARG B 44 ARG.? 18.52 O ACY A 121 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 3.97 24.42 42.90 6.03 24.50 43.46 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 6.31 22.16 46.81 4.95 24.70 47.95 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1v0e_c04 ENDO-ALPHA-SIALIDASE user 2 3 # 2 E 581 GLU B 39 GLU.? 14.67 OXT ACY A 120 E 596 ARG B 44 ARG.? 18.52 O ACY A 121 E 647 ARG A 44 ARG.? 16.49 O ACY A 121 coo 13.14 -15.80 20.26 11.08 -15.36 20.42 2.54 12.93 51.58 4.67 12.91 51.32 coo 10.98 -16.04 15.26 8.84 -14.68 17.08 6.69 16.72 49.11 8.85 18.83 48.43 coo 3.51 -16.91 15.71 4.51 -14.91 17.79 6.31 22.16 46.81 4.95 24.70 47.95 1v0e_c04 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c04 naa= 3 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 1 3 # 1 F 581 GLU A 39 GLU^? 13.07 O ACY A 121 F 596 ARG A 44 ARG.? 16.49 O ACY A 121 F 647 ARG B 44 ARG.? 18.52 O ACY A 121 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 3.97 24.42 42.90 6.03 24.50 43.46 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 6.31 22.16 46.81 4.95 24.70 47.95 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 6.69 16.72 49.11 8.85 18.83 48.43 ULMN 3 1v0e_c05 ENDO-ALPHA-SIALIDASE user 2 3 # 2 F 581 GLU B 39 GLU.? 14.67 OXT ACY A 120 F 596 ARG B 44 ARG.? 18.52 O ACY A 121 F 647 ARG A 44 ARG.? 16.49 O ACY A 121 coo -13.62 -54.34 53.96 -12.26 -52.95 53.12 2.54 12.93 51.58 4.67 12.91 51.32 coo -9.88 -56.64 50.98 -8.81 -53.71 51.30 6.69 16.72 49.11 8.85 18.83 48.43 coo -6.86 -51.53 46.20 -7.51 -50.44 49.00 6.31 22.16 46.81 4.95 24.70 47.95 1v0e_c05 source 1v0e ENDO-ALPHA-SIALIDASE : 2 hits 1v0e_c05 naa= 3 ULMN 3 1vom_c00 MYOSIN user 1 3 # 1 233 ASN A 6 ASN.? 7.96 O ACY A 120 457 GLY B 57 GLY.? -3.44 ZN ZN B 118s 459 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -11.99 10.76 51.07 -13.19 11.09 52.81 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -17.31 6.32 43.48 -17.60 5.82 42.91 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 3 1vom_c00 MYOSIN user 2 3 # 2 233 ASN B 6 ASN.? 8.30 OXT ACY B 120 457 GLY A 57 GLY.? 4.30 ZN ZN A 119 459 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 59.14 42.15 -25.87 60.93 42.86 -24.97 -9.87 26.28 39.29 -10.81 26.02 37.42 coo 63.27 35.38 -30.38 62.82 35.87 -30.84 -18.19 30.32 43.90 -18.50 30.85 44.43 coo 57.92 36.85 -33.37 58.28 38.94 -33.63 -13.74 27.15 46.45 -14.38 29.06 45.84 1vom_c00 source 1vom MYOSIN : 2 hits 1vom_c00 naa= 3 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 1 3 # 1 A 16 TYR A 63 TYR^? 13.00 ZN ZN A 119 A 40 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 103 LEU A 50 LEU^? 9.64 ZN ZN A 119 coo 12.09 16.13 10.57 11.28 18.80 10.73 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 7.55 25.51 14.34 9.65 25.73 14.24 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 11.83 18.73 16.99 10.99 19.71 15.26 -9.53 30.58 53.36 -10.77 31.04 55.17 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 2 3 # 2 A 16 TYR A 63 TYR^? 13.00 ZN ZN A 119 A 40 ASP A 86 ASP~? 22.55 ZN ZN A 119 A 103 LEU A 88 LEU~? 13.45 ZN ZN A 119 coo 12.09 16.13 10.57 11.28 18.80 10.73 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 7.55 25.51 14.34 9.65 25.73 14.24 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 11.83 18.73 16.99 10.99 19.71 15.26 -10.40 38.33 56.93 -10.60 36.17 57.15 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 3 3 # 3 A 16 TYR B 63 TYR^? 12.86 ZN ZN B 118 A 40 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 103 LEU B 50 LEU^? 9.59 ZN ZN B 118 coo 12.09 16.13 10.57 11.28 18.80 10.73 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 7.55 25.51 14.34 9.65 25.73 14.24 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 11.83 18.73 16.99 10.99 19.71 15.26 -6.85 6.47 37.85 -7.39 6.15 35.74 ULMN 3 1vzz_c00 STEROID DELTA-ISOMERASE user 4 3 # 4 A 16 TYR B 63 TYR^? 12.86 ZN ZN B 118 A 40 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 103 LEU B 88 LEU~? 13.53 ZN ZN B 118 coo 12.09 16.13 10.57 11.28 18.80 10.73 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 7.55 25.51 14.34 9.65 25.73 14.24 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 11.83 18.73 16.99 10.99 19.71 15.26 -6.19 -1.12 34.28 -6.06 1.03 33.84 1vzz_c00 source 1vzz STEROID DELTA-ISOMERASE : 4 hits 1vzz_c00 naa= 3 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 1 3 # 1 B 16 TYR A 63 TYR^? 13.00 ZN ZN A 119 B 40 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 103 LEU A 50 LEU^? 9.64 ZN ZN A 119 coo 14.25 20.09 37.35 13.48 17.40 37.38 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 9.39 10.77 34.53 11.50 10.63 34.41 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 12.89 17.60 31.13 12.34 16.51 32.90 -9.53 30.58 53.36 -10.77 31.04 55.17 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 2 3 # 2 B 16 TYR A 63 TYR^? 13.00 ZN ZN A 119 B 40 ASP A 86 ASP~? 22.55 ZN ZN A 119 B 103 LEU A 88 LEU~? 13.45 ZN ZN A 119 coo 14.25 20.09 37.35 13.48 17.40 37.38 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 9.39 10.77 34.53 11.50 10.63 34.41 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 12.89 17.60 31.13 12.34 16.51 32.90 -10.40 38.33 56.93 -10.60 36.17 57.15 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 3 3 # 3 B 16 TYR B 63 TYR^? 12.86 ZN ZN B 118 B 40 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 103 LEU B 50 LEU^? 9.59 ZN ZN B 118 coo 14.25 20.09 37.35 13.48 17.40 37.38 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 9.39 10.77 34.53 11.50 10.63 34.41 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 12.89 17.60 31.13 12.34 16.51 32.90 -6.85 6.47 37.85 -7.39 6.15 35.74 ULMN 3 1vzz_c01 STEROID DELTA-ISOMERASE user 4 3 # 4 B 16 TYR B 63 TYR^? 12.86 ZN ZN B 118 B 40 ASP B 86 ASP~? 22.13 ZN ZN B 118 B 103 LEU B 88 LEU~? 13.53 ZN ZN B 118 coo 14.25 20.09 37.35 13.48 17.40 37.38 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 9.39 10.77 34.53 11.50 10.63 34.41 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 12.89 17.60 31.13 12.34 16.51 32.90 -6.19 -1.12 34.28 -6.06 1.03 33.84 1vzz_c01 source 1vzz STEROID DELTA-ISOMERASE : 4 hits 1vzz_c01 naa= 3 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 1 3 # 1 A 183 GLY A 77 GLY.? 7.71 O ACY A 120 B 419 GLY A 78 GLY^? 6.33 CH3 ACY A 120 B 420 ALA A 21 ALA^? 9.29 CH3 ACY A 120 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -14.40 19.56 63.33 -14.08 20.34 63.32 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -12.40 21.69 60.91 -11.92 21.55 61.59 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -14.76 24.38 57.77 -15.72 24.16 58.96 ULMN 3 1xny_c00 PROPIONYL-COA CARBOXYLASE COMPLEX B user 2 3 # 2 A 183 GLY B 77 GLY.? 7.77 OXT ACY B 120 B 419 GLY B 78 GLY^? 6.35 CH3 ACY B 120 B 420 ALA B 21 ALA^? 9.36 CH3 ACY B 120 coo 26.12 -67.67-130.71 26.18 -67.32-131.45 -8.24 17.31 26.84 -7.89 16.59 26.97 coo 25.10 -66.82-126.88 25.40 -66.55-126.17 -7.09 15.30 29.87 -6.41 15.40 29.36 coo 26.37 -68.04-123.51 27.50 -67.42-122.72 -10.37 12.66 32.04 -10.93 12.80 30.64 1xny_c00 source 1xny PROPIONYL-COA CARBOXYLASE COMPLEX B SUBUNIT : 2 hits 1xny_c00 naa= 3 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 1 3 # 1 200 SER A 51 SER^? 4.15 ZN ZN A 119 327 GLU B 4 GLU.? -2.30 ZN ZN A 119s 440 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 6.96 64.04 57.84 6.74 63.69 60.26 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 14.82 64.63 62.37 13.47 65.72 61.17 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 9.52 66.51 63.07 8.75 65.02 61.81 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 3 2ace_c00 ACETYLCHOLINESTERASE user 2 3 # 2 200 SER B 51 SER^? 4.27 ZN ZN B 118 327 GLU A 4 GLU.? -2.10 ZN ZN B 118s 440 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 6.96 64.04 57.84 6.74 63.69 60.26 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 14.82 64.63 62.37 13.47 65.72 61.17 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 9.52 66.51 63.07 8.75 65.02 61.81 -10.33 3.56 43.54 -12.07 4.44 44.29 2ace_c00 source 2ace ACETYLCHOLINESTERASE : 2 hits 2ace_c00 naa= 3 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 1 3 # 1 35 ASP A 15 ASP~? 8.61 ZN ZN B 118 38 SER A 14 SER~? 11.41 CH3 ACY A 120 218 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 41.14 58.72 105.19 42.39 59.85 103.92 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 46.04 57.35 103.96 44.97 58.52 105.78 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 41.33 60.20 97.63 42.00 60.96 99.49 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 2apr_c04 ACID PROTEINASE (RHIZOPUSPEPSIN) (E.user 2 3 # 2 35 ASP B 15 ASP~? 8.50 ZN ZN A 119 38 SER B 14 SER~? 11.46 CH3 ACY B 120 218 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 41.14 58.72 105.19 42.39 59.85 103.92 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 46.04 57.35 103.96 44.97 58.52 105.78 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 41.33 60.20 97.63 42.00 60.96 99.49 -12.98 14.88 47.28 -12.40 12.90 47.92 2apr_c04 source 2apr ACID PROTEINASE (RHIZOPUSPEPSIN) (E.C.3.4.23.6: 2 hits 2apr_c04 naa= 3 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 1 3 # 1 A 14 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 161 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 174 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 3 2c7v_c08 PTERIDINE REDUCTASE user 2 3 # 2 A 14 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 161 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 174 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 14.43 -13.26 8.40 11.75 -14.25 9.60 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 3.82 -4.94 15.61 3.37 -6.97 16.02 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -4.17 2.05 38.57 -1.76 0.81 38.01 2c7v_c08 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c08 naa= 3 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 1 3 # 1 B 14 ARG A 35 ARG^? 4.87 ZN ZN A 119 B 161 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 174 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 3 2c7v_c09 PTERIDINE REDUCTASE user 2 3 # 2 B 14 ARG B 35 ARG.? 5.03 ZN ZN B 118 B 161 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 174 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo -18.34 17.48 -4.91 -16.98 18.69 -2.39 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -14.86 10.19 8.14 -14.82 12.31 8.42 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -4.17 2.05 38.57 -1.76 0.81 38.01 2c7v_c09 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c09 naa= 3 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 1 3 # 1 C 14 ARG A 35 ARG^? 4.87 ZN ZN A 119 C 161 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 174 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 2.84 19.43 40.34 1.59 20.35 37.65 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 5.94 13.28 27.17 3.53 13.05 28.58 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 3 2c7v_c10 PTERIDINE REDUCTASE user 2 3 # 2 C 14 ARG B 35 ARG.? 5.03 ZN ZN B 118 C 161 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 174 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 2.84 19.43 40.34 1.59 20.35 37.65 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -0.62 11.10 28.05 -0.65 13.15 27.46 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 5.94 13.28 27.17 3.53 13.05 28.58 -4.17 2.05 38.57 -1.76 0.81 38.01 2c7v_c10 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c10 naa= 3 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 1 3 # 1 D 14 ARG A 35 ARG^? 4.87 ZN ZN A 119 D 161 ASP A 61 ASP^? 8.97 ZN ZN A 119 D 174 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 3 2c7v_c11 PTERIDINE REDUCTASE user 2 3 # 2 D 14 ARG B 35 ARG.? 5.03 ZN ZN B 118 D 161 ASP B 61 ASP^? 9.02 ZN ZN B 118 D 174 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo -30.56 -11.62 29.88 -27.98 -12.86 28.66 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -19.83 -4.38 21.99 -19.35 -6.45 21.76 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -4.17 2.05 38.57 -1.76 0.81 38.01 2c7v_c11 source 2c7v PTERIDINE REDUCTASE : 2 hits 2c7v_c11 naa= 3 ULMN 3 2dw7_c32 BLL6730 PROTEIN user 1 3 # 1 A 182 LYS A 40 LYS.? -3.18 C ACY A 121s A 184 LYS B 10 LYS.? 9.83 CH3 ACY A 121 A 345 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 5.98 42.76 7.73 10.19 38.62 9.02 1.80 21.48 38.21 -1.61 24.69 34.09 coo 2.77 37.17 4.99 6.33 34.76 8.06 2.14 27.03 37.15 7.00 28.76 35.76 coo 0.07 40.30 18.65 -0.21 42.34 18.18 -12.05 22.20 42.61 -11.41 24.21 42.00 2dw7_c32 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c32 naa= 3 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 1 3 # 1 B 182 LYS A 40 LYS.? -3.18 C ACY A 121s B 184 LYS B 10 LYS.? 9.83 CH3 ACY A 121 B 345 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 38.76 2.27 4.00 34.00 5.99 4.37 1.80 21.48 38.21 -1.61 24.69 34.09 coo 40.63 7.13 9.06 35.85 7.36 8.95 2.14 27.03 37.15 7.00 28.76 35.76 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 2dw7_c33 BLL6730 PROTEIN user 2 3 # 2 B 182 LYS B 40 LYS.? 4.59 ZN ZN A 118 B 184 LYS A 10 LYS.? 12.65 OXT ACY A 120 B 345 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 38.76 2.27 4.00 34.00 5.99 4.37 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 40.63 7.13 9.06 35.85 7.36 8.95 -0.98 10.25 56.97 2.99 9.65 58.52 coo 34.36 -6.33 13.69 36.02 -6.07 12.41 -12.98 14.88 47.28 -12.40 12.90 47.92 2dw7_c33 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c33 naa= 3 ULMN 3 2dw7_c34 BLL6730 PROTEIN user 1 3 # 1 C 182 LYS A 40 LYS.? -3.18 C ACY A 121s C 184 LYS B 10 LYS.? 9.83 CH3 ACY A 121 C 345 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -5.66 12.40 71.13 -2.66 9.98 66.50 1.80 21.48 38.21 -1.61 24.69 34.09 coo 0.95 12.72 73.51 1.58 12.72 68.31 2.14 27.03 37.15 7.00 28.76 35.76 coo -4.59 24.28 66.67 -6.26 24.34 67.99 -12.05 22.20 42.61 -11.41 24.21 42.00 2dw7_c34 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c34 naa= 3 ULMN 3 2dw7_c38 BLL6730 PROTEIN user 1 3 # 1 G 182 LYS A 40 LYS.? -3.18 C ACY A 121s G 184 LYS B 10 LYS.? 9.83 CH3 ACY A 121 G 345 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 39.68 42.04 76.11 43.42 46.43 74.96 1.80 21.48 38.21 -1.61 24.69 34.09 coo 36.69 47.69 78.93 39.38 50.40 75.35 2.14 27.03 37.15 7.00 28.76 35.76 coo 33.43 44.37 65.47 33.10 42.30 65.37 -12.05 22.20 42.61 -11.41 24.21 42.00 2dw7_c38 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c38 naa= 3 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 1 3 # 1 J 182 LYS A 40 LYS.? -3.18 C ACY A 121s J 184 LYS B 10 LYS.? 9.83 CH3 ACY A 121 J 345 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 25.22 70.55 14.03 27.64 73.07 18.65 1.80 21.48 38.21 -1.61 24.69 34.09 coo 31.73 69.87 11.50 32.73 70.19 16.40 2.14 27.03 37.15 7.00 28.76 35.76 coo 25.87 58.42 18.79 23.95 58.54 17.90 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 2dw7_c41 BLL6730 PROTEIN user 2 3 # 2 J 182 LYS B 40 LYS.? 4.59 ZN ZN A 118 J 184 LYS A 10 LYS.? 12.65 OXT ACY A 120 J 345 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 25.22 70.55 14.03 27.64 73.07 18.65 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 31.73 69.87 11.50 32.73 70.19 16.40 -0.98 10.25 56.97 2.99 9.65 58.52 coo 25.87 58.42 18.79 23.95 58.54 17.90 -12.98 14.88 47.28 -12.40 12.90 47.92 2dw7_c41 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c41 naa= 3 ULMN 3 2dw7_c42 BLL6730 PROTEIN user 1 3 # 1 K 182 LYS A 40 LYS.? -3.18 C ACY A 121s K 184 LYS B 10 LYS.? 9.83 CH3 ACY A 121 K 345 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 51.91 50.98 -7.18 47.83 49.38 -11.15 1.80 21.48 38.21 -1.61 24.69 34.09 coo 54.95 45.24 -9.88 51.94 46.65 -13.66 2.14 27.03 37.15 7.00 28.76 35.76 coo 58.09 58.36 -15.39 58.48 59.93 -14.05 -12.05 22.20 42.61 -11.41 24.21 42.00 2dw7_c42 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c42 naa= 3 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 1 3 # 1 L 182 LYS A 40 LYS.? -3.18 C ACY A 121s L 184 LYS B 10 LYS.? 9.83 CH3 ACY A 121 L 345 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 1.80 21.48 38.21 -1.61 24.69 34.09 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 2.14 27.03 37.15 7.00 28.76 35.76 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 2dw7_c43 BLL6730 PROTEIN user 2 3 # 2 L 182 LYS B 40 LYS.? 4.59 ZN ZN A 118 L 184 LYS A 10 LYS.? 12.65 OXT ACY A 120 L 345 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 20.72 21.86 -37.85 25.46 24.17 -34.95 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 18.47 28.51 -37.00 23.90 28.36 -37.29 -0.98 10.25 56.97 2.99 9.65 58.52 coo 25.62 23.75 -50.41 24.07 23.21 -49.03 -12.98 14.88 47.28 -12.40 12.90 47.92 2dw7_c43 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c43 naa= 3 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 1 3 # 1 M 182 LYS A 40 LYS.? -3.18 C ACY A 121s M 184 LYS B 10 LYS.? 9.83 CH3 ACY A 121 M 345 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 1.80 21.48 38.21 -1.61 24.69 34.09 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 2.14 27.03 37.15 7.00 28.76 35.76 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 2dw7_c44 BLL6730 PROTEIN user 2 3 # 2 M 182 LYS B 40 LYS.? 4.59 ZN ZN A 118 M 184 LYS A 10 LYS.? 12.65 OXT ACY A 120 M 345 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -16.84 -32.78 53.48 -13.51 -32.22 58.34 -0.91 15.74 55.76 -5.29 12.34 58.61 coo -11.12 -36.54 51.97 -12.06 -36.49 56.95 -0.98 10.25 56.97 2.99 9.65 58.52 coo -23.86 -43.59 58.54 -23.60 -42.14 57.00 -12.98 14.88 47.28 -12.40 12.90 47.92 2dw7_c44 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c44 naa= 3 ULMN 3 2dw7_c46 BLL6730 PROTEIN user 1 3 # 1 O 182 LYS A 40 LYS.? -3.18 C ACY A 121s O 184 LYS B 10 LYS.? 9.83 CH3 ACY A 121 O 345 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 54.57 -51.89 -4.22 51.14 -49.62 0.15 1.80 21.48 38.21 -1.61 24.69 34.09 coo 48.40 -53.90 -6.78 48.57 -49.84 -4.13 2.14 27.03 37.15 7.00 28.76 35.76 coo 54.15 -41.12 -10.77 56.24 -41.47 -10.94 -12.05 22.20 42.61 -11.41 24.21 42.00 2dw7_c46 source 2dw7 BLL6730 PROTEIN : 1 hits 2dw7_c46 naa= 3 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 1 3 # 1 P 182 LYS A 40 LYS.? -3.18 C ACY A 121s P 184 LYS B 10 LYS.? 9.83 CH3 ACY A 121 P 345 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 1.80 21.48 38.21 -1.61 24.69 34.09 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 2.14 27.03 37.15 7.00 28.76 35.76 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 2dw7_c47 BLL6730 PROTEIN user 2 3 # 2 P 182 LYS B 40 LYS.? 4.59 ZN ZN A 118 P 184 LYS A 10 LYS.? 12.65 OXT ACY A 120 P 345 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 14.97 -47.15 29.92 18.26 -47.80 24.89 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 20.57 -43.13 31.26 20.62 -43.22 26.05 -0.98 10.25 56.97 2.99 9.65 58.52 coo 7.60 -36.55 24.79 7.77 -37.99 26.35 -12.98 14.88 47.28 -12.40 12.90 47.92 2dw7_c47 source 2dw7 BLL6730 PROTEIN : 2 hits 2dw7_c47 naa= 3 ULMN 3 2gsa_c04 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 3 # 1 A 157 PHE A 55 PHE.? 11.31 ZN ZN A 119 A 245 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 273 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 9.49 9.24 -34.27 7.12 7.86 -33.75 -23.76 31.53 49.05 -25.99 32.30 50.52 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -0.09 22.51 -29.56 4.47 22.51 -33.59 -8.24 41.47 45.26 -7.63 47.05 46.72 2gsa_c04 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 1 hits 2gsa_c04 naa= 3 ULMN 3 2jxr_c04 LIGAND CP-081282 user 1 3 # 1 A 32 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 35 SER A 14 SER~? 11.41 CH3 ACY A 120 A 215 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -8.58 16.80 48.15 -8.42 16.11 45.83 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 3 2jxr_c04 LIGAND CP-081282 user 2 3 # 2 A 32 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 35 SER B 14 SER~? 11.46 CH3 ACY B 120 A 215 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -14.00 61.45 43.99 -14.19 63.14 42.84 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -13.21 66.21 45.84 -15.49 65.90 45.84 -7.60 20.35 43.19 -8.11 21.15 45.47 coo -10.72 64.19 37.77 -12.20 64.43 39.15 -12.98 14.88 47.28 -12.40 12.90 47.92 2jxr_c04 source 2jxr LIGAND CP-081282 : 2 hits 2jxr_c04 naa= 3 ULMN 3 2lpr_c02 ALPHA-LYTIC PROTEASE user 1 3 # 1 A 57 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 102 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 193 GLY A 95 GLY.? 11.34 ZN ZN A 119 coo 14.96 29.22 19.55 15.62 29.93 17.67 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 19.64 30.69 22.61 18.18 29.94 21.25 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 14.54 28.99 9.76 15.06 29.59 10.02 -4.39 36.14 43.27 -4.07 36.89 43.24 2lpr_c02 source 2lpr ALPHA-LYTIC PROTEASE : 1 hits 2lpr_c02 naa= 3 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 1 3 # 1 141 ASP A 15 ASP~? 8.61 ZN ZN B 118 166 GLY A 31 GLY^? 10.46 ZN ZN A 119 169 GLU A 28 GLU.? 19.71 ZN ZN A 119 coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -15.56 30.08 55.93 -15.09 29.60 56.48 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -17.43 33.27 64.86 -17.71 35.42 64.60 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 2 3 # 2 141 ASP A 15 ASP~? 8.61 ZN ZN B 118 166 GLY A 77 GLY.? 7.71 O ACY A 120 169 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -14.40 19.56 63.33 -14.08 20.34 63.32 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 3 3 # 3 141 ASP A 15 ASP~? 8.61 ZN ZN B 118 166 GLY B 53 GLY.? 9.42 ZN ZN B 118 169 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -15.05 1.05 35.38 -15.07 1.78 35.76 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -7.13 -6.28 33.53 -6.83 -7.93 32.24 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 4 3 # 4 141 ASP A 26 ASP.? 19.54 CH3 ACY A 120 166 GLY A 53 GLY.? 9.26 ZN ZN A 119 169 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.39 35.86 52.61 -18.29 35.05 52.32 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 5 3 # 5 141 ASP A 60 ASP.? -2.37 ZN ZN A 119s 166 GLY A 27 GLY.? 16.01 CH3 ACY A 120 169 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 8.28 6.87 1.62 10.08 5.77 1.34 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -13.31 29.37 67.32 -13.49 30.12 67.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 6 3 # 6 141 ASP A 60 ASP.? -2.37 ZN ZN A 119s 166 GLY A 78 GLY^? 6.33 CH3 ACY A 120 169 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 8.28 6.87 1.62 10.08 5.77 1.34 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -12.40 21.69 60.91 -11.92 21.55 61.59 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 7 3 # 7 141 ASP A 60 ASP.? -2.37 ZN ZN A 119s 166 GLY A 97 GLY.? 16.19 CH3 ACY A 121 169 GLU A 39 GLU^? 13.07 O ACY A 121 coo 8.28 6.87 1.62 10.08 5.77 1.34 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.89 35.61 41.95 0.36 36.21 42.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 8 3 # 8 141 ASP A 60 ASP.? -2.37 ZN ZN A 119s 166 GLY A 97 GLY.? 16.19 CH3 ACY A 121 169 GLU A 99 GLU.? 20.42 CH3 ACY A 121 coo 8.28 6.87 1.62 10.08 5.77 1.34 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.89 35.61 41.95 0.36 36.21 42.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 4.40 42.94 40.00 4.87 41.71 38.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 9 3 # 9 141 ASP A 61 ASP^? 8.97 ZN ZN A 119 166 GLY A 27 GLY.? 16.01 CH3 ACY A 120 169 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -13.31 29.37 67.32 -13.49 30.12 67.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 10 3 # 10 141 ASP A 61 ASP^? 8.97 ZN ZN A 119 166 GLY A 78 GLY^? 6.33 CH3 ACY A 120 169 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 8.28 6.87 1.62 10.08 5.77 1.34 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -12.40 21.69 60.91 -11.92 21.55 61.59 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 11 3 # 11 141 ASP A 86 ASP~? 22.55 ZN ZN A 119 166 GLY A 27 GLY.? 16.01 CH3 ACY A 120 169 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 8.28 6.87 1.62 10.08 5.77 1.34 -6.95 43.63 60.82 -7.76 45.08 62.19 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -13.31 29.37 67.32 -13.49 30.12 67.06 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 12 3 # 12 141 ASP A 86 ASP~? 22.55 ZN ZN A 119 166 GLY A 95 GLY.? 11.34 ZN ZN A 119 169 GLU A 99 GLU.? 20.42 CH3 ACY A 121 coo 8.28 6.87 1.62 10.08 5.77 1.34 -6.95 43.63 60.82 -7.76 45.08 62.19 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -4.39 36.14 43.27 -4.07 36.89 43.24 coo -16.67 7.89 2.78 -17.65 6.56 1.49 4.40 42.94 40.00 4.87 41.71 38.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 13 3 # 13 141 ASP B 15 ASP~? 8.50 ZN ZN A 119 166 GLY A 53 GLY.? 9.26 ZN ZN A 119 169 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -18.39 35.86 52.61 -18.29 35.05 52.32 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 14 3 # 14 141 ASP B 15 ASP~? 8.50 ZN ZN A 119 166 GLY A 97 GLY.? 16.19 CH3 ACY A 121 169 GLU A 99 GLU.? 20.42 CH3 ACY A 121 coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -8.58 13.22 3.21 -8.90 13.15 4.05 0.89 35.61 41.95 0.36 36.21 42.05 coo -16.67 7.89 2.78 -17.65 6.56 1.49 4.40 42.94 40.00 4.87 41.71 38.33 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 15 3 # 15 141 ASP B 15 ASP~? 8.50 ZN ZN A 119 166 GLY B 31 GLY^? 10.38 ZN ZN B 118 169 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -11.44 6.93 33.52 -10.95 7.47 33.07 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -8.23 3.75 25.31 -7.96 1.78 24.56 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 16 3 # 16 141 ASP B 15 ASP~? 8.50 ZN ZN A 119 166 GLY B 77 GLY.? 7.77 OXT ACY B 120 169 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo 8.28 6.87 1.62 10.08 5.77 1.34 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -8.24 17.31 26.84 -7.89 16.59 26.97 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -3.38 17.56 20.48 -2.28 16.44 19.03 ULMN 3 2tdt_c00 TETRAHYDRODIPICOLINATE N-SUCCINYLTRAuser 17 3 # 17 141 ASP B 86 ASP~? 22.13 ZN ZN B 118 166 GLY B 27 GLY.? 15.88 CH3 ACY B 120 169 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo 8.28 6.87 1.62 10.08 5.77 1.34 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo -8.58 13.22 3.21 -8.90 13.15 4.05 -5.69 8.07 23.28 -5.94 7.34 23.49 coo -16.67 7.89 2.78 -17.65 6.56 1.49 -3.38 17.56 20.48 -2.28 16.44 19.03 2tdt_c00 source 2tdt TETRAHYDRODIPICOLINATE N-SUCCINYLTRANSFERASE : 17 hits 2tdt_c00 naa= 3 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 A 169 TYR A 63 TYR^? 13.00 ZN ZN A 119 A 172 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 267 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 26.78 20.44 0.03 28.51 18.26 0.09 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 3 2tmd_c00 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 A 169 TYR B 63 TYR^? 12.86 ZN ZN B 118 A 172 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 267 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 26.78 20.44 0.03 28.51 18.26 0.09 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 29.39 14.39 -1.75 31.15 15.06 -2.66 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 33.26 12.70 -5.86 33.92 14.66 -5.47 -15.33 3.33 40.18 -15.00 4.24 42.07 2tmd_c00 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c00 naa= 3 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 1 3 # 1 B 169 TYR A 63 TYR^? 13.00 ZN ZN A 119 B 172 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 267 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 44.86 1.98 33.27 42.75 1.12 31.67 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 3 2tmd_c01 TRIMETHYLAMINE DEHYDROGENASE user 2 3 # 2 B 169 TYR B 63 TYR^? 12.86 ZN ZN B 118 B 172 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 267 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 44.86 1.98 33.27 42.75 1.12 31.67 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 40.83 -2.48 29.90 39.16 -2.39 31.17 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 36.38 -5.89 31.55 36.22 -4.28 32.93 -15.33 3.33 40.18 -15.00 4.24 42.07 2tmd_c01 source 2tmd TRIMETHYLAMINE DEHYDROGENASE : 2 hits 2tmd_c01 naa= 3 ULMN 3 2tps_c00 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 A 59 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 130 SER B 46 SER^? 14.91 OXT ACY A 120 A 159 LYS A 16 LYS~? -3.27 O ACY A 120s coo 18.35 45.84 20.99 16.20 47.83 21.89 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 15.14 43.67 10.77 15.61 44.43 13.04 1.20 11.37 47.30 1.64 9.60 48.90 coo 11.57 48.49 22.18 13.51 49.99 17.21 -12.18 15.96 51.84 -12.69 14.73 56.98 2tps_c00 source 2tps THIAMIN PHOSPHATE SYNTHASE : 1 hits 2tps_c00 naa= 3 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 1 3 # 1 B 59 ARG A 35 ARG^? 4.87 ZN ZN A 119 B 130 SER A 46 SER^? 14.68 O ACY A 121 B 159 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 58.72 31.58 20.45 60.80 29.39 20.94 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 61.66 35.17 10.39 61.29 34.14 12.56 1.31 25.87 47.03 1.94 27.83 45.77 coo 65.38 28.77 21.17 63.49 28.03 16.12 -10.13 21.11 38.47 -9.52 22.58 33.19 ULMN 3 2tps_c01 THIAMIN PHOSPHATE SYNTHASE user 2 3 # 2 B 59 ARG B 35 ARG.? 5.03 ZN ZN B 118 B 130 SER B 46 SER^? 14.91 OXT ACY A 120 B 159 LYS A 16 LYS~? -3.27 O ACY A 120s coo 58.72 31.58 20.45 60.80 29.39 20.94 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 61.66 35.17 10.39 61.29 34.14 12.56 1.20 11.37 47.30 1.64 9.60 48.90 coo 65.38 28.77 21.17 63.49 28.03 16.12 -12.18 15.96 51.84 -12.69 14.73 56.98 2tps_c01 source 2tps THIAMIN PHOSPHATE SYNTHASE : 2 hits 2tps_c01 naa= 3 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 1 1 # 1 A 461 ASN A 6 ASN.? 7.96 O ACY A 120 coo 5.80 63.03 55.85 5.52 65.03 56.45 -11.99 10.76 51.07 -13.19 11.09 52.81 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 2 1 # 2 A 461 ASN A 73 ASN^? 11.43 OXT ACY A 120 coo 5.80 63.03 55.85 5.52 65.03 56.45 -9.59 22.33 65.64 -10.09 22.46 67.69 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 3 1 # 3 A 461 ASN B 6 ASN.? 8.30 OXT ACY B 120 coo 5.80 63.03 55.85 5.52 65.03 56.45 -9.87 26.28 39.29 -10.81 26.02 37.42 ULMN 1 1kbk_p00 ALPHA-AMYLASE, PANCREATIC user 4 1 # 4 A 461 ASN B 73 ASN^? 10.74 OXT ACY A 121 coo 5.80 63.03 55.85 5.52 65.03 56.45 -2.85 14.93 26.35 -2.72 14.72 24.20 1kbk_p00 source 1kbk ALPHA-AMYLASE, PANCREATIC : 4 hits 1kbk_p00 naa= 1 ULMN 3 2p3i_p00 VP4 user 1 3 # 1 A 101 ARG A 44 ARG.? 16.49 O ACY A 121 A 188 TYR A 47 TYR^? 12.01 ZN ZN A 119 A 190 SER A 46 SER^? 14.68 O ACY A 121 coo 37.69 7.64 13.51 38.82 8.84 16.11 6.31 22.16 46.81 4.95 24.70 47.95 coo 47.14 12.10 13.73 48.75 12.33 16.01 -2.05 29.36 47.71 -2.93 30.35 45.23 coo 43.77 6.93 15.46 45.49 7.21 17.11 1.31 25.87 47.03 1.94 27.83 45.77 2p3i_p00 source 2p3i VP4 : 1 hits 2p3i_p00 naa= 3 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 1 3 # 1 I 303 TYR A 23 TYR^? 11.58 CH3 ACY A 120 I 306 VAL A 81 VAL.? 12.25 CH3 ACY A 120 I 308 VAL A 83 VAL.? 16.83 ZN ZN A 119 coo 26.18 35.24 6.87 24.33 35.18 8.97 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 23.55 29.53 9.81 23.15 27.39 10.24 -5.97 29.08 61.50 -6.93 29.23 59.52 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.85 34.88 60.90 -6.33 34.38 58.84 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 2 3 # 2 I 303 TYR A 63 TYR^? 13.00 ZN ZN A 119 I 306 VAL A 49 VAL^? 7.06 ZN ZN A 119 I 308 VAL A 36 VAL^? 11.33 CH3 ACY A 120 coo 26.18 35.24 6.87 24.33 35.18 8.97 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 -7.92 28.81 49.14 -8.38 29.50 47.14 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.88 23.78 47.09 -5.53 21.87 48.13 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 3 3 # 3 I 303 TYR A 63 TYR^? 13.00 ZN ZN A 119 I 306 VAL A 83 VAL.? 16.83 ZN ZN A 119 I 308 VAL A 81 VAL.? 12.25 CH3 ACY A 120 coo 26.18 35.24 6.87 24.33 35.18 8.97 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 -5.85 34.88 60.90 -6.33 34.38 58.84 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.97 29.08 61.50 -6.93 29.23 59.52 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 4 3 # 4 I 303 TYR A 63 TYR^? 13.00 ZN ZN A 119 I 306 VAL A 83 VAL.? 16.83 ZN ZN A 119 I 308 VAL A 85 VAL~? 18.71 ZN ZN A 119 coo 26.18 35.24 6.87 24.33 35.18 8.97 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 23.55 29.53 9.81 23.15 27.39 10.24 -5.85 34.88 60.90 -6.33 34.38 58.84 coo 16.43 30.18 9.35 15.05 30.67 11.01 -10.31 40.10 61.16 -12.14 40.85 62.08 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 5 3 # 5 I 303 TYR A 79 TYR^? -4.35 CH3 ACY A 120s I 306 VAL A 17 VAL~? 5.31 CH3 ACY A 120 I 308 VAL A 36 VAL^? 11.33 CH3 ACY A 120 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 23.55 29.53 9.81 23.15 27.39 10.24 -10.07 19.10 52.17 -7.95 19.60 51.90 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.88 23.78 47.09 -5.53 21.87 48.13 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 6 3 # 6 I 303 TYR A 79 TYR^? -4.35 CH3 ACY A 120s I 306 VAL A 81 VAL.? 12.25 CH3 ACY A 120 I 308 VAL A 83 VAL.? 16.83 ZN ZN A 119 coo 26.18 35.24 6.87 24.33 35.18 8.97 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 23.55 29.53 9.81 23.15 27.39 10.24 -5.97 29.08 61.50 -6.93 29.23 59.52 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.85 34.88 60.90 -6.33 34.38 58.84 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 7 3 # 7 I 303 TYR B 23 TYR^? 11.37 CH3 ACY B 120 I 306 VAL B 81 VAL.? 12.15 CH3 ACY B 120 I 308 VAL B 83 VAL.? 16.85 ZN ZN B 118 coo 26.18 35.24 6.87 24.33 35.18 8.97 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.79 8.15 31.35 -2.32 7.91 32.93 coo 16.43 30.18 9.35 15.05 30.67 11.01 -0.76 2.25 31.88 -2.02 3.11 33.46 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 8 3 # 8 I 303 TYR B 63 TYR^? 12.86 ZN ZN B 118 I 306 VAL B 49 VAL^? 6.98 ZN ZN B 118 I 308 VAL B 36 VAL.? 11.16 CH3 ACY B 120 coo 26.18 35.24 6.87 24.33 35.18 8.97 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 23.55 29.53 9.81 23.15 27.39 10.24 -6.80 8.29 42.39 -7.81 7.38 44.13 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.71 13.44 44.97 -4.54 14.71 43.71 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 9 3 # 9 I 303 TYR B 63 TYR^? 12.86 ZN ZN B 118 I 306 VAL B 83 VAL.? 16.85 ZN ZN B 118 I 308 VAL B 81 VAL.? 12.15 CH3 ACY B 120 coo 26.18 35.24 6.87 24.33 35.18 8.97 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.76 2.25 31.88 -2.02 3.11 33.46 coo 16.43 30.18 9.35 15.05 30.67 11.01 -0.79 8.15 31.35 -2.32 7.91 32.93 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 10 3 # 10 I 303 TYR B 63 TYR^? 12.86 ZN ZN B 118 I 306 VAL B 83 VAL.? 16.85 ZN ZN B 118 I 308 VAL B 85 VAL~? 18.29 ZN ZN B 118 coo 26.18 35.24 6.87 24.33 35.18 8.97 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.76 2.25 31.88 -2.02 3.11 33.46 coo 16.43 30.18 9.35 15.05 30.67 11.01 -4.95 -2.88 30.42 -6.58 -3.48 29.07 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 11 3 # 11 I 303 TYR B 79 TYR^? -4.21 CH3 ACY B 120s I 306 VAL B 17 VAL~? 5.17 CH3 ACY B 120 I 308 VAL B 36 VAL.? 11.16 CH3 ACY B 120 coo 26.18 35.24 6.87 24.33 35.18 8.97 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 23.55 29.53 9.81 23.15 27.39 10.24 -7.84 18.04 38.74 -5.92 17.57 39.68 coo 16.43 30.18 9.35 15.05 30.67 11.01 -5.71 13.44 44.97 -4.54 14.71 43.71 ULMN 3 1cqt_d00 GENE REGULATION/DNA user 12 3 # 12 I 303 TYR B 79 TYR^? -4.21 CH3 ACY B 120s I 306 VAL B 81 VAL.? 12.15 CH3 ACY B 120 I 308 VAL B 83 VAL.? 16.85 ZN ZN B 118 coo 26.18 35.24 6.87 24.33 35.18 8.97 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 23.55 29.53 9.81 23.15 27.39 10.24 -0.79 8.15 31.35 -2.32 7.91 32.93 coo 16.43 30.18 9.35 15.05 30.67 11.01 -0.76 2.25 31.88 -2.02 3.11 33.46 1cqt_d00 source 1cqt GENE REGULATION/DNA : 12 hits 1cqt_d00 naa= 3 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 1 3 # 1 D 23 LYS A 16 LYS~? -3.27 O ACY A 120s D 25 THR A 20 THR.? 4.16 CH3 ACY A 120 D 27 SER A 32 SER^? 8.89 ZN ZN A 119 coo 86.60 33.38 44.00 87.05 39.52 42.71 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 81.20 31.58 48.03 79.23 32.24 47.54 -13.83 21.70 55.31 -12.29 20.44 56.16 coo 79.09 29.82 54.20 77.17 28.90 53.05 -14.23 26.97 54.31 -16.02 26.35 52.81 ULMN 3 1mjo_d00 TRANSCRIPTION/DNA user 2 3 # 2 D 23 LYS B 16 LYS~? -4.10 OXT ACY B 120s D 25 THR B 20 THR.? 4.10 CH3 ACY B 120 D 27 SER B 32 SER^? 8.58 ZN ZN B 118 coo 86.60 33.38 44.00 87.05 39.52 42.71 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 81.20 31.58 48.03 79.23 32.24 47.54 -10.29 15.42 34.68 -8.60 16.74 34.44 coo 79.09 29.82 54.20 77.17 28.90 53.05 -11.02 10.19 35.41 -13.14 10.52 36.50 1mjo_d00 source 1mjo TRANSCRIPTION/DNA : 2 hits 1mjo_d00 naa= 3 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 1 3 # 1 A1290 LYS A 16 LYS~? -3.27 O ACY A 120s A1294 ASN A 6 ASN.? 7.96 O ACY A 120 A1297 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 39.24 18.84-161.99 36.62 21.47-165.99 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 33.53 17.37-161.81 34.31 17.81-163.76 -11.99 10.76 51.07 -13.19 11.09 52.81 coo 29.78 23.31-161.30 31.23 23.66-162.84 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 2 3 # 2 A1290 LYS A 16 LYS~? -3.27 O ACY A 120s A1294 ASN A 6 ASN.? 7.96 O ACY A 120 A1297 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 39.24 18.84-161.99 36.62 21.47-165.99 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 33.53 17.37-161.81 34.31 17.81-163.76 -11.99 10.76 51.07 -13.19 11.09 52.81 coo 29.78 23.31-161.30 31.23 23.66-162.84 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 3 3 # 3 A1290 LYS A 71 LYS^? 11.96 OXT ACY A 120 A1294 ASN A 73 ASN^? 11.43 OXT ACY A 120 A1297 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 39.24 18.84-161.99 36.62 21.47-165.99 -4.35 22.91 61.78 1.12 23.33 62.25 coo 33.53 17.37-161.81 34.31 17.81-163.76 -9.59 22.33 65.64 -10.09 22.46 67.69 coo 29.78 23.31-161.30 31.23 23.66-162.84 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 4 3 # 4 A1290 LYS B 16 LYS~? -4.10 OXT ACY B 120s A1294 ASN B 6 ASN.? 8.30 OXT ACY B 120 A1297 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 39.24 18.84-161.99 36.62 21.47-165.99 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 33.53 17.37-161.81 34.31 17.81-163.76 -9.87 26.28 39.29 -10.81 26.02 37.42 coo 29.78 23.31-161.30 31.23 23.66-162.84 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 5 3 # 5 A1290 LYS B 16 LYS~? -4.10 OXT ACY B 120s A1294 ASN B 6 ASN.? 8.30 OXT ACY B 120 A1297 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 39.24 18.84-161.99 36.62 21.47-165.99 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 33.53 17.37-161.81 34.31 17.81-163.76 -9.87 26.28 39.29 -10.81 26.02 37.42 coo 29.78 23.31-161.30 31.23 23.66-162.84 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 3 1xpx_d00 TRANSCRIPTION REGULATION/DNA user 6 3 # 6 A1290 LYS B 71 LYS^? 12.90 O ACY A 121 A1294 ASN B 73 ASN^? 10.74 OXT ACY A 121 A1297 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo 39.24 18.84-161.99 36.62 21.47-165.99 0.91 14.36 31.66 5.84 10.91 29.66 coo 33.53 17.37-161.81 34.31 17.81-163.76 -2.85 14.93 26.35 -2.72 14.72 24.20 coo 29.78 23.31-161.30 31.23 23.66-162.84 -3.38 17.56 20.48 -2.28 16.44 19.03 1xpx_d00 source 1xpx TRANSCRIPTION REGULATION/DNA : 6 hits 1xpx_d00 naa= 3 ULMN 4 2bgw_d00 HYDROLASE user 1 4 # 1 A 86 ALA A 91 ALA.? 11.21 ZN ZN A 119 A 87 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 123 TYR A 63 TYR^? 13.00 ZN ZN A 119 A 182 ARG A 90 ARG~? 21.28 ZN ZN A 119 coo 33.66 63.14 16.62 34.95 63.46 15.91 -7.50 39.92 51.50 -8.68 39.00 51.45 coo 28.97 64.99 12.92 27.92 64.06 11.28 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 38.40 63.73 13.00 38.79 62.53 10.47 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 29.35 67.59 19.60 30.93 68.47 17.09 -4.89 45.59 55.49 -2.75 44.62 57.47 ULMN 4 2bgw_d00 HYDROLASE user 2 4 # 2 A 86 ALA B 91 ALA.? 11.25 ZN ZN B 118 A 87 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 123 TYR B 63 TYR^? 12.86 ZN ZN B 118 A 182 ARG B 90 ARG~? 22.74 ZN ZN B 118 coo 33.66 63.14 16.62 34.95 63.46 15.91 -5.13 -2.73 40.48 -6.21 -1.76 40.05 coo 28.97 64.99 12.92 27.92 64.06 11.28 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 38.40 63.73 13.00 38.79 62.53 10.47 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 29.35 67.59 19.60 30.93 68.47 17.09 -1.29 -8.08 37.25 0.33 -10.46 36.18 2bgw_d00 source 2bgw HYDROLASE : 2 hits 2bgw_d00 naa= 4 ULMN 3 2bsq_d00 TRANSCRIPTION user 1 3 # 1 E 3 SER A 14 SER~? 11.41 CH3 ACY A 120 E 5 VAL A 36 VAL^? 11.33 CH3 ACY A 120 E 7 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -8.58 16.80 48.15 -8.42 16.11 45.83 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -5.88 23.78 47.09 -5.53 21.87 48.13 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 3 2bsq_d00 TRANSCRIPTION user 2 3 # 2 E 3 SER A 32 SER^? 8.89 ZN ZN A 119 E 5 VAL A 49 VAL^? 7.06 ZN ZN A 119 E 7 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -14.23 26.97 54.31 -16.02 26.35 52.81 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -7.92 28.81 49.14 -8.38 29.50 47.14 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 3 2bsq_d00 TRANSCRIPTION user 3 3 # 3 E 3 SER A 46 SER^? 14.68 O ACY A 121 E 5 VAL A 36 VAL^? 11.33 CH3 ACY A 120 E 7 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 1.31 25.87 47.03 1.94 27.83 45.77 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -5.88 23.78 47.09 -5.53 21.87 48.13 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 3 2bsq_d00 TRANSCRIPTION user 4 3 # 4 E 3 SER B 14 SER~? 11.46 CH3 ACY B 120 E 5 VAL B 36 VAL.? 11.16 CH3 ACY B 120 E 7 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -7.60 20.35 43.19 -8.11 21.15 45.47 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -5.71 13.44 44.97 -4.54 14.71 43.71 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 3 2bsq_d00 TRANSCRIPTION user 5 3 # 5 E 3 SER B 32 SER^? 8.58 ZN ZN B 118 E 5 VAL B 49 VAL^? 6.98 ZN ZN B 118 E 7 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 -11.02 10.19 35.41 -13.14 10.52 36.50 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -6.80 8.29 42.39 -7.81 7.38 44.13 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 3 2bsq_d00 TRANSCRIPTION user 6 3 # 6 E 3 SER B 46 SER^? 14.91 OXT ACY A 120 E 5 VAL B 36 VAL.? 11.16 CH3 ACY B 120 E 7 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo -3.82 -25.91 35.53 -5.28 -27.06 37.10 1.20 11.37 47.30 1.64 9.60 48.90 coo -8.42 -21.09 33.22 -10.34 -21.69 33.92 -5.71 13.44 44.97 -4.54 14.71 43.71 coo -12.01 -17.19 33.96 -11.18 -17.21 36.88 -9.55 10.54 47.29 -12.21 9.06 46.81 2bsq_d00 source 2bsq TRANSCRIPTION : 6 hits 2bsq_d00 naa= 3 ULMN 4 2p0j_d00 HYDROLASE/DNA user 1 4 # 1 A 46 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 133 LYS A 29 LYS^? 13.52 CH3 ACY A 120 A 134 TYR A 23 TYR^? 11.58 CH3 ACY A 120 A 172 SER A 32 SER^? 8.89 ZN ZN A 119 coo 29.36 7.53 2.81 27.47 7.30 3.73 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 20.43 15.67 9.20 23.49 12.62 10.53 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 18.60 12.45 12.36 19.78 10.10 11.41 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 23.78 7.59 5.40 26.01 7.14 6.26 -14.23 26.97 54.31 -16.02 26.35 52.81 ULMN 4 2p0j_d00 HYDROLASE/DNA user 2 4 # 2 A 46 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 133 LYS B 29 LYS^? 13.36 ZN ZN B 118 A 134 TYR B 23 TYR^? 11.37 CH3 ACY B 120 A 172 SER B 32 SER^? 8.58 ZN ZN B 118 coo 29.36 7.53 2.81 27.47 7.30 3.73 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 20.43 15.67 9.20 23.49 12.62 10.53 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 18.60 12.45 12.36 19.78 10.10 11.41 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 23.78 7.59 5.40 26.01 7.14 6.26 -11.02 10.19 35.41 -13.14 10.52 36.50 2p0j_d00 source 2p0j HYDROLASE/DNA : 2 hits 2p0j_d00 naa= 4 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 1 2 # 1 246 SER A 32 SER^? 8.89 ZN ZN A 119 360 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo -2.27 5.01 11.02 -1.56 7.27 11.54 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 3.38 8.39 11.51 1.79 8.22 12.92 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 2 2 # 2 246 SER A 42 SER.? 12.48 O ACY A 121 360 GLU A 39 GLU^? 13.07 O ACY A 121 coo -2.27 5.01 11.02 -1.56 7.27 11.54 6.18 19.13 41.68 6.03 20.94 43.24 coo 3.38 8.39 11.51 1.79 8.22 12.92 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 3 2 # 3 246 SER A 46 SER^? 14.68 O ACY A 121 360 GLU A 39 GLU^? 13.07 O ACY A 121 coo -2.27 5.01 11.02 -1.56 7.27 11.54 1.31 25.87 47.03 1.94 27.83 45.77 coo 3.38 8.39 11.51 1.79 8.22 12.92 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 4 2 # 4 246 SER A 51 SER^? 4.15 ZN ZN A 119 360 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo -2.27 5.01 11.02 -1.56 7.27 11.54 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 3.38 8.39 11.51 1.79 8.22 12.92 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 5 2 # 5 246 SER A 98 SER.? 16.73 ZN ZN A 119 360 GLU A 99 GLU.? 20.42 CH3 ACY A 121 coo -2.27 5.01 11.02 -1.56 7.27 11.54 0.17 39.20 41.01 -1.56 40.86 40.71 coo 3.38 8.39 11.51 1.79 8.22 12.92 4.40 42.94 40.00 4.87 41.71 38.33 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 6 2 # 6 246 SER B 32 SER^? 8.58 ZN ZN B 118 360 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo -2.27 5.01 11.02 -1.56 7.27 11.54 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 3.38 8.39 11.51 1.79 8.22 12.92 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 7 2 # 7 246 SER B 42 SER.? 13.83 OXT ACY A 120 360 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -2.27 5.01 11.02 -1.56 7.27 11.54 4.20 18.00 53.79 4.49 16.52 51.91 coo 3.38 8.39 11.51 1.79 8.22 12.92 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 8 2 # 8 246 SER B 46 SER^? 14.91 OXT ACY A 120 360 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -2.27 5.01 11.02 -1.56 7.27 11.54 1.20 11.37 47.30 1.64 9.60 48.90 coo 3.38 8.39 11.51 1.79 8.22 12.92 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1oxa_c00 CYTOCHROME P450 ERYF user 9 2 # 9 246 SER B 51 SER^? 4.27 ZN ZN B 118 360 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo -2.27 5.01 11.02 -1.56 7.27 11.54 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 3.38 8.39 11.51 1.79 8.22 12.92 -13.07 9.82 43.01 -13.89 7.88 43.30 1oxa_c00 source 1oxa CYTOCHROME P450 ERYF : 9 hits 1oxa_c00 naa= 2 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 1 2 # 1 X 16 LYS A 29 LYS^? 13.52 CH3 ACY A 120 X 119 ASN A 73 ASN^? 11.43 OXT ACY A 120 coo 9.69 63.83 35.55 11.00 62.83 41.36 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 11.13 57.62 41.98 10.56 59.50 42.87 -9.59 22.33 65.64 -10.09 22.46 67.69 ULMN 2 1pae_c00 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 2 2 # 2 X 16 LYS B 29 LYS^? 13.36 ZN ZN B 118 X 119 ASN B 73 ASN^? 10.74 OXT ACY A 121 coo 9.69 63.83 35.55 11.00 62.83 41.36 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 11.13 57.62 41.98 10.56 59.50 42.87 -2.85 14.93 26.35 -2.72 14.72 24.20 1pae_c00 source 1pae NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSOLIC : 2 hits 1pae_c00 naa= 2 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 1 2 # 1 X 16 LYS A 10 LYS.? 12.65 OXT ACY A 120 X 56 TYR A 72 TYR^? -3.77 O ACY A 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 -0.98 10.25 56.97 2.99 9.65 58.52 coo 10.51 70.44 44.57 10.41 68.10 43.00 -8.74 18.57 61.24 -11.39 17.69 61.31 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 2 2 # 2 X 16 LYS A 10 LYS.? 12.65 OXT ACY A 120 X 56 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 9.69 63.83 35.55 11.00 62.83 41.36 -0.98 10.25 56.97 2.99 9.65 58.52 coo 10.51 70.44 44.57 10.41 68.10 43.00 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 3 2 # 3 X 16 LYS A 16 LYS~? -3.27 O ACY A 120s X 56 TYR A 72 TYR^? -3.77 O ACY A 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 10.51 70.44 44.57 10.41 68.10 43.00 -8.74 18.57 61.24 -11.39 17.69 61.31 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 4 2 # 4 X 16 LYS A 16 LYS~? -3.27 O ACY A 120s X 56 TYR A 79 TYR^? -4.35 CH3 ACY A 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 10.51 70.44 44.57 10.41 68.10 43.00 -8.40 22.97 58.06 -7.77 20.89 56.30 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 5 2 # 5 X 16 LYS A 29 LYS^? 13.52 CH3 ACY A 120 X 56 TYR A 79 TYR^? -4.35 CH3 ACY A 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 10.51 70.44 44.57 10.41 68.10 43.00 -8.40 22.97 58.06 -7.77 20.89 56.30 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 6 2 # 6 X 16 LYS A 40 LYS.? -3.18 C ACY A 121s X 56 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 9.69 63.83 35.55 11.00 62.83 41.36 1.80 21.48 38.21 -1.61 24.69 34.09 coo 10.51 70.44 44.57 10.41 68.10 43.00 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 7 2 # 7 X 16 LYS A 40 LYS.? -3.18 C ACY A 121s X 56 TYR B 72 TYR^? 3.72 OXT ACY B 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 1.80 21.48 38.21 -1.61 24.69 34.09 coo 10.51 70.44 44.57 10.41 68.10 43.00 -3.38 18.68 30.67 -5.90 19.37 29.75 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 8 2 # 8 X 16 LYS A 40 LYS.? -3.18 C ACY A 121s X 56 TYR B 79 TYR^? -4.21 CH3 ACY B 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 1.80 21.48 38.21 -1.61 24.69 34.09 coo 10.51 70.44 44.57 10.41 68.10 43.00 -4.08 14.27 33.90 -4.00 16.42 35.66 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 9 2 # 9 X 16 LYS A 71 LYS^? 11.96 OXT ACY A 120 X 56 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 9.69 63.83 35.55 11.00 62.83 41.36 -4.35 22.91 61.78 1.12 23.33 62.25 coo 10.51 70.44 44.57 10.41 68.10 43.00 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 10 2 # 10 X 16 LYS A 93 LYS.? 17.16 ZN ZN A 119 X 56 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 9.69 63.83 35.55 11.00 62.83 41.36 -8.24 41.47 45.26 -7.63 47.05 46.72 coo 10.51 70.44 44.57 10.41 68.10 43.00 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 11 2 # 11 X 16 LYS B 10 LYS.? 9.83 CH3 ACY A 121 X 56 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 9.69 63.83 35.55 11.00 62.83 41.36 2.14 27.03 37.15 7.00 28.76 35.76 coo 10.51 70.44 44.57 10.41 68.10 43.00 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 12 2 # 12 X 16 LYS B 10 LYS.? 9.83 CH3 ACY A 121 X 56 TYR B 72 TYR^? 3.72 OXT ACY B 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 2.14 27.03 37.15 7.00 28.76 35.76 coo 10.51 70.44 44.57 10.41 68.10 43.00 -3.38 18.68 30.67 -5.90 19.37 29.75 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 13 2 # 13 X 16 LYS B 16 LYS~? -4.10 OXT ACY B 120s X 56 TYR B 72 TYR^? 3.72 OXT ACY B 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 10.51 70.44 44.57 10.41 68.10 43.00 -3.38 18.68 30.67 -5.90 19.37 29.75 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 14 2 # 14 X 16 LYS B 16 LYS~? -4.10 OXT ACY B 120s X 56 TYR B 79 TYR^? -4.21 CH3 ACY B 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 10.51 70.44 44.57 10.41 68.10 43.00 -4.08 14.27 33.90 -4.00 16.42 35.66 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 15 2 # 15 X 16 LYS B 29 LYS^? 13.36 ZN ZN B 118 X 56 TYR B 79 TYR^? -4.21 CH3 ACY B 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 10.51 70.44 44.57 10.41 68.10 43.00 -4.08 14.27 33.90 -4.00 16.42 35.66 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 16 2 # 16 X 16 LYS B 40 LYS.? 4.59 ZN ZN A 118 X 56 TYR A 72 TYR^? -3.77 O ACY A 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 10.51 70.44 44.57 10.41 68.10 43.00 -8.74 18.57 61.24 -11.39 17.69 61.31 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 17 2 # 17 X 16 LYS B 40 LYS.? 4.59 ZN ZN A 118 X 56 TYR A 79 TYR^? -4.35 CH3 ACY A 120s coo 9.69 63.83 35.55 11.00 62.83 41.36 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 10.51 70.44 44.57 10.41 68.10 43.00 -8.40 22.97 58.06 -7.77 20.89 56.30 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 18 2 # 18 X 16 LYS B 40 LYS.? 4.59 ZN ZN A 118 X 56 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 9.69 63.83 35.55 11.00 62.83 41.36 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 10.51 70.44 44.57 10.41 68.10 43.00 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1pae_c01 NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSuser 19 2 # 19 X 16 LYS B 71 LYS^? 12.90 O ACY A 121 X 56 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 9.69 63.83 35.55 11.00 62.83 41.36 0.91 14.36 31.66 5.84 10.91 29.66 coo 10.51 70.44 44.57 10.41 68.10 43.00 -7.61 10.49 27.32 -9.94 11.99 27.12 1pae_c01 source 1pae NUCLEOSIDE DIPHOSPHATE KINASE, CYTOSOLIC : 19 hits 1pae_c01 naa= 2 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 A 160 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 375 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 63.94 10.02 33.47 64.31 8.24 32.38 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 61.89 10.05 27.30 63.60 9.39 28.40 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 A 160 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 375 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 63.94 10.02 33.47 64.31 8.24 32.38 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 61.89 10.05 27.30 63.60 9.39 28.40 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 A 160 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 375 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 63.94 10.02 33.47 64.31 8.24 32.38 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 61.89 10.05 27.30 63.60 9.39 28.40 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1pbg_c02 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 A 160 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 375 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 63.94 10.02 33.47 64.31 8.24 32.38 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 61.89 10.05 27.30 63.60 9.39 28.40 -15.62 6.11 47.30 -14.46 5.85 45.55 1pbg_c02 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 4 hits 1pbg_c02 naa= 2 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 B 160 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 375 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 23.66 16.69 85.20 24.17 18.76 84.94 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 21.67 20.74 89.92 23.35 20.55 88.67 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 B 160 GLU A 34 GLU^? -2.26 ZN ZN A 119s B 375 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 23.66 16.69 85.20 24.17 18.76 84.94 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 21.67 20.74 89.92 23.35 20.55 88.67 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 B 160 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 375 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 23.66 16.69 85.20 24.17 18.76 84.94 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 21.67 20.74 89.92 23.35 20.55 88.67 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1pbg_c03 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 B 160 GLU B 34 GLU.? -2.23 ZN ZN B 118s B 375 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 23.66 16.69 85.20 24.17 18.76 84.94 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 21.67 20.74 89.92 23.35 20.55 88.67 -15.62 6.11 47.30 -14.46 5.85 45.55 1pbg_c03 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 4 hits 1pbg_c03 naa= 2 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 A 160 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 269 GLU A 39 GLU^? 13.07 O ACY A 121 coo 63.94 10.02 33.47 64.31 8.24 32.38 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 A 160 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 269 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 63.94 10.02 33.47 64.31 8.24 32.38 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 A 160 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 269 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 63.94 10.02 33.47 64.31 8.24 32.38 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 A 160 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 269 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 63.94 10.02 33.47 64.31 8.24 32.38 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 A 160 GLU A 7 GLU.? 2.09 ZN ZN A 118s A 269 GLU A 28 GLU.? 19.71 ZN ZN A 119 coo 63.94 10.02 33.47 64.31 8.24 32.38 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -17.43 33.27 64.86 -17.71 35.42 64.60 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 A 160 GLU A 7 GLU.? 2.09 ZN ZN A 118s A 269 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 63.94 10.02 33.47 64.31 8.24 32.38 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 7 2 # 7 A 160 GLU A 7 GLU.? 2.09 ZN ZN A 118s A 269 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 63.94 10.02 33.47 64.31 8.24 32.38 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 8 2 # 8 A 160 GLU A 28 GLU.? 19.71 ZN ZN A 119 A 269 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 63.94 10.02 33.47 64.31 8.24 32.38 -17.43 33.27 64.86 -17.71 35.42 64.60 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 9 2 # 9 A 160 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 269 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 63.94 10.02 33.47 64.31 8.24 32.38 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 10 2 # 10 A 160 GLU A 39 GLU^? 13.07 O ACY A 121 A 269 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 63.94 10.02 33.47 64.31 8.24 32.38 3.97 24.42 42.90 6.03 24.50 43.46 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 11 2 # 11 A 160 GLU A 39 GLU^? 13.07 O ACY A 121 A 269 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 63.94 10.02 33.47 64.31 8.24 32.38 3.97 24.42 42.90 6.03 24.50 43.46 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 12 2 # 12 A 160 GLU A 75 GLU.? 14.61 ZN ZN A 118 A 269 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 63.94 10.02 33.47 64.31 8.24 32.38 -11.14 20.14 70.42 -10.69 21.09 72.30 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 13 2 # 13 A 160 GLU A 75 GLU.? 14.61 ZN ZN A 118 A 269 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 63.94 10.02 33.47 64.31 8.24 32.38 -11.14 20.14 70.42 -10.69 21.09 72.30 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 14 2 # 14 A 160 GLU A 75 GLU.? 14.61 ZN ZN A 118 A 269 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 63.94 10.02 33.47 64.31 8.24 32.38 -11.14 20.14 70.42 -10.69 21.09 72.30 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 15 2 # 15 A 160 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 269 GLU A 39 GLU^? 13.07 O ACY A 121 coo 63.94 10.02 33.47 64.31 8.24 32.38 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 16 2 # 16 A 160 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 269 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 63.94 10.02 33.47 64.31 8.24 32.38 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 17 2 # 17 A 160 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 269 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 63.94 10.02 33.47 64.31 8.24 32.38 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 18 2 # 18 A 160 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 269 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 63.94 10.02 33.47 64.31 8.24 32.38 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 19 2 # 19 A 160 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 269 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 63.94 10.02 33.47 64.31 8.24 32.38 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 20 2 # 20 A 160 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 269 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo 63.94 10.02 33.47 64.31 8.24 32.38 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -3.38 17.56 20.48 -2.28 16.44 19.03 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 21 2 # 21 A 160 GLU B 7 GLU.? -2.20 ZN ZN B 119s A 269 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 63.94 10.02 33.47 64.31 8.24 32.38 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 22 2 # 22 A 160 GLU B 7 GLU.? -2.20 ZN ZN B 119s A 269 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 63.94 10.02 33.47 64.31 8.24 32.38 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 23 2 # 23 A 160 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 269 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo 63.94 10.02 33.47 64.31 8.24 32.38 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -3.38 17.56 20.48 -2.28 16.44 19.03 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 24 2 # 24 A 160 GLU B 39 GLU.? 14.67 OXT ACY A 120 A 269 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 63.94 10.02 33.47 64.31 8.24 32.38 2.54 12.93 51.58 4.67 12.91 51.32 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 25 2 # 25 A 160 GLU B 39 GLU.? 14.67 OXT ACY A 120 A 269 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 63.94 10.02 33.47 64.31 8.24 32.38 2.54 12.93 51.58 4.67 12.91 51.32 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -7.13 -6.28 33.53 -6.83 -7.93 32.24 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 26 2 # 26 A 160 GLU B 75 GLU.? 13.95 OXT ACY A 121 A 269 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 63.94 10.02 33.47 64.31 8.24 32.38 -3.38 17.56 20.48 -2.28 16.44 19.03 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 27 2 # 27 A 160 GLU B 75 GLU.? 13.95 OXT ACY A 121 A 269 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 63.94 10.02 33.47 64.31 8.24 32.38 -3.38 17.56 20.48 -2.28 16.44 19.03 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 28 2 # 28 A 160 GLU B 75 GLU.? 13.95 OXT ACY A 121 A 269 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 63.94 10.02 33.47 64.31 8.24 32.38 -3.38 17.56 20.48 -2.28 16.44 19.03 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -7.13 -6.28 33.53 -6.83 -7.93 32.24 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 29 2 # 29 A 160 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 269 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 63.94 10.02 33.47 64.31 8.24 32.38 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1pbg_c04 6-PHOSPHO-BETA-D-GALACTOSIDASE user 30 2 # 30 A 160 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 269 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo 63.94 10.02 33.47 64.31 8.24 32.38 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 61.33 -0.47 58.24 61.00 -1.97 59.70 -3.38 17.56 20.48 -2.28 16.44 19.03 1pbg_c04 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 30 hits 1pbg_c04 naa= 2 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 1 2 # 1 B 160 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 269 GLU A 39 GLU^? 13.07 O ACY A 121 coo 23.66 16.69 85.20 24.17 18.76 84.94 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 21.20 8.49 59.63 20.88 8.62 57.55 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 2 2 # 2 B 160 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 269 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 23.66 16.69 85.20 24.17 18.76 84.94 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 21.20 8.49 59.63 20.88 8.62 57.55 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 3 2 # 3 B 160 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 269 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 23.66 16.69 85.20 24.17 18.76 84.94 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 21.20 8.49 59.63 20.88 8.62 57.55 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 4 2 # 4 B 160 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 269 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 23.66 16.69 85.20 24.17 18.76 84.94 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 21.20 8.49 59.63 20.88 8.62 57.55 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 5 2 # 5 B 160 GLU A 7 GLU.? 2.09 ZN ZN A 118s B 269 GLU A 28 GLU.? 19.71 ZN ZN A 119 coo 23.66 16.69 85.20 24.17 18.76 84.94 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 21.20 8.49 59.63 20.88 8.62 57.55 -17.43 33.27 64.86 -17.71 35.42 64.60 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 6 2 # 6 B 160 GLU A 7 GLU.? 2.09 ZN ZN A 118s B 269 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 23.66 16.69 85.20 24.17 18.76 84.94 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 21.20 8.49 59.63 20.88 8.62 57.55 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 7 2 # 7 B 160 GLU A 7 GLU.? 2.09 ZN ZN A 118s B 269 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 23.66 16.69 85.20 24.17 18.76 84.94 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 21.20 8.49 59.63 20.88 8.62 57.55 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 8 2 # 8 B 160 GLU A 28 GLU.? 19.71 ZN ZN A 119 B 269 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 23.66 16.69 85.20 24.17 18.76 84.94 -17.43 33.27 64.86 -17.71 35.42 64.60 coo 21.20 8.49 59.63 20.88 8.62 57.55 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 9 2 # 9 B 160 GLU A 34 GLU^? -2.26 ZN ZN A 119s B 269 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 23.66 16.69 85.20 24.17 18.76 84.94 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 21.20 8.49 59.63 20.88 8.62 57.55 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 10 2 # 10 B 160 GLU A 39 GLU^? 13.07 O ACY A 121 B 269 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 23.66 16.69 85.20 24.17 18.76 84.94 3.97 24.42 42.90 6.03 24.50 43.46 coo 21.20 8.49 59.63 20.88 8.62 57.55 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 11 2 # 11 B 160 GLU A 39 GLU^? 13.07 O ACY A 121 B 269 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 23.66 16.69 85.20 24.17 18.76 84.94 3.97 24.42 42.90 6.03 24.50 43.46 coo 21.20 8.49 59.63 20.88 8.62 57.55 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 12 2 # 12 B 160 GLU A 75 GLU.? 14.61 ZN ZN A 118 B 269 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 23.66 16.69 85.20 24.17 18.76 84.94 -11.14 20.14 70.42 -10.69 21.09 72.30 coo 21.20 8.49 59.63 20.88 8.62 57.55 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 13 2 # 13 B 160 GLU A 75 GLU.? 14.61 ZN ZN A 118 B 269 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 23.66 16.69 85.20 24.17 18.76 84.94 -11.14 20.14 70.42 -10.69 21.09 72.30 coo 21.20 8.49 59.63 20.88 8.62 57.55 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 14 2 # 14 B 160 GLU A 75 GLU.? 14.61 ZN ZN A 118 B 269 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 23.66 16.69 85.20 24.17 18.76 84.94 -11.14 20.14 70.42 -10.69 21.09 72.30 coo 21.20 8.49 59.63 20.88 8.62 57.55 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 15 2 # 15 B 160 GLU A 89 GLU~? 19.37 ZN ZN A 119 B 269 GLU A 39 GLU^? 13.07 O ACY A 121 coo 23.66 16.69 85.20 24.17 18.76 84.94 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 21.20 8.49 59.63 20.88 8.62 57.55 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 16 2 # 16 B 160 GLU A 89 GLU~? 19.37 ZN ZN A 119 B 269 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 23.66 16.69 85.20 24.17 18.76 84.94 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 21.20 8.49 59.63 20.88 8.62 57.55 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 17 2 # 17 B 160 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 269 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 23.66 16.69 85.20 24.17 18.76 84.94 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 21.20 8.49 59.63 20.88 8.62 57.55 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 18 2 # 18 B 160 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 269 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 23.66 16.69 85.20 24.17 18.76 84.94 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 21.20 8.49 59.63 20.88 8.62 57.55 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 19 2 # 19 B 160 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 269 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 23.66 16.69 85.20 24.17 18.76 84.94 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 21.20 8.49 59.63 20.88 8.62 57.55 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 20 2 # 20 B 160 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 269 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo 23.66 16.69 85.20 24.17 18.76 84.94 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 21.20 8.49 59.63 20.88 8.62 57.55 -3.38 17.56 20.48 -2.28 16.44 19.03 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 21 2 # 21 B 160 GLU B 7 GLU.? -2.20 ZN ZN B 119s B 269 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 23.66 16.69 85.20 24.17 18.76 84.94 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 21.20 8.49 59.63 20.88 8.62 57.55 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 22 2 # 22 B 160 GLU B 7 GLU.? -2.20 ZN ZN B 119s B 269 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 23.66 16.69 85.20 24.17 18.76 84.94 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 21.20 8.49 59.63 20.88 8.62 57.55 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 23 2 # 23 B 160 GLU B 34 GLU.? -2.23 ZN ZN B 118s B 269 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo 23.66 16.69 85.20 24.17 18.76 84.94 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 21.20 8.49 59.63 20.88 8.62 57.55 -3.38 17.56 20.48 -2.28 16.44 19.03 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 24 2 # 24 B 160 GLU B 39 GLU.? 14.67 OXT ACY A 120 B 269 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 23.66 16.69 85.20 24.17 18.76 84.94 2.54 12.93 51.58 4.67 12.91 51.32 coo 21.20 8.49 59.63 20.88 8.62 57.55 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 25 2 # 25 B 160 GLU B 39 GLU.? 14.67 OXT ACY A 120 B 269 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 23.66 16.69 85.20 24.17 18.76 84.94 2.54 12.93 51.58 4.67 12.91 51.32 coo 21.20 8.49 59.63 20.88 8.62 57.55 -7.13 -6.28 33.53 -6.83 -7.93 32.24 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 26 2 # 26 B 160 GLU B 75 GLU.? 13.95 OXT ACY A 121 B 269 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 23.66 16.69 85.20 24.17 18.76 84.94 -3.38 17.56 20.48 -2.28 16.44 19.03 coo 21.20 8.49 59.63 20.88 8.62 57.55 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 27 2 # 27 B 160 GLU B 75 GLU.? 13.95 OXT ACY A 121 B 269 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 23.66 16.69 85.20 24.17 18.76 84.94 -3.38 17.56 20.48 -2.28 16.44 19.03 coo 21.20 8.49 59.63 20.88 8.62 57.55 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 28 2 # 28 B 160 GLU B 75 GLU.? 13.95 OXT ACY A 121 B 269 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 23.66 16.69 85.20 24.17 18.76 84.94 -3.38 17.56 20.48 -2.28 16.44 19.03 coo 21.20 8.49 59.63 20.88 8.62 57.55 -7.13 -6.28 33.53 -6.83 -7.93 32.24 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 29 2 # 29 B 160 GLU B 89 GLU~? 19.03 ZN ZN B 118 B 269 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 23.66 16.69 85.20 24.17 18.76 84.94 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 21.20 8.49 59.63 20.88 8.62 57.55 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1pbg_c05 6-PHOSPHO-BETA-D-GALACTOSIDASE user 30 2 # 30 B 160 GLU B 89 GLU~? 19.03 ZN ZN B 118 B 269 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo 23.66 16.69 85.20 24.17 18.76 84.94 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 21.20 8.49 59.63 20.88 8.62 57.55 -3.38 17.56 20.48 -2.28 16.44 19.03 1pbg_c05 source 1pbg 6-PHOSPHO-BETA-D-GALACTOSIDASE : 30 hits 1pbg_c05 naa= 2 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 1 2 # 1 A 178 TYR A 23 TYR^? 11.58 CH3 ACY A 120 A 283 TYR A 72 TYR^? -3.77 O ACY A 120s coo 29.64 7.69 5.12 29.91 9.25 2.80 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 25.32 16.13 3.80 24.28 14.46 1.84 -8.74 18.57 61.24 -11.39 17.69 61.31 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 2 2 # 2 A 178 TYR A 23 TYR^? 11.58 CH3 ACY A 120 A 283 TYR A 79 TYR^? -4.35 CH3 ACY A 120s coo 29.64 7.69 5.12 29.91 9.25 2.80 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 25.32 16.13 3.80 24.28 14.46 1.84 -8.40 22.97 58.06 -7.77 20.89 56.30 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 3 2 # 3 A 178 TYR A 47 TYR^? 12.01 ZN ZN A 119 A 283 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 29.64 7.69 5.12 29.91 9.25 2.80 -2.05 29.36 47.71 -2.93 30.35 45.23 coo 25.32 16.13 3.80 24.28 14.46 1.84 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 4 2 # 4 A 178 TYR A 63 TYR^? 13.00 ZN ZN A 119 A 283 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 29.64 7.69 5.12 29.91 9.25 2.80 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 25.32 16.13 3.80 24.28 14.46 1.84 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 5 2 # 5 A 178 TYR A 72 TYR^? -3.77 O ACY A 120s A 283 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 29.64 7.69 5.12 29.91 9.25 2.80 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 25.32 16.13 3.80 24.28 14.46 1.84 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 6 2 # 6 A 178 TYR A 79 TYR^? -4.35 CH3 ACY A 120s A 283 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 29.64 7.69 5.12 29.91 9.25 2.80 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 25.32 16.13 3.80 24.28 14.46 1.84 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 7 2 # 7 A 178 TYR B 23 TYR^? 11.37 CH3 ACY B 120 A 283 TYR B 72 TYR^? 3.72 OXT ACY B 120s coo 29.64 7.69 5.12 29.91 9.25 2.80 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 25.32 16.13 3.80 24.28 14.46 1.84 -3.38 18.68 30.67 -5.90 19.37 29.75 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 8 2 # 8 A 178 TYR B 23 TYR^? 11.37 CH3 ACY B 120 A 283 TYR B 79 TYR^? -4.21 CH3 ACY B 120s coo 29.64 7.69 5.12 29.91 9.25 2.80 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 25.32 16.13 3.80 24.28 14.46 1.84 -4.08 14.27 33.90 -4.00 16.42 35.66 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 9 2 # 9 A 178 TYR B 47 TYR^? 11.86 ZN ZN B 118 A 283 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 29.64 7.69 5.12 29.91 9.25 2.80 -1.77 7.84 45.62 -3.44 6.86 47.62 coo 25.32 16.13 3.80 24.28 14.46 1.84 -4.17 2.05 38.57 -1.76 0.81 38.01 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 10 2 # 10 A 178 TYR B 63 TYR^? 12.86 ZN ZN B 118 A 283 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 29.64 7.69 5.12 29.91 9.25 2.80 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 25.32 16.13 3.80 24.28 14.46 1.84 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 11 2 # 11 A 178 TYR B 72 TYR^? 3.72 OXT ACY B 120s A 283 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 29.64 7.69 5.12 29.91 9.25 2.80 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 25.32 16.13 3.80 24.28 14.46 1.84 -7.61 10.49 27.32 -9.94 11.99 27.12 ULMN 2 1peg_c00 HISTONE H3 METHYLTRANSFERASE DIM-5 user 12 2 # 12 A 178 TYR B 79 TYR^? -4.21 CH3 ACY B 120s A 283 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 29.64 7.69 5.12 29.91 9.25 2.80 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 25.32 16.13 3.80 24.28 14.46 1.84 -7.61 10.49 27.32 -9.94 11.99 27.12 1peg_c00 source 1peg HISTONE H3 METHYLTRANSFERASE DIM-5 : 12 hits 1peg_c00 naa= 2 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 1 2 # 1 B 178 TYR A 23 TYR^? 11.58 CH3 ACY A 120 B 283 TYR A 72 TYR^? -3.77 O ACY A 120s coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -8.74 18.57 61.24 -11.39 17.69 61.31 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 2 2 # 2 B 178 TYR A 23 TYR^? 11.58 CH3 ACY A 120 B 283 TYR A 79 TYR^? -4.35 CH3 ACY A 120s coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -8.40 22.97 58.06 -7.77 20.89 56.30 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 3 2 # 3 B 178 TYR A 47 TYR^? 12.01 ZN ZN A 119 B 283 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -2.05 29.36 47.71 -2.93 30.35 45.23 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 4 2 # 4 B 178 TYR A 63 TYR^? 13.00 ZN ZN A 119 B 283 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 5 2 # 5 B 178 TYR A 72 TYR^? -3.77 O ACY A 120s B 283 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 6 2 # 6 B 178 TYR A 79 TYR^? -4.35 CH3 ACY A 120s B 283 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 7 2 # 7 B 178 TYR B 23 TYR^? 11.37 CH3 ACY B 120 B 283 TYR B 72 TYR^? 3.72 OXT ACY B 120s coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -3.38 18.68 30.67 -5.90 19.37 29.75 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 8 2 # 8 B 178 TYR B 23 TYR^? 11.37 CH3 ACY B 120 B 283 TYR B 79 TYR^? -4.21 CH3 ACY B 120s coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -4.08 14.27 33.90 -4.00 16.42 35.66 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 9 2 # 9 B 178 TYR B 47 TYR^? 11.86 ZN ZN B 118 B 283 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -1.77 7.84 45.62 -3.44 6.86 47.62 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -4.17 2.05 38.57 -1.76 0.81 38.01 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 10 2 # 10 B 178 TYR B 63 TYR^? 12.86 ZN ZN B 118 B 283 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 11 2 # 11 B 178 TYR B 72 TYR^? 3.72 OXT ACY B 120s B 283 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -7.61 10.49 27.32 -9.94 11.99 27.12 ULMN 2 1peg_c01 HISTONE H3 METHYLTRANSFERASE DIM-5 user 12 2 # 12 B 178 TYR B 79 TYR^? -4.21 CH3 ACY B 120s B 283 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 37.00 -13.69 -17.06 34.39 -13.98 -18.00 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 34.77 -17.57 -25.66 33.85 -14.96 -25.79 -7.61 10.49 27.32 -9.94 11.99 27.12 1peg_c01 source 1peg HISTONE H3 METHYLTRANSFERASE DIM-5 : 12 hits 1peg_c01 naa= 2 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 1 2 # 1 60 ASP A 15 ASP~? 8.61 ZN ZN B 118 206 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 2 2 # 2 60 ASP A 60 ASP.? -2.37 ZN ZN A 119s 206 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 3 2 # 3 60 ASP A 60 ASP.? -2.37 ZN ZN A 119s 206 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 4 2 # 4 60 ASP A 61 ASP^? 8.97 ZN ZN A 119 206 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 5 2 # 5 60 ASP B 15 ASP~? 8.50 ZN ZN A 119 206 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 6 2 # 6 60 ASP B 60 ASP.? -2.30 ZN ZN B 118s 206 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 7 2 # 7 60 ASP B 60 ASP.? -2.30 ZN ZN B 118s 206 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1pgs_c00 PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSuser 8 2 # 8 60 ASP B 61 ASP^? 9.02 ZN ZN B 118 206 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 18.81 -14.51 26.14 20.51 -15.78 26.04 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 24.76 -17.26 31.97 24.04 -17.39 29.99 -7.13 -6.28 33.53 -6.83 -7.93 32.24 1pgs_c00 source 1pgs PEPTIDE-N(4)-(N-ACETYL-BETA-D-GLUCOSAMINYL) AS: 8 hits 1pgs_c00 naa= 2 ULMN 2 1pow_c04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 2 # 1 A 394 VAL A 36 VAL^? 11.33 CH3 ACY A 120 A 422 MET A 37 MET?? 10.48 O ACY B 120 coo 20.28 63.26 5.82 18.13 63.68 5.60 -5.88 23.78 47.09 -5.53 21.87 48.13 coo 19.32 67.77 3.69 20.14 66.07 0.03 -3.65 25.16 44.33 -5.41 26.98 42.18 ULMN 2 1pow_c04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 2 # 2 A 394 VAL A 45 VAL^? 13.33 CH3 ACY A 120 A 422 MET A 37 MET?? 10.48 O ACY B 120 coo 20.28 63.26 5.82 18.13 63.68 5.60 0.37 22.26 47.43 -1.40 21.95 48.63 coo 19.32 67.77 3.69 20.14 66.07 0.03 -3.65 25.16 44.33 -5.41 26.98 42.18 ULMN 2 1pow_c04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 2 # 3 A 394 VAL A 81 VAL.? 12.25 CH3 ACY A 120 A 422 MET A 82 MET?? 17.59 CH3 ACY A 120 coo 20.28 63.26 5.82 18.13 63.68 5.60 -5.97 29.08 61.50 -6.93 29.23 59.52 coo 19.32 67.77 3.69 20.14 66.07 0.03 -4.17 32.12 62.91 -3.50 31.57 66.28 ULMN 2 1pow_c04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 2 # 4 A 394 VAL A 83 VAL.? 16.83 ZN ZN A 119 A 422 MET A 82 MET?? 17.59 CH3 ACY A 120 coo 20.28 63.26 5.82 18.13 63.68 5.60 -5.85 34.88 60.90 -6.33 34.38 58.84 coo 19.32 67.77 3.69 20.14 66.07 0.03 -4.17 32.12 62.91 -3.50 31.57 66.28 ULMN 2 1pow_c04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 2 # 5 A 394 VAL B 36 VAL.? 11.16 CH3 ACY B 120 A 422 MET B 37 MET?? 10.55 ZN ZN B 118 coo 20.28 63.26 5.82 18.13 63.68 5.60 -5.71 13.44 44.97 -4.54 14.71 43.71 coo 19.32 67.77 3.69 20.14 66.07 0.03 -4.27 12.21 48.29 -6.60 10.21 49.60 ULMN 2 1pow_c04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 2 # 6 A 394 VAL B 45 VAL^? 13.07 CH3 ACY B 120 A 422 MET B 37 MET?? 10.55 ZN ZN B 118 coo 20.28 63.26 5.82 18.13 63.68 5.60 0.45 15.00 46.59 -0.80 15.32 44.85 coo 19.32 67.77 3.69 20.14 66.07 0.03 -4.27 12.21 48.29 -6.60 10.21 49.60 ULMN 2 1pow_c04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 2 # 7 A 394 VAL B 81 VAL.? 12.15 CH3 ACY B 120 A 422 MET B 82 MET?? 18.84 O ACY A 121 coo 20.28 63.26 5.82 18.13 63.68 5.60 -0.79 8.15 31.35 -2.32 7.91 32.93 coo 19.32 67.77 3.69 20.14 66.07 0.03 1.34 5.10 30.59 3.37 3.64 28.04 ULMN 2 1pow_c04 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 2 # 8 A 394 VAL B 83 VAL.? 16.85 ZN ZN B 118 A 422 MET B 82 MET?? 18.84 O ACY A 121 coo 20.28 63.26 5.82 18.13 63.68 5.60 -0.76 2.25 31.88 -2.02 3.11 33.46 coo 19.32 67.77 3.69 20.14 66.07 0.03 1.34 5.10 30.59 3.37 3.64 28.04 1pow_c04 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 8 hits 1pow_c04 naa= 2 ULMN 2 1pow_c05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 1 2 # 1 B 394 VAL A 36 VAL^? 11.33 CH3 ACY A 120 B 422 MET A 37 MET?? 10.48 O ACY B 120 coo -29.52 83.24 14.45 -27.41 83.13 13.96 -5.88 23.78 47.09 -5.53 21.87 48.13 coo -28.53 81.64 9.59 -29.29 85.60 8.64 -3.65 25.16 44.33 -5.41 26.98 42.18 ULMN 2 1pow_c05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 2 2 # 2 B 394 VAL A 45 VAL^? 13.33 CH3 ACY A 120 B 422 MET A 37 MET?? 10.48 O ACY B 120 coo -29.52 83.24 14.45 -27.41 83.13 13.96 0.37 22.26 47.43 -1.40 21.95 48.63 coo -28.53 81.64 9.59 -29.29 85.60 8.64 -3.65 25.16 44.33 -5.41 26.98 42.18 ULMN 2 1pow_c05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 3 2 # 3 B 394 VAL A 81 VAL.? 12.25 CH3 ACY A 120 B 422 MET A 82 MET?? 17.59 CH3 ACY A 120 coo -29.52 83.24 14.45 -27.41 83.13 13.96 -5.97 29.08 61.50 -6.93 29.23 59.52 coo -28.53 81.64 9.59 -29.29 85.60 8.64 -4.17 32.12 62.91 -3.50 31.57 66.28 ULMN 2 1pow_c05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 4 2 # 4 B 394 VAL A 83 VAL.? 16.83 ZN ZN A 119 B 422 MET A 82 MET?? 17.59 CH3 ACY A 120 coo -29.52 83.24 14.45 -27.41 83.13 13.96 -5.85 34.88 60.90 -6.33 34.38 58.84 coo -28.53 81.64 9.59 -29.29 85.60 8.64 -4.17 32.12 62.91 -3.50 31.57 66.28 ULMN 2 1pow_c05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 5 2 # 5 B 394 VAL B 36 VAL.? 11.16 CH3 ACY B 120 B 422 MET B 37 MET?? 10.55 ZN ZN B 118 coo -29.52 83.24 14.45 -27.41 83.13 13.96 -5.71 13.44 44.97 -4.54 14.71 43.71 coo -28.53 81.64 9.59 -29.29 85.60 8.64 -4.27 12.21 48.29 -6.60 10.21 49.60 ULMN 2 1pow_c05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 6 2 # 6 B 394 VAL B 45 VAL^? 13.07 CH3 ACY B 120 B 422 MET B 37 MET?? 10.55 ZN ZN B 118 coo -29.52 83.24 14.45 -27.41 83.13 13.96 0.45 15.00 46.59 -0.80 15.32 44.85 coo -28.53 81.64 9.59 -29.29 85.60 8.64 -4.27 12.21 48.29 -6.60 10.21 49.60 ULMN 2 1pow_c05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 7 2 # 7 B 394 VAL B 81 VAL.? 12.15 CH3 ACY B 120 B 422 MET B 82 MET?? 18.84 O ACY A 121 coo -29.52 83.24 14.45 -27.41 83.13 13.96 -0.79 8.15 31.35 -2.32 7.91 32.93 coo -28.53 81.64 9.59 -29.29 85.60 8.64 1.34 5.10 30.59 3.37 3.64 28.04 ULMN 2 1pow_c05 PYRUVATE OXIDASE (E.C.1.2.3.3) (WILDuser 8 2 # 8 B 394 VAL B 83 VAL.? 16.85 ZN ZN B 118 B 422 MET B 82 MET?? 18.84 O ACY A 121 coo -29.52 83.24 14.45 -27.41 83.13 13.96 -0.76 2.25 31.88 -2.02 3.11 33.46 coo -28.53 81.64 9.59 -29.29 85.60 8.64 1.34 5.10 30.59 3.37 3.64 28.04 1pow_c05 source 1pow PYRUVATE OXIDASE (E.C.1.2.3.3) (WILD TYPE) : 8 hits 1pow_c05 naa= 2 ULMN 2 1ps1_c00 PENTALENENE SYNTHASE user 1 2 # 1 A 77 PHE A 55 PHE.? 11.31 ZN ZN A 119 A 309 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 50.92 66.26 27.35 49.39 65.20 29.47 -23.76 31.53 49.05 -25.99 32.30 50.52 coo 40.83 63.47 32.68 42.69 62.61 32.19 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1ps1_c00 PENTALENENE SYNTHASE user 2 2 # 2 A 77 PHE B 55 PHE.? 11.31 ZN ZN B 118 A 309 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 50.92 66.26 27.35 49.39 65.20 29.47 -21.82 4.67 37.54 -23.75 3.88 35.71 coo 40.83 63.47 32.68 42.69 62.61 32.19 -10.33 3.56 43.54 -12.07 4.44 44.29 1ps1_c00 source 1ps1 PENTALENENE SYNTHASE : 2 hits 1ps1_c00 naa= 2 ULMN 2 1ps1_c01 PENTALENENE SYNTHASE user 1 2 # 1 B 77 PHE A 55 PHE.? 11.31 ZN ZN A 119 B 309 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 70.89 30.37 52.79 69.71 32.41 54.33 -23.76 31.53 49.05 -25.99 32.30 50.52 coo 69.54 37.51 61.78 69.32 37.78 59.70 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1ps1_c01 PENTALENENE SYNTHASE user 2 2 # 2 B 77 PHE B 55 PHE.? 11.31 ZN ZN B 118 B 309 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 70.89 30.37 52.79 69.71 32.41 54.33 -21.82 4.67 37.54 -23.75 3.88 35.71 coo 69.54 37.51 61.78 69.32 37.78 59.70 -10.33 3.56 43.54 -12.07 4.44 44.29 1ps1_c01 source 1ps1 PENTALENENE SYNTHASE : 2 hits 1ps1_c01 naa= 2 ULMN 2 1ps9_c00 2,4-DIENOYL-COA REDUCTASE user 1 2 # 1 A 166 TYR A 63 TYR^? 13.00 ZN ZN A 119 A 252 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 20.63 0.63 7.88 19.21 1.89 9.96 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 22.03 4.62 13.09 20.10 5.00 12.34 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1ps9_c00 2,4-DIENOYL-COA REDUCTASE user 2 2 # 2 A 166 TYR B 63 TYR^? 12.86 ZN ZN B 118 A 252 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 20.63 0.63 7.88 19.21 1.89 9.96 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 22.03 4.62 13.09 20.10 5.00 12.34 -10.33 3.56 43.54 -12.07 4.44 44.29 1ps9_c00 source 1ps9 2,4-DIENOYL-COA REDUCTASE : 2 hits 1ps9_c00 naa= 2 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 1 2 # 1 A 269 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 292 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 38.27 25.19 38.30 39.02 23.31 37.65 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 41.07 20.90 35.69 40.38 19.20 36.71 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 2 2 # 2 A 269 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 292 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 38.27 25.19 38.30 39.02 23.31 37.65 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 41.07 20.90 35.69 40.38 19.20 36.71 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 3 2 # 3 A 269 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 292 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 38.27 25.19 38.30 39.02 23.31 37.65 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 41.07 20.90 35.69 40.38 19.20 36.71 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1psd_c00 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 4 2 # 4 A 269 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 292 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 38.27 25.19 38.30 39.02 23.31 37.65 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 41.07 20.90 35.69 40.38 19.20 36.71 -10.33 3.56 43.54 -12.07 4.44 44.29 1psd_c00 source 1psd D-3-PHOSPHOGLYCERATE DEHYDROGENASE (PHOSPHOGLY: 4 hits 1psd_c00 naa= 2 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 1 2 # 1 B 269 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 292 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 73.23 38.34 28.02 73.78 36.50 28.89 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 73.82 33.94 31.43 75.53 32.98 30.68 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 2 2 # 2 B 269 GLU A 34 GLU^? -2.26 ZN ZN A 119s B 292 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 73.23 38.34 28.02 73.78 36.50 28.89 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 73.82 33.94 31.43 75.53 32.98 30.68 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 3 2 # 3 B 269 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 292 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 73.23 38.34 28.02 73.78 36.50 28.89 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 73.82 33.94 31.43 75.53 32.98 30.68 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1psd_c01 D-3-PHOSPHOGLYCERATE DEHYDROGENASE (user 4 2 # 4 B 269 GLU B 34 GLU.? -2.23 ZN ZN B 118s B 292 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 73.23 38.34 28.02 73.78 36.50 28.89 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 73.82 33.94 31.43 75.53 32.98 30.68 -10.33 3.56 43.54 -12.07 4.44 44.29 1psd_c01 source 1psd D-3-PHOSPHOGLYCERATE DEHYDROGENASE (PHOSPHOGLY: 4 hits 1psd_c01 naa= 2 ULMN 2 1pwv_c00 LETHAL FACTOR user 1 2 # 1 A 687 GLU A 7 GLU.? 2.09 ZN ZN A 118s A 728 TYR A 79 TYR^? -4.35 CH3 ACY A 120s coo 77.63 40.02 139.16 79.74 39.94 138.95 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 84.86 31.94 140.08 85.28 34.63 139.44 -8.40 22.97 58.06 -7.77 20.89 56.30 ULMN 2 1pwv_c00 LETHAL FACTOR user 2 2 # 2 A 687 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 728 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 77.63 40.02 139.16 79.74 39.94 138.95 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 84.86 31.94 140.08 85.28 34.63 139.44 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1pwv_c00 LETHAL FACTOR user 3 2 # 3 A 687 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 728 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 77.63 40.02 139.16 79.74 39.94 138.95 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 84.86 31.94 140.08 85.28 34.63 139.44 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1pwv_c00 LETHAL FACTOR user 4 2 # 4 A 687 GLU A 39 GLU^? 13.07 O ACY A 121 A 728 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 77.63 40.02 139.16 79.74 39.94 138.95 3.97 24.42 42.90 6.03 24.50 43.46 coo 84.86 31.94 140.08 85.28 34.63 139.44 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1pwv_c00 LETHAL FACTOR user 5 2 # 5 A 687 GLU A 75 GLU.? 14.61 ZN ZN A 118 A 728 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 77.63 40.02 139.16 79.74 39.94 138.95 -11.14 20.14 70.42 -10.69 21.09 72.30 coo 84.86 31.94 140.08 85.28 34.63 139.44 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1pwv_c00 LETHAL FACTOR user 6 2 # 6 A 687 GLU A 75 GLU.? 14.61 ZN ZN A 118 A 728 TYR A 72 TYR^? -3.77 O ACY A 120s coo 77.63 40.02 139.16 79.74 39.94 138.95 -11.14 20.14 70.42 -10.69 21.09 72.30 coo 84.86 31.94 140.08 85.28 34.63 139.44 -8.74 18.57 61.24 -11.39 17.69 61.31 ULMN 2 1pwv_c00 LETHAL FACTOR user 7 2 # 7 A 687 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 728 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 77.63 40.02 139.16 79.74 39.94 138.95 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 84.86 31.94 140.08 85.28 34.63 139.44 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1pwv_c00 LETHAL FACTOR user 8 2 # 8 A 687 GLU A 99 GLU.? 20.42 CH3 ACY A 121 A 728 TYR A 94 TYR.? 14.61 ZN ZN A 119 coo 77.63 40.02 139.16 79.74 39.94 138.95 4.40 42.94 40.00 4.87 41.71 38.33 coo 84.86 31.94 140.08 85.28 34.63 139.44 -5.97 41.42 41.15 -7.10 43.78 40.18 ULMN 2 1pwv_c00 LETHAL FACTOR user 9 2 # 9 A 687 GLU B 7 GLU.? -2.20 ZN ZN B 119s A 728 TYR B 79 TYR^? -4.21 CH3 ACY B 120s coo 77.63 40.02 139.16 79.74 39.94 138.95 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 84.86 31.94 140.08 85.28 34.63 139.44 -4.08 14.27 33.90 -4.00 16.42 35.66 ULMN 2 1pwv_c00 LETHAL FACTOR user 10 2 # 10 A 687 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 728 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 77.63 40.02 139.16 79.74 39.94 138.95 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 84.86 31.94 140.08 85.28 34.63 139.44 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1pwv_c00 LETHAL FACTOR user 11 2 # 11 A 687 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 728 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 77.63 40.02 139.16 79.74 39.94 138.95 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 84.86 31.94 140.08 85.28 34.63 139.44 -4.17 2.05 38.57 -1.76 0.81 38.01 ULMN 2 1pwv_c00 LETHAL FACTOR user 12 2 # 12 A 687 GLU B 39 GLU.? 14.67 OXT ACY A 120 A 728 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 77.63 40.02 139.16 79.74 39.94 138.95 2.54 12.93 51.58 4.67 12.91 51.32 coo 84.86 31.94 140.08 85.28 34.63 139.44 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1pwv_c00 LETHAL FACTOR user 13 2 # 13 A 687 GLU B 75 GLU.? 13.95 OXT ACY A 121 A 728 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 77.63 40.02 139.16 79.74 39.94 138.95 -3.38 17.56 20.48 -2.28 16.44 19.03 coo 84.86 31.94 140.08 85.28 34.63 139.44 -7.61 10.49 27.32 -9.94 11.99 27.12 ULMN 2 1pwv_c00 LETHAL FACTOR user 14 2 # 14 A 687 GLU B 75 GLU.? 13.95 OXT ACY A 121 A 728 TYR B 72 TYR^? 3.72 OXT ACY B 120s coo 77.63 40.02 139.16 79.74 39.94 138.95 -3.38 17.56 20.48 -2.28 16.44 19.03 coo 84.86 31.94 140.08 85.28 34.63 139.44 -3.38 18.68 30.67 -5.90 19.37 29.75 ULMN 2 1pwv_c00 LETHAL FACTOR user 15 2 # 15 A 687 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 728 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 77.63 40.02 139.16 79.74 39.94 138.95 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 84.86 31.94 140.08 85.28 34.63 139.44 -4.17 2.05 38.57 -1.76 0.81 38.01 1pwv_c00 source 1pwv LETHAL FACTOR : 15 hits 1pwv_c00 naa= 2 ULMN 2 1pwv_c01 LETHAL FACTOR user 1 2 # 1 B 687 GLU A 7 GLU.? 2.09 ZN ZN A 118s B 728 TYR A 79 TYR^? -4.35 CH3 ACY A 120s coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 105.30 6.94 120.65 104.99 4.15 120.81 -8.40 22.97 58.06 -7.77 20.89 56.30 ULMN 2 1pwv_c01 LETHAL FACTOR user 2 2 # 2 B 687 GLU A 34 GLU^? -2.26 ZN ZN A 119s B 728 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 105.30 6.94 120.65 104.99 4.15 120.81 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1pwv_c01 LETHAL FACTOR user 3 2 # 3 B 687 GLU A 34 GLU^? -2.26 ZN ZN A 119s B 728 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 105.30 6.94 120.65 104.99 4.15 120.81 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1pwv_c01 LETHAL FACTOR user 4 2 # 4 B 687 GLU A 39 GLU^? 13.07 O ACY A 121 B 728 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 3.97 24.42 42.90 6.03 24.50 43.46 coo 105.30 6.94 120.65 104.99 4.15 120.81 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1pwv_c01 LETHAL FACTOR user 5 2 # 5 B 687 GLU A 75 GLU.? 14.61 ZN ZN A 118 B 728 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -11.14 20.14 70.42 -10.69 21.09 72.30 coo 105.30 6.94 120.65 104.99 4.15 120.81 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1pwv_c01 LETHAL FACTOR user 6 2 # 6 B 687 GLU A 75 GLU.? 14.61 ZN ZN A 118 B 728 TYR A 72 TYR^? -3.77 O ACY A 120s coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -11.14 20.14 70.42 -10.69 21.09 72.30 coo 105.30 6.94 120.65 104.99 4.15 120.81 -8.74 18.57 61.24 -11.39 17.69 61.31 ULMN 2 1pwv_c01 LETHAL FACTOR user 7 2 # 7 B 687 GLU A 89 GLU~? 19.37 ZN ZN A 119 B 728 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 105.30 6.94 120.65 104.99 4.15 120.81 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1pwv_c01 LETHAL FACTOR user 8 2 # 8 B 687 GLU A 99 GLU.? 20.42 CH3 ACY A 121 B 728 TYR A 94 TYR.? 14.61 ZN ZN A 119 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 4.40 42.94 40.00 4.87 41.71 38.33 coo 105.30 6.94 120.65 104.99 4.15 120.81 -5.97 41.42 41.15 -7.10 43.78 40.18 ULMN 2 1pwv_c01 LETHAL FACTOR user 9 2 # 9 B 687 GLU B 7 GLU.? -2.20 ZN ZN B 119s B 728 TYR B 79 TYR^? -4.21 CH3 ACY B 120s coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 105.30 6.94 120.65 104.99 4.15 120.81 -4.08 14.27 33.90 -4.00 16.42 35.66 ULMN 2 1pwv_c01 LETHAL FACTOR user 10 2 # 10 B 687 GLU B 34 GLU.? -2.23 ZN ZN B 118s B 728 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 105.30 6.94 120.65 104.99 4.15 120.81 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1pwv_c01 LETHAL FACTOR user 11 2 # 11 B 687 GLU B 34 GLU.? -2.23 ZN ZN B 118s B 728 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 105.30 6.94 120.65 104.99 4.15 120.81 -4.17 2.05 38.57 -1.76 0.81 38.01 ULMN 2 1pwv_c01 LETHAL FACTOR user 12 2 # 12 B 687 GLU B 39 GLU.? 14.67 OXT ACY A 120 B 728 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 2.54 12.93 51.58 4.67 12.91 51.32 coo 105.30 6.94 120.65 104.99 4.15 120.81 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1pwv_c01 LETHAL FACTOR user 13 2 # 13 B 687 GLU B 75 GLU.? 13.95 OXT ACY A 121 B 728 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -3.38 17.56 20.48 -2.28 16.44 19.03 coo 105.30 6.94 120.65 104.99 4.15 120.81 -7.61 10.49 27.32 -9.94 11.99 27.12 ULMN 2 1pwv_c01 LETHAL FACTOR user 14 2 # 14 B 687 GLU B 75 GLU.? 13.95 OXT ACY A 121 B 728 TYR B 72 TYR^? 3.72 OXT ACY B 120s coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -3.38 17.56 20.48 -2.28 16.44 19.03 coo 105.30 6.94 120.65 104.99 4.15 120.81 -3.38 18.68 30.67 -5.90 19.37 29.75 ULMN 2 1pwv_c01 LETHAL FACTOR user 15 2 # 15 B 687 GLU B 89 GLU~? 19.03 ZN ZN B 118 B 728 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 106.08 -0.13 112.33 105.62 -0.25 114.40 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 105.30 6.94 120.65 104.99 4.15 120.81 -4.17 2.05 38.57 -1.76 0.81 38.01 1pwv_c01 source 1pwv LETHAL FACTOR : 15 hits 1pwv_c01 naa= 2 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 2 # 1 A 62 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 64 LYS A 16 LYS~? -3.27 O ACY A 120s coo 61.71 14.20 19.64 60.68 14.94 21.37 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 55.72 12.42 20.66 58.31 17.81 21.97 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 2 # 2 A 62 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 64 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 61.71 14.20 19.64 60.68 14.94 21.37 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 55.72 12.42 20.66 58.31 17.81 21.97 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 1q6l_c00 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 2 # 3 A 62 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 64 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 61.71 14.20 19.64 60.68 14.94 21.37 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 55.72 12.42 20.66 58.31 17.81 21.97 -10.13 21.11 38.47 -9.52 22.58 33.19 1q6l_c00 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 3 hits 1q6l_c00 naa= 2 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 1 2 # 1 B 62 ASP A 15 ASP~? 8.61 ZN ZN B 118 B 64 LYS A 16 LYS~? -3.27 O ACY A 120s coo 45.81 14.64 11.83 45.04 13.82 13.65 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 48.63 16.35 17.25 45.95 10.72 16.28 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 2 2 # 2 B 62 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 64 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 45.81 14.64 11.83 45.04 13.82 13.65 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 48.63 16.35 17.25 45.95 10.72 16.28 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 1q6l_c01 3-KETO-L-GULONATE 6-PHOSPHATE DECARBuser 3 2 # 3 B 62 ASP B 15 ASP~? 8.50 ZN ZN A 119 B 64 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 45.81 14.64 11.83 45.04 13.82 13.65 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 48.63 16.35 17.25 45.95 10.72 16.28 -10.13 21.11 38.47 -9.52 22.58 33.19 1q6l_c01 source 1q6l 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE : 3 hits 1q6l_c01 naa= 2 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 1 2 # 1 A 334 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 550 SER A 32 SER^? 8.89 ZN ZN A 119 coo 38.40 88.96 58.48 39.26 87.53 59.75 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 46.35 85.43 65.37 45.80 86.30 63.18 -14.23 26.97 54.31 -16.02 26.35 52.81 ULMN 2 1q6x_c02 CHOLINE O-ACETYLTRANSFERASE user 2 2 # 2 A 334 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 550 SER B 32 SER^? 8.58 ZN ZN B 118 coo 38.40 88.96 58.48 39.26 87.53 59.75 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 46.35 85.43 65.37 45.80 86.30 63.18 -11.02 10.19 35.41 -13.14 10.52 36.50 1q6x_c02 source 1q6x CHOLINE O-ACETYLTRANSFERASE : 2 hits 1q6x_c02 naa= 2 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 1 2 # 1 B 334 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 550 SER A 32 SER^? 8.89 ZN ZN A 119 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -14.23 26.97 54.31 -16.02 26.35 52.81 ULMN 2 1q6x_c03 CHOLINE O-ACETYLTRANSFERASE user 2 2 # 2 B 334 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 550 SER B 32 SER^? 8.58 ZN ZN B 118 coo 11.97 -36.55 1.94 11.54 -35.11 0.47 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 11.79 -32.98 -8.58 13.12 -33.83 -6.73 -11.02 10.19 35.41 -13.14 10.52 36.50 1q6x_c03 source 1q6x CHOLINE O-ACETYLTRANSFERASE : 2 hits 1q6x_c03 naa= 2 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 1 2 # 1 A 41 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 43 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 19.89 38.63 33.96 18.35 38.95 32.59 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 13.89 41.64 32.32 13.68 43.65 31.73 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 2 2 # 2 A 41 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 43 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 19.89 38.63 33.96 18.35 38.95 32.59 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 13.89 41.64 32.32 13.68 43.65 31.73 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 3 2 # 3 A 41 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 43 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 19.89 38.63 33.96 18.35 38.95 32.59 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 13.89 41.64 32.32 13.68 43.65 31.73 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 4 2 # 4 A 41 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 43 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 19.89 38.63 33.96 18.35 38.95 32.59 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 13.89 41.64 32.32 13.68 43.65 31.73 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 5 2 # 5 A 41 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 43 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 19.89 38.63 33.96 18.35 38.95 32.59 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 13.89 41.64 32.32 13.68 43.65 31.73 -11.52 -0.56 39.66 -12.44 -2.44 39.86 ULMN 2 1q91_c00 5(3)-DEOXYRIBONUCLEOTIDASE user 6 2 # 6 A 41 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 43 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 19.89 38.63 33.96 18.35 38.95 32.59 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 13.89 41.64 32.32 13.68 43.65 31.73 -15.33 3.33 40.18 -15.00 4.24 42.07 1q91_c00 source 1q91 5(3)-DEOXYRIBONUCLEOTIDASE : 6 hits 1q91_c00 naa= 2 ULMN 2 1qam_c00 ERMC' METHYLTRANSFERASE user 1 2 # 1 A 59 GLU A 28 GLU.? 19.71 ZN ZN A 119 A 101 ASN A 73 ASN^? 11.43 OXT ACY A 120 coo 17.21 39.80 29.23 17.83 38.53 27.67 -17.43 33.27 64.86 -17.71 35.42 64.60 coo 11.70 33.75 21.15 12.72 34.11 19.33 -9.59 22.33 65.64 -10.09 22.46 67.69 ULMN 2 1qam_c00 ERMC' METHYLTRANSFERASE user 2 2 # 2 A 59 GLU B 28 GLU.? 20.25 ZN ZN B 118 A 101 ASN B 73 ASN^? 10.74 OXT ACY A 121 coo 17.21 39.80 29.23 17.83 38.53 27.67 -8.23 3.75 25.31 -7.96 1.78 24.56 coo 11.70 33.75 21.15 12.72 34.11 19.33 -2.85 14.93 26.35 -2.72 14.72 24.20 1qam_c00 source 1qam ERMC' METHYLTRANSFERASE : 2 hits 1qam_c00 naa= 2 ULMN 2 1qba_c00 CHITOBIASE user 1 2 # 1 539 ASP A 86 ASP~? 22.55 ZN ZN A 119 540 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 29.81 50.17 23.56 27.68 49.90 23.71 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 30.20 53.24 26.35 28.57 54.55 26.04 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1qba_c00 CHITOBIASE user 2 2 # 2 539 ASP B 26 ASP.? 19.38 CH3 ACY B 120 540 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 29.81 50.17 23.56 27.68 49.90 23.71 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 30.20 53.24 26.35 28.57 54.55 26.04 -8.23 3.75 25.31 -7.96 1.78 24.56 ULMN 2 1qba_c00 CHITOBIASE user 3 2 # 3 539 ASP B 86 ASP~? 22.13 ZN ZN B 118 540 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 29.81 50.17 23.56 27.68 49.90 23.71 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 30.20 53.24 26.35 28.57 54.55 26.04 -7.13 -6.28 33.53 -6.83 -7.93 32.24 1qba_c00 source 1qba CHITOBIASE : 3 hits 1qba_c00 naa= 2 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 1 2 # 1 C 142 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 146 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 15.87 13.94 20.94 16.37 13.66 20.42 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 2 2 # 2 C 142 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 146 GLY A 27 GLY.? 16.01 CH3 ACY A 120 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 15.87 13.94 20.94 16.37 13.66 20.42 -13.31 29.37 67.32 -13.49 30.12 67.06 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 3 2 # 3 C 142 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 146 GLY A 43 GLY.? 10.93 O ACY A 121 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 15.87 13.94 20.94 16.37 13.66 20.42 2.67 18.14 42.78 3.17 18.66 43.17 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 4 2 # 4 C 142 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 146 GLY A 77 GLY.? 7.71 O ACY A 120 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 15.87 13.94 20.94 16.37 13.66 20.42 -14.40 19.56 63.33 -14.08 20.34 63.32 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 5 2 # 5 C 142 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 146 GLY B 19 GLY.? 9.20 CH3 ACY B 120 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 15.87 13.94 20.94 16.37 13.66 20.42 -13.06 15.01 37.28 -12.27 15.10 37.18 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 6 2 # 6 C 142 HIS B 62 HIS^? -3.22 ZN ZN B 118s D 146 GLY A 19 GLY.? 9.19 CH3 ACY A 120 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 15.87 13.94 20.94 16.37 13.66 20.42 -15.53 22.05 51.92 -14.82 21.95 52.30 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 7 2 # 7 C 142 HIS B 62 HIS^? -3.22 ZN ZN B 118s D 146 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 15.87 13.94 20.94 16.37 13.66 20.42 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 8 2 # 8 C 142 HIS B 62 HIS^? -3.22 ZN ZN B 118s D 146 GLY B 27 GLY.? 15.88 CH3 ACY B 120 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 15.87 13.94 20.94 16.37 13.66 20.42 -5.69 8.07 23.28 -5.94 7.34 23.49 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 9 2 # 9 C 142 HIS B 62 HIS^? -3.22 ZN ZN B 118s D 146 GLY B 43 GLY.? 11.77 OXT ACY A 120 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 15.87 13.94 20.94 16.37 13.66 20.42 1.41 19.22 51.53 1.94 18.61 51.36 ULMN 2 1qd6_c00 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA)user 10 2 # 10 C 142 HIS B 62 HIS^? -3.22 ZN ZN B 118s D 146 GLY B 77 GLY.? 7.77 OXT ACY B 120 coo 8.68 -2.92 32.88 10.75 -2.98 32.53 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 15.87 13.94 20.94 16.37 13.66 20.42 -8.24 17.31 26.84 -7.89 16.59 26.97 1qd6_c00 source 1qd6 OUTER MEMBRANE PHOSPHOLIPASE (OMPLA) : 10 hits 1qd6_c00 naa= 2 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 1 2 # 1 A 72 GLU A 7 GLU.? 2.09 ZN ZN A 118s A 147 THR A 5 THR.? 10.24 ZN ZN B 118 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -11.20 6.24 51.51 -9.77 5.38 52.87 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 2 2 # 2 A 72 GLU A 28 GLU.? 19.71 ZN ZN A 119 A 147 THR A 84 THR~? 20.88 ZN ZN A 119 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -17.43 33.27 64.86 -17.71 35.42 64.60 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -7.32 38.08 62.29 -5.65 39.33 62.81 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 3 2 # 3 A 72 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 147 THR A 20 THR.? 4.16 CH3 ACY A 120 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -13.83 21.70 55.31 -12.29 20.44 56.16 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 4 2 # 4 A 72 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 147 THR B 5 THR.? 9.07 ZN ZN A 119 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -9.78 30.84 38.74 -8.10 32.14 39.13 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 5 2 # 5 A 72 GLU A 39 GLU^? 13.07 O ACY A 121 A 147 THR B 8 THR.? 9.69 CH3 ACY A 121 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 3.97 24.42 42.90 6.03 24.50 43.46 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -2.71 29.36 36.26 -2.04 29.94 38.25 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 6 2 # 6 A 72 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 147 THR A 84 THR~? 20.88 ZN ZN A 119 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -7.32 38.08 62.29 -5.65 39.33 62.81 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 7 2 # 7 A 72 GLU B 7 GLU.? -2.20 ZN ZN B 119s A 147 THR B 5 THR.? 9.07 ZN ZN A 119 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -9.78 30.84 38.74 -8.10 32.14 39.13 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 8 2 # 8 A 72 GLU B 28 GLU.? 20.25 ZN ZN B 118 A 147 THR B 84 THR~? 20.78 ZN ZN B 118 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -8.23 3.75 25.31 -7.96 1.78 24.56 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -1.74 -0.91 30.07 0.00 -2.14 30.22 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 9 2 # 9 A 72 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 147 THR A 5 THR.? 10.24 ZN ZN B 118 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -11.20 6.24 51.51 -9.77 5.38 52.87 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 10 2 # 10 A 72 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 147 THR B 20 THR.? 4.10 CH3 ACY B 120 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -10.29 15.42 34.68 -8.60 16.74 34.44 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 11 2 # 11 A 72 GLU B 39 GLU.? 14.67 OXT ACY A 120 A 147 THR A 8 THR.? 9.96 ZN ZN A 118 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 2.54 12.93 51.58 4.67 12.91 51.32 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -5.91 7.98 55.94 -4.35 7.02 54.82 ULMN 2 1qgx_c00 3',5'-ADENOSINE BISPHOSPHATASE user 12 2 # 12 A 72 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 147 THR B 84 THR~? 20.78 ZN ZN B 118 coo 6.70 20.46 -23.42 7.00 18.64 -24.32 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -1.74 -0.91 30.07 0.00 -2.14 30.22 1qgx_c00 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 12 hits 1qgx_c00 naa= 2 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 1 2 # 1 A 32 LYS A 10 LYS.? 12.65 OXT ACY A 120 A 147 THR A 5 THR.? 10.24 ZN ZN B 118 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -0.98 10.25 56.97 2.99 9.65 58.52 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -11.20 6.24 51.51 -9.77 5.38 52.87 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 2 2 # 2 A 32 LYS A 16 LYS~? -3.27 O ACY A 120s A 147 THR A 8 THR.? 9.96 ZN ZN A 118 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -5.91 7.98 55.94 -4.35 7.02 54.82 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 3 2 # 3 A 32 LYS A 29 LYS^? 13.52 CH3 ACY A 120 A 147 THR A 20 THR.? 4.16 CH3 ACY A 120 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -13.83 21.70 55.31 -12.29 20.44 56.16 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 4 2 # 4 A 32 LYS A 29 LYS^? 13.52 CH3 ACY A 120 A 147 THR A 84 THR~? 20.88 ZN ZN A 119 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -7.32 38.08 62.29 -5.65 39.33 62.81 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 5 2 # 5 A 32 LYS A 40 LYS.? -3.18 C ACY A 121s A 147 THR B 20 THR.? 4.10 CH3 ACY B 120 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 1.80 21.48 38.21 -1.61 24.69 34.09 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -10.29 15.42 34.68 -8.60 16.74 34.44 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 6 2 # 6 A 32 LYS A 71 LYS^? 11.96 OXT ACY A 120 A 147 THR A 20 THR.? 4.16 CH3 ACY A 120 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -4.35 22.91 61.78 1.12 23.33 62.25 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -13.83 21.70 55.31 -12.29 20.44 56.16 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 7 2 # 7 A 32 LYS A 93 LYS.? 17.16 ZN ZN A 119 A 147 THR B 5 THR.? 9.07 ZN ZN A 119 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -8.24 41.47 45.26 -7.63 47.05 46.72 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -9.78 30.84 38.74 -8.10 32.14 39.13 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 8 2 # 8 A 32 LYS B 10 LYS.? 9.83 CH3 ACY A 121 A 147 THR B 5 THR.? 9.07 ZN ZN A 119 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 2.14 27.03 37.15 7.00 28.76 35.76 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -9.78 30.84 38.74 -8.10 32.14 39.13 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 9 2 # 9 A 32 LYS B 16 LYS~? -4.10 OXT ACY B 120s A 147 THR B 8 THR.? 9.69 CH3 ACY A 121 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -2.71 29.36 36.26 -2.04 29.94 38.25 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 10 2 # 10 A 32 LYS B 29 LYS^? 13.36 ZN ZN B 118 A 147 THR B 20 THR.? 4.10 CH3 ACY B 120 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -10.29 15.42 34.68 -8.60 16.74 34.44 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 11 2 # 11 A 32 LYS B 29 LYS^? 13.36 ZN ZN B 118 A 147 THR B 84 THR~? 20.78 ZN ZN B 118 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -1.74 -0.91 30.07 0.00 -2.14 30.22 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 12 2 # 12 A 32 LYS B 40 LYS.? 4.59 ZN ZN A 118 A 147 THR A 20 THR.? 4.16 CH3 ACY A 120 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -13.83 21.70 55.31 -12.29 20.44 56.16 ULMN 2 1qgx_c01 3',5'-ADENOSINE BISPHOSPHATASE user 13 2 # 13 A 32 LYS B 71 LYS^? 12.90 O ACY A 121 A 147 THR B 20 THR.? 4.10 CH3 ACY B 120 coo -3.03 9.62 -35.40 -1.29 4.99 -37.46 0.91 14.36 31.66 5.84 10.91 29.66 coo 6.09 11.55 -27.32 4.75 13.20 -27.33 -10.29 15.42 34.68 -8.60 16.74 34.44 1qgx_c01 source 1qgx 3',5'-ADENOSINE BISPHOSPHATASE : 13 hits 1qgx_c01 naa= 2 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 1 2 # 1 A 118 SER A 14 SER~? 11.41 CH3 ACY A 120 A 151 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 17.70 9.25 13.10 16.68 11.30 13.99 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 25.75 6.80 15.75 21.60 9.40 11.84 -10.13 21.11 38.47 -9.52 22.58 33.19 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 2 2 # 2 A 118 SER A 32 SER^? 8.89 ZN ZN A 119 A 151 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 17.70 9.25 13.10 16.68 11.30 13.99 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 25.75 6.80 15.75 21.60 9.40 11.84 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 3 2 # 3 A 118 SER A 42 SER.? 12.48 O ACY A 121 A 151 LYS B 10 LYS.? 9.83 CH3 ACY A 121 coo 17.70 9.25 13.10 16.68 11.30 13.99 6.18 19.13 41.68 6.03 20.94 43.24 coo 25.75 6.80 15.75 21.60 9.40 11.84 2.14 27.03 37.15 7.00 28.76 35.76 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 4 2 # 4 A 118 SER A 46 SER^? 14.68 O ACY A 121 A 151 LYS A 40 LYS.? -3.18 C ACY A 121s coo 17.70 9.25 13.10 16.68 11.30 13.99 1.31 25.87 47.03 1.94 27.83 45.77 coo 25.75 6.80 15.75 21.60 9.40 11.84 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 5 2 # 5 A 118 SER A 46 SER^? 14.68 O ACY A 121 A 151 LYS B 10 LYS.? 9.83 CH3 ACY A 121 coo 17.70 9.25 13.10 16.68 11.30 13.99 1.31 25.87 47.03 1.94 27.83 45.77 coo 25.75 6.80 15.75 21.60 9.40 11.84 2.14 27.03 37.15 7.00 28.76 35.76 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 6 2 # 6 A 118 SER A 98 SER.? 16.73 ZN ZN A 119 A 151 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 17.70 9.25 13.10 16.68 11.30 13.99 0.17 39.20 41.01 -1.56 40.86 40.71 coo 25.75 6.80 15.75 21.60 9.40 11.84 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 7 2 # 7 A 118 SER B 14 SER~? 11.46 CH3 ACY B 120 A 151 LYS A 16 LYS~? -3.27 O ACY A 120s coo 17.70 9.25 13.10 16.68 11.30 13.99 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 25.75 6.80 15.75 21.60 9.40 11.84 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 8 2 # 8 A 118 SER B 14 SER~? 11.46 CH3 ACY B 120 A 151 LYS A 40 LYS.? -3.18 C ACY A 121s coo 17.70 9.25 13.10 16.68 11.30 13.99 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 25.75 6.80 15.75 21.60 9.40 11.84 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 9 2 # 9 A 118 SER B 32 SER^? 8.58 ZN ZN B 118 A 151 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 17.70 9.25 13.10 16.68 11.30 13.99 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 25.75 6.80 15.75 21.60 9.40 11.84 -10.40 7.25 27.78 -14.86 10.45 31.09 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 10 2 # 10 A 118 SER B 42 SER.? 13.83 OXT ACY A 120 A 151 LYS A 10 LYS.? 12.65 OXT ACY A 120 coo 17.70 9.25 13.10 16.68 11.30 13.99 4.20 18.00 53.79 4.49 16.52 51.91 coo 25.75 6.80 15.75 21.60 9.40 11.84 -0.98 10.25 56.97 2.99 9.65 58.52 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 11 2 # 11 A 118 SER B 46 SER^? 14.91 OXT ACY A 120 A 151 LYS A 10 LYS.? 12.65 OXT ACY A 120 coo 17.70 9.25 13.10 16.68 11.30 13.99 1.20 11.37 47.30 1.64 9.60 48.90 coo 25.75 6.80 15.75 21.60 9.40 11.84 -0.98 10.25 56.97 2.99 9.65 58.52 ULMN 2 1qh9_c00 2-HALOACID DEHALOGENASE user 12 2 # 12 A 118 SER B 46 SER^? 14.91 OXT ACY A 120 A 151 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 17.70 9.25 13.10 16.68 11.30 13.99 1.20 11.37 47.30 1.64 9.60 48.90 coo 25.75 6.80 15.75 21.60 9.40 11.84 -0.91 15.74 55.76 -5.29 12.34 58.61 1qh9_c00 source 1qh9 2-HALOACID DEHALOGENASE : 12 hits 1qh9_c00 naa= 2 ULMN 2 1qho_c00 ALPHA-AMYLASE user 1 2 # 1 A 228 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 253 LEU A 11 LEU^? 10.57 OXT ACY A 120 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 18.60 67.37 33.24 17.63 66.99 31.31 -2.89 10.27 52.74 -1.16 9.35 51.85 ULMN 2 1qho_c00 ALPHA-AMYLASE user 2 2 # 2 A 228 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 253 LEU A 56 LEU.? 5.91 ZN ZN A 119 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 18.60 67.37 33.24 17.63 66.99 31.31 -18.26 27.80 47.78 -17.06 26.97 49.39 ULMN 2 1qho_c00 ALPHA-AMYLASE user 3 2 # 3 A 228 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 253 LEU B 50 LEU^? 9.59 ZN ZN B 118 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 18.60 67.37 33.24 17.63 66.99 31.31 -6.85 6.47 37.85 -7.39 6.15 35.74 ULMN 2 1qho_c00 ALPHA-AMYLASE user 4 2 # 4 A 228 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 253 LEU B 56 LEU.? 6.31 ZN ZN B 118 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 18.60 67.37 33.24 17.63 66.99 31.31 -17.44 9.05 39.55 -15.59 10.10 39.06 ULMN 2 1qho_c00 ALPHA-AMYLASE user 5 2 # 5 A 228 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 253 LEU A 76 LEU.? 12.17 CH3 ACY A 120 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 18.60 67.37 33.24 17.63 66.99 31.31 -13.60 23.38 65.80 -13.41 24.99 67.20 ULMN 2 1qho_c00 ALPHA-AMYLASE user 6 2 # 6 A 228 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 253 LEU A 88 LEU~? 13.45 ZN ZN A 119 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 18.60 67.37 33.24 17.63 66.99 31.31 -10.40 38.33 56.93 -10.60 36.17 57.15 ULMN 2 1qho_c00 ALPHA-AMYLASE user 7 2 # 7 A 228 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 253 LEU A 88 LEU~? 13.45 ZN ZN A 119 coo 28.46 69.88 26.74 30.40 70.70 26.53 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 18.60 67.37 33.24 17.63 66.99 31.31 -10.40 38.33 56.93 -10.60 36.17 57.15 ULMN 2 1qho_c00 ALPHA-AMYLASE user 8 2 # 8 A 228 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 253 LEU A 56 LEU.? 5.91 ZN ZN A 119 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 18.60 67.37 33.24 17.63 66.99 31.31 -18.26 27.80 47.78 -17.06 26.97 49.39 ULMN 2 1qho_c00 ALPHA-AMYLASE user 9 2 # 9 A 228 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 253 LEU A 65 LEU^? 12.86 CH3 ACY A 120 coo 28.46 69.88 26.74 30.40 70.70 26.53 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 18.60 67.37 33.24 17.63 66.99 31.31 -4.23 29.30 54.22 -5.79 30.03 55.45 ULMN 2 1qho_c00 ALPHA-AMYLASE user 10 2 # 10 A 228 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 253 LEU A 50 LEU^? 9.64 ZN ZN A 119 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 18.60 67.37 33.24 17.63 66.99 31.31 -9.53 30.58 53.36 -10.77 31.04 55.17 ULMN 2 1qho_c00 ALPHA-AMYLASE user 11 2 # 11 A 228 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 253 LEU B 11 LEU^? 10.23 O ACY A 121 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 18.60 67.37 33.24 17.63 66.99 31.31 -1.11 26.82 40.56 0.27 27.81 41.87 ULMN 2 1qho_c00 ALPHA-AMYLASE user 12 2 # 12 A 228 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 253 LEU B 76 LEU.? 12.13 CH3 ACY B 120 coo 28.46 69.88 26.74 30.40 70.70 26.53 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 18.60 67.37 33.24 17.63 66.99 31.31 -6.47 13.63 24.78 -5.64 11.86 23.83 ULMN 2 1qho_c00 ALPHA-AMYLASE user 13 2 # 13 A 228 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 253 LEU B 88 LEU~? 13.53 ZN ZN B 118 coo 28.46 69.88 26.74 30.40 70.70 26.53 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 18.60 67.37 33.24 17.63 66.99 31.31 -6.19 -1.12 34.28 -6.06 1.03 33.84 ULMN 2 1qho_c00 ALPHA-AMYLASE user 14 2 # 14 A 228 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 253 LEU B 88 LEU~? 13.53 ZN ZN B 118 coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 18.60 67.37 33.24 17.63 66.99 31.31 -6.19 -1.12 34.28 -6.06 1.03 33.84 ULMN 2 1qho_c00 ALPHA-AMYLASE user 15 2 # 15 A 228 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 253 LEU B 56 LEU.? 6.31 ZN ZN B 118 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 18.60 67.37 33.24 17.63 66.99 31.31 -17.44 9.05 39.55 -15.59 10.10 39.06 ULMN 2 1qho_c00 ALPHA-AMYLASE user 16 2 # 16 A 228 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 253 LEU B 65 LEU^? 12.66 CH3 ACY B 120 coo 28.46 69.88 26.74 30.40 70.70 26.53 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 18.60 67.37 33.24 17.63 66.99 31.31 -1.75 8.03 38.66 -2.76 7.02 37.02 1qho_c00 source 1qho ALPHA-AMYLASE : 16 hits 1qho_c00 naa= 2 ULMN 2 1qho_c02 ALPHA-AMYLASE user 1 2 # 1 A 228 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 256 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 30.54 71.65 32.58 31.73 72.26 30.92 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1qho_c02 ALPHA-AMYLASE user 2 2 # 2 A 228 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 256 GLU A 28 GLU.? 19.71 ZN ZN A 119 coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 30.54 71.65 32.58 31.73 72.26 30.92 -17.43 33.27 64.86 -17.71 35.42 64.60 ULMN 2 1qho_c02 ALPHA-AMYLASE user 3 2 # 3 A 228 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 256 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 28.46 69.88 26.74 30.40 70.70 26.53 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 30.54 71.65 32.58 31.73 72.26 30.92 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1qho_c02 ALPHA-AMYLASE user 4 2 # 4 A 228 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 256 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 28.46 69.88 26.74 30.40 70.70 26.53 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 30.54 71.65 32.58 31.73 72.26 30.92 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1qho_c02 ALPHA-AMYLASE user 5 2 # 5 A 228 ASP A 86 ASP~? 22.55 ZN ZN A 119 A 256 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 28.46 69.88 26.74 30.40 70.70 26.53 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 30.54 71.65 32.58 31.73 72.26 30.92 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1qho_c02 ALPHA-AMYLASE user 6 2 # 6 A 228 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 256 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 28.46 69.88 26.74 30.40 70.70 26.53 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 30.54 71.65 32.58 31.73 72.26 30.92 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1qho_c02 ALPHA-AMYLASE user 7 2 # 7 A 228 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 256 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 28.46 69.88 26.74 30.40 70.70 26.53 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 30.54 71.65 32.58 31.73 72.26 30.92 -8.23 3.75 25.31 -7.96 1.78 24.56 ULMN 2 1qho_c02 ALPHA-AMYLASE user 8 2 # 8 A 228 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 256 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 30.54 71.65 32.58 31.73 72.26 30.92 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1qho_c02 ALPHA-AMYLASE user 9 2 # 9 A 228 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 256 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 28.46 69.88 26.74 30.40 70.70 26.53 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 30.54 71.65 32.58 31.73 72.26 30.92 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1qho_c02 ALPHA-AMYLASE user 10 2 # 10 A 228 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 256 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 28.46 69.88 26.74 30.40 70.70 26.53 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 30.54 71.65 32.58 31.73 72.26 30.92 -7.13 -6.28 33.53 -6.83 -7.93 32.24 1qho_c02 source 1qho ALPHA-AMYLASE : 10 hits 1qho_c02 naa= 2 ULMN 2 1qi9_c00 VANADIUM BROMOPEROXIDASE user 1 2 # 1 A 341 LYS A 16 LYS~? -3.27 O ACY A 120s A 418 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 104.35 34.37 32.90 100.82 36.32 29.09 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 96.54 35.93 21.66 94.52 36.26 22.15 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1qi9_c00 VANADIUM BROMOPEROXIDASE user 2 2 # 2 A 341 LYS B 16 LYS~? -4.10 OXT ACY B 120s A 418 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 104.35 34.37 32.90 100.82 36.32 29.09 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 96.54 35.93 21.66 94.52 36.26 22.15 -11.17 33.63 46.78 -12.74 33.06 45.52 1qi9_c00 source 1qi9 VANADIUM BROMOPEROXIDASE : 2 hits 1qi9_c00 naa= 2 ULMN 2 1qi9_c01 VANADIUM BROMOPEROXIDASE user 1 2 # 1 B 341 LYS A 16 LYS~? -3.27 O ACY A 120s B 418 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 86.35 -0.78 12.68 84.14 3.90 10.48 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 81.39 11.93 10.46 82.24 12.93 8.84 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1qi9_c01 VANADIUM BROMOPEROXIDASE user 2 2 # 2 B 341 LYS B 16 LYS~? -4.10 OXT ACY B 120s B 418 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 86.35 -0.78 12.68 84.14 3.90 10.48 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 81.39 11.93 10.46 82.24 12.93 8.84 -11.17 33.63 46.78 -12.74 33.06 45.52 1qi9_c01 source 1qi9 VANADIUM BROMOPEROXIDASE : 2 hits 1qi9_c01 naa= 2 ULMN 2 1qib_c00 GELATINASE A user 1 2 # 1 A 202 GLU A 7 GLU.? 2.09 ZN ZN A 118s A 219 MET B 37 MET?? 10.55 ZN ZN B 118 coo 69.37 28.50 22.00 67.35 27.95 22.47 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 67.80 19.62 26.30 69.14 20.29 23.54 -4.27 12.21 48.29 -6.60 10.21 49.60 ULMN 2 1qib_c00 GELATINASE A user 2 2 # 2 A 202 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 219 MET A 37 MET?? 10.48 O ACY B 120 coo 69.37 28.50 22.00 67.35 27.95 22.47 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 67.80 19.62 26.30 69.14 20.29 23.54 -3.65 25.16 44.33 -5.41 26.98 42.18 ULMN 2 1qib_c00 GELATINASE A user 3 2 # 3 A 202 GLU B 7 GLU.? -2.20 ZN ZN B 119s A 219 MET A 37 MET?? 10.48 O ACY B 120 coo 69.37 28.50 22.00 67.35 27.95 22.47 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 67.80 19.62 26.30 69.14 20.29 23.54 -3.65 25.16 44.33 -5.41 26.98 42.18 ULMN 2 1qib_c00 GELATINASE A user 4 2 # 4 A 202 GLU B 28 GLU.? 20.25 ZN ZN B 118 A 219 MET B 82 MET?? 18.84 O ACY A 121 coo 69.37 28.50 22.00 67.35 27.95 22.47 -8.23 3.75 25.31 -7.96 1.78 24.56 coo 67.80 19.62 26.30 69.14 20.29 23.54 1.34 5.10 30.59 3.37 3.64 28.04 ULMN 2 1qib_c00 GELATINASE A user 5 2 # 5 A 202 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 219 MET B 37 MET?? 10.55 ZN ZN B 118 coo 69.37 28.50 22.00 67.35 27.95 22.47 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 67.80 19.62 26.30 69.14 20.29 23.54 -4.27 12.21 48.29 -6.60 10.21 49.60 1qib_c00 source 1qib GELATINASE A : 5 hits 1qib_c00 naa= 2 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 1 2 # 1 B 240 GLN A 18 GLN.? 11.66 ZN ZN A 119 B 387 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo 41.56 93.59 65.64 41.16 91.60 64.94 -11.72 21.08 47.54 -11.51 20.01 45.71 coo 33.50 85.40 62.90 31.25 87.48 62.36 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 2 1qj2_c02 CARBON MONOXIDE DEHYDROGENASE user 2 2 # 2 B 240 GLN B 18 GLN~? 11.75 ZN ZN B 118 B 387 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 41.56 93.59 65.64 41.16 91.60 64.94 -10.66 16.34 42.67 -11.39 17.08 44.58 coo 33.50 85.40 62.90 31.25 87.48 62.36 -8.90 26.62 43.60 -11.56 28.13 43.24 1qj2_c02 source 1qj2 CARBON MONOXIDE DEHYDROGENASE : 2 hits 1qj2_c02 naa= 2 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 1 2 # 1 H 240 GLN A 18 GLN.? 11.66 ZN ZN A 119 H 387 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo 41.71 128.87 87.62 42.13 130.32 89.13 -11.72 21.08 47.54 -11.51 20.01 45.71 coo 49.59 134.55 94.31 52.01 134.13 92.45 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 2 1qj2_c03 CARBON MONOXIDE DEHYDROGENASE user 2 2 # 2 H 240 GLN B 18 GLN~? 11.75 ZN ZN B 118 H 387 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 41.71 128.87 87.62 42.13 130.32 89.13 -10.66 16.34 42.67 -11.39 17.08 44.58 coo 49.59 134.55 94.31 52.01 134.13 92.45 -8.90 26.62 43.60 -11.56 28.13 43.24 1qj2_c03 source 1qj2 CARBON MONOXIDE DEHYDROGENASE : 2 hits 1qj2_c03 naa= 2 ULMN 2 1qlh_c00 ALCOHOL DEHYDROGENASE user 1 2 # 1 A 48 SER A 51 SER^? 4.15 ZN ZN A 119 A 51 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 3.80 7.50 22.51 3.35 9.20 24.18 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 3.61 3.70 24.10 5.06 4.06 25.58 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1qlh_c00 ALCOHOL DEHYDROGENASE user 2 2 # 2 A 48 SER B 51 SER^? 4.27 ZN ZN B 118 A 51 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 3.80 7.50 22.51 3.35 9.20 24.18 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 3.61 3.70 24.10 5.06 4.06 25.58 -10.33 3.56 43.54 -12.07 4.44 44.29 1qlh_c00 source 1qlh ALCOHOL DEHYDROGENASE : 2 hits 1qlh_c00 naa= 2 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 1 2 # 1 A 182 TYR A 72 TYR^? -3.77 O ACY A 120s A 186 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 73.61 90.42 31.12 71.36 89.66 29.64 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 73.54 84.00 28.64 69.01 86.68 29.71 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 2 2 # 2 A 182 TYR A 79 TYR^? -4.35 CH3 ACY A 120s A 186 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 73.61 90.42 31.12 71.36 89.66 29.64 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 73.54 84.00 28.64 69.01 86.68 29.71 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 3 2 # 3 A 182 TYR B 72 TYR^? 3.72 OXT ACY B 120s A 186 LYS B 71 LYS^? 12.90 O ACY A 121 coo 73.61 90.42 31.12 71.36 89.66 29.64 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 73.54 84.00 28.64 69.01 86.68 29.71 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1qrr_c02 SULFOLIPID BIOSYNTHESIS (SQD1) PROTEuser 4 2 # 4 A 182 TYR B 79 TYR^? -4.21 CH3 ACY B 120s A 186 LYS B 71 LYS^? 12.90 O ACY A 121 coo 73.61 90.42 31.12 71.36 89.66 29.64 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 73.54 84.00 28.64 69.01 86.68 29.71 0.91 14.36 31.66 5.84 10.91 29.66 1qrr_c02 source 1qrr SULFOLIPID BIOSYNTHESIS (SQD1) PROTEIN : 4 hits 1qrr_c02 naa= 2 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 A 156 TYR A 23 TYR^? 11.58 CH3 ACY A 120 A 163 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 11.31 14.43 4.90 11.33 12.74 7.13 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 12.44 6.23 6.82 12.36 8.68 11.73 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 A 156 TYR A 72 TYR^? -3.77 O ACY A 120s A 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 11.31 14.43 4.90 11.33 12.74 7.13 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 12.44 6.23 6.82 12.36 8.68 11.73 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 A 156 TYR A 72 TYR^? -3.77 O ACY A 120s A 163 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 11.31 14.43 4.90 11.33 12.74 7.13 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 12.44 6.23 6.82 12.36 8.68 11.73 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 A 156 TYR A 79 TYR^? -4.35 CH3 ACY A 120s A 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 11.31 14.43 4.90 11.33 12.74 7.13 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 12.44 6.23 6.82 12.36 8.68 11.73 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 A 156 TYR B 23 TYR^? 11.37 CH3 ACY B 120 A 163 LYS B 71 LYS^? 12.90 O ACY A 121 coo 11.31 14.43 4.90 11.33 12.74 7.13 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 12.44 6.23 6.82 12.36 8.68 11.73 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 A 156 TYR B 72 TYR^? 3.72 OXT ACY B 120s A 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 11.31 14.43 4.90 11.33 12.74 7.13 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 12.44 6.23 6.82 12.36 8.68 11.73 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 A 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s A 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 11.31 14.43 4.90 11.33 12.74 7.13 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 12.44 6.23 6.82 12.36 8.68 11.73 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c00 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 A 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s A 163 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 11.31 14.43 4.90 11.33 12.74 7.13 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 12.44 6.23 6.82 12.36 8.68 11.73 -10.13 21.11 38.47 -9.52 22.58 33.19 1qsg_c00 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c00 naa= 2 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 B 156 TYR A 23 TYR^? 11.58 CH3 ACY A 120 B 163 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 B 156 TYR A 72 TYR^? -3.77 O ACY A 120s B 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 B 156 TYR A 72 TYR^? -3.77 O ACY A 120s B 163 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 B 156 TYR A 79 TYR^? -4.35 CH3 ACY A 120s B 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 B 156 TYR B 23 TYR^? 11.37 CH3 ACY B 120 B 163 LYS B 71 LYS^? 12.90 O ACY A 121 coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 B 156 TYR B 72 TYR^? 3.72 OXT ACY B 120s B 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 B 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s B 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c01 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 B 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s B 163 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 15.85 -10.34 0.09 16.27 -8.70 -2.14 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 15.39 -2.16 -1.87 17.74 -4.36 -6.36 -10.13 21.11 38.47 -9.52 22.58 33.19 1qsg_c01 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c01 naa= 2 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 C 156 TYR A 23 TYR^? 11.58 CH3 ACY A 120 C 163 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -13.79 26.73 63.12 -16.10 25.28 62.65 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 C 156 TYR A 72 TYR^? -3.77 O ACY A 120s C 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -8.74 18.57 61.24 -11.39 17.69 61.31 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 C 156 TYR A 72 TYR^? -3.77 O ACY A 120s C 163 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -8.74 18.57 61.24 -11.39 17.69 61.31 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 C 156 TYR A 79 TYR^? -4.35 CH3 ACY A 120s C 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -8.40 22.97 58.06 -7.77 20.89 56.30 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 C 156 TYR B 23 TYR^? 11.37 CH3 ACY B 120 C 163 LYS B 71 LYS^? 12.90 O ACY A 121 coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -7.61 10.49 27.32 -9.94 11.99 27.12 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 C 156 TYR B 72 TYR^? 3.72 OXT ACY B 120s C 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -3.38 18.68 30.67 -5.90 19.37 29.75 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 C 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s C 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -4.08 14.27 33.90 -4.00 16.42 35.66 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c02 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 C 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s C 163 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo -12.90 -13.93 1.76 -13.79 -12.06 3.67 -4.08 14.27 33.90 -4.00 16.42 35.66 coo -14.62 -5.69 2.26 -16.40 -7.71 7.18 -10.13 21.11 38.47 -9.52 22.58 33.19 1qsg_c02 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c02 naa= 2 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 D 156 TYR A 23 TYR^? 11.58 CH3 ACY A 120 D 163 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -13.79 26.73 63.12 -16.10 25.28 62.65 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 D 156 TYR A 72 TYR^? -3.77 O ACY A 120s D 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -8.74 18.57 61.24 -11.39 17.69 61.31 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 D 156 TYR A 72 TYR^? -3.77 O ACY A 120s D 163 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -8.74 18.57 61.24 -11.39 17.69 61.31 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 D 156 TYR A 79 TYR^? -4.35 CH3 ACY A 120s D 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -8.40 22.97 58.06 -7.77 20.89 56.30 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 D 156 TYR B 23 TYR^? 11.37 CH3 ACY B 120 D 163 LYS B 71 LYS^? 12.90 O ACY A 121 coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -7.61 10.49 27.32 -9.94 11.99 27.12 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 D 156 TYR B 72 TYR^? 3.72 OXT ACY B 120s D 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -3.38 18.68 30.67 -5.90 19.37 29.75 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 D 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s D 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -4.08 14.27 33.90 -4.00 16.42 35.66 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c03 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 D 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s D 163 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo -14.65 10.03 -7.21 -14.25 8.11 -9.20 -4.08 14.27 33.90 -4.00 16.42 35.66 coo -13.69 1.67 -7.76 -14.16 3.32 -13.07 -10.13 21.11 38.47 -9.52 22.58 33.19 1qsg_c03 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c03 naa= 2 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 E 156 TYR A 23 TYR^? 11.58 CH3 ACY A 120 E 163 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 58.73 53.92 40.85 59.76 52.11 42.68 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 60.51 45.70 41.25 62.67 47.81 45.91 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 E 156 TYR A 72 TYR^? -3.77 O ACY A 120s E 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 58.73 53.92 40.85 59.76 52.11 42.68 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 60.51 45.70 41.25 62.67 47.81 45.91 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 E 156 TYR A 72 TYR^? -3.77 O ACY A 120s E 163 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 58.73 53.92 40.85 59.76 52.11 42.68 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 60.51 45.70 41.25 62.67 47.81 45.91 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 E 156 TYR A 79 TYR^? -4.35 CH3 ACY A 120s E 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 58.73 53.92 40.85 59.76 52.11 42.68 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 60.51 45.70 41.25 62.67 47.81 45.91 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 E 156 TYR B 23 TYR^? 11.37 CH3 ACY B 120 E 163 LYS B 71 LYS^? 12.90 O ACY A 121 coo 58.73 53.92 40.85 59.76 52.11 42.68 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 60.51 45.70 41.25 62.67 47.81 45.91 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 E 156 TYR B 72 TYR^? 3.72 OXT ACY B 120s E 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 58.73 53.92 40.85 59.76 52.11 42.68 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 60.51 45.70 41.25 62.67 47.81 45.91 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 E 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s E 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 58.73 53.92 40.85 59.76 52.11 42.68 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 60.51 45.70 41.25 62.67 47.81 45.91 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c04 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 E 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s E 163 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 58.73 53.92 40.85 59.76 52.11 42.68 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 60.51 45.70 41.25 62.67 47.81 45.91 -10.13 21.11 38.47 -9.52 22.58 33.19 1qsg_c04 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c04 naa= 2 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 F 156 TYR A 23 TYR^? 11.58 CH3 ACY A 120 F 163 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 60.02 29.87 32.03 59.43 31.82 30.12 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 58.88 38.21 31.46 58.96 36.46 26.25 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 F 156 TYR A 72 TYR^? -3.77 O ACY A 120s F 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 60.02 29.87 32.03 59.43 31.82 30.12 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 58.88 38.21 31.46 58.96 36.46 26.25 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 F 156 TYR A 72 TYR^? -3.77 O ACY A 120s F 163 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 60.02 29.87 32.03 59.43 31.82 30.12 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 58.88 38.21 31.46 58.96 36.46 26.25 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 F 156 TYR A 79 TYR^? -4.35 CH3 ACY A 120s F 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 60.02 29.87 32.03 59.43 31.82 30.12 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 58.88 38.21 31.46 58.96 36.46 26.25 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 F 156 TYR B 23 TYR^? 11.37 CH3 ACY B 120 F 163 LYS B 71 LYS^? 12.90 O ACY A 121 coo 60.02 29.87 32.03 59.43 31.82 30.12 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 58.88 38.21 31.46 58.96 36.46 26.25 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 F 156 TYR B 72 TYR^? 3.72 OXT ACY B 120s F 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 60.02 29.87 32.03 59.43 31.82 30.12 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 58.88 38.21 31.46 58.96 36.46 26.25 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 F 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s F 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 60.02 29.87 32.03 59.43 31.82 30.12 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 58.88 38.21 31.46 58.96 36.46 26.25 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c05 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 F 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s F 163 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 60.02 29.87 32.03 59.43 31.82 30.12 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 58.88 38.21 31.46 58.96 36.46 26.25 -10.13 21.11 38.47 -9.52 22.58 33.19 1qsg_c05 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c05 naa= 2 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 G 156 TYR A 23 TYR^? 11.58 CH3 ACY A 120 G 163 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 35.34 25.18 46.17 35.45 26.86 48.38 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 34.29 33.26 48.25 34.81 30.77 53.10 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 G 156 TYR A 72 TYR^? -3.77 O ACY A 120s G 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 35.34 25.18 46.17 35.45 26.86 48.38 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 34.29 33.26 48.25 34.81 30.77 53.10 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 G 156 TYR A 72 TYR^? -3.77 O ACY A 120s G 163 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 35.34 25.18 46.17 35.45 26.86 48.38 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 34.29 33.26 48.25 34.81 30.77 53.10 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 G 156 TYR A 79 TYR^? -4.35 CH3 ACY A 120s G 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 35.34 25.18 46.17 35.45 26.86 48.38 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 34.29 33.26 48.25 34.81 30.77 53.10 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 G 156 TYR B 23 TYR^? 11.37 CH3 ACY B 120 G 163 LYS B 71 LYS^? 12.90 O ACY A 121 coo 35.34 25.18 46.17 35.45 26.86 48.38 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 34.29 33.26 48.25 34.81 30.77 53.10 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 G 156 TYR B 72 TYR^? 3.72 OXT ACY B 120s G 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 35.34 25.18 46.17 35.45 26.86 48.38 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 34.29 33.26 48.25 34.81 30.77 53.10 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 G 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s G 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 35.34 25.18 46.17 35.45 26.86 48.38 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 34.29 33.26 48.25 34.81 30.77 53.10 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c06 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 G 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s G 163 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 35.34 25.18 46.17 35.45 26.86 48.38 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 34.29 33.26 48.25 34.81 30.77 53.10 -10.13 21.11 38.47 -9.52 22.58 33.19 1qsg_c06 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c06 naa= 2 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 1 2 # 1 H 156 TYR A 23 TYR^? 11.58 CH3 ACY A 120 H 163 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 30.12 49.87 41.75 29.53 48.20 39.59 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 30.50 41.69 39.85 27.67 43.89 35.58 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 2 2 # 2 H 156 TYR A 72 TYR^? -3.77 O ACY A 120s H 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 30.12 49.87 41.75 29.53 48.20 39.59 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 30.50 41.69 39.85 27.67 43.89 35.58 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 3 2 # 3 H 156 TYR A 72 TYR^? -3.77 O ACY A 120s H 163 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 30.12 49.87 41.75 29.53 48.20 39.59 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 30.50 41.69 39.85 27.67 43.89 35.58 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 4 2 # 4 H 156 TYR A 79 TYR^? -4.35 CH3 ACY A 120s H 163 LYS A 16 LYS~? -3.27 O ACY A 120s coo 30.12 49.87 41.75 29.53 48.20 39.59 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 30.50 41.69 39.85 27.67 43.89 35.58 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 5 2 # 5 H 156 TYR B 23 TYR^? 11.37 CH3 ACY B 120 H 163 LYS B 71 LYS^? 12.90 O ACY A 121 coo 30.12 49.87 41.75 29.53 48.20 39.59 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 30.50 41.69 39.85 27.67 43.89 35.58 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 6 2 # 6 H 156 TYR B 72 TYR^? 3.72 OXT ACY B 120s H 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 30.12 49.87 41.75 29.53 48.20 39.59 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 30.50 41.69 39.85 27.67 43.89 35.58 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 7 2 # 7 H 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s H 163 LYS A 40 LYS.? -3.18 C ACY A 121s coo 30.12 49.87 41.75 29.53 48.20 39.59 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 30.50 41.69 39.85 27.67 43.89 35.58 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1qsg_c07 ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTAuser 8 2 # 8 H 156 TYR B 79 TYR^? -4.21 CH3 ACY B 120s H 163 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 30.12 49.87 41.75 29.53 48.20 39.59 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 30.50 41.69 39.85 27.67 43.89 35.58 -10.13 21.11 38.47 -9.52 22.58 33.19 1qsg_c07 source 1qsg ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE : 8 hits 1qsg_c07 naa= 2 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 1 2 # 1 A 204 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 341 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 33.05 61.37 6.97 31.64 62.95 7.54 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 33.24 65.52 14.74 32.32 65.05 12.93 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1qwn_c00 ALPHA-MANNOSIDASE II user 2 2 # 2 A 204 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 341 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 33.05 61.37 6.97 31.64 62.95 7.54 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 33.24 65.52 14.74 32.32 65.05 12.93 -12.98 14.88 47.28 -12.40 12.90 47.92 1qwn_c00 source 1qwn ALPHA-MANNOSIDASE II : 2 hits 1qwn_c00 naa= 2 ULMN 2 1qz9_c00 KYNURENINASE user 1 2 # 1 A 129 PHE A 52 PHE^? 9.40 ZN ZN A 119 A 201 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 23.39 49.81 32.16 21.33 51.68 32.26 -13.64 35.13 53.79 -11.95 37.28 53.18 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 1qz9_c00 KYNURENINASE user 2 2 # 2 A 129 PHE A 55 PHE.? 11.31 ZN ZN A 119 A 201 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 23.39 49.81 32.16 21.33 51.68 32.26 -23.76 31.53 49.05 -25.99 32.30 50.52 coo 25.52 45.12 37.98 23.98 46.65 37.85 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 1qz9_c00 KYNURENINASE user 3 2 # 3 A 129 PHE B 52 PHE^? 9.45 ZN ZN B 118 A 201 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 23.39 49.81 32.16 21.33 51.68 32.26 -10.22 1.91 36.10 -8.88 -0.23 37.26 coo 25.52 45.12 37.98 23.98 46.65 37.85 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 1qz9_c00 KYNURENINASE user 4 2 # 4 A 129 PHE B 55 PHE.? 11.31 ZN ZN B 118 A 201 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 23.39 49.81 32.16 21.33 51.68 32.26 -21.82 4.67 37.54 -23.75 3.88 35.71 coo 25.52 45.12 37.98 23.98 46.65 37.85 -15.33 3.33 40.18 -15.00 4.24 42.07 1qz9_c00 source 1qz9 KYNURENINASE : 4 hits 1qz9_c00 naa= 2 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 1 2 # 1 A 98 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 179 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 34.76 2.28 18.45 36.75 1.46 18.65 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 2 2 # 2 A 98 GLU A 7 GLU.? 2.09 ZN ZN A 118s A 179 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 34.76 2.28 18.45 36.75 1.46 18.65 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 3 2 # 3 A 98 GLU A 7 GLU.? 2.09 ZN ZN A 118s A 179 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 34.76 2.28 18.45 36.75 1.46 18.65 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 4 2 # 4 A 98 GLU A 28 GLU.? 19.71 ZN ZN A 119 A 179 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 34.76 2.28 18.45 36.75 1.46 18.65 -17.43 33.27 64.86 -17.71 35.42 64.60 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 5 2 # 5 A 98 GLU A 39 GLU^? 13.07 O ACY A 121 A 179 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 34.76 2.28 18.45 36.75 1.46 18.65 3.97 24.42 42.90 6.03 24.50 43.46 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 6 2 # 6 A 98 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 179 GLU A 28 GLU.? 19.71 ZN ZN A 119 coo 34.76 2.28 18.45 36.75 1.46 18.65 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -17.43 33.27 64.86 -17.71 35.42 64.60 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 7 2 # 7 A 98 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 179 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 34.76 2.28 18.45 36.75 1.46 18.65 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 8 2 # 8 A 98 GLU B 7 GLU.? -2.20 ZN ZN B 119s A 179 GLU A 39 GLU^? 13.07 O ACY A 121 coo 34.76 2.28 18.45 36.75 1.46 18.65 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 9 2 # 9 A 98 GLU B 7 GLU.? -2.20 ZN ZN B 119s A 179 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 34.76 2.28 18.45 36.75 1.46 18.65 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 10 2 # 10 A 98 GLU B 28 GLU.? 20.25 ZN ZN B 118 A 179 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 34.76 2.28 18.45 36.75 1.46 18.65 -8.23 3.75 25.31 -7.96 1.78 24.56 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -7.13 -6.28 33.53 -6.83 -7.93 32.24 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 11 2 # 11 A 98 GLU B 39 GLU.? 14.67 OXT ACY A 120 A 179 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 34.76 2.28 18.45 36.75 1.46 18.65 2.54 12.93 51.58 4.67 12.91 51.32 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1r16_c00 ADP-RIBOSYL CYCLASE user 12 2 # 12 A 98 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 179 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 34.76 2.28 18.45 36.75 1.46 18.65 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 45.86 -1.20 22.31 44.68 -1.47 20.44 -8.23 3.75 25.31 -7.96 1.78 24.56 1r16_c00 source 1r16 ADP-RIBOSYL CYCLASE : 12 hits 1r16_c00 naa= 2 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 1 2 # 1 B 98 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 179 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 2 2 # 2 B 98 GLU A 7 GLU.? 2.09 ZN ZN A 118s B 179 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 3 2 # 3 B 98 GLU A 7 GLU.? 2.09 ZN ZN A 118s B 179 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 4 2 # 4 B 98 GLU A 28 GLU.? 19.71 ZN ZN A 119 B 179 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -17.43 33.27 64.86 -17.71 35.42 64.60 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 5 2 # 5 B 98 GLU A 39 GLU^? 13.07 O ACY A 121 B 179 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 14.02 -0.93 13.90 12.71 -1.64 12.30 3.97 24.42 42.90 6.03 24.50 43.46 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 6 2 # 6 B 98 GLU A 89 GLU~? 19.37 ZN ZN A 119 B 179 GLU A 28 GLU.? 19.71 ZN ZN A 119 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -17.43 33.27 64.86 -17.71 35.42 64.60 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 7 2 # 7 B 98 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 179 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 8 2 # 8 B 98 GLU B 7 GLU.? -2.20 ZN ZN B 119s B 179 GLU A 39 GLU^? 13.07 O ACY A 121 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 9 2 # 9 B 98 GLU B 7 GLU.? -2.20 ZN ZN B 119s B 179 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 10 2 # 10 B 98 GLU B 28 GLU.? 20.25 ZN ZN B 118 B 179 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -8.23 3.75 25.31 -7.96 1.78 24.56 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -7.13 -6.28 33.53 -6.83 -7.93 32.24 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 11 2 # 11 B 98 GLU B 39 GLU.? 14.67 OXT ACY A 120 B 179 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 14.02 -0.93 13.90 12.71 -1.64 12.30 2.54 12.93 51.58 4.67 12.91 51.32 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1r16_c01 ADP-RIBOSYL CYCLASE user 12 2 # 12 B 98 GLU B 89 GLU~? 19.03 ZN ZN B 118 B 179 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 14.02 -0.93 13.90 12.71 -1.64 12.30 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 4.79 -1.17 6.15 6.58 -2.43 6.75 -8.23 3.75 25.31 -7.96 1.78 24.56 1r16_c01 source 1r16 ADP-RIBOSYL CYCLASE : 12 hits 1r16_c01 naa= 2 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 A 71 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo 29.52 23.28 0.51 26.83 22.05 1.22 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 18.49 20.71 4.77 20.29 21.80 4.49 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 A 71 ARG A 44 ARG.? 16.49 O ACY A 121 A 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 29.52 23.28 0.51 26.83 22.05 1.22 6.31 22.16 46.81 4.95 24.70 47.95 coo 18.49 20.71 4.77 20.29 21.80 4.49 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 A 71 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 29.52 23.28 0.51 26.83 22.05 1.22 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 18.49 20.71 4.77 20.29 21.80 4.49 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c00 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 A 71 ARG B 44 ARG.? 18.52 O ACY A 121 A 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo 29.52 23.28 0.51 26.83 22.05 1.22 6.69 16.72 49.11 8.85 18.83 48.43 coo 18.49 20.71 4.77 20.29 21.80 4.49 3.97 24.42 42.90 6.03 24.50 43.46 1r44_c00 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c00 naa= 2 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 B 71 ARG A 35 ARG^? 4.87 ZN ZN A 119 B 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo 25.64 17.80 33.30 23.89 16.05 31.49 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 20.92 9.87 25.44 22.46 10.92 26.39 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 B 71 ARG A 44 ARG.? 16.49 O ACY A 121 B 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 25.64 17.80 33.30 23.89 16.05 31.49 6.31 22.16 46.81 4.95 24.70 47.95 coo 20.92 9.87 25.44 22.46 10.92 26.39 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 B 71 ARG B 35 ARG.? 5.03 ZN ZN B 118 B 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 25.64 17.80 33.30 23.89 16.05 31.49 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 20.92 9.87 25.44 22.46 10.92 26.39 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c01 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 B 71 ARG B 44 ARG.? 18.52 O ACY A 121 B 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo 25.64 17.80 33.30 23.89 16.05 31.49 6.69 16.72 49.11 8.85 18.83 48.43 coo 20.92 9.87 25.44 22.46 10.92 26.39 3.97 24.42 42.90 6.03 24.50 43.46 1r44_c01 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c01 naa= 2 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 C 71 ARG A 35 ARG^? 4.87 ZN ZN A 119 C 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 0.79 12.24 58.58 -0.51 13.53 57.59 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 C 71 ARG A 44 ARG.? 16.49 O ACY A 121 C 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -2.50 20.54 50.36 -1.04 18.63 52.25 6.31 22.16 46.81 4.95 24.70 47.95 coo 0.79 12.24 58.58 -0.51 13.53 57.59 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 C 71 ARG B 35 ARG.? 5.03 ZN ZN B 118 C 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -2.50 20.54 50.36 -1.04 18.63 52.25 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 0.79 12.24 58.58 -0.51 13.53 57.59 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c02 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 C 71 ARG B 44 ARG.? 18.52 O ACY A 121 C 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo -2.50 20.54 50.36 -1.04 18.63 52.25 6.69 16.72 49.11 8.85 18.83 48.43 coo 0.79 12.24 58.58 -0.51 13.53 57.59 3.97 24.42 42.90 6.03 24.50 43.46 1r44_c02 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c02 naa= 2 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 D 71 ARG A 35 ARG^? 4.87 ZN ZN A 119 D 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 2.99 23.21 78.86 1.22 24.31 78.95 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 D 71 ARG A 44 ARG.? 16.49 O ACY A 121 D 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -8.22 25.82 82.56 -5.47 24.59 82.05 6.31 22.16 46.81 4.95 24.70 47.95 coo 2.99 23.21 78.86 1.22 24.31 78.95 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 D 71 ARG B 35 ARG.? 5.03 ZN ZN B 118 D 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -8.22 25.82 82.56 -5.47 24.59 82.05 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 2.99 23.21 78.86 1.22 24.31 78.95 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c03 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 D 71 ARG B 44 ARG.? 18.52 O ACY A 121 D 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo -8.22 25.82 82.56 -5.47 24.59 82.05 6.69 16.72 49.11 8.85 18.83 48.43 coo 2.99 23.21 78.86 1.22 24.31 78.95 3.97 24.42 42.90 6.03 24.50 43.46 1r44_c03 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c03 naa= 2 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 E 71 ARG A 35 ARG^? 4.87 ZN ZN A 119 E 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -2.51 13.58 115.60 -2.82 11.62 114.90 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 E 71 ARG A 44 ARG.? 16.49 O ACY A 121 E 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -6.10 4.89 107.96 -5.54 7.53 109.43 6.31 22.16 46.81 4.95 24.70 47.95 coo -2.51 13.58 115.60 -2.82 11.62 114.90 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 E 71 ARG B 35 ARG.? 5.03 ZN ZN B 118 E 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -6.10 4.89 107.96 -5.54 7.53 109.43 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -2.51 13.58 115.60 -2.82 11.62 114.90 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c04 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 E 71 ARG B 44 ARG.? 18.52 O ACY A 121 E 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo -6.10 4.89 107.96 -5.54 7.53 109.43 6.69 16.72 49.11 8.85 18.83 48.43 coo -2.51 13.58 115.60 -2.82 11.62 114.90 3.97 24.42 42.90 6.03 24.50 43.46 1r44_c04 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c04 naa= 2 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 1 2 # 1 F 71 ARG A 35 ARG^? 4.87 ZN ZN A 119 F 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -18.48 11.33 132.65 -18.10 9.35 133.28 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 2 2 # 2 F 71 ARG A 44 ARG.? 16.49 O ACY A 121 F 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -14.30 2.56 139.83 -15.02 5.20 138.45 6.31 22.16 46.81 4.95 24.70 47.95 coo -18.48 11.33 132.65 -18.10 9.35 133.28 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 3 2 # 3 F 71 ARG B 35 ARG.? 5.03 ZN ZN B 118 F 181 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -14.30 2.56 139.83 -15.02 5.20 138.45 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -18.48 11.33 132.65 -18.10 9.35 133.28 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1r44_c05 D-ALANYL-D-ALANINE DIPEPTIDASE user 4 2 # 4 F 71 ARG B 44 ARG.? 18.52 O ACY A 121 F 181 GLU A 39 GLU^? 13.07 O ACY A 121 coo -14.30 2.56 139.83 -15.02 5.20 138.45 6.69 16.72 49.11 8.85 18.83 48.43 coo -18.48 11.33 132.65 -18.10 9.35 133.28 3.97 24.42 42.90 6.03 24.50 43.46 1r44_c05 source 1r44 D-ALANYL-D-ALANINE DIPEPTIDASE : 4 hits 1r44_c05 naa= 2 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 1 2 # 1 A 133 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 235 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 31.15 12.07 13.86 31.85 13.16 16.74 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 27.79 29.07 13.69 29.71 23.15 14.63 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 2 2 # 2 A 133 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 235 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 31.15 12.07 13.86 31.85 13.16 16.74 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 27.79 29.07 13.69 29.71 23.15 14.63 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 3 2 # 3 A 133 ARG A 44 ARG.? 16.49 O ACY A 121 A 235 LYS A 10 LYS.? 12.65 OXT ACY A 120 coo 31.15 12.07 13.86 31.85 13.16 16.74 6.31 22.16 46.81 4.95 24.70 47.95 coo 27.79 29.07 13.69 29.71 23.15 14.63 -0.98 10.25 56.97 2.99 9.65 58.52 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 4 2 # 4 A 133 ARG A 44 ARG.? 16.49 O ACY A 121 A 235 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 31.15 12.07 13.86 31.85 13.16 16.74 6.31 22.16 46.81 4.95 24.70 47.95 coo 27.79 29.07 13.69 29.71 23.15 14.63 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 5 2 # 5 A 133 ARG A 44 ARG.? 16.49 O ACY A 121 A 235 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 31.15 12.07 13.86 31.85 13.16 16.74 6.31 22.16 46.81 4.95 24.70 47.95 coo 27.79 29.07 13.69 29.71 23.15 14.63 -10.13 21.11 38.47 -9.52 22.58 33.19 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 6 2 # 6 A 133 ARG A 44 ARG.? 16.49 O ACY A 121 A 235 LYS B 71 LYS^? 12.90 O ACY A 121 coo 31.15 12.07 13.86 31.85 13.16 16.74 6.31 22.16 46.81 4.95 24.70 47.95 coo 27.79 29.07 13.69 29.71 23.15 14.63 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 7 2 # 7 A 133 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 235 LYS A 40 LYS.? -3.18 C ACY A 121s coo 31.15 12.07 13.86 31.85 13.16 16.74 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 27.79 29.07 13.69 29.71 23.15 14.63 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 8 2 # 8 A 133 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 235 LYS B 71 LYS^? 12.90 O ACY A 121 coo 31.15 12.07 13.86 31.85 13.16 16.74 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 27.79 29.07 13.69 29.71 23.15 14.63 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 9 2 # 9 A 133 ARG B 44 ARG.? 18.52 O ACY A 121 A 235 LYS A 16 LYS~? -3.27 O ACY A 120s coo 31.15 12.07 13.86 31.85 13.16 16.74 6.69 16.72 49.11 8.85 18.83 48.43 coo 27.79 29.07 13.69 29.71 23.15 14.63 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 10 2 # 10 A 133 ARG B 44 ARG.? 18.52 O ACY A 121 A 235 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 31.15 12.07 13.86 31.85 13.16 16.74 6.69 16.72 49.11 8.85 18.83 48.43 coo 27.79 29.07 13.69 29.71 23.15 14.63 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 11 2 # 11 A 133 ARG B 44 ARG.? 18.52 O ACY A 121 A 235 LYS B 10 LYS.? 9.83 CH3 ACY A 121 coo 31.15 12.07 13.86 31.85 13.16 16.74 6.69 16.72 49.11 8.85 18.83 48.43 coo 27.79 29.07 13.69 29.71 23.15 14.63 2.14 27.03 37.15 7.00 28.76 35.76 ULMN 2 1r6w_c00 O-SUCCINYLBENZOATE SYNTHASE user 12 2 # 12 A 133 ARG B 44 ARG.? 18.52 O ACY A 121 A 235 LYS B 71 LYS^? 12.90 O ACY A 121 coo 31.15 12.07 13.86 31.85 13.16 16.74 6.69 16.72 49.11 8.85 18.83 48.43 coo 27.79 29.07 13.69 29.71 23.15 14.63 0.91 14.36 31.66 5.84 10.91 29.66 1r6w_c00 source 1r6w O-SUCCINYLBENZOATE SYNTHASE : 12 hits 1r6w_c00 naa= 2 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 1 2 # 1 A 156 GLN A 18 GLN.? 11.66 ZN ZN A 119 A 217 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 0.57 24.33 98.25 1.75 23.60 99.87 -11.72 21.08 47.54 -11.51 20.01 45.71 coo 5.48 17.66 105.85 5.34 19.71 105.34 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 2 2 # 2 A 156 GLN A 18 GLN.? 11.66 ZN ZN A 119 A 217 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 0.57 24.33 98.25 1.75 23.60 99.87 -11.72 21.08 47.54 -11.51 20.01 45.71 coo 5.48 17.66 105.85 5.34 19.71 105.34 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 3 2 # 3 A 156 GLN A 80 GLN^? 13.49 CH3 ACY A 120 A 217 GLU A 28 GLU.? 19.71 ZN ZN A 119 coo 0.57 24.33 98.25 1.75 23.60 99.87 -8.25 27.21 65.12 -8.76 26.74 67.12 coo 5.48 17.66 105.85 5.34 19.71 105.34 -17.43 33.27 64.86 -17.71 35.42 64.60 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 4 2 # 4 A 156 GLN A 80 GLN^? 13.49 CH3 ACY A 120 A 217 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 0.57 24.33 98.25 1.75 23.60 99.87 -8.25 27.21 65.12 -8.76 26.74 67.12 coo 5.48 17.66 105.85 5.34 19.71 105.34 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 5 2 # 5 A 156 GLN B 18 GLN~? 11.75 ZN ZN B 118 A 217 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 0.57 24.33 98.25 1.75 23.60 99.87 -10.66 16.34 42.67 -11.39 17.08 44.58 coo 5.48 17.66 105.85 5.34 19.71 105.34 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 6 2 # 6 A 156 GLN B 18 GLN~? 11.75 ZN ZN B 118 A 217 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 0.57 24.33 98.25 1.75 23.60 99.87 -10.66 16.34 42.67 -11.39 17.08 44.58 coo 5.48 17.66 105.85 5.34 19.71 105.34 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 7 2 # 7 A 156 GLN B 80 GLN^? 13.44 O ACY A 121 A 217 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 0.57 24.33 98.25 1.75 23.60 99.87 -1.66 10.00 27.14 -1.43 10.41 25.06 coo 5.48 17.66 105.85 5.34 19.71 105.34 -8.23 3.75 25.31 -7.96 1.78 24.56 ULMN 2 1ra0_c00 CYTOSINE DEAMINASE user 8 2 # 8 A 156 GLN B 80 GLN^? 13.44 O ACY A 121 A 217 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo 0.57 24.33 98.25 1.75 23.60 99.87 -1.66 10.00 27.14 -1.43 10.41 25.06 coo 5.48 17.66 105.85 5.34 19.71 105.34 -3.38 17.56 20.48 -2.28 16.44 19.03 1ra0_c00 source 1ra0 CYTOSINE DEAMINASE : 8 hits 1ra0_c00 naa= 2 ULMN 2 1req_c08 METHYLMALONYL-COA MUTASE user 1 2 # 1 A 608 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 610 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 75.99 81.56 1.86 73.91 81.34 2.28 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 71.04 78.84 0.46 71.54 76.90 1.02 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1req_c08 METHYLMALONYL-COA MUTASE user 2 2 # 2 A 608 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 610 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 75.99 81.56 1.86 73.91 81.34 2.28 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 71.04 78.84 0.46 71.54 76.90 1.02 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1req_c08 METHYLMALONYL-COA MUTASE user 3 2 # 3 A 608 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 610 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 75.99 81.56 1.86 73.91 81.34 2.28 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 71.04 78.84 0.46 71.54 76.90 1.02 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1req_c08 METHYLMALONYL-COA MUTASE user 4 2 # 4 A 608 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 610 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 75.99 81.56 1.86 73.91 81.34 2.28 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 71.04 78.84 0.46 71.54 76.90 1.02 -10.33 3.56 43.54 -12.07 4.44 44.29 1req_c08 source 1req METHYLMALONYL-COA MUTASE : 4 hits 1req_c08 naa= 2 ULMN 2 1req_c09 METHYLMALONYL-COA MUTASE user 1 2 # 1 C 608 ASP A 60 ASP.? -2.37 ZN ZN A 119s C 610 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo -17.65 80.52 58.00 -16.23 80.79 56.41 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1req_c09 METHYLMALONYL-COA MUTASE user 2 2 # 2 C 608 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 610 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo -17.65 80.52 58.00 -16.23 80.79 56.41 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1req_c09 METHYLMALONYL-COA MUTASE user 3 2 # 3 C 608 ASP B 60 ASP.? -2.30 ZN ZN B 118s C 610 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo -17.65 80.52 58.00 -16.23 80.79 56.41 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1req_c09 METHYLMALONYL-COA MUTASE user 4 2 # 4 C 608 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 610 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo -17.65 80.52 58.00 -16.23 80.79 56.41 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -16.56 83.18 53.03 -16.33 85.18 53.60 -10.33 3.56 43.54 -12.07 4.44 44.29 1req_c09 source 1req METHYLMALONYL-COA MUTASE : 4 hits 1req_c09 naa= 2 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 1 2 # 1 A 126 THR A 5 THR.? 10.24 ZN ZN B 118 A 160 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo 51.19 2.52 10.94 50.16 2.43 9.01 -11.20 6.24 51.51 -9.77 5.38 52.87 coo 51.97 0.60 16.16 51.18 3.08 14.54 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 2 1rql_c00 PHOSPHONOACETALDEHYDE HYDROLASE user 2 2 # 2 A 126 THR B 5 THR.? 9.07 ZN ZN A 119 A 160 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 51.19 2.52 10.94 50.16 2.43 9.01 -9.78 30.84 38.74 -8.10 32.14 39.13 coo 51.97 0.60 16.16 51.18 3.08 14.54 -8.90 26.62 43.60 -11.56 28.13 43.24 1rql_c00 source 1rql PHOSPHONOACETALDEHYDE HYDROLASE : 2 hits 1rql_c00 naa= 2 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 1 2 # 1 B 126 THR A 5 THR.? 10.24 ZN ZN B 118 B 160 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 -11.20 6.24 51.51 -9.77 5.38 52.87 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 2 1rql_c01 PHOSPHONOACETALDEHYDE HYDROLASE user 2 2 # 2 B 126 THR B 5 THR.? 9.07 ZN ZN A 119 B 160 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 81.10 -6.09 8.07 81.50 -7.56 6.55 -9.78 30.84 38.74 -8.10 32.14 39.13 coo 81.89 -1.02 10.42 82.47 -4.03 10.41 -8.90 26.62 43.60 -11.56 28.13 43.24 1rql_c01 source 1rql PHOSPHONOACETALDEHYDE HYDROLASE : 2 hits 1rql_c01 naa= 2 ULMN 2 1rtf_c00 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 2 # 1 B 57 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 102 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -4.60 27.52 42.88 -4.63 27.41 40.76 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 1rtf_c00 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 2 # 2 B 57 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 102 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 1rtf_c00 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 2 # 3 B 57 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 102 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -4.60 27.52 42.88 -4.63 27.41 40.76 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 1rtf_c00 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 2 # 4 B 57 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 102 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo -4.60 27.52 42.88 -4.63 27.41 40.76 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -0.27 31.24 43.51 -1.49 29.62 42.98 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1rtf_c00 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 4 hits 1rtf_c00 naa= 2 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 1 2 # 1 B 195 SER A 14 SER~? 11.41 CH3 ACY A 120 B 196 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 0.64 25.09 37.94 0.51 25.31 37.16 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 2 2 # 2 B 195 SER A 32 SER^? 8.89 ZN ZN A 119 B 196 GLY A 19 GLY.? 9.19 CH3 ACY A 120 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 0.64 25.09 37.94 0.51 25.31 37.16 -15.53 22.05 51.92 -14.82 21.95 52.30 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 3 2 # 3 B 195 SER A 32 SER^? 8.89 ZN ZN A 119 B 196 GLY A 31 GLY^? 10.46 ZN ZN A 119 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 0.64 25.09 37.94 0.51 25.31 37.16 -15.56 30.08 55.93 -15.09 29.60 56.48 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 4 2 # 4 B 195 SER A 42 SER.? 12.48 O ACY A 121 B 196 GLY A 43 GLY.? 10.93 O ACY A 121 coo -2.83 25.96 36.71 -4.77 27.03 37.63 6.18 19.13 41.68 6.03 20.94 43.24 coo 0.64 25.09 37.94 0.51 25.31 37.16 2.67 18.14 42.78 3.17 18.66 43.17 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 5 2 # 5 B 195 SER A 51 SER^? 4.15 ZN ZN A 119 B 196 GLY A 31 GLY^? 10.46 ZN ZN A 119 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 0.64 25.09 37.94 0.51 25.31 37.16 -15.56 30.08 55.93 -15.09 29.60 56.48 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 6 2 # 6 B 195 SER A 98 SER.? 16.73 ZN ZN A 119 B 196 GLY A 97 GLY.? 16.19 CH3 ACY A 121 coo -2.83 25.96 36.71 -4.77 27.03 37.63 0.17 39.20 41.01 -1.56 40.86 40.71 coo 0.64 25.09 37.94 0.51 25.31 37.16 0.89 35.61 41.95 0.36 36.21 42.05 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 7 2 # 7 B 195 SER B 14 SER~? 11.46 CH3 ACY B 120 B 196 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 0.64 25.09 37.94 0.51 25.31 37.16 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 8 2 # 8 B 195 SER B 32 SER^? 8.58 ZN ZN B 118 B 196 GLY B 19 GLY.? 9.20 CH3 ACY B 120 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 0.64 25.09 37.94 0.51 25.31 37.16 -13.06 15.01 37.28 -12.27 15.10 37.18 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 9 2 # 9 B 195 SER B 32 SER^? 8.58 ZN ZN B 118 B 196 GLY B 31 GLY^? 10.38 ZN ZN B 118 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 0.64 25.09 37.94 0.51 25.31 37.16 -11.44 6.93 33.52 -10.95 7.47 33.07 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 10 2 # 10 B 195 SER B 42 SER.? 13.83 OXT ACY A 120 B 196 GLY B 43 GLY.? 11.77 OXT ACY A 120 coo -2.83 25.96 36.71 -4.77 27.03 37.63 4.20 18.00 53.79 4.49 16.52 51.91 coo 0.64 25.09 37.94 0.51 25.31 37.16 1.41 19.22 51.53 1.94 18.61 51.36 ULMN 2 1rtf_c01 TWO CHAIN TISSUE PLASMINOGEN ACTIVATuser 11 2 # 11 B 195 SER B 51 SER^? 4.27 ZN ZN B 118 B 196 GLY B 31 GLY^? 10.38 ZN ZN B 118 coo -2.83 25.96 36.71 -4.77 27.03 37.63 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 0.64 25.09 37.94 0.51 25.31 37.16 -11.44 6.93 33.52 -10.95 7.47 33.07 1rtf_c01 source 1rtf TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR : 11 hits 1rtf_c01 naa= 2 ULMN 2 1s2k_c00 ALA-ILE-HIS TRIPEPTIDE user 1 2 # 1 A 53 GLN A 18 GLN.? 11.66 ZN ZN A 119 A 136 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 80.69 40.00 16.06 79.05 40.72 17.21 -11.72 21.08 47.54 -11.51 20.01 45.71 coo 71.34 40.73 18.57 73.36 41.35 18.80 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1s2k_c00 ALA-ILE-HIS TRIPEPTIDE user 2 2 # 2 A 53 GLN A 80 GLN^? 13.49 CH3 ACY A 120 A 136 GLU A 28 GLU.? 19.71 ZN ZN A 119 coo 80.69 40.00 16.06 79.05 40.72 17.21 -8.25 27.21 65.12 -8.76 26.74 67.12 coo 71.34 40.73 18.57 73.36 41.35 18.80 -17.43 33.27 64.86 -17.71 35.42 64.60 ULMN 2 1s2k_c00 ALA-ILE-HIS TRIPEPTIDE user 3 2 # 3 A 53 GLN A 80 GLN^? 13.49 CH3 ACY A 120 A 136 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo 80.69 40.00 16.06 79.05 40.72 17.21 -8.25 27.21 65.12 -8.76 26.74 67.12 coo 71.34 40.73 18.57 73.36 41.35 18.80 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 2 1s2k_c00 ALA-ILE-HIS TRIPEPTIDE user 4 2 # 4 A 53 GLN A 87 GLN~? 19.46 ZN ZN A 119 A 136 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 80.69 40.00 16.06 79.05 40.72 17.21 -3.98 39.54 59.02 -3.02 37.88 59.98 coo 71.34 40.73 18.57 73.36 41.35 18.80 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1s2k_c00 ALA-ILE-HIS TRIPEPTIDE user 5 2 # 5 A 53 GLN B 80 GLN^? 13.44 O ACY A 121 A 136 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 80.69 40.00 16.06 79.05 40.72 17.21 -1.66 10.00 27.14 -1.43 10.41 25.06 coo 71.34 40.73 18.57 73.36 41.35 18.80 -8.23 3.75 25.31 -7.96 1.78 24.56 ULMN 2 1s2k_c00 ALA-ILE-HIS TRIPEPTIDE user 6 2 # 6 A 53 GLN B 80 GLN^? 13.44 O ACY A 121 A 136 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo 80.69 40.00 16.06 79.05 40.72 17.21 -1.66 10.00 27.14 -1.43 10.41 25.06 coo 71.34 40.73 18.57 73.36 41.35 18.80 -3.38 17.56 20.48 -2.28 16.44 19.03 ULMN 2 1s2k_c00 ALA-ILE-HIS TRIPEPTIDE user 7 2 # 7 A 53 GLN B 87 GLN~? 19.50 ZN ZN B 118 A 136 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 80.69 40.00 16.06 79.05 40.72 17.21 0.47 -2.28 34.19 1.41 -0.62 33.25 coo 71.34 40.73 18.57 73.36 41.35 18.80 -7.13 -6.28 33.53 -6.83 -7.93 32.24 1s2k_c00 source 1s2k ALA-ILE-HIS TRIPEPTIDE : 7 hits 1s2k_c00 naa= 2 ULMN 2 1s3i_c01 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 1 2 # 1 A 106 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 142 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -17.00 64.03 23.46 -18.21 65.65 22.90 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 1s3i_c01 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 2 2 # 2 A 106 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 142 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 1s3i_c01 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 3 2 # 3 A 106 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 142 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -17.00 64.03 23.46 -18.21 65.65 22.90 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 1s3i_c01 10-FORMYLTETRAHYDROFOLATE DEHYDROGENuser 4 2 # 4 A 106 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 142 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo -17.00 64.03 23.46 -18.21 65.65 22.90 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -17.05 67.91 26.85 -18.66 66.47 26.76 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1s3i_c01 source 1s3i 10-FORMYLTETRAHYDROFOLATE DEHYDROGENASE : 4 hits 1s3i_c01 naa= 2 ULMN 2 1s95_c00 SERINE/THREONINE PROTEIN PHOSPHATASEuser 1 2 # 1 A 274 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 304 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 18.41 23.75 25.69 20.54 23.70 26.14 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 18.06 23.17 29.78 17.74 21.15 29.38 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1s95_c00 SERINE/THREONINE PROTEIN PHOSPHATASEuser 2 2 # 2 A 274 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 304 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 18.41 23.75 25.69 20.54 23.70 26.14 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 18.06 23.17 29.78 17.74 21.15 29.38 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1s95_c00 SERINE/THREONINE PROTEIN PHOSPHATASEuser 3 2 # 3 A 274 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 304 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 18.41 23.75 25.69 20.54 23.70 26.14 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 18.06 23.17 29.78 17.74 21.15 29.38 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1s95_c00 SERINE/THREONINE PROTEIN PHOSPHATASEuser 4 2 # 4 A 274 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 304 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 18.41 23.75 25.69 20.54 23.70 26.14 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 18.06 23.17 29.78 17.74 21.15 29.38 -10.33 3.56 43.54 -12.07 4.44 44.29 1s95_c00 source 1s95 SERINE/THREONINE PROTEIN PHOSPHATASE 5 : 4 hits 1s95_c00 naa= 2 ULMN 2 1s95_c01 SERINE/THREONINE PROTEIN PHOSPHATASEuser 1 2 # 1 B 274 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 304 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 11.08 2.22 21.17 12.89 1.17 20.72 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 10.74 3.09 17.16 11.36 5.03 17.57 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1s95_c01 SERINE/THREONINE PROTEIN PHOSPHATASEuser 2 2 # 2 B 274 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 304 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 11.08 2.22 21.17 12.89 1.17 20.72 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 10.74 3.09 17.16 11.36 5.03 17.57 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1s95_c01 SERINE/THREONINE PROTEIN PHOSPHATASEuser 3 2 # 3 B 274 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 304 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 11.08 2.22 21.17 12.89 1.17 20.72 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 10.74 3.09 17.16 11.36 5.03 17.57 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1s95_c01 SERINE/THREONINE PROTEIN PHOSPHATASEuser 4 2 # 4 B 274 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 304 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 11.08 2.22 21.17 12.89 1.17 20.72 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 10.74 3.09 17.16 11.36 5.03 17.57 -10.33 3.56 43.54 -12.07 4.44 44.29 1s95_c01 source 1s95 SERINE/THREONINE PROTEIN PHOSPHATASE 5 : 4 hits 1s95_c01 naa= 2 ULMN 2 1slm_c00 STROMELYSIN-1 user 1 2 # 1 202 GLU A 7 GLU.? 2.09 ZN ZN A 118s 219 MET B 37 MET?? 10.55 ZN ZN B 118 coo 17.90 89.78 76.20 17.93 89.03 78.20 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 23.61 94.73 82.41 24.46 93.13 79.93 -4.27 12.21 48.29 -6.60 10.21 49.60 ULMN 2 1slm_c00 STROMELYSIN-1 user 2 2 # 2 202 GLU A 34 GLU^? -2.26 ZN ZN A 119s 219 MET A 37 MET?? 10.48 O ACY B 120 coo 17.90 89.78 76.20 17.93 89.03 78.20 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 23.61 94.73 82.41 24.46 93.13 79.93 -3.65 25.16 44.33 -5.41 26.98 42.18 ULMN 2 1slm_c00 STROMELYSIN-1 user 3 2 # 3 202 GLU B 7 GLU.? -2.20 ZN ZN B 119s 219 MET A 37 MET?? 10.48 O ACY B 120 coo 17.90 89.78 76.20 17.93 89.03 78.20 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 23.61 94.73 82.41 24.46 93.13 79.93 -3.65 25.16 44.33 -5.41 26.98 42.18 ULMN 2 1slm_c00 STROMELYSIN-1 user 4 2 # 4 202 GLU B 28 GLU.? 20.25 ZN ZN B 118 219 MET B 82 MET?? 18.84 O ACY A 121 coo 17.90 89.78 76.20 17.93 89.03 78.20 -8.23 3.75 25.31 -7.96 1.78 24.56 coo 23.61 94.73 82.41 24.46 93.13 79.93 1.34 5.10 30.59 3.37 3.64 28.04 ULMN 2 1slm_c00 STROMELYSIN-1 user 5 2 # 5 202 GLU B 34 GLU.? -2.23 ZN ZN B 118s 219 MET B 37 MET?? 10.55 ZN ZN B 118 coo 17.90 89.78 76.20 17.93 89.03 78.20 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 23.61 94.73 82.41 24.46 93.13 79.93 -4.27 12.21 48.29 -6.60 10.21 49.60 1slm_c00 source 1slm STROMELYSIN-1 : 5 hits 1slm_c00 naa= 2 ULMN 2 1sme_c10 PLASMEPSIN II user 1 2 # 1 A 34 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 214 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 51.75 60.57 19.10 52.05 60.90 21.19 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 48.59 58.89 25.78 50.13 59.74 24.61 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1sme_c10 PLASMEPSIN II user 2 2 # 2 A 34 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 214 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 51.75 60.57 19.10 52.05 60.90 21.19 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 48.59 58.89 25.78 50.13 59.74 24.61 -12.98 14.88 47.28 -12.40 12.90 47.92 1sme_c10 source 1sme PLASMEPSIN II : 2 hits 1sme_c10 naa= 2 ULMN 2 1sme_c11 PLASMEPSIN II user 1 2 # 1 B 34 ASP A 15 ASP~? 8.61 ZN ZN B 118 B 214 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 17.69 97.58 52.73 17.33 97.19 54.77 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 12.41 98.71 58.47 14.37 98.17 58.05 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1sme_c11 PLASMEPSIN II user 2 2 # 2 B 34 ASP B 15 ASP~? 8.50 ZN ZN A 119 B 214 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 17.69 97.58 52.73 17.33 97.19 54.77 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 12.41 98.71 58.47 14.37 98.17 58.05 -12.98 14.88 47.28 -12.40 12.90 47.92 1sme_c11 source 1sme PLASMEPSIN II : 2 hits 1sme_c11 naa= 2 ULMN 2 1snz_c00 ALDOSE 1-EPIMERASE user 1 2 # 1 A 176 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 307 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo -11.45 7.93 45.89 -12.23 7.21 44.11 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -12.20 3.67 48.18 -13.56 4.31 46.73 -13.07 9.82 43.01 -13.89 7.88 43.30 1snz_c00 source 1snz ALDOSE 1-EPIMERASE : 1 hits 1snz_c00 naa= 2 ULMN 2 1sox_c00 SULFITE OXIDASE user 1 2 # 1 A 138 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 322 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 29.11 98.43 27.28 31.52 97.24 28.79 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 28.34 90.08 25.08 29.22 92.59 25.94 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1sox_c00 SULFITE OXIDASE user 2 2 # 2 A 138 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 322 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 29.11 98.43 27.28 31.52 97.24 28.79 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 28.34 90.08 25.08 29.22 92.59 25.94 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1sox_c00 SULFITE OXIDASE user 3 2 # 3 A 138 ARG B 90 ARG~? 22.74 ZN ZN B 118 A 322 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 29.11 98.43 27.28 31.52 97.24 28.79 -1.29 -8.08 37.25 0.33 -10.46 36.18 coo 28.34 90.08 25.08 29.22 92.59 25.94 -4.17 2.05 38.57 -1.76 0.81 38.01 1sox_c00 source 1sox SULFITE OXIDASE : 3 hits 1sox_c00 naa= 2 ULMN 2 1sox_c01 SULFITE OXIDASE user 1 2 # 1 B 138 ARG A 35 ARG^? 4.87 ZN ZN A 119 B 322 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1sox_c01 SULFITE OXIDASE user 2 2 # 2 B 138 ARG B 35 ARG.? 5.03 ZN ZN B 118 B 322 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo -7.30 67.54 21.22 -9.56 67.99 23.16 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -6.47 76.05 22.16 -7.36 73.40 22.11 -1.77 7.84 45.62 -3.44 6.86 47.62 1sox_c01 source 1sox SULFITE OXIDASE : 2 hits 1sox_c01 naa= 2 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 1 2 # 1 E 166 ASP A 15 ASP~? 8.61 ZN ZN B 118 E 170 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 5.36 16.20 22.10 3.88 17.00 23.31 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 2.36 26.80 21.76 1.58 25.84 20.04 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 2 2 # 2 E 166 ASP A 15 ASP~? 8.61 ZN ZN B 118 E 170 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 5.36 16.20 22.10 3.88 17.00 23.31 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 2.36 26.80 21.76 1.58 25.84 20.04 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 3 2 # 3 E 166 ASP A 15 ASP~? 8.61 ZN ZN B 118 E 170 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 5.36 16.20 22.10 3.88 17.00 23.31 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 2.36 26.80 21.76 1.58 25.84 20.04 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 4 2 # 4 E 166 ASP A 61 ASP^? 8.97 ZN ZN A 119 E 170 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 5.36 16.20 22.10 3.88 17.00 23.31 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 2.36 26.80 21.76 1.58 25.84 20.04 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 5 2 # 5 E 166 ASP A 61 ASP^? 8.97 ZN ZN A 119 E 170 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 5.36 16.20 22.10 3.88 17.00 23.31 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 2.36 26.80 21.76 1.58 25.84 20.04 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 6 2 # 6 E 166 ASP A 61 ASP^? 8.97 ZN ZN A 119 E 170 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 5.36 16.20 22.10 3.88 17.00 23.31 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 2.36 26.80 21.76 1.58 25.84 20.04 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 7 2 # 7 E 166 ASP B 15 ASP~? 8.50 ZN ZN A 119 E 170 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 5.36 16.20 22.10 3.88 17.00 23.31 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 2.36 26.80 21.76 1.58 25.84 20.04 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 8 2 # 8 E 166 ASP B 15 ASP~? 8.50 ZN ZN A 119 E 170 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 5.36 16.20 22.10 3.88 17.00 23.31 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 2.36 26.80 21.76 1.58 25.84 20.04 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 9 2 # 9 E 166 ASP B 61 ASP^? 9.02 ZN ZN B 118 E 170 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 5.36 16.20 22.10 3.88 17.00 23.31 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 2.36 26.80 21.76 1.58 25.84 20.04 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 10 2 # 10 E 166 ASP B 61 ASP^? 9.02 ZN ZN B 118 E 170 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 5.36 16.20 22.10 3.88 17.00 23.31 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 2.36 26.80 21.76 1.58 25.84 20.04 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1stc_c00 CAMP-DEPENDENT PROTEIN KINASE user 11 2 # 11 E 166 ASP B 61 ASP^? 9.02 ZN ZN B 118 E 170 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 5.36 16.20 22.10 3.88 17.00 23.31 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 2.36 26.80 21.76 1.58 25.84 20.04 -7.13 -6.28 33.53 -6.83 -7.93 32.24 1stc_c00 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 11 hits 1stc_c00 naa= 2 ULMN 2 1stc_c01 CAMP-DEPENDENT PROTEIN KINASE user 1 2 # 1 E 166 ASP A 26 ASP.? 19.54 CH3 ACY A 120 E 168 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 5.36 16.20 22.10 3.88 17.00 23.31 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 5.06 22.32 18.11 1.02 22.08 22.74 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 2 1stc_c01 CAMP-DEPENDENT PROTEIN KINASE user 2 2 # 2 E 166 ASP A 61 ASP^? 8.97 ZN ZN A 119 E 168 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 5.36 16.20 22.10 3.88 17.00 23.31 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 5.06 22.32 18.11 1.02 22.08 22.74 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 1stc_c01 CAMP-DEPENDENT PROTEIN KINASE user 3 2 # 3 E 166 ASP B 26 ASP.? 19.38 CH3 ACY B 120 E 168 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 5.36 16.20 22.10 3.88 17.00 23.31 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 5.06 22.32 18.11 1.02 22.08 22.74 -10.40 7.25 27.78 -14.86 10.45 31.09 1stc_c01 source 1stc CAMP-DEPENDENT PROTEIN KINASE : 3 hits 1stc_c01 naa= 2 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 1 2 # 1 A 8 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 80 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 2 2 # 2 A 8 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 80 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 3 2 # 3 A 8 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 80 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1t0u_c00 URIDINE PHOSPHORYLASE user 4 2 # 4 A 8 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 80 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo -26.49 11.99 -26.21 -24.54 12.74 -26.25 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -26.78 7.08 -23.74 -27.10 9.15 -24.19 -13.07 9.82 43.01 -13.89 7.88 43.30 1t0u_c00 source 1t0u URIDINE PHOSPHORYLASE : 4 hits 1t0u_c00 naa= 2 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 1 2 # 1 62 LYS A 10 LYS.? 12.65 OXT ACY A 120 288 SER A 14 SER~? 11.41 CH3 ACY A 120 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -0.98 10.25 56.97 2.99 9.65 58.52 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -8.58 16.80 48.15 -8.42 16.11 45.83 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 2 2 # 2 62 LYS A 16 LYS~? -3.27 O ACY A 120s 288 SER A 32 SER^? 8.89 ZN ZN A 119 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -12.18 15.96 51.84 -12.69 14.73 56.98 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -14.23 26.97 54.31 -16.02 26.35 52.81 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 3 2 # 3 62 LYS A 16 LYS~? -3.27 O ACY A 120s 288 SER B 46 SER^? 14.91 OXT ACY A 120 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -12.18 15.96 51.84 -12.69 14.73 56.98 coo -14.37 3.44 26.58 -14.65 5.84 27.07 1.20 11.37 47.30 1.64 9.60 48.90 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 4 2 # 4 62 LYS A 29 LYS^? 13.52 CH3 ACY A 120 288 SER A 51 SER^? 4.15 ZN ZN A 119 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -16.25 29.91 61.58 -19.73 26.30 57.65 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 5 2 # 5 62 LYS A 40 LYS.? -3.18 C ACY A 121s 288 SER B 46 SER^? 14.91 OXT ACY A 120 coo -13.90 11.27 16.35 -15.53 10.62 20.90 1.80 21.48 38.21 -1.61 24.69 34.09 coo -14.37 3.44 26.58 -14.65 5.84 27.07 1.20 11.37 47.30 1.64 9.60 48.90 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 6 2 # 6 62 LYS A 71 LYS^? 11.96 OXT ACY A 120 288 SER A 32 SER^? 8.89 ZN ZN A 119 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -4.35 22.91 61.78 1.12 23.33 62.25 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -14.23 26.97 54.31 -16.02 26.35 52.81 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 7 2 # 7 62 LYS A 71 LYS^? 11.96 OXT ACY A 120 288 SER B 42 SER.? 13.83 OXT ACY A 120 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -4.35 22.91 61.78 1.12 23.33 62.25 coo -14.37 3.44 26.58 -14.65 5.84 27.07 4.20 18.00 53.79 4.49 16.52 51.91 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 8 2 # 8 62 LYS A 93 LYS.? 17.16 ZN ZN A 119 288 SER A 51 SER^? 4.15 ZN ZN A 119 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -8.24 41.47 45.26 -7.63 47.05 46.72 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 9 2 # 9 62 LYS B 10 LYS.? 9.83 CH3 ACY A 121 288 SER A 98 SER.? 16.73 ZN ZN A 119 coo -13.90 11.27 16.35 -15.53 10.62 20.90 2.14 27.03 37.15 7.00 28.76 35.76 coo -14.37 3.44 26.58 -14.65 5.84 27.07 0.17 39.20 41.01 -1.56 40.86 40.71 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 10 2 # 10 62 LYS B 10 LYS.? 9.83 CH3 ACY A 121 288 SER B 14 SER~? 11.46 CH3 ACY B 120 coo -13.90 11.27 16.35 -15.53 10.62 20.90 2.14 27.03 37.15 7.00 28.76 35.76 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -7.60 20.35 43.19 -8.11 21.15 45.47 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 11 2 # 11 62 LYS B 16 LYS~? -4.10 OXT ACY B 120s 288 SER B 32 SER^? 8.58 ZN ZN B 118 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -10.13 21.11 38.47 -9.52 22.58 33.19 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -11.02 10.19 35.41 -13.14 10.52 36.50 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 12 2 # 12 62 LYS B 29 LYS^? 13.36 ZN ZN B 118 288 SER B 51 SER^? 4.27 ZN ZN B 118 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -10.40 7.25 27.78 -14.86 10.45 31.09 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -11.41 5.84 39.04 -13.87 6.10 39.28 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 13 2 # 13 62 LYS B 40 LYS.? 4.59 ZN ZN A 118 288 SER A 46 SER^? 14.68 O ACY A 121 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -0.91 15.74 55.76 -5.29 12.34 58.61 coo -14.37 3.44 26.58 -14.65 5.84 27.07 1.31 25.87 47.03 1.94 27.83 45.77 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 14 2 # 14 62 LYS B 71 LYS^? 12.90 O ACY A 121 288 SER A 42 SER.? 12.48 O ACY A 121 coo -13.90 11.27 16.35 -15.53 10.62 20.90 0.91 14.36 31.66 5.84 10.91 29.66 coo -14.37 3.44 26.58 -14.65 5.84 27.07 6.18 19.13 41.68 6.03 20.94 43.24 ULMN 2 1tdj_c00 BIOSYNTHETIC THREONINE DEAMINASE user 15 2 # 15 62 LYS B 71 LYS^? 12.90 O ACY A 121 288 SER B 32 SER^? 8.58 ZN ZN B 118 coo -13.90 11.27 16.35 -15.53 10.62 20.90 0.91 14.36 31.66 5.84 10.91 29.66 coo -14.37 3.44 26.58 -14.65 5.84 27.07 -11.02 10.19 35.41 -13.14 10.52 36.50 1tdj_c00 source 1tdj BIOSYNTHETIC THREONINE DEAMINASE : 15 hits 1tdj_c00 naa= 2 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 1 2 # 1 62 LYS A 10 LYS.? 12.65 OXT ACY A 120 315 SER B 42 SER.? 13.83 OXT ACY A 120 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -0.98 10.25 56.97 2.99 9.65 58.52 coo -13.07 3.29 19.97 -14.02 3.00 22.17 4.20 18.00 53.79 4.49 16.52 51.91 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 2 2 # 2 62 LYS A 10 LYS.? 12.65 OXT ACY A 120 315 SER B 46 SER^? 14.91 OXT ACY A 120 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -0.98 10.25 56.97 2.99 9.65 58.52 coo -13.07 3.29 19.97 -14.02 3.00 22.17 1.20 11.37 47.30 1.64 9.60 48.90 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 3 2 # 3 62 LYS A 16 LYS~? -3.27 O ACY A 120s 315 SER B 14 SER~? 11.46 CH3 ACY B 120 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -12.18 15.96 51.84 -12.69 14.73 56.98 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -7.60 20.35 43.19 -8.11 21.15 45.47 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 4 2 # 4 62 LYS A 29 LYS^? 13.52 CH3 ACY A 120 315 SER A 32 SER^? 8.89 ZN ZN A 119 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -16.25 29.91 61.58 -19.73 26.30 57.65 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -14.23 26.97 54.31 -16.02 26.35 52.81 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 5 2 # 5 62 LYS A 40 LYS.? -3.18 C ACY A 121s 315 SER A 46 SER^? 14.68 O ACY A 121 coo -13.90 11.27 16.35 -15.53 10.62 20.90 1.80 21.48 38.21 -1.61 24.69 34.09 coo -13.07 3.29 19.97 -14.02 3.00 22.17 1.31 25.87 47.03 1.94 27.83 45.77 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 6 2 # 6 62 LYS A 40 LYS.? -3.18 C ACY A 121s 315 SER B 14 SER~? 11.46 CH3 ACY B 120 coo -13.90 11.27 16.35 -15.53 10.62 20.90 1.80 21.48 38.21 -1.61 24.69 34.09 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -7.60 20.35 43.19 -8.11 21.15 45.47 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 7 2 # 7 62 LYS A 93 LYS.? 17.16 ZN ZN A 119 315 SER A 98 SER.? 16.73 ZN ZN A 119 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -8.24 41.47 45.26 -7.63 47.05 46.72 coo -13.07 3.29 19.97 -14.02 3.00 22.17 0.17 39.20 41.01 -1.56 40.86 40.71 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 8 2 # 8 62 LYS B 10 LYS.? 9.83 CH3 ACY A 121 315 SER A 42 SER.? 12.48 O ACY A 121 coo -13.90 11.27 16.35 -15.53 10.62 20.90 2.14 27.03 37.15 7.00 28.76 35.76 coo -13.07 3.29 19.97 -14.02 3.00 22.17 6.18 19.13 41.68 6.03 20.94 43.24 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 9 2 # 9 62 LYS B 10 LYS.? 9.83 CH3 ACY A 121 315 SER A 46 SER^? 14.68 O ACY A 121 coo -13.90 11.27 16.35 -15.53 10.62 20.90 2.14 27.03 37.15 7.00 28.76 35.76 coo -13.07 3.29 19.97 -14.02 3.00 22.17 1.31 25.87 47.03 1.94 27.83 45.77 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 10 2 # 10 62 LYS B 16 LYS~? -4.10 OXT ACY B 120s 315 SER A 14 SER~? 11.41 CH3 ACY A 120 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -10.13 21.11 38.47 -9.52 22.58 33.19 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -8.58 16.80 48.15 -8.42 16.11 45.83 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 11 2 # 11 62 LYS B 29 LYS^? 13.36 ZN ZN B 118 315 SER B 32 SER^? 8.58 ZN ZN B 118 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -10.40 7.25 27.78 -14.86 10.45 31.09 coo -13.07 3.29 19.97 -14.02 3.00 22.17 -11.02 10.19 35.41 -13.14 10.52 36.50 ULMN 2 1tdj_c02 BIOSYNTHETIC THREONINE DEAMINASE user 12 2 # 12 62 LYS B 40 LYS.? 4.59 ZN ZN A 118 315 SER B 46 SER^? 14.91 OXT ACY A 120 coo -13.90 11.27 16.35 -15.53 10.62 20.90 -0.91 15.74 55.76 -5.29 12.34 58.61 coo -13.07 3.29 19.97 -14.02 3.00 22.17 1.20 11.37 47.30 1.64 9.60 48.90 1tdj_c02 source 1tdj BIOSYNTHETIC THREONINE DEAMINASE : 12 hits 1tdj_c02 naa= 2 ULMN 2 1tht_c00 THIOESTERASE user 1 2 # 1 A 114 SER A 51 SER^? 4.15 ZN ZN A 119 A 241 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 16.60 41.02 19.48 18.96 41.23 20.11 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 21.64 42.49 16.30 20.20 41.39 17.28 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1tht_c00 THIOESTERASE user 2 2 # 2 A 114 SER B 51 SER^? 4.27 ZN ZN B 118 A 241 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 16.60 41.02 19.48 18.96 41.23 20.11 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 21.64 42.49 16.30 20.20 41.39 17.28 -10.33 3.56 43.54 -12.07 4.44 44.29 1tht_c00 source 1tht THIOESTERASE : 2 hits 1tht_c00 naa= 2 ULMN 2 1tht_c01 THIOESTERASE user 1 2 # 1 B 114 SER A 51 SER^? 4.15 ZN ZN A 119 B 241 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 22.54 -2.32 19.28 20.22 -2.50 20.19 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 17.49 -3.87 16.17 18.95 -2.77 17.03 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1tht_c01 THIOESTERASE user 2 2 # 2 B 114 SER B 51 SER^? 4.27 ZN ZN B 118 B 241 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 22.54 -2.32 19.28 20.22 -2.50 20.19 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 17.49 -3.87 16.17 18.95 -2.77 17.03 -10.33 3.56 43.54 -12.07 4.44 44.29 1tht_c01 source 1tht THIOESTERASE : 2 hits 1tht_c01 naa= 2 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 1 2 # 1 117 ASP A 15 ASP~? 8.61 ZN ZN B 118 265 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 2 2 # 2 117 ASP A 26 ASP.? 19.54 CH3 ACY A 120 265 ASP A 86 ASP~? 22.55 ZN ZN A 119 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -6.95 43.63 60.82 -7.76 45.08 62.19 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 3 2 # 3 117 ASP A 60 ASP.? -2.37 ZN ZN A 119s 265 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 4 2 # 4 117 ASP A 61 ASP^? 8.97 ZN ZN A 119 265 ASP A 86 ASP~? 22.55 ZN ZN A 119 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -6.95 43.63 60.82 -7.76 45.08 62.19 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 5 2 # 5 117 ASP A 86 ASP~? 22.55 ZN ZN A 119 265 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 6 2 # 6 117 ASP A 86 ASP~? 22.55 ZN ZN A 119 265 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 7 2 # 7 117 ASP B 15 ASP~? 8.50 ZN ZN A 119 265 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 8 2 # 8 117 ASP B 26 ASP.? 19.38 CH3 ACY B 120 265 ASP B 86 ASP~? 22.13 ZN ZN B 118 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -2.05 -6.64 31.60 -2.83 -8.07 30.18 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 9 2 # 9 117 ASP B 60 ASP.? -2.30 ZN ZN B 118s 265 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 10 2 # 10 117 ASP B 61 ASP^? 9.02 ZN ZN B 118 265 ASP B 86 ASP~? 22.13 ZN ZN B 118 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -2.05 -6.64 31.60 -2.83 -8.07 30.18 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 11 2 # 11 117 ASP B 86 ASP~? 22.13 ZN ZN B 118 265 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 1tml_c01 ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1user 12 2 # 12 117 ASP B 86 ASP~? 22.13 ZN ZN B 118 265 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 3.35 49.90 -16.55 3.54 50.44 -14.49 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 10.80 58.89 -11.76 10.49 57.51 -10.17 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1tml_c01 source 1tml ENDO-1,4-BETA-D-GLUCANASE (E.C.3.2.1.4) : 12 hits 1tml_c01 naa= 2 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 1 2 # 1 A 130 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 185 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 8.81 3.41 29.07 10.49 4.61 29.53 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 17.44 9.63 28.94 15.61 8.68 29.31 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1uas_c00 ALPHA-GALACTOSIDASE user 2 2 # 2 A 130 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 185 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 8.81 3.41 29.07 10.49 4.61 29.53 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 17.44 9.63 28.94 15.61 8.68 29.31 -12.98 14.88 47.28 -12.40 12.90 47.92 1uas_c00 source 1uas ALPHA-GALACTOSIDASE : 2 hits 1uas_c00 naa= 2 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 1 2 # 1 199 ASP A 15 ASP~? 8.61 ZN ZN B 118 255 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 52.57 37.12 10.17 53.37 35.95 11.75 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 2 2 # 2 199 ASP A 26 ASP.? 19.54 CH3 ACY A 120 255 GLU A 28 GLU.? 19.71 ZN ZN A 119 coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 52.57 37.12 10.17 53.37 35.95 11.75 -17.43 33.27 64.86 -17.71 35.42 64.60 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 3 2 # 3 199 ASP A 60 ASP.? -2.37 ZN ZN A 119s 255 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 49.16 35.16 15.19 51.08 34.43 15.65 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 52.57 37.12 10.17 53.37 35.95 11.75 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 4 2 # 4 199 ASP A 60 ASP.? -2.37 ZN ZN A 119s 255 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 49.16 35.16 15.19 51.08 34.43 15.65 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 52.57 37.12 10.17 53.37 35.95 11.75 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 5 2 # 5 199 ASP A 86 ASP~? 22.55 ZN ZN A 119 255 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 49.16 35.16 15.19 51.08 34.43 15.65 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 52.57 37.12 10.17 53.37 35.95 11.75 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 6 2 # 6 199 ASP B 15 ASP~? 8.50 ZN ZN A 119 255 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 49.16 35.16 15.19 51.08 34.43 15.65 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 52.57 37.12 10.17 53.37 35.95 11.75 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 7 2 # 7 199 ASP B 26 ASP.? 19.38 CH3 ACY B 120 255 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 49.16 35.16 15.19 51.08 34.43 15.65 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 52.57 37.12 10.17 53.37 35.95 11.75 -8.23 3.75 25.31 -7.96 1.78 24.56 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 8 2 # 8 199 ASP B 60 ASP.? -2.30 ZN ZN B 118s 255 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 52.57 37.12 10.17 53.37 35.95 11.75 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 9 2 # 9 199 ASP B 60 ASP.? -2.30 ZN ZN B 118s 255 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 49.16 35.16 15.19 51.08 34.43 15.65 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 52.57 37.12 10.17 53.37 35.95 11.75 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1uok_c01 OLIGO-1,6-GLUCOSIDASE user 10 2 # 10 199 ASP B 86 ASP~? 22.13 ZN ZN B 118 255 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 49.16 35.16 15.19 51.08 34.43 15.65 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 52.57 37.12 10.17 53.37 35.95 11.75 -7.13 -6.28 33.53 -6.83 -7.93 32.24 1uok_c01 source 1uok OLIGO-1,6-GLUCOSIDASE : 10 hits 1uok_c01 naa= 2 ULMN 2 1uox_c00 URATE OXIDASE user 1 2 # 1 28 THR A 5 THR.? 10.24 ZN ZN B 118 76 PRO B 92 PRO.? 13.03 ZN ZN B 118 coo 16.78 65.34 48.92 15.62 64.41 47.34 -11.20 6.24 51.51 -9.77 5.38 52.87 coo 23.62 58.48 37.29 23.51 60.61 36.65 -2.71 -1.87 43.94 -4.68 -2.92 43.60 ULMN 2 1uox_c00 URATE OXIDASE user 2 2 # 2 28 THR A 8 THR.? 9.96 ZN ZN A 118 76 PRO A 3 PRO.? 7.68 ZN ZN B 118 coo 16.78 65.34 48.92 15.62 64.41 47.34 -5.91 7.98 55.94 -4.35 7.02 54.82 coo 23.62 58.48 37.29 23.51 60.61 36.65 -15.08 -0.63 48.65 -15.04 1.50 49.41 ULMN 2 1uox_c00 URATE OXIDASE user 3 2 # 3 28 THR A 8 THR.? 9.96 ZN ZN A 118 76 PRO B 64 PRO^? 11.15 ZN ZN B 118 coo 16.78 65.34 48.92 15.62 64.41 47.34 -5.91 7.98 55.94 -4.35 7.02 54.82 coo 23.62 58.48 37.29 23.51 60.61 36.65 -2.55 3.00 43.32 -3.41 4.52 41.89 ULMN 2 1uox_c00 URATE OXIDASE user 4 2 # 4 28 THR A 8 THR.? 9.96 ZN ZN A 118 76 PRO B 92 PRO.? 13.03 ZN ZN B 118 coo 16.78 65.34 48.92 15.62 64.41 47.34 -5.91 7.98 55.94 -4.35 7.02 54.82 coo 23.62 58.48 37.29 23.51 60.61 36.65 -2.71 -1.87 43.94 -4.68 -2.92 43.60 ULMN 2 1uox_c00 URATE OXIDASE user 5 2 # 5 28 THR A 20 THR.? 4.16 CH3 ACY A 120 76 PRO A 25 PRO.? 17.39 CH3 ACY A 120 coo 16.78 65.34 48.92 15.62 64.41 47.34 -13.83 21.70 55.31 -12.29 20.44 56.16 coo 23.62 58.48 37.29 23.51 60.61 36.65 -7.30 33.51 65.78 -8.64 31.75 66.17 ULMN 2 1uox_c00 URATE OXIDASE user 6 2 # 6 28 THR A 20 THR.? 4.16 CH3 ACY A 120 76 PRO A 64 PRO^? 10.85 ZN ZN A 119 coo 16.78 65.34 48.92 15.62 64.41 47.34 -13.83 21.70 55.31 -12.29 20.44 56.16 coo 23.62 58.48 37.29 23.51 60.61 36.65 -4.17 34.12 49.24 -5.16 32.71 50.71 ULMN 2 1uox_c00 URATE OXIDASE user 7 2 # 7 28 THR A 20 THR.? 4.16 CH3 ACY A 120 76 PRO A 66 PRO~? 14.96 CH3 ACY A 120 coo 16.78 65.34 48.92 15.62 64.41 47.34 -13.83 21.70 55.31 -12.29 20.44 56.16 coo 23.62 58.48 37.29 23.51 60.61 36.65 0.58 29.52 55.24 -0.42 28.65 53.44 ULMN 2 1uox_c00 URATE OXIDASE user 8 2 # 8 28 THR A 84 THR~? 20.88 ZN ZN A 119 76 PRO A 64 PRO^? 10.85 ZN ZN A 119 coo 16.78 65.34 48.92 15.62 64.41 47.34 -7.32 38.08 62.29 -5.65 39.33 62.81 coo 23.62 58.48 37.29 23.51 60.61 36.65 -4.17 34.12 49.24 -5.16 32.71 50.71 ULMN 2 1uox_c00 URATE OXIDASE user 9 2 # 9 28 THR A 84 THR~? 20.88 ZN ZN A 119 76 PRO A 66 PRO~? 14.96 CH3 ACY A 120 coo 16.78 65.34 48.92 15.62 64.41 47.34 -7.32 38.08 62.29 -5.65 39.33 62.81 coo 23.62 58.48 37.29 23.51 60.61 36.65 0.58 29.52 55.24 -0.42 28.65 53.44 ULMN 2 1uox_c00 URATE OXIDASE user 10 2 # 10 28 THR A 84 THR~? 20.88 ZN ZN A 119 76 PRO A 92 PRO.? 12.50 ZN ZN A 119 coo 16.78 65.34 48.92 15.62 64.41 47.34 -7.32 38.08 62.29 -5.65 39.33 62.81 coo 23.62 58.48 37.29 23.51 60.61 36.65 -4.50 38.48 48.78 -6.08 40.12 48.68 ULMN 2 1uox_c00 URATE OXIDASE user 11 2 # 11 28 THR B 5 THR.? 9.07 ZN ZN A 119 76 PRO A 92 PRO.? 12.50 ZN ZN A 119 coo 16.78 65.34 48.92 15.62 64.41 47.34 -9.78 30.84 38.74 -8.10 32.14 39.13 coo 23.62 58.48 37.29 23.51 60.61 36.65 -4.50 38.48 48.78 -6.08 40.12 48.68 ULMN 2 1uox_c00 URATE OXIDASE user 12 2 # 12 28 THR B 8 THR.? 9.69 CH3 ACY A 121 76 PRO A 64 PRO^? 10.85 ZN ZN A 119 coo 16.78 65.34 48.92 15.62 64.41 47.34 -2.71 29.36 36.26 -2.04 29.94 38.25 coo 23.62 58.48 37.29 23.51 60.61 36.65 -4.17 34.12 49.24 -5.16 32.71 50.71 ULMN 2 1uox_c00 URATE OXIDASE user 13 2 # 13 28 THR B 8 THR.? 9.69 CH3 ACY A 121 76 PRO A 92 PRO.? 12.50 ZN ZN A 119 coo 16.78 65.34 48.92 15.62 64.41 47.34 -2.71 29.36 36.26 -2.04 29.94 38.25 coo 23.62 58.48 37.29 23.51 60.61 36.65 -4.50 38.48 48.78 -6.08 40.12 48.68 ULMN 2 1uox_c00 URATE OXIDASE user 14 2 # 14 28 THR B 8 THR.? 9.69 CH3 ACY A 121 76 PRO B 3 PRO.? 7.51 ZN ZN A 119 coo 16.78 65.34 48.92 15.62 64.41 47.34 -2.71 29.36 36.26 -2.04 29.94 38.25 coo 23.62 58.48 37.29 23.51 60.61 36.65 -14.07 37.52 41.31 -13.48 36.05 39.71 ULMN 2 1uox_c00 URATE OXIDASE user 15 2 # 15 28 THR B 20 THR.? 4.10 CH3 ACY B 120 76 PRO B 64 PRO^? 11.15 ZN ZN B 118 coo 16.78 65.34 48.92 15.62 64.41 47.34 -10.29 15.42 34.68 -8.60 16.74 34.44 coo 23.62 58.48 37.29 23.51 60.61 36.65 -2.55 3.00 43.32 -3.41 4.52 41.89 ULMN 2 1uox_c00 URATE OXIDASE user 16 2 # 16 28 THR B 20 THR.? 4.10 CH3 ACY B 120 76 PRO B 66 PRO~? 15.24 CH3 ACY B 120 coo 16.78 65.34 48.92 15.62 64.41 47.34 -10.29 15.42 34.68 -8.60 16.74 34.44 coo 23.62 58.48 37.29 23.51 60.61 36.65 3.24 7.14 40.85 1.59 8.67 40.89 ULMN 2 1uox_c00 URATE OXIDASE user 17 2 # 17 28 THR B 84 THR~? 20.78 ZN ZN B 118 76 PRO B 64 PRO^? 11.15 ZN ZN B 118 coo 16.78 65.34 48.92 15.62 64.41 47.34 -1.74 -0.91 30.07 0.00 -2.14 30.22 coo 23.62 58.48 37.29 23.51 60.61 36.65 -2.55 3.00 43.32 -3.41 4.52 41.89 ULMN 2 1uox_c00 URATE OXIDASE user 18 2 # 18 28 THR B 84 THR~? 20.78 ZN ZN B 118 76 PRO B 66 PRO~? 15.24 CH3 ACY B 120 coo 16.78 65.34 48.92 15.62 64.41 47.34 -1.74 -0.91 30.07 0.00 -2.14 30.22 coo 23.62 58.48 37.29 23.51 60.61 36.65 3.24 7.14 40.85 1.59 8.67 40.89 ULMN 2 1uox_c00 URATE OXIDASE user 19 2 # 19 28 THR B 84 THR~? 20.78 ZN ZN B 118 76 PRO B 92 PRO.? 13.03 ZN ZN B 118 coo 16.78 65.34 48.92 15.62 64.41 47.34 -1.74 -0.91 30.07 0.00 -2.14 30.22 coo 23.62 58.48 37.29 23.51 60.61 36.65 -2.71 -1.87 43.94 -4.68 -2.92 43.60 1uox_c00 source 1uox URATE OXIDASE : 19 hits 1uox_c00 naa= 2 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 1 2 # 1 A 154 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 361 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 38.53 29.77 11.27 37.61 30.69 9.62 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 36.69 27.02 21.98 35.77 25.65 20.58 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1uqt_c00 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 2 2 # 2 A 154 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 361 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 38.53 29.77 11.27 37.61 30.69 9.62 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 36.69 27.02 21.98 35.77 25.65 20.58 -12.98 14.88 47.28 -12.40 12.90 47.92 1uqt_c00 source 1uqt ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTHASE : 2 hits 1uqt_c00 naa= 2 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 1 2 # 1 B 154 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 361 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1uqt_c01 ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTuser 2 2 # 2 B 154 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 361 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 25.86 -24.68 45.05 24.67 -25.16 46.70 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 25.49 -20.60 34.47 25.26 -19.12 36.06 -12.98 14.88 47.28 -12.40 12.90 47.92 1uqt_c01 source 1uqt ALPHA,ALPHA-TREHALOSE-PHOSPHATE SYNTHASE : 2 hits 1uqt_c01 naa= 2 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 1 2 # 1 A 86 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 164 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 9.32 71.14 66.67 9.35 73.22 66.22 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 10.68 80.16 70.30 11.55 80.13 67.63 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 2 2 # 2 A 86 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 164 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 9.32 71.14 66.67 9.35 73.22 66.22 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 10.68 80.16 70.30 11.55 80.13 67.63 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 3 2 # 3 A 86 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 164 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 9.32 71.14 66.67 9.35 73.22 66.22 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 10.68 80.16 70.30 11.55 80.13 67.63 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 4 2 # 4 A 86 ASP A 86 ASP~? 22.55 ZN ZN A 119 A 164 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 9.32 71.14 66.67 9.35 73.22 66.22 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 10.68 80.16 70.30 11.55 80.13 67.63 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 5 2 # 5 A 86 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 164 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 9.32 71.14 66.67 9.35 73.22 66.22 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 10.68 80.16 70.30 11.55 80.13 67.63 -7.61 10.49 27.32 -9.94 11.99 27.12 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 6 2 # 6 A 86 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 164 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 9.32 71.14 66.67 9.35 73.22 66.22 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 10.68 80.16 70.30 11.55 80.13 67.63 -4.17 2.05 38.57 -1.76 0.81 38.01 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 7 2 # 7 A 86 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 164 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 9.32 71.14 66.67 9.35 73.22 66.22 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 10.68 80.16 70.30 11.55 80.13 67.63 -4.17 2.05 38.57 -1.76 0.81 38.01 ULMN 2 1uro_c00 UROPORPHYRINOGEN DECARBOXYLASE user 8 2 # 8 A 86 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 164 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 9.32 71.14 66.67 9.35 73.22 66.22 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 10.68 80.16 70.30 11.55 80.13 67.63 -4.17 2.05 38.57 -1.76 0.81 38.01 1uro_c00 source 1uro UROPORPHYRINOGEN DECARBOXYLASE : 8 hits 1uro_c00 naa= 2 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 1 2 # 1 A 92 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 162 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 22.28 19.87 14.60 19.43 20.27 13.40 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 20.49 15.91 11.17 19.72 15.53 13.15 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 2 2 # 2 A 92 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 162 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 22.28 19.87 14.60 19.43 20.27 13.40 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 20.49 15.91 11.17 19.72 15.53 13.15 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 3 2 # 3 A 92 ARG A 44 ARG.? 16.49 O ACY A 121 A 162 GLU A 39 GLU^? 13.07 O ACY A 121 coo 22.28 19.87 14.60 19.43 20.27 13.40 6.31 22.16 46.81 4.95 24.70 47.95 coo 20.49 15.91 11.17 19.72 15.53 13.15 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 4 2 # 4 A 92 ARG A 90 ARG~? 21.28 ZN ZN A 119 A 162 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 22.28 19.87 14.60 19.43 20.27 13.40 -4.89 45.59 55.49 -2.75 44.62 57.47 coo 20.49 15.91 11.17 19.72 15.53 13.15 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 5 2 # 5 A 92 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 162 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 22.28 19.87 14.60 19.43 20.27 13.40 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 20.49 15.91 11.17 19.72 15.53 13.15 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 6 2 # 6 A 92 ARG B 44 ARG.? 18.52 O ACY A 121 A 162 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 22.28 19.87 14.60 19.43 20.27 13.40 6.69 16.72 49.11 8.85 18.83 48.43 coo 20.49 15.91 11.17 19.72 15.53 13.15 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1uw8_c02 OXALATE DECARBOXYLASE OXDC user 7 2 # 7 A 92 ARG B 90 ARG~? 22.74 ZN ZN B 118 A 162 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 22.28 19.87 14.60 19.43 20.27 13.40 -1.29 -8.08 37.25 0.33 -10.46 36.18 coo 20.49 15.91 11.17 19.72 15.53 13.15 -7.13 -6.28 33.53 -6.83 -7.93 32.24 1uw8_c02 source 1uw8 OXALATE DECARBOXYLASE OXDC : 7 hits 1uw8_c02 naa= 2 ULMN 2 1v25_c00 LONG-CHAIN-FATTY-ACID-COA SYNTHETASEuser 1 2 # 1 A 439 LYS A 40 LYS.? -3.18 C ACY A 121s A 444 TRP B 67 TRP~? 8.66 O ACY A 121 coo -0.26 64.22 156.87 2.65 58.72 157.59 1.80 21.48 38.21 -1.61 24.69 34.09 coo 3.93 62.21 161.01 0.25 60.87 160.66 2.75 16.18 40.14 -1.04 17.32 40.14 ULMN 2 1v25_c00 LONG-CHAIN-FATTY-ACID-COA SYNTHETASEuser 2 2 # 2 A 439 LYS B 40 LYS.? 4.59 ZN ZN A 118 A 444 TRP A 67 TRP~? 8.96 OXT ACY A 120 coo -0.26 64.22 156.87 2.65 58.72 157.59 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 3.93 62.21 161.01 0.25 60.87 160.66 0.44 21.10 54.22 -3.18 20.00 53.11 1v25_c00 source 1v25 LONG-CHAIN-FATTY-ACID-COA SYNTHETASE : 2 hits 1v25_c00 naa= 2 ULMN 2 1v25_c01 LONG-CHAIN-FATTY-ACID-COA SYNTHETASEuser 1 2 # 1 B 439 LYS A 40 LYS.? -3.18 C ACY A 121s B 444 TRP B 67 TRP~? 8.66 O ACY A 121 coo 23.39 6.36 151.97 20.82 11.81 153.70 1.80 21.48 38.21 -1.61 24.69 34.09 coo 21.20 8.21 157.57 24.35 9.59 155.65 2.75 16.18 40.14 -1.04 17.32 40.14 ULMN 2 1v25_c01 LONG-CHAIN-FATTY-ACID-COA SYNTHETASEuser 2 2 # 2 B 439 LYS B 40 LYS.? 4.59 ZN ZN A 118 B 444 TRP A 67 TRP~? 8.96 OXT ACY A 120 coo 23.39 6.36 151.97 20.82 11.81 153.70 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 21.20 8.21 157.57 24.35 9.59 155.65 0.44 21.10 54.22 -3.18 20.00 53.11 1v25_c01 source 1v25 LONG-CHAIN-FATTY-ACID-COA SYNTHETASE : 2 hits 1v25_c01 naa= 2 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 1 2 # 1 144 LYS A 16 LYS~? -3.27 O ACY A 120s 199 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo -16.96 58.67 52.82 -20.37 61.54 50.53 -12.18 15.96 51.84 -12.69 14.73 56.98 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 2 2 # 2 144 LYS A 16 LYS~? -3.27 O ACY A 120s 199 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -12.18 15.96 51.84 -12.69 14.73 56.98 coo -29.64 64.57 49.45 -27.60 64.41 50.00 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 3 2 # 3 144 LYS A 29 LYS^? 13.52 CH3 ACY A 120 199 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo -16.96 58.67 52.82 -20.37 61.54 50.53 -16.25 29.91 61.58 -19.73 26.30 57.65 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 4 2 # 4 144 LYS A 29 LYS^? 13.52 CH3 ACY A 120 199 GLU A 75 GLU.? 14.61 ZN ZN A 118 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -16.25 29.91 61.58 -19.73 26.30 57.65 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -11.14 20.14 70.42 -10.69 21.09 72.30 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 5 2 # 5 144 LYS A 29 LYS^? 13.52 CH3 ACY A 120 199 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -16.25 29.91 61.58 -19.73 26.30 57.65 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 6 2 # 6 144 LYS A 40 LYS.? -3.18 C ACY A 121s 199 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -16.96 58.67 52.82 -20.37 61.54 50.53 1.80 21.48 38.21 -1.61 24.69 34.09 coo -29.64 64.57 49.45 -27.60 64.41 50.00 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 7 2 # 7 144 LYS A 71 LYS^? 11.96 OXT ACY A 120 199 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo -16.96 58.67 52.82 -20.37 61.54 50.53 -4.35 22.91 61.78 1.12 23.33 62.25 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 8 2 # 8 144 LYS A 71 LYS^? 11.96 OXT ACY A 120 199 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -4.35 22.91 61.78 1.12 23.33 62.25 coo -29.64 64.57 49.45 -27.60 64.41 50.00 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 9 2 # 9 144 LYS A 93 LYS.? 17.16 ZN ZN A 119 199 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo -16.96 58.67 52.82 -20.37 61.54 50.53 -8.24 41.47 45.26 -7.63 47.05 46.72 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 10 2 # 10 144 LYS A 93 LYS.? 17.16 ZN ZN A 119 199 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -8.24 41.47 45.26 -7.63 47.05 46.72 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 11 2 # 11 144 LYS A 93 LYS.? 17.16 ZN ZN A 119 199 GLU A 99 GLU.? 20.42 CH3 ACY A 121 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -8.24 41.47 45.26 -7.63 47.05 46.72 coo -29.64 64.57 49.45 -27.60 64.41 50.00 4.40 42.94 40.00 4.87 41.71 38.33 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 12 2 # 12 144 LYS A 93 LYS.? 17.16 ZN ZN A 119 199 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo -16.96 58.67 52.82 -20.37 61.54 50.53 -8.24 41.47 45.26 -7.63 47.05 46.72 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 13 2 # 13 144 LYS B 10 LYS.? 9.83 CH3 ACY A 121 199 GLU A 99 GLU.? 20.42 CH3 ACY A 121 coo -16.96 58.67 52.82 -20.37 61.54 50.53 2.14 27.03 37.15 7.00 28.76 35.76 coo -29.64 64.57 49.45 -27.60 64.41 50.00 4.40 42.94 40.00 4.87 41.71 38.33 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 14 2 # 14 144 LYS B 16 LYS~? -4.10 OXT ACY B 120s 199 GLU A 39 GLU^? 13.07 O ACY A 121 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -10.13 21.11 38.47 -9.52 22.58 33.19 coo -29.64 64.57 49.45 -27.60 64.41 50.00 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 15 2 # 15 144 LYS B 16 LYS~? -4.10 OXT ACY B 120s 199 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo -16.96 58.67 52.82 -20.37 61.54 50.53 -10.13 21.11 38.47 -9.52 22.58 33.19 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 16 2 # 16 144 LYS B 29 LYS^? 13.36 ZN ZN B 118 199 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo -16.96 58.67 52.82 -20.37 61.54 50.53 -10.40 7.25 27.78 -14.86 10.45 31.09 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 17 2 # 17 144 LYS B 29 LYS^? 13.36 ZN ZN B 118 199 GLU B 75 GLU.? 13.95 OXT ACY A 121 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -10.40 7.25 27.78 -14.86 10.45 31.09 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -3.38 17.56 20.48 -2.28 16.44 19.03 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 18 2 # 18 144 LYS B 29 LYS^? 13.36 ZN ZN B 118 199 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -10.40 7.25 27.78 -14.86 10.45 31.09 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -7.13 -6.28 33.53 -6.83 -7.93 32.24 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 19 2 # 19 144 LYS B 40 LYS.? 4.59 ZN ZN A 118 199 GLU A 39 GLU^? 13.07 O ACY A 121 coo -16.96 58.67 52.82 -20.37 61.54 50.53 -0.91 15.74 55.76 -5.29 12.34 58.61 coo -29.64 64.57 49.45 -27.60 64.41 50.00 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 20 2 # 20 144 LYS B 71 LYS^? 12.90 O ACY A 121 199 GLU A 39 GLU^? 13.07 O ACY A 121 coo -16.96 58.67 52.82 -20.37 61.54 50.53 0.91 14.36 31.66 5.84 10.91 29.66 coo -29.64 64.57 49.45 -27.60 64.41 50.00 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 21 2 # 21 144 LYS B 71 LYS^? 12.90 O ACY A 121 199 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo -16.96 58.67 52.82 -20.37 61.54 50.53 0.91 14.36 31.66 5.84 10.91 29.66 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1vid_c00 CATECHOL O-METHYLTRANSFERASE user 22 2 # 22 144 LYS B 71 LYS^? 12.90 O ACY A 121 199 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo -16.96 58.67 52.82 -20.37 61.54 50.53 0.91 14.36 31.66 5.84 10.91 29.66 coo -29.64 64.57 49.45 -27.60 64.41 50.00 -8.23 3.75 25.31 -7.96 1.78 24.56 1vid_c00 source 1vid CATECHOL O-METHYLTRANSFERASE : 22 hits 1vid_c00 naa= 2 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 1 2 # 1 A 501 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 869 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 2 2 # 2 A 501 ARG A 44 ARG.? 16.49 O ACY A 121 A 869 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 6.31 22.16 46.81 4.95 24.70 47.95 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 3 2 # 3 A 501 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 869 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 4 2 # 4 A 501 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 869 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 42.01 -29.51 34.21 41.36 -31.37 31.85 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1vlb_c01 ALDEHYDE OXIDOREDUCTASE user 5 2 # 5 A 501 ARG B 44 ARG.? 18.52 O ACY A 121 A 869 GLU A 39 GLU^? 13.07 O ACY A 121 coo 42.01 -29.51 34.21 41.36 -31.37 31.85 6.69 16.72 49.11 8.85 18.83 48.43 coo 47.42 -23.08 29.80 45.97 -24.60 29.62 3.97 24.42 42.90 6.03 24.50 43.46 1vlb_c01 source 1vlb ALDEHYDE OXIDOREDUCTASE : 5 hits 1vlb_c01 naa= 2 ULMN 2 1vnc_c00 VANADIUM-CONTAINING CHLOROPEROXIDASEuser 1 2 # 1 353 LYS A 16 LYS~? -3.27 O ACY A 120s 404 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo -19.07 26.71 -0.11 -18.94 21.35 0.28 -12.18 15.96 51.84 -12.69 14.73 56.98 coo -22.51 13.48 0.87 -21.91 12.34 -0.78 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1vnc_c00 VANADIUM-CONTAINING CHLOROPEROXIDASEuser 2 2 # 2 353 LYS B 16 LYS~? -4.10 OXT ACY B 120s 404 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo -19.07 26.71 -0.11 -18.94 21.35 0.28 -10.13 21.11 38.47 -9.52 22.58 33.19 coo -22.51 13.48 0.87 -21.91 12.34 -0.78 -11.17 33.63 46.78 -12.74 33.06 45.52 1vnc_c00 source 1vnc VANADIUM-CONTAINING CHLOROPEROXIDASE : 2 hits 1vnc_c00 naa= 2 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 2 # 1 A 151 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 197 ASN A 73 ASN^? 11.43 OXT ACY A 120 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -9.59 22.33 65.64 -10.09 22.46 67.69 ULMN 2 1vq1_c02 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 2 # 2 A 151 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 197 ASN B 73 ASN^? 10.74 OXT ACY A 121 coo 11.44 -10.39 31.15 9.67 -9.38 30.57 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 6.86 -1.03 36.13 5.08 -0.39 35.24 -2.85 14.93 26.35 -2.72 14.72 24.20 1vq1_c02 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 2 hits 1vq1_c02 naa= 2 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 1 2 # 1 B 151 ASP A 26 ASP.? 19.54 CH3 ACY A 120 B 197 ASN A 73 ASN^? 11.43 OXT ACY A 120 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -9.59 22.33 65.64 -10.09 22.46 67.69 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 2 2 # 2 B 151 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 197 ASN B 6 ASN.? 8.30 OXT ACY B 120 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -9.87 26.28 39.29 -10.81 26.02 37.42 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 3 2 # 3 B 151 ASP B 26 ASP.? 19.38 CH3 ACY B 120 B 197 ASN B 73 ASN^? 10.74 OXT ACY A 121 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -2.85 14.93 26.35 -2.72 14.72 24.20 ULMN 2 1vq1_c03 N5-GLUTAMINE METHYLTRANSFERASE, HEMKuser 4 2 # 4 B 151 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 197 ASN A 6 ASN.? 7.96 O ACY A 120 coo 22.17 -6.30 1.54 20.43 -7.30 0.84 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 21.71 -15.65 -5.30 19.75 -16.44 -5.47 -11.99 10.76 51.07 -13.19 11.09 52.81 1vq1_c03 source 1vq1 N5-GLUTAMINE METHYLTRANSFERASE, HEMK : 4 hits 1vq1_c03 naa= 2 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 1 2 # 1 A 136 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 293 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 9.79 77.23 39.90 9.95 75.15 39.48 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 8.49 71.12 42.20 8.38 69.13 41.54 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 2 2 # 2 A 136 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 293 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 9.79 77.23 39.90 9.95 75.15 39.48 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 8.49 71.12 42.20 8.38 69.13 41.54 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 3 2 # 3 A 136 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 293 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 9.79 77.23 39.90 9.95 75.15 39.48 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 8.49 71.12 42.20 8.38 69.13 41.54 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1w0h_c00 3-5 EXONUCLEASE ERI1 user 4 2 # 4 A 136 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 293 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 9.79 77.23 39.90 9.95 75.15 39.48 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 8.49 71.12 42.20 8.38 69.13 41.54 -10.33 3.56 43.54 -12.07 4.44 44.29 1w0h_c00 source 1w0h 3-5 EXONUCLEASE ERI1 : 4 hits 1w0h_c00 naa= 2 ULMN 2 1w27_c00 PHENYLALANINE AMMONIA-LYASE 1 user 1 2 # 1 A 400 PHE A 52 PHE^? 9.40 ZN ZN A 119 B 351 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 18.03 16.65 31.65 16.97 14.73 33.36 -13.64 35.13 53.79 -11.95 37.28 53.18 coo 12.26 15.31 35.10 13.20 15.01 32.53 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1w27_c00 PHENYLALANINE AMMONIA-LYASE 1 user 2 2 # 2 A 400 PHE B 52 PHE^? 9.45 ZN ZN B 118 B 351 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 18.03 16.65 31.65 16.97 14.73 33.36 -10.22 1.91 36.10 -8.88 -0.23 37.26 coo 12.26 15.31 35.10 13.20 15.01 32.53 -4.17 2.05 38.57 -1.76 0.81 38.01 1w27_c00 source 1w27 PHENYLALANINE AMMONIA-LYASE 1 : 2 hits 1w27_c00 naa= 2 ULMN 2 1w27_c02 PHENYLALANINE AMMONIA-LYASE 1 user 1 2 # 1 A 400 PHE A 52 PHE^? 9.40 ZN ZN A 119 B 351 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 18.03 16.65 31.65 16.97 14.73 33.36 -13.64 35.13 53.79 -11.95 37.28 53.18 coo 12.26 15.31 35.10 13.20 15.01 32.53 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1w27_c02 PHENYLALANINE AMMONIA-LYASE 1 user 2 2 # 2 A 400 PHE B 52 PHE^? 9.45 ZN ZN B 118 B 351 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 18.03 16.65 31.65 16.97 14.73 33.36 -10.22 1.91 36.10 -8.88 -0.23 37.26 coo 12.26 15.31 35.10 13.20 15.01 32.53 -4.17 2.05 38.57 -1.76 0.81 38.01 1w27_c02 source 1w27 PHENYLALANINE AMMONIA-LYASE 1 : 2 hits 1w27_c02 naa= 2 ULMN 2 1wnw_c00 HEME OXYGENASE user 1 2 # 1 A 136 ASN A 6 ASN.? 7.96 O ACY A 120 A 140 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -11.99 10.76 51.07 -13.19 11.09 52.81 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1wnw_c00 HEME OXYGENASE user 2 2 # 2 A 136 ASN A 73 ASN^? 11.43 OXT ACY A 120 A 140 GLY A 77 GLY.? 7.71 O ACY A 120 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -9.59 22.33 65.64 -10.09 22.46 67.69 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -14.40 19.56 63.33 -14.08 20.34 63.32 ULMN 2 1wnw_c00 HEME OXYGENASE user 3 2 # 3 A 136 ASN A 73 ASN^? 11.43 OXT ACY A 120 A 140 GLY A 78 GLY^? 6.33 CH3 ACY A 120 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -9.59 22.33 65.64 -10.09 22.46 67.69 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -12.40 21.69 60.91 -11.92 21.55 61.59 ULMN 2 1wnw_c00 HEME OXYGENASE user 4 2 # 4 A 136 ASN B 6 ASN.? 8.30 OXT ACY B 120 A 140 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -9.87 26.28 39.29 -10.81 26.02 37.42 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 2 1wnw_c00 HEME OXYGENASE user 5 2 # 5 A 136 ASN B 73 ASN^? 10.74 OXT ACY A 121 A 140 GLY B 77 GLY.? 7.77 OXT ACY B 120 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -2.85 14.93 26.35 -2.72 14.72 24.20 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -8.24 17.31 26.84 -7.89 16.59 26.97 ULMN 2 1wnw_c00 HEME OXYGENASE user 6 2 # 6 A 136 ASN B 73 ASN^? 10.74 OXT ACY A 121 A 140 GLY B 78 GLY^? 6.35 CH3 ACY B 120 coo 27.07 -2.54 -4.25 26.56 -2.21 -6.33 -2.85 14.93 26.35 -2.72 14.72 24.20 coo 25.46 -6.68 -6.61 25.84 -7.38 -6.84 -7.09 15.30 29.87 -6.41 15.40 29.36 1wnw_c00 source 1wnw HEME OXYGENASE : 6 hits 1wnw_c00 naa= 2 ULMN 2 1wnw_c01 HEME OXYGENASE user 1 2 # 1 B 136 ASN A 6 ASN.? 7.96 O ACY A 120 B 140 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo 10.41 13.55 22.30 12.49 13.88 22.44 -11.99 10.76 51.07 -13.19 11.09 52.81 coo 12.77 16.12 18.53 12.82 15.99 17.73 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1wnw_c01 HEME OXYGENASE user 2 2 # 2 B 136 ASN A 73 ASN^? 11.43 OXT ACY A 120 B 140 GLY A 77 GLY.? 7.71 O ACY A 120 coo 10.41 13.55 22.30 12.49 13.88 22.44 -9.59 22.33 65.64 -10.09 22.46 67.69 coo 12.77 16.12 18.53 12.82 15.99 17.73 -14.40 19.56 63.33 -14.08 20.34 63.32 ULMN 2 1wnw_c01 HEME OXYGENASE user 3 2 # 3 B 136 ASN A 73 ASN^? 11.43 OXT ACY A 120 B 140 GLY A 78 GLY^? 6.33 CH3 ACY A 120 coo 10.41 13.55 22.30 12.49 13.88 22.44 -9.59 22.33 65.64 -10.09 22.46 67.69 coo 12.77 16.12 18.53 12.82 15.99 17.73 -12.40 21.69 60.91 -11.92 21.55 61.59 ULMN 2 1wnw_c01 HEME OXYGENASE user 4 2 # 4 B 136 ASN B 6 ASN.? 8.30 OXT ACY B 120 B 140 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo 10.41 13.55 22.30 12.49 13.88 22.44 -9.87 26.28 39.29 -10.81 26.02 37.42 coo 12.77 16.12 18.53 12.82 15.99 17.73 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 2 1wnw_c01 HEME OXYGENASE user 5 2 # 5 B 136 ASN B 73 ASN^? 10.74 OXT ACY A 121 B 140 GLY B 77 GLY.? 7.77 OXT ACY B 120 coo 10.41 13.55 22.30 12.49 13.88 22.44 -2.85 14.93 26.35 -2.72 14.72 24.20 coo 12.77 16.12 18.53 12.82 15.99 17.73 -8.24 17.31 26.84 -7.89 16.59 26.97 ULMN 2 1wnw_c01 HEME OXYGENASE user 6 2 # 6 B 136 ASN B 73 ASN^? 10.74 OXT ACY A 121 B 140 GLY B 78 GLY^? 6.35 CH3 ACY B 120 coo 10.41 13.55 22.30 12.49 13.88 22.44 -2.85 14.93 26.35 -2.72 14.72 24.20 coo 12.77 16.12 18.53 12.82 15.99 17.73 -7.09 15.30 29.87 -6.41 15.40 29.36 1wnw_c01 source 1wnw HEME OXYGENASE : 6 hits 1wnw_c01 naa= 2 ULMN 2 1wnw_c02 HEME OXYGENASE user 1 2 # 1 C 136 ASN A 6 ASN.? 7.96 O ACY A 120 C 140 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo 26.63 1.54 53.35 24.49 1.91 53.34 -11.99 10.76 51.07 -13.19 11.09 52.81 coo 23.86 0.66 57.49 23.81 0.02 58.00 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1wnw_c02 HEME OXYGENASE user 2 2 # 2 C 136 ASN A 73 ASN^? 11.43 OXT ACY A 120 C 140 GLY A 77 GLY.? 7.71 O ACY A 120 coo 26.63 1.54 53.35 24.49 1.91 53.34 -9.59 22.33 65.64 -10.09 22.46 67.69 coo 23.86 0.66 57.49 23.81 0.02 58.00 -14.40 19.56 63.33 -14.08 20.34 63.32 ULMN 2 1wnw_c02 HEME OXYGENASE user 3 2 # 3 C 136 ASN A 73 ASN^? 11.43 OXT ACY A 120 C 140 GLY A 78 GLY^? 6.33 CH3 ACY A 120 coo 26.63 1.54 53.35 24.49 1.91 53.34 -9.59 22.33 65.64 -10.09 22.46 67.69 coo 23.86 0.66 57.49 23.81 0.02 58.00 -12.40 21.69 60.91 -11.92 21.55 61.59 ULMN 2 1wnw_c02 HEME OXYGENASE user 4 2 # 4 C 136 ASN B 6 ASN.? 8.30 OXT ACY B 120 C 140 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo 26.63 1.54 53.35 24.49 1.91 53.34 -9.87 26.28 39.29 -10.81 26.02 37.42 coo 23.86 0.66 57.49 23.81 0.02 58.00 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 2 1wnw_c02 HEME OXYGENASE user 5 2 # 5 C 136 ASN B 73 ASN^? 10.74 OXT ACY A 121 C 140 GLY B 77 GLY.? 7.77 OXT ACY B 120 coo 26.63 1.54 53.35 24.49 1.91 53.34 -2.85 14.93 26.35 -2.72 14.72 24.20 coo 23.86 0.66 57.49 23.81 0.02 58.00 -8.24 17.31 26.84 -7.89 16.59 26.97 ULMN 2 1wnw_c02 HEME OXYGENASE user 6 2 # 6 C 136 ASN B 73 ASN^? 10.74 OXT ACY A 121 C 140 GLY B 78 GLY^? 6.35 CH3 ACY B 120 coo 26.63 1.54 53.35 24.49 1.91 53.34 -2.85 14.93 26.35 -2.72 14.72 24.20 coo 23.86 0.66 57.49 23.81 0.02 58.00 -7.09 15.30 29.87 -6.41 15.40 29.36 1wnw_c02 source 1wnw HEME OXYGENASE : 6 hits 1wnw_c02 naa= 2 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 1 2 # 1 A 56 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 228 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 27.49 35.40 20.60 28.62 36.02 22.28 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 33.88 38.22 25.20 34.46 38.14 23.17 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 2 2 # 2 A 56 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 228 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 27.49 35.40 20.60 28.62 36.02 22.28 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 33.88 38.22 25.20 34.46 38.14 23.17 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 3 2 # 3 A 56 GLU A 28 GLU.? 19.71 ZN ZN A 119 A 228 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 27.49 35.40 20.60 28.62 36.02 22.28 -17.43 33.27 64.86 -17.71 35.42 64.60 coo 33.88 38.22 25.20 34.46 38.14 23.17 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 4 2 # 4 A 56 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 228 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 27.49 35.40 20.60 28.62 36.02 22.28 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 33.88 38.22 25.20 34.46 38.14 23.17 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 5 2 # 5 A 56 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 228 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 27.49 35.40 20.60 28.62 36.02 22.28 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 33.88 38.22 25.20 34.46 38.14 23.17 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 6 2 # 6 A 56 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 228 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 27.49 35.40 20.60 28.62 36.02 22.28 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 33.88 38.22 25.20 34.46 38.14 23.17 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 7 2 # 7 A 56 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 228 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 27.49 35.40 20.60 28.62 36.02 22.28 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 33.88 38.22 25.20 34.46 38.14 23.17 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 8 2 # 8 A 56 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 228 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 27.49 35.40 20.60 28.62 36.02 22.28 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 33.88 38.22 25.20 34.46 38.14 23.17 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 9 2 # 9 A 56 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 228 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 27.49 35.40 20.60 28.62 36.02 22.28 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 33.88 38.22 25.20 34.46 38.14 23.17 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 10 2 # 10 A 56 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 228 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 27.49 35.40 20.60 28.62 36.02 22.28 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 33.88 38.22 25.20 34.46 38.14 23.17 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 1x7d_c00 ORNITHINE CYCLODEAMINASE user 11 2 # 11 A 56 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 228 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 27.49 35.40 20.60 28.62 36.02 22.28 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 33.88 38.22 25.20 34.46 38.14 23.17 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1x7d_c00 source 1x7d ORNITHINE CYCLODEAMINASE : 11 hits 1x7d_c00 naa= 2 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 1 2 # 1 B 56 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 228 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 8.97 35.22 21.27 7.95 33.38 21.10 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 2.71 29.91 19.58 2.03 31.89 19.36 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 2 2 # 2 B 56 GLU A 4 GLU.? -2.10 ZN ZN B 118s B 228 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 8.97 35.22 21.27 7.95 33.38 21.10 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 2.71 29.91 19.58 2.03 31.89 19.36 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 3 2 # 3 B 56 GLU A 28 GLU.? 19.71 ZN ZN A 119 B 228 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 8.97 35.22 21.27 7.95 33.38 21.10 -17.43 33.27 64.86 -17.71 35.42 64.60 coo 2.71 29.91 19.58 2.03 31.89 19.36 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 4 2 # 4 B 56 GLU A 34 GLU^? -2.26 ZN ZN A 119s B 228 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 8.97 35.22 21.27 7.95 33.38 21.10 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 2.71 29.91 19.58 2.03 31.89 19.36 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 5 2 # 5 B 56 GLU A 34 GLU^? -2.26 ZN ZN A 119s B 228 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 8.97 35.22 21.27 7.95 33.38 21.10 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 2.71 29.91 19.58 2.03 31.89 19.36 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 6 2 # 6 B 56 GLU A 89 GLU~? 19.37 ZN ZN A 119 B 228 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 8.97 35.22 21.27 7.95 33.38 21.10 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 2.71 29.91 19.58 2.03 31.89 19.36 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 7 2 # 7 B 56 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 228 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 8.97 35.22 21.27 7.95 33.38 21.10 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 2.71 29.91 19.58 2.03 31.89 19.36 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 8 2 # 8 B 56 GLU B 4 GLU.? -2.30 ZN ZN A 119s B 228 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 8.97 35.22 21.27 7.95 33.38 21.10 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 2.71 29.91 19.58 2.03 31.89 19.36 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 9 2 # 9 B 56 GLU B 34 GLU.? -2.23 ZN ZN B 118s B 228 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 8.97 35.22 21.27 7.95 33.38 21.10 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 2.71 29.91 19.58 2.03 31.89 19.36 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 10 2 # 10 B 56 GLU B 34 GLU.? -2.23 ZN ZN B 118s B 228 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 8.97 35.22 21.27 7.95 33.38 21.10 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 2.71 29.91 19.58 2.03 31.89 19.36 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 1x7d_c01 ORNITHINE CYCLODEAMINASE user 11 2 # 11 B 56 GLU B 89 GLU~? 19.03 ZN ZN B 118 B 228 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 8.97 35.22 21.27 7.95 33.38 21.10 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 2.71 29.91 19.58 2.03 31.89 19.36 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1x7d_c01 source 1x7d ORNITHINE CYCLODEAMINASE : 11 hits 1x7d_c01 naa= 2 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 1 2 # 1 A 165 SER A 14 SER~? 11.41 CH3 ACY A 120 A 187 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 8.34 44.73 23.71 9.07 45.54 21.52 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 6.50 51.89 29.29 8.22 51.77 30.59 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 2 2 # 2 A 165 SER A 14 SER~? 11.41 CH3 ACY A 120 A 187 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 8.34 44.73 23.71 9.07 45.54 21.52 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 6.50 51.89 29.29 8.22 51.77 30.59 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 3 2 # 3 A 165 SER A 32 SER^? 8.89 ZN ZN A 119 A 187 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 8.34 44.73 23.71 9.07 45.54 21.52 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 6.50 51.89 29.29 8.22 51.77 30.59 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 4 2 # 4 A 165 SER A 51 SER^? 4.15 ZN ZN A 119 A 187 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 8.34 44.73 23.71 9.07 45.54 21.52 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 6.50 51.89 29.29 8.22 51.77 30.59 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 5 2 # 5 A 165 SER B 14 SER~? 11.46 CH3 ACY B 120 A 187 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 8.34 44.73 23.71 9.07 45.54 21.52 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 6.50 51.89 29.29 8.22 51.77 30.59 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 6 2 # 6 A 165 SER B 14 SER~? 11.46 CH3 ACY B 120 A 187 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 8.34 44.73 23.71 9.07 45.54 21.52 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 6.50 51.89 29.29 8.22 51.77 30.59 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 7 2 # 7 A 165 SER B 32 SER^? 8.58 ZN ZN B 118 A 187 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 8.34 44.73 23.71 9.07 45.54 21.52 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 6.50 51.89 29.29 8.22 51.77 30.59 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1xgm_c00 METHIONINE AMINOPEPTIDASE user 8 2 # 8 A 165 SER B 51 SER^? 4.27 ZN ZN B 118 A 187 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 8.34 44.73 23.71 9.07 45.54 21.52 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 6.50 51.89 29.29 8.22 51.77 30.59 -15.62 6.11 47.30 -14.46 5.85 45.55 1xgm_c00 source 1xgm METHIONINE AMINOPEPTIDASE : 8 hits 1xgm_c00 naa= 2 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 1 2 # 1 B 165 SER A 14 SER~? 11.41 CH3 ACY A 120 B 187 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 12.53 42.28 15.16 11.35 44.10 16.30 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 12.85 44.05 6.07 11.44 42.52 5.44 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 2 2 # 2 B 165 SER A 14 SER~? 11.41 CH3 ACY A 120 B 187 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 12.53 42.28 15.16 11.35 44.10 16.30 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 12.85 44.05 6.07 11.44 42.52 5.44 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 3 2 # 3 B 165 SER A 32 SER^? 8.89 ZN ZN A 119 B 187 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 12.53 42.28 15.16 11.35 44.10 16.30 -14.23 26.97 54.31 -16.02 26.35 52.81 coo 12.85 44.05 6.07 11.44 42.52 5.44 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 4 2 # 4 B 165 SER A 51 SER^? 4.15 ZN ZN A 119 B 187 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 12.53 42.28 15.16 11.35 44.10 16.30 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 12.85 44.05 6.07 11.44 42.52 5.44 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 5 2 # 5 B 165 SER B 14 SER~? 11.46 CH3 ACY B 120 B 187 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 12.53 42.28 15.16 11.35 44.10 16.30 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 12.85 44.05 6.07 11.44 42.52 5.44 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 6 2 # 6 B 165 SER B 14 SER~? 11.46 CH3 ACY B 120 B 187 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 12.53 42.28 15.16 11.35 44.10 16.30 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 12.85 44.05 6.07 11.44 42.52 5.44 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 7 2 # 7 B 165 SER B 32 SER^? 8.58 ZN ZN B 118 B 187 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 12.53 42.28 15.16 11.35 44.10 16.30 -11.02 10.19 35.41 -13.14 10.52 36.50 coo 12.85 44.05 6.07 11.44 42.52 5.44 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1xgm_c01 METHIONINE AMINOPEPTIDASE user 8 2 # 8 B 165 SER B 51 SER^? 4.27 ZN ZN B 118 B 187 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 12.53 42.28 15.16 11.35 44.10 16.30 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 12.85 44.05 6.07 11.44 42.52 5.44 -15.62 6.11 47.30 -14.46 5.85 45.55 1xgm_c01 source 1xgm METHIONINE AMINOPEPTIDASE : 8 hits 1xgm_c01 naa= 2 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 1 2 # 1 A 242 ALA A 21 ALA^? 9.29 CH3 ACY A 120 A 243 THR A 20 THR.? 4.16 CH3 ACY A 120 coo 7.23 22.00 24.48 6.68 23.42 24.57 -14.76 24.38 57.77 -15.72 24.16 58.96 coo 9.58 21.79 21.50 11.25 23.03 20.90 -13.83 21.70 55.31 -12.29 20.44 56.16 ULMN 2 1xqd_c00 CYTOCHROME P450 55A1 user 2 2 # 2 A 242 ALA B 21 ALA^? 9.36 CH3 ACY B 120 A 243 THR B 20 THR.? 4.10 CH3 ACY B 120 coo 7.23 22.00 24.48 6.68 23.42 24.57 -10.37 12.66 32.04 -10.93 12.80 30.64 coo 9.58 21.79 21.50 11.25 23.03 20.90 -10.29 15.42 34.68 -8.60 16.74 34.44 1xqd_c00 source 1xqd CYTOCHROME P450 55A1 : 2 hits 1xqd_c00 naa= 2 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 1 2 # 1 A 286 SER A 14 SER~? 11.41 CH3 ACY A 120 A 393 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 13.16 26.08 17.48 14.86 26.70 19.08 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 8.26 27.79 16.87 9.99 28.97 17.08 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 2 2 # 2 A 286 SER A 51 SER^? 4.15 ZN ZN A 119 A 393 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 13.16 26.08 17.48 14.86 26.70 19.08 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 8.26 27.79 16.87 9.99 28.97 17.08 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 3 2 # 3 A 286 SER A 51 SER^? 4.15 ZN ZN A 119 A 393 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 13.16 26.08 17.48 14.86 26.70 19.08 -13.42 31.14 50.76 -15.54 30.86 49.58 coo 8.26 27.79 16.87 9.99 28.97 17.08 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 4 2 # 4 A 286 SER B 14 SER~? 11.46 CH3 ACY B 120 A 393 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 13.16 26.08 17.48 14.86 26.70 19.08 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 8.26 27.79 16.87 9.99 28.97 17.08 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 5 2 # 5 A 286 SER B 51 SER^? 4.27 ZN ZN B 118 A 393 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 13.16 26.08 17.48 14.86 26.70 19.08 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 8.26 27.79 16.87 9.99 28.97 17.08 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 1xqd_c01 CYTOCHROME P450 55A1 user 6 2 # 6 A 286 SER B 51 SER^? 4.27 ZN ZN B 118 A 393 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 13.16 26.08 17.48 14.86 26.70 19.08 -11.41 5.84 39.04 -13.87 6.10 39.28 coo 8.26 27.79 16.87 9.99 28.97 17.08 -11.52 -0.56 39.66 -12.44 -2.44 39.86 1xqd_c01 source 1xqd CYTOCHROME P450 55A1 : 6 hits 1xqd_c01 naa= 2 ULMN 2 1xrs_c01 D-LYSINE 5,6-AMINOMUTASE BETA SUBUNIuser 1 2 # 1 B 131 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 133 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 81.14 48.06 68.84 80.66 49.22 70.52 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 78.80 48.83 73.93 80.34 49.02 75.34 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1xrs_c01 D-LYSINE 5,6-AMINOMUTASE BETA SUBUNIuser 2 2 # 2 B 131 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 133 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 81.14 48.06 68.84 80.66 49.22 70.52 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 78.80 48.83 73.93 80.34 49.02 75.34 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 1xrs_c01 D-LYSINE 5,6-AMINOMUTASE BETA SUBUNIuser 3 2 # 3 B 131 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 133 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 81.14 48.06 68.84 80.66 49.22 70.52 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 78.80 48.83 73.93 80.34 49.02 75.34 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1xrs_c01 D-LYSINE 5,6-AMINOMUTASE BETA SUBUNIuser 4 2 # 4 B 131 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 133 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 81.14 48.06 68.84 80.66 49.22 70.52 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 78.80 48.83 73.93 80.34 49.02 75.34 -10.33 3.56 43.54 -12.07 4.44 44.29 1xrs_c01 source 1xrs D-LYSINE 5,6-AMINOMUTASE BETA SUBUNIT : 4 hits 1xrs_c01 naa= 2 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 A 128 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 130 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 A 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 130 GLY A 24 GLY.? 15.19 CH3 ACY A 120 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -10.32 31.44 63.56 -10.61 30.81 64.05 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 A 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 130 GLY A 27 GLY.? 16.01 CH3 ACY A 120 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -13.31 29.37 67.32 -13.49 30.12 67.06 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 A 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 A 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 130 GLY A 54 GLY.? 9.09 ZN ZN A 119 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -21.24 35.01 50.29 -20.80 34.52 50.80 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 A 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 130 GLY A 57 GLY.? 4.30 ZN ZN A 119 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -18.19 30.32 43.90 -18.50 30.85 44.43 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 A 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 2 # 8 A 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 2 # 9 A 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 2 # 10 A 128 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 130 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 2 # 11 A 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 130 GLY B 24 GLY.? 15.12 CH3 ACY B 120 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -4.03 5.76 27.94 -4.16 6.37 27.38 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 2 # 12 A 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 130 GLY B 27 GLY.? 15.88 CH3 ACY B 120 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -5.69 8.07 23.28 -5.94 7.34 23.49 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 2 # 13 A 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 2 # 14 A 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 2 # 15 A 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 130 GLY B 57 GLY.? -3.44 ZN ZN B 118s coo -16.14 7.55 9.89 -16.27 5.86 11.13 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -17.31 6.32 43.48 -17.60 5.82 42.91 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 2 # 16 A 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -18.86 0.25 41.49 -18.36 0.89 41.57 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 2 # 17 A 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 2 # 18 A 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c00 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 2 # 19 A 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo -16.14 7.55 9.89 -16.27 5.86 11.13 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -17.69 11.71 5.97 -16.98 11.70 6.47 -18.86 0.25 41.49 -18.36 0.89 41.57 1xs1_c00 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 19 hits 1xs1_c00 naa= 2 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 B 128 ASP A 15 ASP~? 8.61 ZN ZN B 118 B 130 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo 8.08 5.58 9.89 6.73 6.58 11.12 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 12.76 4.19 5.97 12.32 3.80 6.57 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 B 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 B 130 GLY A 24 GLY.? 15.19 CH3 ACY A 120 coo 8.08 5.58 9.89 6.73 6.58 11.12 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 12.76 4.19 5.97 12.32 3.80 6.57 -10.32 31.44 63.56 -10.61 30.81 64.05 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 B 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 B 130 GLY A 27 GLY.? 16.01 CH3 ACY A 120 coo 8.08 5.58 9.89 6.73 6.58 11.12 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 12.76 4.19 5.97 12.32 3.80 6.57 -13.31 29.37 67.32 -13.49 30.12 67.06 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 B 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo 8.08 5.58 9.89 6.73 6.58 11.12 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 12.76 4.19 5.97 12.32 3.80 6.57 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 B 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 130 GLY A 54 GLY.? 9.09 ZN ZN A 119 coo 8.08 5.58 9.89 6.73 6.58 11.12 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 12.76 4.19 5.97 12.32 3.80 6.57 -21.24 35.01 50.29 -20.80 34.52 50.80 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 B 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 130 GLY A 57 GLY.? 4.30 ZN ZN A 119 coo 8.08 5.58 9.89 6.73 6.58 11.12 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 12.76 4.19 5.97 12.32 3.80 6.57 -18.19 30.32 43.90 -18.50 30.85 44.43 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 B 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo 8.08 5.58 9.89 6.73 6.58 11.12 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 12.76 4.19 5.97 12.32 3.80 6.57 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 2 # 8 B 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo 8.08 5.58 9.89 6.73 6.58 11.12 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 12.76 4.19 5.97 12.32 3.80 6.57 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 2 # 9 B 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 130 GLY A 54 GLY.? 9.09 ZN ZN A 119 coo 8.08 5.58 9.89 6.73 6.58 11.12 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 12.76 4.19 5.97 12.32 3.80 6.57 -21.24 35.01 50.29 -20.80 34.52 50.80 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 2 # 10 B 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo 8.08 5.58 9.89 6.73 6.58 11.12 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 12.76 4.19 5.97 12.32 3.80 6.57 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 2 # 11 B 128 ASP B 15 ASP~? 8.50 ZN ZN A 119 B 130 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo 8.08 5.58 9.89 6.73 6.58 11.12 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 12.76 4.19 5.97 12.32 3.80 6.57 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 2 # 12 B 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 B 130 GLY B 24 GLY.? 15.12 CH3 ACY B 120 coo 8.08 5.58 9.89 6.73 6.58 11.12 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 12.76 4.19 5.97 12.32 3.80 6.57 -4.03 5.76 27.94 -4.16 6.37 27.38 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 2 # 13 B 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 B 130 GLY B 27 GLY.? 15.88 CH3 ACY B 120 coo 8.08 5.58 9.89 6.73 6.58 11.12 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 12.76 4.19 5.97 12.32 3.80 6.57 -5.69 8.07 23.28 -5.94 7.34 23.49 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 2 # 14 B 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo 8.08 5.58 9.89 6.73 6.58 11.12 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 12.76 4.19 5.97 12.32 3.80 6.57 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 2 # 15 B 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo 8.08 5.58 9.89 6.73 6.58 11.12 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 12.76 4.19 5.97 12.32 3.80 6.57 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 2 # 16 B 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 130 GLY B 57 GLY.? -3.44 ZN ZN B 118s coo 8.08 5.58 9.89 6.73 6.58 11.12 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 12.76 4.19 5.97 12.32 3.80 6.57 -17.31 6.32 43.48 -17.60 5.82 42.91 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 2 # 17 B 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo 8.08 5.58 9.89 6.73 6.58 11.12 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 12.76 4.19 5.97 12.32 3.80 6.57 -18.86 0.25 41.49 -18.36 0.89 41.57 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 2 # 18 B 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo 8.08 5.58 9.89 6.73 6.58 11.12 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 12.76 4.19 5.97 12.32 3.80 6.57 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 2 # 19 B 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo 8.08 5.58 9.89 6.73 6.58 11.12 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 12.76 4.19 5.97 12.32 3.80 6.57 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c01 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 20 2 # 20 B 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo 8.08 5.58 9.89 6.73 6.58 11.12 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 12.76 4.19 5.97 12.32 3.80 6.57 -18.86 0.25 41.49 -18.36 0.89 41.57 1xs1_c01 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 20 hits 1xs1_c01 naa= 2 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 C 128 ASP A 15 ASP~? 8.61 ZN ZN B 118 C 130 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 C 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 C 130 GLY A 24 GLY.? 15.19 CH3 ACY A 120 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -10.32 31.44 63.56 -10.61 30.81 64.05 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 C 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 C 130 GLY A 27 GLY.? 16.01 CH3 ACY A 120 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -13.31 29.37 67.32 -13.49 30.12 67.06 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 C 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s C 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 C 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s C 130 GLY A 54 GLY.? 9.09 ZN ZN A 119 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -21.24 35.01 50.29 -20.80 34.52 50.80 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 C 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s C 130 GLY A 57 GLY.? 4.30 ZN ZN A 119 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -18.19 30.32 43.90 -18.50 30.85 44.43 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 C 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s C 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 2 # 8 C 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 2 # 9 C 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 C 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 2 # 10 C 128 ASP B 15 ASP~? 8.50 ZN ZN A 119 C 130 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 2 # 11 C 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 C 130 GLY B 24 GLY.? 15.12 CH3 ACY B 120 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -4.03 5.76 27.94 -4.16 6.37 27.38 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 2 # 12 C 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 C 130 GLY B 27 GLY.? 15.88 CH3 ACY B 120 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -5.69 8.07 23.28 -5.94 7.34 23.49 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 2 # 13 C 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s C 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 2 # 14 C 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s C 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 2 # 15 C 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s C 130 GLY B 57 GLY.? -3.44 ZN ZN B 118s coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -17.31 6.32 43.48 -17.60 5.82 42.91 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 2 # 16 C 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s C 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -18.86 0.25 41.49 -18.36 0.89 41.57 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 2 # 17 C 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 2 # 18 C 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c02 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 2 # 19 C 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 C 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo -5.87 -14.45 11.20 -4.27 -13.52 12.23 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -8.99 -18.13 7.59 -9.28 -17.49 8.06 -18.86 0.25 41.49 -18.36 0.89 41.57 1xs1_c02 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 19 hits 1xs1_c02 naa= 2 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 D 128 ASP A 15 ASP~? 8.61 ZN ZN B 118 D 130 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 D 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 D 130 GLY A 24 GLY.? 15.19 CH3 ACY A 120 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -10.32 31.44 63.56 -10.61 30.81 64.05 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 D 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 D 130 GLY A 27 GLY.? 16.01 CH3 ACY A 120 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -13.31 29.37 67.32 -13.49 30.12 67.06 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 D 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s D 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 D 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s D 130 GLY A 54 GLY.? 9.09 ZN ZN A 119 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -21.24 35.01 50.29 -20.80 34.52 50.80 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 D 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s D 130 GLY A 57 GLY.? 4.30 ZN ZN A 119 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -18.19 30.32 43.90 -18.50 30.85 44.43 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 D 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s D 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 2 # 8 D 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 D 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 2 # 9 D 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 D 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 2 # 10 D 128 ASP B 15 ASP~? 8.50 ZN ZN A 119 D 130 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 2 # 11 D 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 D 130 GLY B 24 GLY.? 15.12 CH3 ACY B 120 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -4.03 5.76 27.94 -4.16 6.37 27.38 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 2 # 12 D 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 D 130 GLY B 27 GLY.? 15.88 CH3 ACY B 120 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -5.69 8.07 23.28 -5.94 7.34 23.49 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 2 # 13 D 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s D 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 2 # 14 D 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s D 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 2 # 15 D 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s D 130 GLY B 57 GLY.? -3.44 ZN ZN B 118s coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -17.31 6.32 43.48 -17.60 5.82 42.91 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 2 # 16 D 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s D 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -18.86 0.25 41.49 -18.36 0.89 41.57 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 2 # 17 D 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 D 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 2 # 18 D 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 D 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c03 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 2 # 19 D 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 D 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo 8.09 -3.30 72.29 6.62 -4.22 71.13 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 12.81 -2.18 75.86 12.44 -1.59 75.38 -18.86 0.25 41.49 -18.36 0.89 41.57 1xs1_c03 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 19 hits 1xs1_c03 naa= 2 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 E 128 ASP A 15 ASP~? 8.61 ZN ZN B 118 E 130 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 E 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 E 130 GLY A 24 GLY.? 15.19 CH3 ACY A 120 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -10.32 31.44 63.56 -10.61 30.81 64.05 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 E 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 E 130 GLY A 27 GLY.? 16.01 CH3 ACY A 120 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -13.31 29.37 67.32 -13.49 30.12 67.06 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 E 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s E 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 E 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s E 130 GLY A 54 GLY.? 9.09 ZN ZN A 119 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -21.24 35.01 50.29 -20.80 34.52 50.80 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 E 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s E 130 GLY A 57 GLY.? 4.30 ZN ZN A 119 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -18.19 30.32 43.90 -18.50 30.85 44.43 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 E 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s E 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 2 # 8 E 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 E 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 2 # 9 E 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 E 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 2 # 10 E 128 ASP B 15 ASP~? 8.50 ZN ZN A 119 E 130 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 2 # 11 E 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 E 130 GLY B 24 GLY.? 15.12 CH3 ACY B 120 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -4.03 5.76 27.94 -4.16 6.37 27.38 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 2 # 12 E 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 E 130 GLY B 27 GLY.? 15.88 CH3 ACY B 120 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -5.69 8.07 23.28 -5.94 7.34 23.49 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 2 # 13 E 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s E 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 2 # 14 E 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s E 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 2 # 15 E 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s E 130 GLY B 57 GLY.? -3.44 ZN ZN B 118s coo -5.69 16.82 71.43 -4.17 15.98 70.17 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -17.31 6.32 43.48 -17.60 5.82 42.91 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 2 # 16 E 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s E 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -18.86 0.25 41.49 -18.36 0.89 41.57 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 2 # 17 E 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 E 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 2 # 18 E 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 E 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c04 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 2 # 19 E 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 E 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo -5.69 16.82 71.43 -4.17 15.98 70.17 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -8.93 20.40 75.02 -9.14 19.76 74.49 -18.86 0.25 41.49 -18.36 0.89 41.57 1xs1_c04 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 19 hits 1xs1_c04 naa= 2 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 F 128 ASP A 15 ASP~? 8.61 ZN ZN B 118 F 130 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 F 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 F 130 GLY A 24 GLY.? 15.19 CH3 ACY A 120 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -10.32 31.44 63.56 -10.61 30.81 64.05 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 F 128 ASP A 26 ASP.? 19.54 CH3 ACY A 120 F 130 GLY A 27 GLY.? 16.01 CH3 ACY A 120 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -13.31 29.37 67.32 -13.49 30.12 67.06 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 F 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s F 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 F 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s F 130 GLY A 54 GLY.? 9.09 ZN ZN A 119 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -21.24 35.01 50.29 -20.80 34.52 50.80 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 6 2 # 6 F 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s F 130 GLY A 57 GLY.? 4.30 ZN ZN A 119 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -18.19 30.32 43.90 -18.50 30.85 44.43 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 7 2 # 7 F 128 ASP A 60 ASP.? -2.37 ZN ZN A 119s F 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 8 2 # 8 F 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 F 130 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 9 2 # 9 F 128 ASP A 61 ASP^? 8.97 ZN ZN A 119 F 130 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 10 2 # 10 F 128 ASP B 15 ASP~? 8.50 ZN ZN A 119 F 130 GLY B 13 GLY^? 8.33 CH3 ACY B 120 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -6.67 23.63 41.51 -6.50 23.00 40.99 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 11 2 # 11 F 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 F 130 GLY B 24 GLY.? 15.12 CH3 ACY B 120 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -4.03 5.76 27.94 -4.16 6.37 27.38 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 12 2 # 12 F 128 ASP B 26 ASP.? 19.38 CH3 ACY B 120 F 130 GLY B 27 GLY.? 15.88 CH3 ACY B 120 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -5.69 8.07 23.28 -5.94 7.34 23.49 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 13 2 # 13 F 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s F 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 14 2 # 14 F 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s F 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 15 2 # 15 F 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s F 130 GLY B 57 GLY.? -3.44 ZN ZN B 118s coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -17.31 6.32 43.48 -17.60 5.82 42.91 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 16 2 # 16 F 128 ASP B 60 ASP.? -2.30 ZN ZN B 118s F 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -18.86 0.25 41.49 -18.36 0.89 41.57 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 17 2 # 17 F 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 F 130 GLY B 53 GLY.? 9.42 ZN ZN B 118 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -15.05 1.05 35.38 -15.07 1.78 35.76 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 18 2 # 18 F 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 F 130 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 1xs1_c05 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 19 2 # 19 F 128 ASP B 61 ASP^? 9.02 ZN ZN B 118 F 130 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo -16.02 -5.28 72.32 -16.05 -3.63 70.99 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -17.44 -9.41 76.35 -16.78 -9.37 75.83 -18.86 0.25 41.49 -18.36 0.89 41.57 1xs1_c05 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 19 hits 1xs1_c05 naa= 2 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 A 111 SER A 14 SER~? 11.41 CH3 ACY A 120 A 115 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo 6.26 6.70 20.48 8.06 5.10 20.15 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 10.04 5.32 23.68 11.46 4.45 21.05 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 A 111 SER A 42 SER.? 12.48 O ACY A 121 A 115 ARG A 44 ARG.? 16.49 O ACY A 121 coo 6.26 6.70 20.48 8.06 5.10 20.15 6.18 19.13 41.68 6.03 20.94 43.24 coo 10.04 5.32 23.68 11.46 4.45 21.05 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 A 111 SER A 46 SER^? 14.68 O ACY A 121 A 115 ARG A 44 ARG.? 16.49 O ACY A 121 coo 6.26 6.70 20.48 8.06 5.10 20.15 1.31 25.87 47.03 1.94 27.83 45.77 coo 10.04 5.32 23.68 11.46 4.45 21.05 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 A 111 SER B 14 SER~? 11.46 CH3 ACY B 120 A 115 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 6.26 6.70 20.48 8.06 5.10 20.15 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 10.04 5.32 23.68 11.46 4.45 21.05 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 2 1xs1_c13 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 A 111 SER B 42 SER.? 13.83 OXT ACY A 120 A 115 ARG B 44 ARG.? 18.52 O ACY A 121 coo 6.26 6.70 20.48 8.06 5.10 20.15 4.20 18.00 53.79 4.49 16.52 51.91 coo 10.04 5.32 23.68 11.46 4.45 21.05 6.69 16.72 49.11 8.85 18.83 48.43 1xs1_c13 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c13 naa= 2 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 B 111 SER A 14 SER~? 11.41 CH3 ACY A 120 B 115 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -8.58 16.80 48.15 -8.42 16.11 45.83 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 B 111 SER A 42 SER.? 12.48 O ACY A 121 B 115 ARG A 44 ARG.? 16.49 O ACY A 121 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 6.18 19.13 41.68 6.03 20.94 43.24 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 B 111 SER A 46 SER^? 14.68 O ACY A 121 B 115 ARG A 44 ARG.? 16.49 O ACY A 121 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 1.31 25.87 47.03 1.94 27.83 45.77 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 B 111 SER B 14 SER~? 11.46 CH3 ACY B 120 B 115 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 -7.60 20.35 43.19 -8.11 21.15 45.47 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 2 1xs1_c14 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 B 111 SER B 42 SER.? 13.83 OXT ACY A 120 B 115 ARG B 44 ARG.? 18.52 O ACY A 121 coo -4.45 -12.43 21.60 -6.79 -13.15 21.26 4.20 18.00 53.79 4.49 16.52 51.91 coo -7.99 -14.79 25.08 -9.16 -15.86 22.37 6.69 16.72 49.11 8.85 18.83 48.43 1xs1_c14 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c14 naa= 2 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 D 111 SER A 14 SER~? 11.41 CH3 ACY A 120 D 115 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -8.58 16.80 48.15 -8.42 16.11 45.83 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 D 111 SER A 42 SER.? 12.48 O ACY A 121 D 115 ARG A 44 ARG.? 16.49 O ACY A 121 coo -4.43 14.92 60.69 -6.72 15.54 61.22 6.18 19.13 41.68 6.03 20.94 43.24 coo -7.63 17.31 57.53 -9.07 18.28 60.09 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 D 111 SER A 46 SER^? 14.68 O ACY A 121 D 115 ARG A 44 ARG.? 16.49 O ACY A 121 coo -4.43 14.92 60.69 -6.72 15.54 61.22 1.31 25.87 47.03 1.94 27.83 45.77 coo -7.63 17.31 57.53 -9.07 18.28 60.09 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 D 111 SER B 14 SER~? 11.46 CH3 ACY B 120 D 115 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo -4.43 14.92 60.69 -6.72 15.54 61.22 -7.60 20.35 43.19 -8.11 21.15 45.47 coo -7.63 17.31 57.53 -9.07 18.28 60.09 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 2 1xs1_c15 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 D 111 SER B 42 SER.? 13.83 OXT ACY A 120 D 115 ARG B 44 ARG.? 18.52 O ACY A 121 coo -4.43 14.92 60.69 -6.72 15.54 61.22 4.20 18.00 53.79 4.49 16.52 51.91 coo -7.63 17.31 57.53 -9.07 18.28 60.09 6.69 16.72 49.11 8.85 18.83 48.43 1xs1_c15 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c15 naa= 2 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 E 111 SER A 14 SER~? 11.41 CH3 ACY A 120 E 115 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -8.58 16.80 48.15 -8.42 16.11 45.83 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 E 111 SER A 42 SER.? 12.48 O ACY A 121 E 115 ARG A 44 ARG.? 16.49 O ACY A 121 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 6.18 19.13 41.68 6.03 20.94 43.24 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 E 111 SER A 46 SER^? 14.68 O ACY A 121 E 115 ARG A 44 ARG.? 16.49 O ACY A 121 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 1.31 25.87 47.03 1.94 27.83 45.77 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 E 111 SER B 14 SER~? 11.46 CH3 ACY B 120 E 115 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 -7.60 20.35 43.19 -8.11 21.15 45.47 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 2 1xs1_c16 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 E 111 SER B 42 SER.? 13.83 OXT ACY A 120 E 115 ARG B 44 ARG.? 18.52 O ACY A 121 coo -15.63 -3.91 61.74 -14.98 -6.16 62.33 4.20 18.00 53.79 4.49 16.52 51.91 coo -16.31 -8.10 58.66 -16.35 -9.57 61.37 6.69 16.72 49.11 8.85 18.83 48.43 1xs1_c16 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c16 naa= 2 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 1 2 # 1 F 111 SER A 14 SER~? 11.41 CH3 ACY A 120 F 115 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -8.58 16.80 48.15 -8.42 16.11 45.83 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 2 2 # 2 F 111 SER A 42 SER.? 12.48 O ACY A 121 F 115 ARG A 44 ARG.? 16.49 O ACY A 121 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 6.18 19.13 41.68 6.03 20.94 43.24 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 3 2 # 3 F 111 SER A 46 SER^? 14.68 O ACY A 121 F 115 ARG A 44 ARG.? 16.49 O ACY A 121 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 1.31 25.87 47.03 1.94 27.83 45.77 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 6.31 22.16 46.81 4.95 24.70 47.95 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 4 2 # 4 F 111 SER B 14 SER~? 11.46 CH3 ACY B 120 F 115 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 -7.60 20.35 43.19 -8.11 21.15 45.47 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 2 1xs1_c17 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASEuser 5 2 # 5 F 111 SER B 42 SER.? 13.83 OXT ACY A 120 F 115 ARG B 44 ARG.? 18.52 O ACY A 121 coo 6.41 -4.25 61.68 8.03 -2.52 62.26 4.20 18.00 53.79 4.49 16.52 51.91 coo 10.12 -2.85 58.44 11.76 -1.85 60.88 6.69 16.72 49.11 8.85 18.83 48.43 1xs1_c17 source 1xs1 DEOXYCYTIDINE TRIPHOSPHATE DEAMINASE : 5 hits 1xs1_c17 naa= 2 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 1 2 # 1 A 175 ARG A 35 ARG^? 4.87 ZN ZN A 119 A 242 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 56.19 79.96 8.87 56.06 80.16 11.92 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 63.28 81.69 5.71 63.99 80.11 7.80 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1xva_c02 GLYCINE N-METHYLTRANSFERASE user 2 2 # 2 A 175 ARG B 35 ARG.? 5.03 ZN ZN B 118 A 242 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 56.19 79.96 8.87 56.06 80.16 11.92 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 63.28 81.69 5.71 63.99 80.11 7.80 -1.77 7.84 45.62 -3.44 6.86 47.62 1xva_c02 source 1xva GLYCINE N-METHYLTRANSFERASE : 2 hits 1xva_c02 naa= 2 ULMN 2 1y9m_c00 EXO-INULINASE user 1 2 # 1 A 41 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 241 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 24.90 6.62 22.11 24.45 8.58 22.70 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 19.12 12.64 24.04 21.16 13.15 23.94 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1y9m_c00 EXO-INULINASE user 2 2 # 2 A 41 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 241 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 24.90 6.62 22.11 24.45 8.58 22.70 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 19.12 12.64 24.04 21.16 13.15 23.94 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1y9m_c00 EXO-INULINASE user 3 2 # 3 A 41 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 241 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 24.90 6.62 22.11 24.45 8.58 22.70 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 19.12 12.64 24.04 21.16 13.15 23.94 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 1y9m_c00 EXO-INULINASE user 4 2 # 4 A 41 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 241 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 24.90 6.62 22.11 24.45 8.58 22.70 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 19.12 12.64 24.04 21.16 13.15 23.94 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1y9m_c00 EXO-INULINASE user 5 2 # 5 A 41 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 241 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 24.90 6.62 22.11 24.45 8.58 22.70 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 19.12 12.64 24.04 21.16 13.15 23.94 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 1y9m_c00 EXO-INULINASE user 6 2 # 6 A 41 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 241 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 24.90 6.62 22.11 24.45 8.58 22.70 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 19.12 12.64 24.04 21.16 13.15 23.94 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 1y9m_c00 EXO-INULINASE user 7 2 # 7 A 41 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 241 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 24.90 6.62 22.11 24.45 8.58 22.70 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 19.12 12.64 24.04 21.16 13.15 23.94 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 1y9m_c00 EXO-INULINASE user 8 2 # 8 A 41 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 241 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 24.90 6.62 22.11 24.45 8.58 22.70 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 19.12 12.64 24.04 21.16 13.15 23.94 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 1y9m_c00 EXO-INULINASE user 9 2 # 9 A 41 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 241 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 24.90 6.62 22.11 24.45 8.58 22.70 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 19.12 12.64 24.04 21.16 13.15 23.94 -7.13 -6.28 33.53 -6.83 -7.93 32.24 1y9m_c00 source 1y9m EXO-INULINASE : 9 hits 1y9m_c00 naa= 2 ULMN 2 1ybv_c04 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 A 175 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 182 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 85.29 7.35 12.75 85.49 9.14 13.81 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 85.30 6.17 22.83 87.26 11.02 23.50 -8.24 41.47 45.26 -7.63 47.05 46.72 1ybv_c04 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 1 hits 1ybv_c04 naa= 2 ULMN 2 1ybv_c05 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 B 175 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 182 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 57.35 -5.59 36.67 57.15 -3.72 37.60 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 57.40 2.23 30.19 55.43 5.44 33.87 -8.24 41.47 45.26 -7.63 47.05 46.72 1ybv_c05 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 1 hits 1ybv_c05 naa= 2 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 A 178 TYR A 72 TYR^? -3.77 O ACY A 120s A 182 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 87.67 8.69 17.10 86.62 10.83 18.52 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 85.30 6.17 22.83 87.26 11.02 23.50 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 2 # 2 A 178 TYR A 79 TYR^? -4.35 CH3 ACY A 120s A 182 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 87.67 8.69 17.10 86.62 10.83 18.52 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 85.30 6.17 22.83 87.26 11.02 23.50 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 2 # 3 A 178 TYR B 72 TYR^? 3.72 OXT ACY B 120s A 182 LYS B 71 LYS^? 12.90 O ACY A 121 coo 87.67 8.69 17.10 86.62 10.83 18.52 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 85.30 6.17 22.83 87.26 11.02 23.50 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1ybv_c06 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 2 # 4 A 178 TYR B 79 TYR^? -4.21 CH3 ACY B 120s A 182 LYS B 71 LYS^? 12.90 O ACY A 121 coo 87.67 8.69 17.10 86.62 10.83 18.52 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 85.30 6.17 22.83 87.26 11.02 23.50 0.91 14.36 31.66 5.84 10.91 29.66 1ybv_c06 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 4 hits 1ybv_c06 naa= 2 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 1 2 # 1 B 178 TYR A 72 TYR^? -3.77 O ACY A 120s B 182 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 57.40 2.23 30.19 55.43 5.44 33.87 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 2 2 # 2 B 178 TYR A 79 TYR^? -4.35 CH3 ACY A 120s B 182 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 57.40 2.23 30.19 55.43 5.44 33.87 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 3 2 # 3 B 178 TYR B 72 TYR^? 3.72 OXT ACY B 120s B 182 LYS B 71 LYS^? 12.90 O ACY A 121 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 57.40 2.23 30.19 55.43 5.44 33.87 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 1ybv_c07 TRIHYDROXYNAPHTHALENE REDUCTASE user 4 2 # 4 B 178 TYR B 79 TYR^? -4.21 CH3 ACY B 120s B 182 LYS B 71 LYS^? 12.90 O ACY A 121 coo 54.99 -1.20 35.40 56.04 1.15 36.44 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 57.40 2.23 30.19 55.43 5.44 33.87 0.91 14.36 31.66 5.84 10.91 29.66 1ybv_c07 source 1ybv TRIHYDROXYNAPHTHALENE REDUCTASE : 4 hits 1ybv_c07 naa= 2 ULMN 2 1ycf_c04 NITRIC OXIDE REDUCTASE user 1 2 # 1 A 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 195 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 106.34 45.08-158.07 106.22 43.60-156.59 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 107.73 45.82-148.69 107.70 43.47-150.21 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1ycf_c04 NITRIC OXIDE REDUCTASE user 2 2 # 2 A 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 195 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 106.34 45.08-158.07 106.22 43.60-156.59 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 107.73 45.82-148.69 107.70 43.47-150.21 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ycf_c04 NITRIC OXIDE REDUCTASE user 3 2 # 3 A 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 195 TYR A 94 TYR.? 14.61 ZN ZN A 119 coo 106.34 45.08-158.07 106.22 43.60-156.59 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 107.73 45.82-148.69 107.70 43.47-150.21 -5.97 41.42 41.15 -7.10 43.78 40.18 ULMN 2 1ycf_c04 NITRIC OXIDE REDUCTASE user 4 2 # 4 A 25 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 195 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 106.34 45.08-158.07 106.22 43.60-156.59 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 107.73 45.82-148.69 107.70 43.47-150.21 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1ycf_c04 NITRIC OXIDE REDUCTASE user 5 2 # 5 A 25 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 195 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 106.34 45.08-158.07 106.22 43.60-156.59 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 107.73 45.82-148.69 107.70 43.47-150.21 -4.17 2.05 38.57 -1.76 0.81 38.01 1ycf_c04 source 1ycf NITRIC OXIDE REDUCTASE : 5 hits 1ycf_c04 naa= 2 ULMN 2 1ycf_c05 NITRIC OXIDE REDUCTASE user 1 2 # 1 B 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 195 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 96.60 74.58-169.45 95.48 75.58-170.91 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 98.52 74.63-178.64 97.12 76.54-177.16 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1ycf_c05 NITRIC OXIDE REDUCTASE user 2 2 # 2 B 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 195 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 96.60 74.58-169.45 95.48 75.58-170.91 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 98.52 74.63-178.64 97.12 76.54-177.16 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ycf_c05 NITRIC OXIDE REDUCTASE user 3 2 # 3 B 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s B 195 TYR A 94 TYR.? 14.61 ZN ZN A 119 coo 96.60 74.58-169.45 95.48 75.58-170.91 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 98.52 74.63-178.64 97.12 76.54-177.16 -5.97 41.42 41.15 -7.10 43.78 40.18 ULMN 2 1ycf_c05 NITRIC OXIDE REDUCTASE user 4 2 # 4 B 25 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 195 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 96.60 74.58-169.45 95.48 75.58-170.91 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 98.52 74.63-178.64 97.12 76.54-177.16 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1ycf_c05 NITRIC OXIDE REDUCTASE user 5 2 # 5 B 25 HIS B 62 HIS^? -3.22 ZN ZN B 118s B 195 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 96.60 74.58-169.45 95.48 75.58-170.91 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 98.52 74.63-178.64 97.12 76.54-177.16 -4.17 2.05 38.57 -1.76 0.81 38.01 1ycf_c05 source 1ycf NITRIC OXIDE REDUCTASE : 5 hits 1ycf_c05 naa= 2 ULMN 2 1ycf_c06 NITRIC OXIDE REDUCTASE user 1 2 # 1 C 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 195 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 119.08 -2.66-195.15 118.61 -1.94-197.06 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 119.26 -8.13-203.10 119.67 -5.37-203.16 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1ycf_c06 NITRIC OXIDE REDUCTASE user 2 2 # 2 C 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 195 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 119.08 -2.66-195.15 118.61 -1.94-197.06 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 119.26 -8.13-203.10 119.67 -5.37-203.16 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ycf_c06 NITRIC OXIDE REDUCTASE user 3 2 # 3 C 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s C 195 TYR A 94 TYR.? 14.61 ZN ZN A 119 coo 119.08 -2.66-195.15 118.61 -1.94-197.06 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 119.26 -8.13-203.10 119.67 -5.37-203.16 -5.97 41.42 41.15 -7.10 43.78 40.18 ULMN 2 1ycf_c06 NITRIC OXIDE REDUCTASE user 4 2 # 4 C 25 HIS B 62 HIS^? -3.22 ZN ZN B 118s C 195 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 119.08 -2.66-195.15 118.61 -1.94-197.06 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 119.26 -8.13-203.10 119.67 -5.37-203.16 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1ycf_c06 NITRIC OXIDE REDUCTASE user 5 2 # 5 C 25 HIS B 62 HIS^? -3.22 ZN ZN B 118s C 195 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 119.08 -2.66-195.15 118.61 -1.94-197.06 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 119.26 -8.13-203.10 119.67 -5.37-203.16 -4.17 2.05 38.57 -1.76 0.81 38.01 1ycf_c06 source 1ycf NITRIC OXIDE REDUCTASE : 5 hits 1ycf_c06 naa= 2 ULMN 2 1ycf_c07 NITRIC OXIDE REDUCTASE user 1 2 # 1 D 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 195 TYR A 47 TYR^? 12.01 ZN ZN A 119 coo 112.06 -23.02-169.87 111.39 -23.40-167.92 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 115.20 -18.37-161.81 113.47 -20.54-162.09 -2.05 29.36 47.71 -2.93 30.35 45.23 ULMN 2 1ycf_c07 NITRIC OXIDE REDUCTASE user 2 2 # 2 D 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 195 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 112.06 -23.02-169.87 111.39 -23.40-167.92 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 115.20 -18.37-161.81 113.47 -20.54-162.09 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ycf_c07 NITRIC OXIDE REDUCTASE user 3 2 # 3 D 25 HIS A 62 HIS^? -3.21 ZN ZN A 119s D 195 TYR A 94 TYR.? 14.61 ZN ZN A 119 coo 112.06 -23.02-169.87 111.39 -23.40-167.92 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 115.20 -18.37-161.81 113.47 -20.54-162.09 -5.97 41.42 41.15 -7.10 43.78 40.18 ULMN 2 1ycf_c07 NITRIC OXIDE REDUCTASE user 4 2 # 4 D 25 HIS B 62 HIS^? -3.22 ZN ZN B 118s D 195 TYR B 47 TYR^? 11.86 ZN ZN B 118 coo 112.06 -23.02-169.87 111.39 -23.40-167.92 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 115.20 -18.37-161.81 113.47 -20.54-162.09 -1.77 7.84 45.62 -3.44 6.86 47.62 ULMN 2 1ycf_c07 NITRIC OXIDE REDUCTASE user 5 2 # 5 D 25 HIS B 62 HIS^? -3.22 ZN ZN B 118s D 195 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 112.06 -23.02-169.87 111.39 -23.40-167.92 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 115.20 -18.37-161.81 113.47 -20.54-162.09 -4.17 2.05 38.57 -1.76 0.81 38.01 1ycf_c07 source 1ycf NITRIC OXIDE REDUCTASE : 5 hits 1ycf_c07 naa= 2 ULMN 2 1ylu_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 A 14 LYS A 10 LYS.? 12.65 OXT ACY A 120 A 74 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 18.28 7.83 36.39 22.82 8.75 39.52 -0.98 10.25 56.97 2.99 9.65 58.52 coo 14.16 13.09 37.03 20.00 12.44 37.49 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 1ylu_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 2 # 2 A 14 LYS A 40 LYS.? -3.18 C ACY A 121s A 74 LYS B 10 LYS.? 9.83 CH3 ACY A 121 coo 18.28 7.83 36.39 22.82 8.75 39.52 1.80 21.48 38.21 -1.61 24.69 34.09 coo 14.16 13.09 37.03 20.00 12.44 37.49 2.14 27.03 37.15 7.00 28.76 35.76 ULMN 2 1ylu_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 2 # 3 A 14 LYS B 10 LYS.? 9.83 CH3 ACY A 121 A 74 LYS A 40 LYS.? -3.18 C ACY A 121s coo 18.28 7.83 36.39 22.82 8.75 39.52 2.14 27.03 37.15 7.00 28.76 35.76 coo 14.16 13.09 37.03 20.00 12.44 37.49 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1ylu_c02 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 2 # 4 A 14 LYS B 40 LYS.? 4.59 ZN ZN A 118 A 74 LYS A 10 LYS.? 12.65 OXT ACY A 120 coo 18.28 7.83 36.39 22.82 8.75 39.52 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 14.16 13.09 37.03 20.00 12.44 37.49 -0.98 10.25 56.97 2.99 9.65 58.52 1ylu_c02 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1ylu_c02 naa= 2 ULMN 2 1ylu_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 1 2 # 1 B 14 LYS A 10 LYS.? 12.65 OXT ACY A 120 B 74 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 13.51 0.92 76.10 12.98 6.13 74.68 -0.98 10.25 56.97 2.99 9.65 58.52 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 1ylu_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 2 2 # 2 B 14 LYS A 40 LYS.? -3.18 C ACY A 121s B 74 LYS B 10 LYS.? 9.83 CH3 ACY A 121 coo 13.51 0.92 76.10 12.98 6.13 74.68 1.80 21.48 38.21 -1.61 24.69 34.09 coo 19.89 -0.55 76.51 17.10 4.32 77.43 2.14 27.03 37.15 7.00 28.76 35.76 ULMN 2 1ylu_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 3 2 # 3 B 14 LYS B 10 LYS.? 9.83 CH3 ACY A 121 B 74 LYS A 40 LYS.? -3.18 C ACY A 121s coo 13.51 0.92 76.10 12.98 6.13 74.68 2.14 27.03 37.15 7.00 28.76 35.76 coo 19.89 -0.55 76.51 17.10 4.32 77.43 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 1ylu_c03 OXYGEN-INSENSITIVE NAD(P)H NITROREDUuser 4 2 # 4 B 14 LYS B 40 LYS.? 4.59 ZN ZN A 118 B 74 LYS A 10 LYS.? 12.65 OXT ACY A 120 coo 13.51 0.92 76.10 12.98 6.13 74.68 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 19.89 -0.55 76.51 17.10 4.32 77.43 -0.98 10.25 56.97 2.99 9.65 58.52 1ylu_c03 source 1ylu OXYGEN-INSENSITIVE NAD(P)H NITROREDUCTASE : 4 hits 1ylu_c03 naa= 2 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 A 39 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 67 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 A 39 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 67 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 A 39 ASP A 86 ASP~? 22.55 ZN ZN A 119 A 67 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 A 39 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 67 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -7.61 10.49 27.32 -9.94 11.99 27.12 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 A 39 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 67 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -4.17 2.05 38.57 -1.76 0.81 38.01 ULMN 2 1ze1_c00 TRNA PSEUDOURIDINE SYNTHASE B user 6 2 # 6 A 39 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 67 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 8.73 -11.32 3.51 10.34 -10.01 3.08 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 4.04 -3.74 8.04 4.92 -3.67 5.38 -4.17 2.05 38.57 -1.76 0.81 38.01 1ze1_c00 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 6 hits 1ze1_c00 naa= 2 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 B 39 ASP A 26 ASP.? 19.54 CH3 ACY A 120 B 67 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 B 39 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 67 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 B 39 ASP A 86 ASP~? 22.55 ZN ZN A 119 B 67 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -6.95 43.63 60.82 -7.76 45.08 62.19 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 B 39 ASP B 26 ASP.? 19.38 CH3 ACY B 120 B 67 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -7.61 10.49 27.32 -9.94 11.99 27.12 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 B 39 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 67 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -4.17 2.05 38.57 -1.76 0.81 38.01 ULMN 2 1ze1_c01 TRNA PSEUDOURIDINE SYNTHASE B user 6 2 # 6 B 39 ASP B 86 ASP~? 22.13 ZN ZN B 118 B 67 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo -2.18 16.79 38.50 -4.08 16.27 37.73 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo -3.28 26.12 34.97 -5.09 24.87 36.72 -4.17 2.05 38.57 -1.76 0.81 38.01 1ze1_c01 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 6 hits 1ze1_c01 naa= 2 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 C 39 ASP A 26 ASP.? 19.54 CH3 ACY A 120 C 67 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 C 39 ASP A 60 ASP.? -2.37 ZN ZN A 119s C 67 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 C 39 ASP A 86 ASP~? 22.55 ZN ZN A 119 C 67 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -6.95 43.63 60.82 -7.76 45.08 62.19 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 C 39 ASP B 26 ASP.? 19.38 CH3 ACY B 120 C 67 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -7.61 10.49 27.32 -9.94 11.99 27.12 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 C 39 ASP B 60 ASP.? -2.30 ZN ZN B 118s C 67 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -4.17 2.05 38.57 -1.76 0.81 38.01 ULMN 2 1ze1_c02 TRNA PSEUDOURIDINE SYNTHASE B user 6 2 # 6 C 39 ASP B 86 ASP~? 22.13 ZN ZN B 118 C 67 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 1.88 -21.31 91.78 3.37 -20.02 92.55 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo -5.10 -15.03 95.35 -3.01 -14.24 93.67 -4.17 2.05 38.57 -1.76 0.81 38.01 1ze1_c02 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 6 hits 1ze1_c02 naa= 2 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 1 2 # 1 D 39 ASP A 26 ASP.? 19.54 CH3 ACY A 120 D 67 TYR A 23 TYR^? 11.58 CH3 ACY A 120 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -13.79 26.73 63.12 -16.10 25.28 62.65 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 2 2 # 2 D 39 ASP A 60 ASP.? -2.37 ZN ZN A 119s D 67 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 3 2 # 3 D 39 ASP A 86 ASP~? 22.55 ZN ZN A 119 D 67 TYR A 63 TYR^? 13.00 ZN ZN A 119 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -6.95 35.16 53.71 -4.78 36.23 55.09 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 4 2 # 4 D 39 ASP B 26 ASP.? 19.38 CH3 ACY B 120 D 67 TYR B 23 TYR^? 11.37 CH3 ACY B 120 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -7.61 10.49 27.32 -9.94 11.99 27.12 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 5 2 # 5 D 39 ASP B 60 ASP.? -2.30 ZN ZN B 118s D 67 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -4.17 2.05 38.57 -1.76 0.81 38.01 ULMN 2 1ze1_c03 TRNA PSEUDOURIDINE SYNTHASE B user 6 2 # 6 D 39 ASP B 86 ASP~? 22.13 ZN ZN B 118 D 67 TYR B 63 TYR^? 12.86 ZN ZN B 118 coo 8.20 -51.87 -48.87 6.22 -52.41 -48.39 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 4.59 -43.79 -53.53 4.08 -44.38 -50.84 -4.17 2.05 38.57 -1.76 0.81 38.01 1ze1_c03 source 1ze1 TRNA PSEUDOURIDINE SYNTHASE B : 6 hits 1ze1_c03 naa= 2 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 1 2 # 1 A 369 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 373 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 1zrz_c00 PROTEIN KINASE C, IOTA user 2 2 # 2 A 369 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 373 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -8.85 26.59 24.55 -9.45 28.36 23.61 -12.98 14.88 47.28 -12.40 12.90 47.92 1zrz_c00 source 1zrz PROTEIN KINASE C, IOTA : 2 hits 1zrz_c00 naa= 2 ULMN 2 1zrz_c01 PROTEIN KINASE C, IOTA user 1 2 # 1 A 369 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 371 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 2 1zrz_c01 PROTEIN KINASE C, IOTA user 2 2 # 2 A 369 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 371 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 1zrz_c01 PROTEIN KINASE C, IOTA user 3 2 # 3 A 369 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 371 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo -5.17 31.09 15.73 -7.07 31.12 16.73 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -4.43 30.92 22.89 -6.61 31.91 19.71 -10.40 7.25 27.78 -14.86 10.45 31.09 1zrz_c01 source 1zrz PROTEIN KINASE C, IOTA : 3 hits 1zrz_c01 naa= 2 ULMN 2 1zym_c00 ENZYME I user 1 2 # 1 A 168 THR A 5 THR.? 10.24 ZN ZN B 118 A 189 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -11.20 6.24 51.51 -9.77 5.38 52.87 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1zym_c00 ENZYME I user 2 2 # 2 A 168 THR B 5 THR.? 9.07 ZN ZN A 119 A 189 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 8.31 -2.39 92.48 6.24 -2.43 93.12 -9.78 30.84 38.74 -8.10 32.14 39.13 coo 1.62 -2.18 93.54 3.32 -3.39 93.35 -11.17 33.63 46.78 -12.74 33.06 45.52 1zym_c00 source 1zym ENZYME I : 2 hits 1zym_c00 naa= 2 ULMN 2 1zym_c01 ENZYME I user 1 2 # 1 B 168 THR A 5 THR.? 10.24 ZN ZN B 118 B 189 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -11.20 6.24 51.51 -9.77 5.38 52.87 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 1zym_c01 ENZYME I user 2 2 # 2 B 168 THR B 5 THR.? 9.07 ZN ZN A 119 B 189 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo -8.63 -3.73 134.97 -6.62 -3.52 134.27 -9.78 30.84 38.74 -8.10 32.14 39.13 coo -1.97 -3.14 134.00 -3.52 -4.53 134.20 -11.17 33.63 46.78 -12.74 33.06 45.52 1zym_c01 source 1zym ENZYME I : 2 hits 1zym_c01 naa= 2 ULMN 2 206l_c00 LYSOZYME user 1 2 # 1 A 11 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 20 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 40.46 12.70 11.55 39.54 14.42 10.81 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 39.78 21.54 11.61 37.90 22.43 11.16 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 206l_c00 LYSOZYME user 2 2 # 2 A 11 GLU A 4 GLU.? -2.10 ZN ZN B 118s A 20 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 40.46 12.70 11.55 39.54 14.42 10.81 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 39.78 21.54 11.61 37.90 22.43 11.16 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 206l_c00 LYSOZYME user 3 2 # 3 A 11 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 20 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 40.46 12.70 11.55 39.54 14.42 10.81 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 39.78 21.54 11.61 37.90 22.43 11.16 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 206l_c00 LYSOZYME user 4 2 # 4 A 11 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 20 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 40.46 12.70 11.55 39.54 14.42 10.81 -11.28 43.45 57.76 -11.76 45.17 58.88 coo 39.78 21.54 11.61 37.90 22.43 11.16 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 206l_c00 LYSOZYME user 5 2 # 5 A 11 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 20 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 40.46 12.70 11.55 39.54 14.42 10.81 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 39.78 21.54 11.61 37.90 22.43 11.16 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 206l_c00 LYSOZYME user 6 2 # 6 A 11 GLU B 4 GLU.? -2.30 ZN ZN A 119s A 20 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 40.46 12.70 11.55 39.54 14.42 10.81 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 39.78 21.54 11.61 37.90 22.43 11.16 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 206l_c00 LYSOZYME user 7 2 # 7 A 11 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 20 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 40.46 12.70 11.55 39.54 14.42 10.81 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 39.78 21.54 11.61 37.90 22.43 11.16 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 206l_c00 LYSOZYME user 8 2 # 8 A 11 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 20 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 40.46 12.70 11.55 39.54 14.42 10.81 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 39.78 21.54 11.61 37.90 22.43 11.16 -11.52 -0.56 39.66 -12.44 -2.44 39.86 206l_c00 source 206l LYSOZYME : 8 hits 206l_c00 naa= 2 ULMN 2 2a0n_c00 4.01.03.0000 user 1 2 # 1 A 11 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 130 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 25.89 89.29 37.40 24.53 87.99 36.37 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 22.18 80.79 26.12 23.22 81.35 27.91 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 2a0n_c00 4.01.03.0000 user 2 2 # 2 A 11 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 130 ASP A 86 ASP~? 22.55 ZN ZN A 119 coo 25.89 89.29 37.40 24.53 87.99 36.37 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 22.18 80.79 26.12 23.22 81.35 27.91 -6.95 43.63 60.82 -7.76 45.08 62.19 ULMN 2 2a0n_c00 4.01.03.0000 user 3 2 # 3 A 11 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 130 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 25.89 89.29 37.40 24.53 87.99 36.37 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 22.18 80.79 26.12 23.22 81.35 27.91 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2a0n_c00 4.01.03.0000 user 4 2 # 4 A 11 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 130 ASP A 86 ASP~? 22.55 ZN ZN A 119 coo 25.89 89.29 37.40 24.53 87.99 36.37 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 22.18 80.79 26.12 23.22 81.35 27.91 -6.95 43.63 60.82 -7.76 45.08 62.19 ULMN 2 2a0n_c00 4.01.03.0000 user 5 2 # 5 A 11 ASP A 86 ASP~? 22.55 ZN ZN A 119 A 130 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 25.89 89.29 37.40 24.53 87.99 36.37 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 22.18 80.79 26.12 23.22 81.35 27.91 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2a0n_c00 4.01.03.0000 user 6 2 # 6 A 11 ASP A 86 ASP~? 22.55 ZN ZN A 119 A 130 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 25.89 89.29 37.40 24.53 87.99 36.37 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 22.18 80.79 26.12 23.22 81.35 27.91 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 2a0n_c00 4.01.03.0000 user 7 2 # 7 A 11 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 130 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 25.89 89.29 37.40 24.53 87.99 36.37 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 22.18 80.79 26.12 23.22 81.35 27.91 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2a0n_c00 4.01.03.0000 user 8 2 # 8 A 11 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 130 ASP B 86 ASP~? 22.13 ZN ZN B 118 coo 25.89 89.29 37.40 24.53 87.99 36.37 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 22.18 80.79 26.12 23.22 81.35 27.91 -2.05 -6.64 31.60 -2.83 -8.07 30.18 ULMN 2 2a0n_c00 4.01.03.0000 user 9 2 # 9 A 11 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 130 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 25.89 89.29 37.40 24.53 87.99 36.37 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 22.18 80.79 26.12 23.22 81.35 27.91 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2a0n_c00 4.01.03.0000 user 10 2 # 10 A 11 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 130 ASP B 86 ASP~? 22.13 ZN ZN B 118 coo 25.89 89.29 37.40 24.53 87.99 36.37 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 22.18 80.79 26.12 23.22 81.35 27.91 -2.05 -6.64 31.60 -2.83 -8.07 30.18 ULMN 2 2a0n_c00 4.01.03.0000 user 11 2 # 11 A 11 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 130 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo 25.89 89.29 37.40 24.53 87.99 36.37 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 22.18 80.79 26.12 23.22 81.35 27.91 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2a0n_c00 4.01.03.0000 user 12 2 # 12 A 11 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 130 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 25.89 89.29 37.40 24.53 87.99 36.37 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 22.18 80.79 26.12 23.22 81.35 27.91 -11.52 -0.56 39.66 -12.44 -2.44 39.86 2a0n_c00 source 2a0n 4.01.03.0000 : 12 hits 2a0n_c00 naa= 2 ULMN 2 2abk_c00 ENDONUCLEASE III user 1 2 # 1 120 LYS A 29 LYS^? 13.52 CH3 ACY A 120 138 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 35.70 11.61 29.91 35.27 16.84 33.08 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 33.57 16.23 36.65 31.90 16.89 37.78 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2abk_c00 ENDONUCLEASE III user 2 2 # 2 120 LYS A 93 LYS.? 17.16 ZN ZN A 119 138 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 35.70 11.61 29.91 35.27 16.84 33.08 -8.24 41.47 45.26 -7.63 47.05 46.72 coo 33.57 16.23 36.65 31.90 16.89 37.78 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 2abk_c00 ENDONUCLEASE III user 3 2 # 3 120 LYS B 29 LYS^? 13.36 ZN ZN B 118 138 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo 35.70 11.61 29.91 35.27 16.84 33.08 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 33.57 16.23 36.65 31.90 16.89 37.78 -4.19 3.69 22.28 -5.55 3.13 23.82 2abk_c00 source 2abk ENDONUCLEASE III : 3 hits 2abk_c00 naa= 2 ULMN 2 2acy_c00 ACYLPHOSPHATASE user 1 2 # 1 23 ARG A 35 ARG^? 4.87 ZN ZN A 119 41 ASN B 6 ASN.? 8.30 OXT ACY B 120 coo 16.80 -14.98 16.98 17.50 -17.52 18.58 -8.90 26.62 43.60 -11.56 28.13 43.24 coo 21.33 -14.94 17.25 19.91 -14.30 18.68 -9.87 26.28 39.29 -10.81 26.02 37.42 ULMN 2 2acy_c00 ACYLPHOSPHATASE user 2 2 # 2 23 ARG B 35 ARG.? 5.03 ZN ZN B 118 41 ASN A 6 ASN.? 7.96 O ACY A 120 coo 16.80 -14.98 16.98 17.50 -17.52 18.58 -9.55 10.54 47.29 -12.21 9.06 46.81 coo 21.33 -14.94 17.25 19.91 -14.30 18.68 -11.99 10.76 51.07 -13.19 11.09 52.81 2acy_c00 source 2acy ACYLPHOSPHATASE : 2 hits 2acy_c00 naa= 2 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 1 2 # 1 49 TYR A 23 TYR^? 11.58 CH3 ACY A 120 79 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 2 2 # 2 49 TYR A 63 TYR^? 13.00 ZN ZN A 119 79 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 3 2 # 3 49 TYR A 72 TYR^? -3.77 O ACY A 120s 79 LYS A 16 LYS~? -3.27 O ACY A 120s coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 4 2 # 4 49 TYR A 72 TYR^? -3.77 O ACY A 120s 79 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 5 2 # 5 49 TYR A 79 TYR^? -4.35 CH3 ACY A 120s 79 LYS A 16 LYS~? -3.27 O ACY A 120s coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 6 2 # 6 49 TYR A 79 TYR^? -4.35 CH3 ACY A 120s 79 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 7 2 # 7 49 TYR B 23 TYR^? 11.37 CH3 ACY B 120 79 LYS B 71 LYS^? 12.90 O ACY A 121 coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 8 2 # 8 49 TYR B 72 TYR^? 3.72 OXT ACY B 120s 79 LYS A 40 LYS.? -3.18 C ACY A 121s coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 9 2 # 9 49 TYR B 72 TYR^? 3.72 OXT ACY B 120s 79 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -10.13 21.11 38.47 -9.52 22.58 33.19 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 10 2 # 10 49 TYR B 79 TYR^? -4.21 CH3 ACY B 120s 79 LYS A 40 LYS.? -3.18 C ACY A 121s coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 2alr_c01 ALDEHYDE REDUCTASE user 11 2 # 11 49 TYR B 79 TYR^? -4.21 CH3 ACY B 120s 79 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 8.78 -8.94 37.04 9.01 -6.91 35.11 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 1.95 -7.11 31.57 6.32 -4.48 33.65 -10.13 21.11 38.47 -9.52 22.58 33.19 2alr_c01 source 2alr ALDEHYDE REDUCTASE : 11 hits 2alr_c01 naa= 2 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 2 # 1 193 ASP A 15 ASP~? 8.61 ZN ZN B 118 218 GLY A 19 GLY.? 9.19 CH3 ACY A 120 coo 27.89 102.52 14.98 29.35 101.92 13.57 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 21.10 106.02 13.04 21.16 106.76 12.59 -15.53 22.05 51.92 -14.82 21.95 52.30 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 2 # 2 193 ASP A 26 ASP.? 19.54 CH3 ACY A 120 218 GLY A 24 GLY.? 15.19 CH3 ACY A 120 coo 27.89 102.52 14.98 29.35 101.92 13.57 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 21.10 106.02 13.04 21.16 106.76 12.59 -10.32 31.44 63.56 -10.61 30.81 64.05 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 2 # 3 193 ASP A 60 ASP.? -2.37 ZN ZN A 119s 218 GLY A 31 GLY^? 10.46 ZN ZN A 119 coo 27.89 102.52 14.98 29.35 101.92 13.57 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 21.10 106.02 13.04 21.16 106.76 12.59 -15.56 30.08 55.93 -15.09 29.60 56.48 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 2 # 4 193 ASP A 61 ASP^? 8.97 ZN ZN A 119 218 GLY A 31 GLY^? 10.46 ZN ZN A 119 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 21.10 106.02 13.04 21.16 106.76 12.59 -15.56 30.08 55.93 -15.09 29.60 56.48 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 2 # 5 193 ASP A 61 ASP^? 8.97 ZN ZN A 119 218 GLY A 54 GLY.? 9.09 ZN ZN A 119 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 21.10 106.02 13.04 21.16 106.76 12.59 -21.24 35.01 50.29 -20.80 34.52 50.80 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 2 # 6 193 ASP A 61 ASP^? 8.97 ZN ZN A 119 218 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo 27.89 102.52 14.98 29.35 101.92 13.57 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 21.10 106.02 13.04 21.16 106.76 12.59 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 2 # 7 193 ASP B 15 ASP~? 8.50 ZN ZN A 119 218 GLY B 19 GLY.? 9.20 CH3 ACY B 120 coo 27.89 102.52 14.98 29.35 101.92 13.57 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 21.10 106.02 13.04 21.16 106.76 12.59 -13.06 15.01 37.28 -12.27 15.10 37.18 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 2 # 8 193 ASP B 26 ASP.? 19.38 CH3 ACY B 120 218 GLY B 24 GLY.? 15.12 CH3 ACY B 120 coo 27.89 102.52 14.98 29.35 101.92 13.57 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 21.10 106.02 13.04 21.16 106.76 12.59 -4.03 5.76 27.94 -4.16 6.37 27.38 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 2 # 9 193 ASP B 60 ASP.? -2.30 ZN ZN B 118s 218 GLY B 31 GLY^? 10.38 ZN ZN B 118 coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 21.10 106.02 13.04 21.16 106.76 12.59 -11.44 6.93 33.52 -10.95 7.47 33.07 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 2 # 10 193 ASP B 61 ASP^? 9.02 ZN ZN B 118 218 GLY B 31 GLY^? 10.38 ZN ZN B 118 coo 27.89 102.52 14.98 29.35 101.92 13.57 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 21.10 106.02 13.04 21.16 106.76 12.59 -11.44 6.93 33.52 -10.95 7.47 33.07 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 11 2 # 11 193 ASP B 61 ASP^? 9.02 ZN ZN B 118 218 GLY B 54 GLY.? 9.20 ZN ZN B 118 coo 27.89 102.52 14.98 29.35 101.92 13.57 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 21.10 106.02 13.04 21.16 106.76 12.59 -18.56 1.34 36.85 -18.13 1.88 36.45 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 12 2 # 12 193 ASP B 61 ASP^? 9.02 ZN ZN B 118 218 GLY B 57 GLY.? -3.44 ZN ZN B 118s coo 27.89 102.52 14.98 29.35 101.92 13.57 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 21.10 106.02 13.04 21.16 106.76 12.59 -17.31 6.32 43.48 -17.60 5.82 42.91 ULMN 2 2amg_c00 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 13 2 # 13 193 ASP B 61 ASP^? 9.02 ZN ZN B 118 218 GLY B 59 GLY.? 7.59 ZN ZN B 118 coo 27.89 102.52 14.98 29.35 101.92 13.57 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 21.10 106.02 13.04 21.16 106.76 12.59 -18.86 0.25 41.49 -18.36 0.89 41.57 2amg_c00 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 13 hits 2amg_c00 naa= 2 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 1 2 # 1 193 ASP A 15 ASP~? 8.61 ZN ZN B 118 219 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 27.89 102.52 14.98 29.35 101.92 13.57 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 25.84 105.87 9.06 27.86 105.55 8.74 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 2 2 # 2 193 ASP A 26 ASP.? 19.54 CH3 ACY A 120 219 GLU A 28 GLU.? 19.71 ZN ZN A 119 coo 27.89 102.52 14.98 29.35 101.92 13.57 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 25.84 105.87 9.06 27.86 105.55 8.74 -17.43 33.27 64.86 -17.71 35.42 64.60 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 3 2 # 3 193 ASP A 60 ASP.? -2.37 ZN ZN A 119s 219 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 27.89 102.52 14.98 29.35 101.92 13.57 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 25.84 105.87 9.06 27.86 105.55 8.74 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 4 2 # 4 193 ASP A 60 ASP.? -2.37 ZN ZN A 119s 219 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 27.89 102.52 14.98 29.35 101.92 13.57 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 25.84 105.87 9.06 27.86 105.55 8.74 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 5 2 # 5 193 ASP A 86 ASP~? 22.55 ZN ZN A 119 219 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 27.89 102.52 14.98 29.35 101.92 13.57 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 25.84 105.87 9.06 27.86 105.55 8.74 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 6 2 # 6 193 ASP B 15 ASP~? 8.50 ZN ZN A 119 219 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 27.89 102.52 14.98 29.35 101.92 13.57 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 25.84 105.87 9.06 27.86 105.55 8.74 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 7 2 # 7 193 ASP B 15 ASP~? 8.50 ZN ZN A 119 219 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 27.89 102.52 14.98 29.35 101.92 13.57 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 25.84 105.87 9.06 27.86 105.55 8.74 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 8 2 # 8 193 ASP B 60 ASP.? -2.30 ZN ZN B 118s 219 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 25.84 105.87 9.06 27.86 105.55 8.74 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 9 2 # 9 193 ASP B 60 ASP.? -2.30 ZN ZN B 118s 219 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 27.89 102.52 14.98 29.35 101.92 13.57 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 25.84 105.87 9.06 27.86 105.55 8.74 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 2amg_c03 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLAuser 10 2 # 10 193 ASP B 86 ASP~? 22.13 ZN ZN B 118 219 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 27.89 102.52 14.98 29.35 101.92 13.57 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 25.84 105.87 9.06 27.86 105.55 8.74 -7.13 -6.28 33.53 -6.83 -7.93 32.24 2amg_c03 source 2amg 1,4-ALPHA-D-GLUCAN MALTOTETRAHYDROLASE : 10 hits 2amg_c03 naa= 2 ULMN 2 2bmi_c01 CLASS B BETA-LACTAMASE user 1 2 # 1 B 86 ASP A 26 ASP.? 19.54 CH3 ACY A 120 B 176 ASN A 73 ASN^? 11.43 OXT ACY A 120 coo -11.22 46.67 61.63 -9.21 47.42 61.86 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -3.84 50.99 67.30 -2.89 49.10 67.47 -9.59 22.33 65.64 -10.09 22.46 67.69 ULMN 2 2bmi_c01 CLASS B BETA-LACTAMASE user 2 2 # 2 B 86 ASP B 26 ASP.? 19.38 CH3 ACY B 120 B 176 ASN B 73 ASN^? 10.74 OXT ACY A 121 coo -11.22 46.67 61.63 -9.21 47.42 61.86 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -3.84 50.99 67.30 -2.89 49.10 67.47 -2.85 14.93 26.35 -2.72 14.72 24.20 2bmi_c01 source 2bmi CLASS B BETA-LACTAMASE : 2 hits 2bmi_c01 naa= 2 ULMN 2 2c7v_c00 PTERIDINE REDUCTASE user 1 2 # 1 A 171 PHE A 52 PHE^? 9.40 ZN ZN A 119 A 178 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -13.64 35.13 53.79 -11.95 37.28 53.18 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 2 2c7v_c00 PTERIDINE REDUCTASE user 2 2 # 2 A 171 PHE A 52 PHE^? 9.40 ZN ZN A 119 A 178 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -13.64 35.13 53.79 -11.95 37.28 53.18 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 2c7v_c00 PTERIDINE REDUCTASE user 3 2 # 3 A 171 PHE B 52 PHE^? 9.45 ZN ZN B 118 A 178 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 7.07 -11.45 22.83 8.29 -13.66 21.61 -10.22 1.91 36.10 -8.88 -0.23 37.26 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -10.40 7.25 27.78 -14.86 10.45 31.09 2c7v_c00 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c00 naa= 2 ULMN 2 2c7v_c01 PTERIDINE REDUCTASE user 1 2 # 1 B 171 PHE A 52 PHE^? 9.40 ZN ZN A 119 B 178 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -13.64 35.13 53.79 -11.95 37.28 53.18 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 2 2c7v_c01 PTERIDINE REDUCTASE user 2 2 # 2 B 171 PHE A 52 PHE^? 9.40 ZN ZN A 119 B 178 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -13.64 35.13 53.79 -11.95 37.28 53.18 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 2c7v_c01 PTERIDINE REDUCTASE user 3 2 # 3 B 171 PHE B 52 PHE^? 9.45 ZN ZN B 118 B 178 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo -21.65 17.34 10.98 -21.84 19.41 9.11 -10.22 1.91 36.10 -8.88 -0.23 37.26 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -10.40 7.25 27.78 -14.86 10.45 31.09 2c7v_c01 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c01 naa= 2 ULMN 2 2c7v_c02 PTERIDINE REDUCTASE user 1 2 # 1 C 171 PHE A 52 PHE^? 9.40 ZN ZN A 119 C 178 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 6.32 17.53 24.32 6.46 19.72 26.09 -13.64 35.13 53.79 -11.95 37.28 53.18 coo 3.63 7.30 27.09 2.92 9.52 32.06 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 2 2c7v_c02 PTERIDINE REDUCTASE user 2 2 # 2 C 171 PHE A 52 PHE^? 9.40 ZN ZN A 119 C 178 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 6.32 17.53 24.32 6.46 19.72 26.09 -13.64 35.13 53.79 -11.95 37.28 53.18 coo 3.63 7.30 27.09 2.92 9.52 32.06 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 2c7v_c02 PTERIDINE REDUCTASE user 3 2 # 3 C 171 PHE B 52 PHE^? 9.45 ZN ZN B 118 C 178 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 6.32 17.53 24.32 6.46 19.72 26.09 -10.22 1.91 36.10 -8.88 -0.23 37.26 coo 3.63 7.30 27.09 2.92 9.52 32.06 -10.40 7.25 27.78 -14.86 10.45 31.09 2c7v_c02 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c02 naa= 2 ULMN 2 2c7v_c03 PTERIDINE REDUCTASE user 1 2 # 1 D 171 PHE A 52 PHE^? 9.40 ZN ZN A 119 D 178 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -13.64 35.13 53.79 -11.95 37.28 53.18 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 2 2c7v_c03 PTERIDINE REDUCTASE user 2 2 # 2 D 171 PHE A 52 PHE^? 9.40 ZN ZN A 119 D 178 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -13.64 35.13 53.79 -11.95 37.28 53.18 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 2c7v_c03 PTERIDINE REDUCTASE user 3 2 # 3 D 171 PHE B 52 PHE^? 9.45 ZN ZN B 118 D 178 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo -23.14 -11.41 15.36 -24.46 -13.43 16.80 -10.22 1.91 36.10 -8.88 -0.23 37.26 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -10.40 7.25 27.78 -14.86 10.45 31.09 2c7v_c03 source 2c7v PTERIDINE REDUCTASE : 3 hits 2c7v_c03 naa= 2 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 1 2 # 1 A 174 TYR A 72 TYR^? -3.77 O ACY A 120s A 178 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 2 2 # 2 A 174 TYR A 79 TYR^? -4.35 CH3 ACY A 120s A 178 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 3 2 # 3 A 174 TYR A 94 TYR.? 14.61 ZN ZN A 119 A 178 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -5.97 41.42 41.15 -7.10 43.78 40.18 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 4 2 # 4 A 174 TYR B 72 TYR^? 3.72 OXT ACY B 120s A 178 LYS B 71 LYS^? 12.90 O ACY A 121 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 2c7v_c04 PTERIDINE REDUCTASE user 5 2 # 5 A 174 TYR B 79 TYR^? -4.21 CH3 ACY B 120s A 178 LYS B 71 LYS^? 12.90 O ACY A 121 coo 8.61 -7.11 20.41 7.51 -6.92 17.85 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 6.59 -1.17 18.88 9.36 -3.26 14.85 0.91 14.36 31.66 5.84 10.91 29.66 2c7v_c04 source 2c7v PTERIDINE REDUCTASE : 5 hits 2c7v_c04 naa= 2 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 1 2 # 1 B 174 TYR A 72 TYR^? -3.77 O ACY A 120s B 178 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -8.74 18.57 61.24 -11.39 17.69 61.31 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 2 2 # 2 B 174 TYR A 79 TYR^? -4.35 CH3 ACY A 120s B 178 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -8.40 22.97 58.06 -7.77 20.89 56.30 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 3 2 # 3 B 174 TYR A 94 TYR.? 14.61 ZN ZN A 119 B 178 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -5.97 41.42 41.15 -7.10 43.78 40.18 coo -19.24 6.75 9.26 -18.50 8.42 4.13 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 4 2 # 4 B 174 TYR B 72 TYR^? 3.72 OXT ACY B 120s B 178 LYS B 71 LYS^? 12.90 O ACY A 121 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -3.38 18.68 30.67 -5.90 19.37 29.75 coo -19.24 6.75 9.26 -18.50 8.42 4.13 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 2c7v_c05 PTERIDINE REDUCTASE user 5 2 # 5 B 174 TYR B 79 TYR^? -4.21 CH3 ACY B 120s B 178 LYS B 71 LYS^? 12.90 O ACY A 121 coo -21.46 12.70 8.53 -19.04 12.30 7.24 -4.08 14.27 33.90 -4.00 16.42 35.66 coo -19.24 6.75 9.26 -18.50 8.42 4.13 0.91 14.36 31.66 5.84 10.91 29.66 2c7v_c05 source 2c7v PTERIDINE REDUCTASE : 5 hits 2c7v_c05 naa= 2 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 1 2 # 1 C 174 TYR A 72 TYR^? -3.77 O ACY A 120s C 178 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 5.94 13.28 27.17 3.53 13.05 28.58 -8.74 18.57 61.24 -11.39 17.69 61.31 coo 3.63 7.30 27.09 2.92 9.52 32.06 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 2 2 # 2 C 174 TYR A 79 TYR^? -4.35 CH3 ACY A 120s C 178 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 5.94 13.28 27.17 3.53 13.05 28.58 -8.40 22.97 58.06 -7.77 20.89 56.30 coo 3.63 7.30 27.09 2.92 9.52 32.06 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 3 2 # 3 C 174 TYR A 94 TYR.? 14.61 ZN ZN A 119 C 178 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 5.94 13.28 27.17 3.53 13.05 28.58 -5.97 41.42 41.15 -7.10 43.78 40.18 coo 3.63 7.30 27.09 2.92 9.52 32.06 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 4 2 # 4 C 174 TYR B 72 TYR^? 3.72 OXT ACY B 120s C 178 LYS B 71 LYS^? 12.90 O ACY A 121 coo 5.94 13.28 27.17 3.53 13.05 28.58 -3.38 18.68 30.67 -5.90 19.37 29.75 coo 3.63 7.30 27.09 2.92 9.52 32.06 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 2c7v_c06 PTERIDINE REDUCTASE user 5 2 # 5 C 174 TYR B 79 TYR^? -4.21 CH3 ACY B 120s C 178 LYS B 71 LYS^? 12.90 O ACY A 121 coo 5.94 13.28 27.17 3.53 13.05 28.58 -4.08 14.27 33.90 -4.00 16.42 35.66 coo 3.63 7.30 27.09 2.92 9.52 32.06 0.91 14.36 31.66 5.84 10.91 29.66 2c7v_c06 source 2c7v PTERIDINE REDUCTASE : 5 hits 2c7v_c06 naa= 2 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 1 2 # 1 D 174 TYR A 72 TYR^? -3.77 O ACY A 120s D 178 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -8.74 18.57 61.24 -11.39 17.69 61.31 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 2 2 # 2 D 174 TYR A 79 TYR^? -4.35 CH3 ACY A 120s D 178 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -8.40 22.97 58.06 -7.77 20.89 56.30 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 3 2 # 3 D 174 TYR A 94 TYR.? 14.61 ZN ZN A 119 D 178 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -5.97 41.42 41.15 -7.10 43.78 40.18 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 4 2 # 4 D 174 TYR B 72 TYR^? 3.72 OXT ACY B 120s D 178 LYS B 71 LYS^? 12.90 O ACY A 121 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -3.38 18.68 30.67 -5.90 19.37 29.75 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 2c7v_c07 PTERIDINE REDUCTASE user 5 2 # 5 D 174 TYR B 79 TYR^? -4.21 CH3 ACY B 120s D 178 LYS B 71 LYS^? 12.90 O ACY A 121 coo -24.51 -6.92 17.31 -23.48 -6.50 19.84 -4.08 14.27 33.90 -4.00 16.42 35.66 coo -22.44 -0.81 18.19 -24.98 -2.45 22.61 0.91 14.36 31.66 5.84 10.91 29.66 2c7v_c07 source 2c7v PTERIDINE REDUCTASE : 5 hits 2c7v_c07 naa= 2 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 1 2 # 1 105 HIS A 62 HIS^? -3.21 ZN ZN A 119s 183 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 2 2 # 2 105 HIS A 62 HIS^? -3.21 ZN ZN A 119s 183 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 3 2 # 3 105 HIS B 62 HIS^? -3.22 ZN ZN B 118s 183 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 2cpo_c00 CHLOROPEROXIDASE user 4 2 # 4 105 HIS B 62 HIS^? -3.22 ZN ZN B 118s 183 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 12.48 24.12 -9.88 11.36 24.64 -8.18 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 7.40 22.78 -5.08 9.19 22.77 -6.20 -13.07 9.82 43.01 -13.89 7.88 43.30 2cpo_c00 source 2cpo CHLOROPEROXIDASE : 4 hits 2cpo_c00 naa= 2 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 1 2 # 1 A 197 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 236 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 12.51 17.07 49.46 12.44 16.89 47.35 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 2 2 # 2 A 197 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 12.51 17.07 49.46 12.44 16.89 47.35 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -11.52 -0.56 39.66 -12.44 -2.44 39.86 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 3 2 # 3 A 197 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 236 ASP A 86 ASP~? 22.55 ZN ZN A 119 coo 12.51 17.07 49.46 12.44 16.89 47.35 -12.31 33.78 68.67 -13.06 34.29 66.76 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -6.95 43.63 60.82 -7.76 45.08 62.19 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 4 2 # 4 A 197 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 236 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 12.51 17.07 49.46 12.44 16.89 47.35 -16.84 33.62 48.35 -16.08 32.62 46.63 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 5 2 # 5 A 197 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 236 ASP A 86 ASP~? 22.55 ZN ZN A 119 coo 12.51 17.07 49.46 12.44 16.89 47.35 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -6.95 43.63 60.82 -7.76 45.08 62.19 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 6 2 # 6 A 197 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 236 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 12.51 17.07 49.46 12.44 16.89 47.35 -13.54 37.53 49.98 -14.44 39.37 49.54 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 7 2 # 7 A 197 ASP A 86 ASP~? 22.55 ZN ZN A 119 A 236 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 12.51 17.07 49.46 12.44 16.89 47.35 -6.95 43.63 60.82 -7.76 45.08 62.19 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 8 2 # 8 A 197 ASP A 86 ASP~? 22.55 ZN ZN A 119 A 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 12.51 17.07 49.46 12.44 16.89 47.35 -6.95 43.63 60.82 -7.76 45.08 62.19 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 9 2 # 9 A 197 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 236 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 12.51 17.07 49.46 12.44 16.89 47.35 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 10 2 # 10 A 197 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 236 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 12.51 17.07 49.46 12.44 16.89 47.35 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 11 2 # 11 A 197 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 236 ASP B 86 ASP~? 22.13 ZN ZN B 118 coo 12.51 17.07 49.46 12.44 16.89 47.35 -4.19 3.69 22.28 -5.55 3.13 23.82 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -2.05 -6.64 31.60 -2.83 -8.07 30.18 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 12 2 # 12 A 197 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 236 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 12.51 17.07 49.46 12.44 16.89 47.35 -15.33 3.33 40.18 -15.00 4.24 42.07 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 13 2 # 13 A 197 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 236 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 12.51 17.07 49.46 12.44 16.89 47.35 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 14 2 # 14 A 197 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 236 ASP B 86 ASP~? 22.13 ZN ZN B 118 coo 12.51 17.07 49.46 12.44 16.89 47.35 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -2.05 -6.64 31.60 -2.83 -8.07 30.18 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 15 2 # 15 A 197 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 236 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo 12.51 17.07 49.46 12.44 16.89 47.35 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2cpu_c00 ALPHA-AMYLASE user 16 2 # 16 A 197 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 236 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 12.51 17.07 49.46 12.44 16.89 47.35 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo -2.69 16.54 48.12 -4.57 15.63 48.33 -11.52 -0.56 39.66 -12.44 -2.44 39.86 2cpu_c00 source 2cpu ALPHA-AMYLASE : 16 hits 2cpu_c00 naa= 2 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 1 2 # 1 22 GLU A 4 GLU.? -2.10 ZN ZN B 118s 100 LYS A 16 LYS~? -3.27 O ACY A 120s coo 48.89 50.87 68.09 48.88 49.14 69.31 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 41.76 43.63 69.91 46.12 48.11 71.43 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 2 2 # 2 22 GLU A 7 GLU.? 2.09 ZN ZN A 118s 100 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 48.89 50.87 68.09 48.88 49.14 69.31 -8.44 11.27 56.65 -9.19 12.79 57.99 coo 41.76 43.63 69.91 46.12 48.11 71.43 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 3 2 # 3 22 GLU A 34 GLU^? -2.26 ZN ZN A 119s 100 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 48.89 50.87 68.09 48.88 49.14 69.31 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 41.76 43.63 69.91 46.12 48.11 71.43 -10.13 21.11 38.47 -9.52 22.58 33.19 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 4 2 # 4 22 GLU A 75 GLU.? 14.61 ZN ZN A 118 100 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 48.89 50.87 68.09 48.88 49.14 69.31 -11.14 20.14 70.42 -10.69 21.09 72.30 coo 41.76 43.63 69.91 46.12 48.11 71.43 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 5 2 # 5 22 GLU B 4 GLU.? -2.30 ZN ZN A 119s 100 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 48.89 50.87 68.09 48.88 49.14 69.31 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 41.76 43.63 69.91 46.12 48.11 71.43 -10.13 21.11 38.47 -9.52 22.58 33.19 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 6 2 # 6 22 GLU B 7 GLU.? -2.20 ZN ZN B 119s 100 LYS A 40 LYS.? -3.18 C ACY A 121s coo 48.89 50.87 68.09 48.88 49.14 69.31 -4.86 25.89 35.02 -5.24 24.36 33.68 coo 41.76 43.63 69.91 46.12 48.11 71.43 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 2dhn_c00 7,8-DIHYDRONEOPTERIN ALDOLASE user 7 2 # 7 22 GLU B 34 GLU.? -2.23 ZN ZN B 118s 100 LYS A 16 LYS~? -3.27 O ACY A 120s coo 48.89 50.87 68.09 48.88 49.14 69.31 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 41.76 43.63 69.91 46.12 48.11 71.43 -12.18 15.96 51.84 -12.69 14.73 56.98 2dhn_c00 source 2dhn 7,8-DIHYDRONEOPTERIN ALDOLASE : 7 hits 2dhn_c00 naa= 2 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 1 2 # 1 130 ASP A 15 ASP~? 8.61 ZN ZN B 118 132 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 25.19 32.92 18.85 27.07 32.05 18.66 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 30.29 33.92 17.74 30.60 31.83 17.87 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 2 2 # 2 130 ASP A 26 ASP.? 19.54 CH3 ACY A 120 132 GLU A 28 GLU.? 19.71 ZN ZN A 119 coo 25.19 32.92 18.85 27.07 32.05 18.66 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 30.29 33.92 17.74 30.60 31.83 17.87 -17.43 33.27 64.86 -17.71 35.42 64.60 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 3 2 # 3 130 ASP A 86 ASP~? 22.55 ZN ZN A 119 132 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 25.19 32.92 18.85 27.07 32.05 18.66 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 30.29 33.92 17.74 30.60 31.83 17.87 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 4 2 # 4 130 ASP B 15 ASP~? 8.50 ZN ZN A 119 132 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 25.19 32.92 18.85 27.07 32.05 18.66 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 30.29 33.92 17.74 30.60 31.83 17.87 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 5 2 # 5 130 ASP B 26 ASP.? 19.38 CH3 ACY B 120 132 GLU B 28 GLU.? 20.25 ZN ZN B 118 coo 25.19 32.92 18.85 27.07 32.05 18.66 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 30.29 33.92 17.74 30.60 31.83 17.87 -8.23 3.75 25.31 -7.96 1.78 24.56 ULMN 2 2ebn_c00 ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1user 6 2 # 6 130 ASP B 86 ASP~? 22.13 ZN ZN B 118 132 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 25.19 32.92 18.85 27.07 32.05 18.66 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 30.29 33.92 17.74 30.60 31.83 17.87 -7.13 -6.28 33.53 -6.83 -7.93 32.24 2ebn_c00 source 2ebn ENDO-BETA-N-ACETYLGLUCOSAMINIDASE F1 (E.C.3.2.: 6 hits 2ebn_c00 naa= 2 ULMN 2 2eng_c00 ENDOGLUCANASE V user 1 2 # 1 10 ASP A 15 ASP~? 8.61 ZN ZN B 118 121 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -12.98 14.88 47.28 -12.40 12.90 47.92 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2eng_c00 ENDOGLUCANASE V user 2 2 # 2 10 ASP B 15 ASP~? 8.50 ZN ZN A 119 121 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -1.15 29.58 35.96 -2.72 28.77 37.06 -12.05 22.20 42.61 -11.41 24.21 42.00 coo -7.97 24.78 30.86 -9.67 25.90 30.49 -12.98 14.88 47.28 -12.40 12.90 47.92 2eng_c00 source 2eng ENDOGLUCANASE V : 2 hits 2eng_c00 naa= 2 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 1 2 # 1 35 GLU A 4 GLU.? -2.10 ZN ZN B 118s 53 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 24.12 3.58 26.55 22.78 2.48 27.73 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 2 2 # 2 35 GLU A 4 GLU.? -2.10 ZN ZN B 118s 53 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -15.62 6.11 47.30 -14.46 5.85 45.55 coo 24.12 3.58 26.55 22.78 2.48 27.73 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 3 2 # 3 35 GLU A 28 GLU.? 19.71 ZN ZN A 119 53 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -17.43 33.27 64.86 -17.71 35.42 64.60 coo 24.12 3.58 26.55 22.78 2.48 27.73 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 4 2 # 4 35 GLU A 34 GLU^? -2.26 ZN ZN A 119s 53 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 24.12 3.58 26.55 22.78 2.48 27.73 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 5 2 # 5 35 GLU A 34 GLU^? -2.26 ZN ZN A 119s 53 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -13.74 27.15 46.45 -14.38 29.06 45.84 coo 24.12 3.58 26.55 22.78 2.48 27.73 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 6 2 # 6 35 GLU B 4 GLU.? -2.30 ZN ZN A 119s 53 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 24.12 3.58 26.55 22.78 2.48 27.73 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 7 2 # 7 35 GLU B 4 GLU.? -2.30 ZN ZN A 119s 53 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -14.65 30.41 41.31 -14.31 31.08 43.33 coo 24.12 3.58 26.55 22.78 2.48 27.73 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 8 2 # 8 35 GLU B 34 GLU.? -2.23 ZN ZN B 118s 53 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 24.12 3.58 26.55 22.78 2.48 27.73 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 9 2 # 9 35 GLU B 34 GLU.? -2.23 ZN ZN B 118s 53 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -13.07 9.82 43.01 -13.89 7.88 43.30 coo 24.12 3.58 26.55 22.78 2.48 27.73 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 2eql_c00 LYSOZYME (APO FORM) user 10 2 # 10 35 GLU B 89 GLU~? 19.03 ZN ZN B 118 53 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 22.26 -1.56 20.98 20.65 -1.60 22.38 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo 24.12 3.58 26.55 22.78 2.48 27.73 -11.52 -0.56 39.66 -12.44 -2.44 39.86 2eql_c00 source 2eql LYSOZYME (APO FORM) : 10 hits 2eql_c00 naa= 2 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 A 28 GLU A 28 GLU.? 19.71 ZN ZN A 119 A 120 ASP A 86 ASP~? 22.55 ZN ZN A 119 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -17.43 33.27 64.86 -17.71 35.42 64.60 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -6.95 43.63 60.82 -7.76 45.08 62.19 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 A 28 GLU A 34 GLU^? -2.26 ZN ZN A 119s A 120 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -13.74 27.15 46.45 -14.38 29.06 45.84 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 A 28 GLU A 75 GLU.? 14.61 ZN ZN A 118 A 120 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -11.14 20.14 70.42 -10.69 21.09 72.30 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 A 28 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 120 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -11.28 43.45 57.76 -11.76 45.17 58.88 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 A 28 GLU A 89 GLU~? 19.37 ZN ZN A 119 A 120 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -11.28 43.45 57.76 -11.76 45.17 58.88 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 A 28 GLU B 28 GLU.? 20.25 ZN ZN B 118 A 120 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -8.23 3.75 25.31 -7.96 1.78 24.56 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -11.52 -0.56 39.66 -12.44 -2.44 39.86 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 7 2 # 7 A 28 GLU B 28 GLU.? 20.25 ZN ZN B 118 A 120 ASP B 86 ASP~? 22.13 ZN ZN B 118 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -8.23 3.75 25.31 -7.96 1.78 24.56 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -2.05 -6.64 31.60 -2.83 -8.07 30.18 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 8 2 # 8 A 28 GLU B 34 GLU.? -2.23 ZN ZN B 118s A 120 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -13.07 9.82 43.01 -13.89 7.88 43.30 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 9 2 # 9 A 28 GLU B 75 GLU.? 13.95 OXT ACY A 121 A 120 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -3.38 17.56 20.48 -2.28 16.44 19.03 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 10 2 # 10 A 28 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 120 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2fmn_c00 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 11 2 # 11 A 28 GLU B 89 GLU~? 19.03 ZN ZN B 118 A 120 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -61.72 -16.57 24.95 -60.22 -17.52 23.81 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo -60.99 -27.15 16.46 -59.77 -26.21 17.91 -15.33 3.33 40.18 -15.00 4.24 42.07 2fmn_c00 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 11 hits 2fmn_c00 naa= 2 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 B 28 GLU A 28 GLU.? 19.71 ZN ZN A 119 B 120 ASP A 86 ASP~? 22.55 ZN ZN A 119 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -17.43 33.27 64.86 -17.71 35.42 64.60 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -6.95 43.63 60.82 -7.76 45.08 62.19 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 B 28 GLU A 34 GLU^? -2.26 ZN ZN A 119s B 120 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -13.74 27.15 46.45 -14.38 29.06 45.84 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 B 28 GLU A 75 GLU.? 14.61 ZN ZN A 118 B 120 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -11.14 20.14 70.42 -10.69 21.09 72.30 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 B 28 GLU A 89 GLU~? 19.37 ZN ZN A 119 B 120 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -11.28 43.45 57.76 -11.76 45.17 58.88 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 B 28 GLU A 89 GLU~? 19.37 ZN ZN A 119 B 120 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -18.25 19.28 62.84 -16.77 17.78 62.83 -11.28 43.45 57.76 -11.76 45.17 58.88 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 B 28 GLU B 28 GLU.? 20.25 ZN ZN B 118 B 120 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -8.23 3.75 25.31 -7.96 1.78 24.56 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -11.52 -0.56 39.66 -12.44 -2.44 39.86 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 7 2 # 7 B 28 GLU B 28 GLU.? 20.25 ZN ZN B 118 B 120 ASP B 86 ASP~? 22.13 ZN ZN B 118 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -8.23 3.75 25.31 -7.96 1.78 24.56 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -2.05 -6.64 31.60 -2.83 -8.07 30.18 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 8 2 # 8 B 28 GLU B 34 GLU.? -2.23 ZN ZN B 118s B 120 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -13.07 9.82 43.01 -13.89 7.88 43.30 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 9 2 # 9 B 28 GLU B 75 GLU.? 13.95 OXT ACY A 121 B 120 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -3.38 17.56 20.48 -2.28 16.44 19.03 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 10 2 # 10 B 28 GLU B 89 GLU~? 19.03 ZN ZN B 118 B 120 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo -18.25 19.28 62.84 -16.77 17.78 62.83 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2fmn_c01 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 11 2 # 11 B 28 GLU B 89 GLU~? 19.03 ZN ZN B 118 B 120 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -18.25 19.28 62.84 -16.77 17.78 62.83 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo -4.96 18.58 65.50 -6.34 17.73 64.12 -15.33 3.33 40.18 -15.00 4.24 42.07 2fmn_c01 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 11 hits 2fmn_c01 naa= 2 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 1 2 # 1 C 28 GLU A 28 GLU.? 19.71 ZN ZN A 119 C 120 ASP A 86 ASP~? 22.55 ZN ZN A 119 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -17.43 33.27 64.86 -17.71 35.42 64.60 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -6.95 43.63 60.82 -7.76 45.08 62.19 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 2 2 # 2 C 28 GLU A 34 GLU^? -2.26 ZN ZN A 119s C 120 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -13.74 27.15 46.45 -14.38 29.06 45.84 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 3 2 # 3 C 28 GLU A 75 GLU.? 14.61 ZN ZN A 118 C 120 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -11.14 20.14 70.42 -10.69 21.09 72.30 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 4 2 # 4 C 28 GLU A 89 GLU~? 19.37 ZN ZN A 119 C 120 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -11.28 43.45 57.76 -11.76 45.17 58.88 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 5 2 # 5 C 28 GLU A 89 GLU~? 19.37 ZN ZN A 119 C 120 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -11.28 43.45 57.76 -11.76 45.17 58.88 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 6 2 # 6 C 28 GLU B 28 GLU.? 20.25 ZN ZN B 118 C 120 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -8.23 3.75 25.31 -7.96 1.78 24.56 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -11.52 -0.56 39.66 -12.44 -2.44 39.86 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 7 2 # 7 C 28 GLU B 28 GLU.? 20.25 ZN ZN B 118 C 120 ASP B 86 ASP~? 22.13 ZN ZN B 118 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -8.23 3.75 25.31 -7.96 1.78 24.56 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -2.05 -6.64 31.60 -2.83 -8.07 30.18 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 8 2 # 8 C 28 GLU B 34 GLU.? -2.23 ZN ZN B 118s C 120 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -13.07 9.82 43.01 -13.89 7.88 43.30 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 9 2 # 9 C 28 GLU B 75 GLU.? 13.95 OXT ACY A 121 C 120 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -3.38 17.56 20.48 -2.28 16.44 19.03 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 10 2 # 10 C 28 GLU B 89 GLU~? 19.03 ZN ZN B 118 C 120 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2fmn_c02 5,10-METHYLENETETRAHYDROFOLATE REDUCuser 11 2 # 11 C 28 GLU B 89 GLU~? 19.03 ZN ZN B 118 C 120 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -44.26 -20.36 65.64 -43.04 -18.67 65.86 -7.13 -6.28 33.53 -6.83 -7.93 32.24 coo -43.81 -9.80 74.11 -43.52 -10.17 72.04 -15.33 3.33 40.18 -15.00 4.24 42.07 2fmn_c02 source 2fmn 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE : 11 hits 2fmn_c02 naa= 2 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 A 150 TYR A 23 TYR^? 11.58 CH3 ACY A 120 A 245 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 A 150 TYR A 63 TYR^? 13.00 ZN ZN A 119 A 245 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 2 # 3 A 150 TYR B 23 TYR^? 11.37 CH3 ACY B 120 A 245 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2gsa_c00 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 2 # 4 A 150 TYR B 63 TYR^? 12.86 ZN ZN B 118 A 245 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 9.74 16.83 -36.21 11.10 17.13 -33.77 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 1.75 12.92 -36.29 2.66 14.31 -34.97 -11.52 -0.56 39.66 -12.44 -2.44 39.86 2gsa_c00 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 4 hits 2gsa_c00 naa= 2 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 150 TYR A 23 TYR^? 11.58 CH3 ACY A 120 B 245 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 B 150 TYR A 63 TYR^? 13.00 ZN ZN A 119 B 245 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 2 # 3 B 150 TYR B 23 TYR^? 11.37 CH3 ACY B 120 B 245 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2gsa_c01 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 2 # 4 B 150 TYR B 63 TYR^? 12.86 ZN ZN B 118 B 245 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -11.52 -0.56 39.66 -12.44 -2.44 39.86 2gsa_c01 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 4 hits 2gsa_c01 naa= 2 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 150 TYR A 23 TYR^? 11.58 CH3 ACY A 120 B 245 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -13.79 26.73 63.12 -16.10 25.28 62.65 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 2 2 # 2 B 150 TYR A 63 TYR^? 13.00 ZN ZN A 119 B 245 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -6.95 35.16 53.71 -4.78 36.23 55.09 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 3 2 # 3 B 150 TYR B 23 TYR^? 11.37 CH3 ACY B 120 B 245 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -7.61 10.49 27.32 -9.94 11.99 27.12 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2gsa_c03 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 4 2 # 4 B 150 TYR B 63 TYR^? 12.86 ZN ZN B 118 B 245 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 10.46 6.37 -13.28 8.79 7.55 -15.21 -4.17 2.05 38.57 -1.76 0.81 38.01 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -11.52 -0.56 39.66 -12.44 -2.44 39.86 2gsa_c03 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 4 hits 2gsa_c03 naa= 2 ULMN 2 2gsa_c05 GLUTAMATE SEMIALDEHYDE AMINOTRANSFERuser 1 2 # 1 B 157 PHE A 55 PHE.? 11.31 ZN ZN A 119 B 245 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 16.60 4.08 -19.14 19.31 4.55 -18.73 -23.76 31.53 49.05 -25.99 32.30 50.52 coo 18.02 10.66 -12.89 15.97 11.09 -13.40 -16.84 33.62 48.35 -16.08 32.62 46.63 2gsa_c05 source 2gsa GLUTAMATE SEMIALDEHYDE AMINOTRANSFERASE : 1 hits 2gsa_c05 naa= 2 ULMN 2 2jcw_c00 CU/ZN SUPEROXIDE DISMUTASE user 1 2 # 1 63 HIS A 62 HIS^? -3.21 ZN ZN A 119s 143 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 7.37 21.96 20.34 6.83 20.29 19.19 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 2.05 15.79 24.54 1.75 18.84 24.36 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 2 2jcw_c00 CU/ZN SUPEROXIDE DISMUTASE user 2 2 # 2 63 HIS B 62 HIS^? -3.22 ZN ZN B 118s 143 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo 7.37 21.96 20.34 6.83 20.29 19.19 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 2.05 15.79 24.54 1.75 18.84 24.36 -9.55 10.54 47.29 -12.21 9.06 46.81 2jcw_c00 source 2jcw CU/ZN SUPEROXIDE DISMUTASE : 2 hits 2jcw_c00 naa= 2 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 1 2 # 1 131 ASP A 15 ASP~? 8.61 ZN ZN B 118 218 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 2 2 # 2 131 ASP A 60 ASP.? -2.37 ZN ZN A 119s 218 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 3 2 # 3 131 ASP A 61 ASP^? 8.97 ZN ZN A 119 218 ARG A 90 ARG~? 21.28 ZN ZN A 119 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -4.89 45.59 55.49 -2.75 44.62 57.47 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 4 2 # 4 131 ASP B 15 ASP~? 8.50 ZN ZN A 119 218 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 5 2 # 5 131 ASP B 60 ASP.? -2.30 ZN ZN B 118s 218 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -9.55 10.54 47.29 -12.21 9.06 46.81 ULMN 2 2pec_c00 PECTATE LYASE C (PLC) (E.C.4.2.2.2) user 6 2 # 6 131 ASP B 61 ASP^? 9.02 ZN ZN B 118 218 ARG B 90 ARG~? 22.74 ZN ZN B 118 coo 29.20 21.16 -9.67 28.83 20.92 -7.62 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 19.50 18.47 -4.28 21.50 18.06 -1.98 -1.29 -8.08 37.25 0.33 -10.46 36.18 2pec_c00 source 2pec PECTATE LYASE C (PLC) (E.C.4.2.2.2) : 6 hits 2pec_c00 naa= 2 ULMN 2 2phk_c00 MC-PEPTIDE user 1 2 # 1 A 149 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 153 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 41.42 17.90 44.98 43.39 18.36 45.61 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 51.07 15.29 42.97 50.55 17.18 42.21 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 2phk_c00 MC-PEPTIDE user 2 2 # 2 A 149 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 153 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 41.42 17.90 44.98 43.39 18.36 45.61 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 51.07 15.29 42.97 50.55 17.18 42.21 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 2phk_c00 MC-PEPTIDE user 3 2 # 3 A 149 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 153 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 41.42 17.90 44.98 43.39 18.36 45.61 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 51.07 15.29 42.97 50.55 17.18 42.21 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 2phk_c00 MC-PEPTIDE user 4 2 # 4 A 149 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 153 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 41.42 17.90 44.98 43.39 18.36 45.61 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 51.07 15.29 42.97 50.55 17.18 42.21 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 2phk_c00 MC-PEPTIDE user 5 2 # 5 A 149 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 153 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 41.42 17.90 44.98 43.39 18.36 45.61 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 51.07 15.29 42.97 50.55 17.18 42.21 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 2phk_c00 MC-PEPTIDE user 6 2 # 6 A 149 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 153 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 41.42 17.90 44.98 43.39 18.36 45.61 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 51.07 15.29 42.97 50.55 17.18 42.21 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 2phk_c00 MC-PEPTIDE user 7 2 # 7 A 149 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 153 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 41.42 17.90 44.98 43.39 18.36 45.61 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 51.07 15.29 42.97 50.55 17.18 42.21 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 2phk_c00 MC-PEPTIDE user 8 2 # 8 A 149 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 153 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 41.42 17.90 44.98 43.39 18.36 45.61 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 51.07 15.29 42.97 50.55 17.18 42.21 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 2phk_c00 MC-PEPTIDE user 9 2 # 9 A 149 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 153 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 41.42 17.90 44.98 43.39 18.36 45.61 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 51.07 15.29 42.97 50.55 17.18 42.21 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 2phk_c00 MC-PEPTIDE user 10 2 # 10 A 149 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 153 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 41.42 17.90 44.98 43.39 18.36 45.61 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 51.07 15.29 42.97 50.55 17.18 42.21 -7.13 -6.28 33.53 -6.83 -7.93 32.24 2phk_c00 source 2phk MC-PEPTIDE : 10 hits 2phk_c00 naa= 2 ULMN 2 2phk_c01 MC-PEPTIDE user 1 2 # 1 A 149 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 151 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 41.42 17.90 44.98 43.39 18.36 45.61 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 45.75 16.58 39.61 47.43 18.26 45.54 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 2 2phk_c01 MC-PEPTIDE user 2 2 # 2 A 149 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 151 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 41.42 17.90 44.98 43.39 18.36 45.61 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 45.75 16.58 39.61 47.43 18.26 45.54 -8.24 41.47 45.26 -7.63 47.05 46.72 2phk_c01 source 2phk MC-PEPTIDE : 2 hits 2phk_c01 naa= 2 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 1 2 # 1 A 549 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 655 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 2 2 # 2 A 549 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 655 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -11.52 -0.56 39.66 -12.44 -2.44 39.86 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 3 2 # 3 A 549 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 655 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 4 2 # 4 A 549 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 655 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 5 2 # 5 A 549 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 655 ASP A 86 ASP~? 22.55 ZN ZN A 119 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -6.95 43.63 60.82 -7.76 45.08 62.19 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 6 2 # 6 A 549 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 655 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 7 2 # 7 A 549 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 655 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 8 2 # 8 A 549 ASP A 86 ASP~? 22.55 ZN ZN A 119 A 655 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 9 2 # 9 A 549 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 655 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 10 2 # 10 A 549 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 655 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 11 2 # 11 A 549 ASP B 26 ASP.? 19.38 CH3 ACY B 120 A 655 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -11.52 -0.56 39.66 -12.44 -2.44 39.86 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 12 2 # 12 A 549 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 655 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 13 2 # 13 A 549 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 655 ASP B 86 ASP~? 22.13 ZN ZN B 118 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -2.05 -6.64 31.60 -2.83 -8.07 30.18 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 14 2 # 14 A 549 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 655 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 15 2 # 15 A 549 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 655 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2qf7_c00 PYRUVATE CARBOXYLASE PROTEIN user 16 2 # 16 A 549 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 655 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 159.55 97.44 -12.01 159.29 98.50 -13.89 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 164.13 113.74 -17.54 162.88 115.12 -18.56 -15.33 3.33 40.18 -15.00 4.24 42.07 2qf7_c00 source 2qf7 PYRUVATE CARBOXYLASE PROTEIN : 16 hits 2qf7_c00 naa= 2 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 1 2 # 1 B 549 ASP A 15 ASP~? 8.61 ZN ZN B 118 B 655 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 76.34 71.89 30.92 75.58 70.99 29.16 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 66.54 57.43 28.71 66.94 55.81 27.41 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 2 2 # 2 B 549 ASP A 15 ASP~? 8.61 ZN ZN B 118 B 655 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 76.34 71.89 30.92 75.58 70.99 29.16 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 66.54 57.43 28.71 66.94 55.81 27.41 -11.52 -0.56 39.66 -12.44 -2.44 39.86 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 3 2 # 3 B 549 ASP A 26 ASP.? 19.54 CH3 ACY A 120 B 655 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 76.34 71.89 30.92 75.58 70.99 29.16 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 66.54 57.43 28.71 66.94 55.81 27.41 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 4 2 # 4 B 549 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 655 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 76.34 71.89 30.92 75.58 70.99 29.16 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 66.54 57.43 28.71 66.94 55.81 27.41 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 5 2 # 5 B 549 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 655 ASP A 86 ASP~? 22.55 ZN ZN A 119 coo 76.34 71.89 30.92 75.58 70.99 29.16 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 66.54 57.43 28.71 66.94 55.81 27.41 -6.95 43.63 60.82 -7.76 45.08 62.19 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 6 2 # 6 B 549 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 655 ASP A 26 ASP.? 19.54 CH3 ACY A 120 coo 76.34 71.89 30.92 75.58 70.99 29.16 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 66.54 57.43 28.71 66.94 55.81 27.41 -12.31 33.78 68.67 -13.06 34.29 66.76 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 7 2 # 7 B 549 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 655 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 76.34 71.89 30.92 75.58 70.99 29.16 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 66.54 57.43 28.71 66.94 55.81 27.41 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 8 2 # 8 B 549 ASP A 86 ASP~? 22.55 ZN ZN A 119 B 655 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo 76.34 71.89 30.92 75.58 70.99 29.16 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 66.54 57.43 28.71 66.94 55.81 27.41 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 9 2 # 9 B 549 ASP B 15 ASP~? 8.50 ZN ZN A 119 B 655 ASP A 61 ASP^? 8.97 ZN ZN A 119 coo 76.34 71.89 30.92 75.58 70.99 29.16 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 66.54 57.43 28.71 66.94 55.81 27.41 -13.54 37.53 49.98 -14.44 39.37 49.54 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 10 2 # 10 B 549 ASP B 15 ASP~? 8.50 ZN ZN A 119 B 655 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 76.34 71.89 30.92 75.58 70.99 29.16 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 66.54 57.43 28.71 66.94 55.81 27.41 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 11 2 # 11 B 549 ASP B 26 ASP.? 19.38 CH3 ACY B 120 B 655 ASP B 61 ASP^? 9.02 ZN ZN B 118 coo 76.34 71.89 30.92 75.58 70.99 29.16 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 66.54 57.43 28.71 66.94 55.81 27.41 -11.52 -0.56 39.66 -12.44 -2.44 39.86 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 12 2 # 12 B 549 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 655 ASP B 15 ASP~? 8.50 ZN ZN A 119 coo 76.34 71.89 30.92 75.58 70.99 29.16 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 66.54 57.43 28.71 66.94 55.81 27.41 -12.05 22.20 42.61 -11.41 24.21 42.00 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 13 2 # 13 B 549 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 655 ASP B 86 ASP~? 22.13 ZN ZN B 118 coo 76.34 71.89 30.92 75.58 70.99 29.16 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 66.54 57.43 28.71 66.94 55.81 27.41 -2.05 -6.64 31.60 -2.83 -8.07 30.18 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 14 2 # 14 B 549 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 655 ASP A 15 ASP~? 8.61 ZN ZN B 118 coo 76.34 71.89 30.92 75.58 70.99 29.16 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 66.54 57.43 28.71 66.94 55.81 27.41 -12.98 14.88 47.28 -12.40 12.90 47.92 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 15 2 # 15 B 549 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 655 ASP B 26 ASP.? 19.38 CH3 ACY B 120 coo 76.34 71.89 30.92 75.58 70.99 29.16 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 66.54 57.43 28.71 66.94 55.81 27.41 -4.19 3.69 22.28 -5.55 3.13 23.82 ULMN 2 2qf7_c01 PYRUVATE CARBOXYLASE PROTEIN user 16 2 # 16 B 549 ASP B 86 ASP~? 22.13 ZN ZN B 118 B 655 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo 76.34 71.89 30.92 75.58 70.99 29.16 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 66.54 57.43 28.71 66.94 55.81 27.41 -15.33 3.33 40.18 -15.00 4.24 42.07 2qf7_c01 source 2qf7 PYRUVATE CARBOXYLASE PROTEIN : 16 hits 2qf7_c01 naa= 2 ULMN 2 2toh_c00 TYROSINE 3-MONOOXYGENASE user 1 2 # 1 A 331 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 395 SER A 51 SER^? 4.15 ZN ZN A 119 coo 76.89 62.57 43.06 74.99 62.50 42.14 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 75.56 65.50 47.86 75.54 65.13 45.50 -13.42 31.14 50.76 -15.54 30.86 49.58 ULMN 2 2toh_c00 TYROSINE 3-MONOOXYGENASE user 2 2 # 2 A 331 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 395 SER B 51 SER^? 4.27 ZN ZN B 118 coo 76.89 62.57 43.06 74.99 62.50 42.14 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 75.56 65.50 47.86 75.54 65.13 45.50 -11.41 5.84 39.04 -13.87 6.10 39.28 2toh_c00 source 2toh TYROSINE 3-MONOOXYGENASE : 2 hits 2toh_c00 naa= 2 ULMN 2 2tpl_c00 TYROSINE PHENOL-LYASE user 1 2 # 1 A 123 PHE A 52 PHE^? 9.40 ZN ZN A 119 A 214 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -13.64 35.13 53.79 -11.95 37.28 53.18 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2tpl_c00 TYROSINE PHENOL-LYASE user 2 2 # 2 A 123 PHE A 55 PHE.? 11.31 ZN ZN A 119 A 214 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -23.76 31.53 49.05 -25.99 32.30 50.52 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2tpl_c00 TYROSINE PHENOL-LYASE user 3 2 # 3 A 123 PHE B 52 PHE^? 9.45 ZN ZN B 118 A 214 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -10.22 1.91 36.10 -8.88 -0.23 37.26 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 2tpl_c00 TYROSINE PHENOL-LYASE user 4 2 # 4 A 123 PHE B 55 PHE.? 11.31 ZN ZN B 118 A 214 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -30.08 -12.81 5.71 -28.04 -12.05 7.46 -21.82 4.67 37.54 -23.75 3.88 35.71 coo -29.95 -11.32 -1.46 -28.83 -11.55 0.31 -15.33 3.33 40.18 -15.00 4.24 42.07 2tpl_c00 source 2tpl TYROSINE PHENOL-LYASE : 4 hits 2tpl_c00 naa= 2 ULMN 2 2tpl_c01 TYROSINE PHENOL-LYASE user 1 2 # 1 B 123 PHE A 52 PHE^? 9.40 ZN ZN A 119 B 214 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -26.81 18.98 9.83 -25.06 17.93 7.94 -13.64 35.13 53.79 -11.95 37.28 53.18 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2tpl_c01 TYROSINE PHENOL-LYASE user 2 2 # 2 B 123 PHE A 55 PHE.? 11.31 ZN ZN A 119 B 214 ASP A 60 ASP.? -2.37 ZN ZN A 119s coo -26.81 18.98 9.83 -25.06 17.93 7.94 -23.76 31.53 49.05 -25.99 32.30 50.52 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -16.84 33.62 48.35 -16.08 32.62 46.63 ULMN 2 2tpl_c01 TYROSINE PHENOL-LYASE user 3 2 # 3 B 123 PHE B 52 PHE^? 9.45 ZN ZN B 118 B 214 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -26.81 18.98 9.83 -25.06 17.93 7.94 -10.22 1.91 36.10 -8.88 -0.23 37.26 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -15.33 3.33 40.18 -15.00 4.24 42.07 ULMN 2 2tpl_c01 TYROSINE PHENOL-LYASE user 4 2 # 4 B 123 PHE B 55 PHE.? 11.31 ZN ZN B 118 B 214 ASP B 60 ASP.? -2.30 ZN ZN B 118s coo -26.81 18.98 9.83 -25.06 17.93 7.94 -21.82 4.67 37.54 -23.75 3.88 35.71 coo -26.88 17.61 16.89 -26.08 17.11 15.00 -15.33 3.33 40.18 -15.00 4.24 42.07 2tpl_c01 source 2tpl TYROSINE PHENOL-LYASE : 4 hits 2tpl_c01 naa= 2 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 N 447 TYR A 47 TYR^? 12.01 ZN ZN A 119 N 457 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo 10.05 43.90 8.55 11.74 45.69 9.93 -2.05 29.36 47.71 -2.93 30.35 45.23 coo 10.54 37.95 11.06 8.06 36.82 12.51 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 2 3pca_c01 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 N 447 TYR B 47 TYR^? 11.86 ZN ZN B 118 N 457 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo 10.05 43.90 8.55 11.74 45.69 9.93 -1.77 7.84 45.62 -3.44 6.86 47.62 coo 10.54 37.95 11.06 8.06 36.82 12.51 -9.55 10.54 47.29 -12.21 9.06 46.81 3pca_c01 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 2 hits 3pca_c01 naa= 2 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 1 2 # 1 R 447 TYR A 47 TYR^? 12.01 ZN ZN A 119 R 457 ARG A 35 ARG^? 4.87 ZN ZN A 119 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -2.05 29.36 47.71 -2.93 30.35 45.23 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -8.90 26.62 43.60 -11.56 28.13 43.24 ULMN 2 3pca_c05 PROTOCATECHUATE 3,4-DIOXYGENASE user 2 2 # 2 R 447 TYR B 47 TYR^? 11.86 ZN ZN B 118 R 457 ARG B 35 ARG.? 5.03 ZN ZN B 118 coo -43.75 -8.52 10.17 -45.67 -9.76 11.79 -1.77 7.84 45.62 -3.44 6.86 47.62 coo -37.85 -11.18 10.60 -36.87 -12.61 7.95 -9.55 10.54 47.29 -12.21 9.06 46.81 3pca_c05 source 3pca PROTOCATECHUATE 3,4-DIOXYGENASE : 2 hits 3pca_c05 naa= 2 ULMN 2 4mdh_c01 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 2 # 1 B 158 ASP B 26 ASP.? 19.38 CH3 ACY B 120 B 185 ASN B 73 ASN^? 10.74 OXT ACY A 121 coo 44.53 16.44 28.54 44.89 18.45 28.77 -4.19 3.69 22.28 -5.55 3.13 23.82 coo 54.37 18.81 28.31 54.76 20.47 29.61 -2.85 14.93 26.35 -2.72 14.72 24.20 4mdh_c01 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 1 hits 4mdh_c01 naa= 2 ULMN 2 4mdh_c04 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 2 # 1 A 158 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 186 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 18.62 26.83 58.17 18.48 28.64 57.08 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 16.67 31.22 54.64 18.74 31.15 54.14 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 4mdh_c04 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 2 # 2 A 158 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 186 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 18.62 26.83 58.17 18.48 28.64 57.08 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 16.67 31.22 54.64 18.74 31.15 54.14 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 4mdh_c04 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 2 # 3 A 158 ASP B 60 ASP.? -2.30 ZN ZN B 118s A 186 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 18.62 26.83 58.17 18.48 28.64 57.08 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 16.67 31.22 54.64 18.74 31.15 54.14 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 4mdh_c04 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 2 # 4 A 158 ASP B 61 ASP^? 9.02 ZN ZN B 118 A 186 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 18.62 26.83 58.17 18.48 28.64 57.08 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 16.67 31.22 54.64 18.74 31.15 54.14 -10.33 3.56 43.54 -12.07 4.44 44.29 4mdh_c04 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 4 hits 4mdh_c04 naa= 2 ULMN 2 4mdh_c05 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 1 2 # 1 B 158 ASP A 60 ASP.? -2.37 ZN ZN A 119s B 186 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 44.53 16.44 28.54 44.89 18.45 28.77 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 48.32 20.00 31.44 46.45 20.91 31.50 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 4mdh_c05 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 2 2 # 2 B 158 ASP A 61 ASP^? 8.97 ZN ZN A 119 B 186 HIS A 62 HIS^? -3.21 ZN ZN A 119s coo 44.53 16.44 28.54 44.89 18.45 28.77 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 48.32 20.00 31.44 46.45 20.91 31.50 -11.17 33.63 46.78 -12.74 33.06 45.52 ULMN 2 4mdh_c05 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 3 2 # 3 B 158 ASP B 60 ASP.? -2.30 ZN ZN B 118s B 186 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 44.53 16.44 28.54 44.89 18.45 28.77 -15.33 3.33 40.18 -15.00 4.24 42.07 coo 48.32 20.00 31.44 46.45 20.91 31.50 -10.33 3.56 43.54 -12.07 4.44 44.29 ULMN 2 4mdh_c05 CYTOPLASMIC MALATE DEHYDROGENASE (E.user 4 2 # 4 B 158 ASP B 61 ASP^? 9.02 ZN ZN B 118 B 186 HIS B 62 HIS^? -3.22 ZN ZN B 118s coo 44.53 16.44 28.54 44.89 18.45 28.77 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 48.32 20.00 31.44 46.45 20.91 31.50 -10.33 3.56 43.54 -12.07 4.44 44.29 4mdh_c05 source 4mdh CYTOPLASMIC MALATE DEHYDROGENASE (E.C.1.1.1.37: 4 hits 4mdh_c05 naa= 2 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 1 2 # 1 127 ARG A 35 ARG^? 4.87 ZN ZN A 119 270 GLU A 39 GLU^? 13.07 O ACY A 121 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -8.90 26.62 43.60 -11.56 28.13 43.24 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 3.97 24.42 42.90 6.03 24.50 43.46 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 2 2 # 2 127 ARG A 44 ARG.? 16.49 O ACY A 121 270 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 6.31 22.16 46.81 4.95 24.70 47.95 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 2.54 12.93 51.58 4.67 12.91 51.32 ULMN 2 5cpa_c00 CARBOXYPEPTIDASE A=ALPHA= (COX) (E.Cuser 3 2 # 3 127 ARG B 35 ARG.? 5.03 ZN ZN B 118 270 GLU B 39 GLU.? 14.67 OXT ACY A 120 coo 2.87 25.67 -2.58 1.96 27.95 -4.18 -9.55 10.54 47.29 -12.21 9.06 46.81 coo -7.41 30.69 -7.56 -5.96 29.61 -6.39 2.54 12.93 51.58 4.67 12.91 51.32 5cpa_c00 source 5cpa CARBOXYPEPTIDASE A=ALPHA= (COX) (E.C.3.4.17.1): 3 hits 5cpa_c00 naa= 2 ULMN 2 5eat_c00 5-EPI-ARISTOLOCHENE SYNTHASE user 1 2 # 1 273 TRP A 100 TRP.? 19.43 ZN ZN A 119 527 TYR A 94 TYR.? 14.61 ZN ZN A 119 coo 117.04 37.52 43.58 116.69 37.55 47.50 -2.26 47.11 41.70 -4.68 47.32 44.78 coo 115.56 42.29 49.60 115.28 44.39 47.77 -5.97 41.42 41.15 -7.10 43.78 40.18 ULMN 2 5eat_c00 5-EPI-ARISTOLOCHENE SYNTHASE user 2 2 # 2 273 TRP B 67 TRP~? 8.66 O ACY A 121 527 TYR B 79 TYR^? -4.21 CH3 ACY B 120s coo 117.04 37.52 43.58 116.69 37.55 47.50 2.75 16.18 40.14 -1.04 17.32 40.14 coo 115.56 42.29 49.60 115.28 44.39 47.77 -4.08 14.27 33.90 -4.00 16.42 35.66 5eat_c00 source 5eat 5-EPI-ARISTOLOCHENE SYNTHASE : 2 hits 5eat_c00 naa= 2 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 1 2 # 1 191 HIS A 62 HIS^? -3.21 ZN ZN A 119s 345 LYS A 10 LYS.? 12.65 OXT ACY A 120 coo 87.81 42.65 46.75 88.49 40.86 45.92 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 103.66 43.57 23.68 98.86 47.65 23.32 -0.98 10.25 56.97 2.99 9.65 58.52 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 2 2 # 2 191 HIS A 62 HIS^? -3.21 ZN ZN A 119s 345 LYS B 71 LYS^? 12.90 O ACY A 121 coo 87.81 42.65 46.75 88.49 40.86 45.92 -11.17 33.63 46.78 -12.74 33.06 45.52 coo 103.66 43.57 23.68 98.86 47.65 23.32 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 3 2 # 3 191 HIS B 62 HIS^? -3.22 ZN ZN B 118s 345 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 87.81 42.65 46.75 88.49 40.86 45.92 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 103.66 43.57 23.68 98.86 47.65 23.32 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 5enl_c02 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 4 2 # 4 191 HIS B 62 HIS^? -3.22 ZN ZN B 118s 345 LYS B 10 LYS.? 9.83 CH3 ACY A 121 coo 87.81 42.65 46.75 88.49 40.86 45.92 -10.33 3.56 43.54 -12.07 4.44 44.29 coo 103.66 43.57 23.68 98.86 47.65 23.32 2.14 27.03 37.15 7.00 28.76 35.76 5enl_c02 source 5enl ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- D-GLYCERATE: 4 hits 5enl_c02 naa= 2 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 1 2 # 1 242 LYS A 10 LYS.? 12.65 OXT ACY A 120 345 LYS A 40 LYS.? -3.18 C ACY A 121s coo 99.51 55.26 43.28 102.26 58.28 46.19 -0.98 10.25 56.97 2.99 9.65 58.52 coo 103.66 43.57 23.68 98.86 47.65 23.32 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 2 2 # 2 242 LYS A 10 LYS.? 12.65 OXT ACY A 120 345 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 99.51 55.26 43.28 102.26 58.28 46.19 -0.98 10.25 56.97 2.99 9.65 58.52 coo 103.66 43.57 23.68 98.86 47.65 23.32 -10.13 21.11 38.47 -9.52 22.58 33.19 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 3 2 # 3 242 LYS A 16 LYS~? -3.27 O ACY A 120s 345 LYS B 10 LYS.? 9.83 CH3 ACY A 121 coo 99.51 55.26 43.28 102.26 58.28 46.19 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 103.66 43.57 23.68 98.86 47.65 23.32 2.14 27.03 37.15 7.00 28.76 35.76 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 4 2 # 4 242 LYS A 16 LYS~? -3.27 O ACY A 120s 345 LYS B 71 LYS^? 12.90 O ACY A 121 coo 99.51 55.26 43.28 102.26 58.28 46.19 -12.18 15.96 51.84 -12.69 14.73 56.98 coo 103.66 43.57 23.68 98.86 47.65 23.32 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 5 2 # 5 242 LYS A 29 LYS^? 13.52 CH3 ACY A 120 345 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 99.51 55.26 43.28 102.26 58.28 46.19 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 103.66 43.57 23.68 98.86 47.65 23.32 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 6 2 # 6 242 LYS A 29 LYS^? 13.52 CH3 ACY A 120 345 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 99.51 55.26 43.28 102.26 58.28 46.19 -16.25 29.91 61.58 -19.73 26.30 57.65 coo 103.66 43.57 23.68 98.86 47.65 23.32 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 7 2 # 7 242 LYS A 40 LYS.? -3.18 C ACY A 121s 345 LYS A 10 LYS.? 12.65 OXT ACY A 120 coo 99.51 55.26 43.28 102.26 58.28 46.19 1.80 21.48 38.21 -1.61 24.69 34.09 coo 103.66 43.57 23.68 98.86 47.65 23.32 -0.98 10.25 56.97 2.99 9.65 58.52 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 8 2 # 8 242 LYS A 40 LYS.? -3.18 C ACY A 121s 345 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 99.51 55.26 43.28 102.26 58.28 46.19 1.80 21.48 38.21 -1.61 24.69 34.09 coo 103.66 43.57 23.68 98.86 47.65 23.32 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 9 2 # 9 242 LYS A 40 LYS.? -3.18 C ACY A 121s 345 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 99.51 55.26 43.28 102.26 58.28 46.19 1.80 21.48 38.21 -1.61 24.69 34.09 coo 103.66 43.57 23.68 98.86 47.65 23.32 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 10 2 # 10 242 LYS A 40 LYS.? -3.18 C ACY A 121s 345 LYS B 29 LYS^? 13.36 ZN ZN B 118 coo 99.51 55.26 43.28 102.26 58.28 46.19 1.80 21.48 38.21 -1.61 24.69 34.09 coo 103.66 43.57 23.68 98.86 47.65 23.32 -10.40 7.25 27.78 -14.86 10.45 31.09 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 11 2 # 11 242 LYS A 71 LYS^? 11.96 OXT ACY A 120 345 LYS A 40 LYS.? -3.18 C ACY A 121s coo 99.51 55.26 43.28 102.26 58.28 46.19 -4.35 22.91 61.78 1.12 23.33 62.25 coo 103.66 43.57 23.68 98.86 47.65 23.32 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 12 2 # 12 242 LYS A 71 LYS^? 11.96 OXT ACY A 120 345 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 99.51 55.26 43.28 102.26 58.28 46.19 -4.35 22.91 61.78 1.12 23.33 62.25 coo 103.66 43.57 23.68 98.86 47.65 23.32 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 13 2 # 13 242 LYS A 71 LYS^? 11.96 OXT ACY A 120 345 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 99.51 55.26 43.28 102.26 58.28 46.19 -4.35 22.91 61.78 1.12 23.33 62.25 coo 103.66 43.57 23.68 98.86 47.65 23.32 -10.13 21.11 38.47 -9.52 22.58 33.19 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 14 2 # 14 242 LYS A 93 LYS.? 17.16 ZN ZN A 119 345 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 99.51 55.26 43.28 102.26 58.28 46.19 -8.24 41.47 45.26 -7.63 47.05 46.72 coo 103.66 43.57 23.68 98.86 47.65 23.32 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 15 2 # 15 242 LYS A 93 LYS.? 17.16 ZN ZN A 119 345 LYS A 40 LYS.? -3.18 C ACY A 121s coo 99.51 55.26 43.28 102.26 58.28 46.19 -8.24 41.47 45.26 -7.63 47.05 46.72 coo 103.66 43.57 23.68 98.86 47.65 23.32 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 16 2 # 16 242 LYS A 93 LYS.? 17.16 ZN ZN A 119 345 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 99.51 55.26 43.28 102.26 58.28 46.19 -8.24 41.47 45.26 -7.63 47.05 46.72 coo 103.66 43.57 23.68 98.86 47.65 23.32 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 17 2 # 17 242 LYS A 93 LYS.? 17.16 ZN ZN A 119 345 LYS B 16 LYS~? -4.10 OXT ACY B 120s coo 99.51 55.26 43.28 102.26 58.28 46.19 -8.24 41.47 45.26 -7.63 47.05 46.72 coo 103.66 43.57 23.68 98.86 47.65 23.32 -10.13 21.11 38.47 -9.52 22.58 33.19 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 18 2 # 18 242 LYS B 10 LYS.? 9.83 CH3 ACY A 121 345 LYS A 16 LYS~? -3.27 O ACY A 120s coo 99.51 55.26 43.28 102.26 58.28 46.19 2.14 27.03 37.15 7.00 28.76 35.76 coo 103.66 43.57 23.68 98.86 47.65 23.32 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 19 2 # 19 242 LYS B 10 LYS.? 9.83 CH3 ACY A 121 345 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 99.51 55.26 43.28 102.26 58.28 46.19 2.14 27.03 37.15 7.00 28.76 35.76 coo 103.66 43.57 23.68 98.86 47.65 23.32 -0.91 15.74 55.76 -5.29 12.34 58.61 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 20 2 # 20 242 LYS B 16 LYS~? -4.10 OXT ACY B 120s 345 LYS A 10 LYS.? 12.65 OXT ACY A 120 coo 99.51 55.26 43.28 102.26 58.28 46.19 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 103.66 43.57 23.68 98.86 47.65 23.32 -0.98 10.25 56.97 2.99 9.65 58.52 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 21 2 # 21 242 LYS B 16 LYS~? -4.10 OXT ACY B 120s 345 LYS A 71 LYS^? 11.96 OXT ACY A 120 coo 99.51 55.26 43.28 102.26 58.28 46.19 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 103.66 43.57 23.68 98.86 47.65 23.32 -4.35 22.91 61.78 1.12 23.33 62.25 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 22 2 # 22 242 LYS B 16 LYS~? -4.10 OXT ACY B 120s 345 LYS A 93 LYS.? 17.16 ZN ZN A 119 coo 99.51 55.26 43.28 102.26 58.28 46.19 -10.13 21.11 38.47 -9.52 22.58 33.19 coo 103.66 43.57 23.68 98.86 47.65 23.32 -8.24 41.47 45.26 -7.63 47.05 46.72 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 23 2 # 23 242 LYS B 29 LYS^? 13.36 ZN ZN B 118 345 LYS A 40 LYS.? -3.18 C ACY A 121s coo 99.51 55.26 43.28 102.26 58.28 46.19 -10.40 7.25 27.78 -14.86 10.45 31.09 coo 103.66 43.57 23.68 98.86 47.65 23.32 1.80 21.48 38.21 -1.61 24.69 34.09 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 24 2 # 24 242 LYS B 40 LYS.? 4.59 ZN ZN A 118 345 LYS A 29 LYS^? 13.52 CH3 ACY A 120 coo 99.51 55.26 43.28 102.26 58.28 46.19 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 103.66 43.57 23.68 98.86 47.65 23.32 -16.25 29.91 61.58 -19.73 26.30 57.65 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 25 2 # 25 242 LYS B 40 LYS.? 4.59 ZN ZN A 118 345 LYS B 10 LYS.? 9.83 CH3 ACY A 121 coo 99.51 55.26 43.28 102.26 58.28 46.19 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 103.66 43.57 23.68 98.86 47.65 23.32 2.14 27.03 37.15 7.00 28.76 35.76 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 26 2 # 26 242 LYS B 40 LYS.? 4.59 ZN ZN A 118 345 LYS B 71 LYS^? 12.90 O ACY A 121 coo 99.51 55.26 43.28 102.26 58.28 46.19 -0.91 15.74 55.76 -5.29 12.34 58.61 coo 103.66 43.57 23.68 98.86 47.65 23.32 0.91 14.36 31.66 5.84 10.91 29.66 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 27 2 # 27 242 LYS B 71 LYS^? 12.90 O ACY A 121 345 LYS A 16 LYS~? -3.27 O ACY A 120s coo 99.51 55.26 43.28 102.26 58.28 46.19 0.91 14.36 31.66 5.84 10.91 29.66 coo 103.66 43.57 23.68 98.86 47.65 23.32 -12.18 15.96 51.84 -12.69 14.73 56.98 ULMN 2 5enl_c03 ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- Duser 28 2 # 28 242 LYS B 71 LYS^? 12.90 O ACY A 121 345 LYS B 40 LYS.? 4.59 ZN ZN A 118 coo 99.51 55.26 43.28 102.26 58.28 46.19 0.91 14.36 31.66 5.84 10.91 29.66 coo 103.66 43.57 23.68 98.86 47.65 23.32 -0.91 15.74 55.76 -5.29 12.34 58.61 5enl_c03 source 5enl ENOLASE (E.C.4.2.1.11) (2-PHOSPHO- D-GLYCERATE: 28 hits 5enl_c03 naa= 2 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 1 2 # 1 151 ASP A 15 ASP~? 8.61 ZN ZN B 118 277 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 25.08 13.39 65.77 24.68 15.22 66.73 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 24.99 20.41 57.94 24.48 20.83 59.94 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 2 2 # 2 151 ASP A 15 ASP~? 8.61 ZN ZN B 118 277 GLU A 7 GLU.? 2.09 ZN ZN A 118s coo 25.08 13.39 65.77 24.68 15.22 66.73 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 24.99 20.41 57.94 24.48 20.83 59.94 -8.44 11.27 56.65 -9.19 12.79 57.99 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 3 2 # 3 151 ASP A 15 ASP~? 8.61 ZN ZN B 118 277 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 25.08 13.39 65.77 24.68 15.22 66.73 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 24.99 20.41 57.94 24.48 20.83 59.94 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 4 2 # 4 151 ASP A 61 ASP^? 8.97 ZN ZN A 119 277 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo 25.08 13.39 65.77 24.68 15.22 66.73 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 24.99 20.41 57.94 24.48 20.83 59.94 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 5 2 # 5 151 ASP A 61 ASP^? 8.97 ZN ZN A 119 277 GLU A 89 GLU~? 19.37 ZN ZN A 119 coo 25.08 13.39 65.77 24.68 15.22 66.73 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 24.99 20.41 57.94 24.48 20.83 59.94 -11.28 43.45 57.76 -11.76 45.17 58.88 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 6 2 # 6 151 ASP A 61 ASP^? 8.97 ZN ZN A 119 277 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 25.08 13.39 65.77 24.68 15.22 66.73 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 24.99 20.41 57.94 24.48 20.83 59.94 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 7 2 # 7 151 ASP B 15 ASP~? 8.50 ZN ZN A 119 277 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo 25.08 13.39 65.77 24.68 15.22 66.73 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 24.99 20.41 57.94 24.48 20.83 59.94 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 8 2 # 8 151 ASP B 15 ASP~? 8.50 ZN ZN A 119 277 GLU B 7 GLU.? -2.20 ZN ZN B 119s coo 25.08 13.39 65.77 24.68 15.22 66.73 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 24.99 20.41 57.94 24.48 20.83 59.94 -4.86 25.89 35.02 -5.24 24.36 33.68 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 9 2 # 9 151 ASP B 15 ASP~? 8.50 ZN ZN A 119 277 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 25.08 13.39 65.77 24.68 15.22 66.73 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 24.99 20.41 57.94 24.48 20.83 59.94 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 10 2 # 10 151 ASP B 61 ASP^? 9.02 ZN ZN B 118 277 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo 25.08 13.39 65.77 24.68 15.22 66.73 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 24.99 20.41 57.94 24.48 20.83 59.94 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 11 2 # 11 151 ASP B 61 ASP^? 9.02 ZN ZN B 118 277 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo 25.08 13.39 65.77 24.68 15.22 66.73 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 24.99 20.41 57.94 24.48 20.83 59.94 -13.07 9.82 43.01 -13.89 7.88 43.30 ULMN 2 7nn9_c00 NEURAMINIDASE N9 user 12 2 # 12 151 ASP B 61 ASP^? 9.02 ZN ZN B 118 277 GLU B 89 GLU~? 19.03 ZN ZN B 118 coo 25.08 13.39 65.77 24.68 15.22 66.73 -11.52 -0.56 39.66 -12.44 -2.44 39.86 coo 24.99 20.41 57.94 24.48 20.83 59.94 -7.13 -6.28 33.53 -6.83 -7.93 32.24 7nn9_c00 source 7nn9 NEURAMINIDASE N9 : 12 hits 7nn9_c00 naa= 2 ULMN 2 7odc_c01 ORNITHINE DECARBOXYLASE user 1 2 # 1 A 197 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 274 GLU A 34 GLU^? -2.26 ZN ZN A 119s coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 -13.74 27.15 46.45 -14.38 29.06 45.84 ULMN 2 7odc_c01 ORNITHINE DECARBOXYLASE user 2 2 # 2 A 197 HIS A 62 HIS^? -3.21 ZN ZN A 119s A 274 GLU B 4 GLU.? -2.30 ZN ZN A 119s coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -11.17 33.63 46.78 -12.74 33.06 45.52 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 -14.65 30.41 41.31 -14.31 31.08 43.33 ULMN 2 7odc_c01 ORNITHINE DECARBOXYLASE user 3 2 # 3 A 197 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 274 GLU A 4 GLU.? -2.10 ZN ZN B 118s coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 -15.62 6.11 47.30 -14.46 5.85 45.55 ULMN 2 7odc_c01 ORNITHINE DECARBOXYLASE user 4 2 # 4 A 197 HIS B 62 HIS^? -3.22 ZN ZN B 118s A 274 GLU B 34 GLU.? -2.23 ZN ZN B 118s coo -14.36 14.33 -4.23 -14.32 12.27 -4.70 -10.33 3.56 43.54 -12.07 4.44 44.29 coo -17.27 16.20 -10.72 -15.74 17.25 -9.63 -13.07 9.82 43.01 -13.89 7.88 43.30 7odc_c01 source 7odc ORNITHINE DECARBOXYLASE : 4 hits 7odc_c01 naa= 2 ULMN 2 1a0h_p00 MEIZOTHROMBIN user 1 2 # 1 A 235 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 236 GLN A 18 GLN.? 11.66 ZN ZN A 119 coo 80.56 14.43 9.14 80.22 13.74 11.11 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 77.64 16.20 13.10 76.02 15.17 12.31 -11.72 21.08 47.54 -11.51 20.01 45.71 ULMN 2 1a0h_p00 MEIZOTHROMBIN user 2 2 # 2 A 235 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 236 GLN B 18 GLN~? 11.75 ZN ZN B 118 coo 80.56 14.43 9.14 80.22 13.74 11.11 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 77.64 16.20 13.10 76.02 15.17 12.31 -10.66 16.34 42.67 -11.39 17.08 44.58 ULMN 2 1a0h_p00 MEIZOTHROMBIN user 3 2 # 3 A 235 ASP A 86 ASP~? 22.55 ZN ZN A 119 A 236 GLN A 87 GLN~? 19.46 ZN ZN A 119 coo 80.56 14.43 9.14 80.22 13.74 11.11 -6.95 43.63 60.82 -7.76 45.08 62.19 coo 77.64 16.20 13.10 76.02 15.17 12.31 -3.98 39.54 59.02 -3.02 37.88 59.98 ULMN 2 1a0h_p00 MEIZOTHROMBIN user 4 2 # 4 A 235 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 236 GLN A 18 GLN.? 11.66 ZN ZN A 119 coo 80.56 14.43 9.14 80.22 13.74 11.11 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 77.64 16.20 13.10 76.02 15.17 12.31 -11.72 21.08 47.54 -11.51 20.01 45.71 ULMN 2 1a0h_p00 MEIZOTHROMBIN user 5 2 # 5 A 235 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 236 GLN B 18 GLN~? 11.75 ZN ZN B 118 coo 80.56 14.43 9.14 80.22 13.74 11.11 -12.05 22.20 42.61 -11.41 24.21 42.00 coo 77.64 16.20 13.10 76.02 15.17 12.31 -10.66 16.34 42.67 -11.39 17.08 44.58 ULMN 2 1a0h_p00 MEIZOTHROMBIN user 6 2 # 6 A 235 ASP B 86 ASP~? 22.13 ZN ZN B 118 A 236 GLN B 87 GLN~? 19.50 ZN ZN B 118 coo 80.56 14.43 9.14 80.22 13.74 11.11 -2.05 -6.64 31.60 -2.83 -8.07 30.18 coo 77.64 16.20 13.10 76.02 15.17 12.31 0.47 -2.28 34.19 1.41 -0.62 33.25 1a0h_p00 source 1a0h MEIZOTHROMBIN : 6 hits 1a0h_p00 naa= 2 ULMN 2 1qmo_p00 MANNOSE BINDING LECTIN, FRIL user 1 2 # 1 A 86 ASP A 15 ASP~? 8.61 ZN ZN B 118 A 104 GLY A 13 GLY^? 8.35 CH3 ACY A 120 coo 55.22 -18.55 56.19 54.31 -20.37 56.64 -12.98 14.88 47.28 -12.40 12.90 47.92 coo 53.69 -21.77 53.58 53.03 -21.45 53.16 -8.10 13.52 49.98 -8.09 14.12 50.54 ULMN 2 1qmo_p00 MANNOSE BINDING LECTIN, FRIL user 2 2 # 2 A 86 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 104 GLY A 24 GLY.? 15.19 CH3 ACY A 120 coo 55.22 -18.55 56.19 54.31 -20.37 56.64 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 53.69 -21.77 53.58 53.03 -21.45 53.16 -10.32 31.44 63.56 -10.61 30.81 64.05 ULMN 2 1qmo_p00 MANNOSE BINDING LECTIN, FRIL user 3 2 # 3 A 86 ASP A 26 ASP.? 19.54 CH3 ACY A 120 A 104 GLY A 27 GLY.? 16.01 CH3 ACY A 120 coo 55.22 -18.55 56.19 54.31 -20.37 56.64 -12.31 33.78 68.67 -13.06 34.29 66.76 coo 53.69 -21.77 53.58 53.03 -21.45 53.16 -13.31 29.37 67.32 -13.49 30.12 67.06 ULMN 2 1qmo_p00 MANNOSE BINDING LECTIN, FRIL user 4 2 # 4 A 86 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 104 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo 55.22 -18.55 56.19 54.31 -20.37 56.64 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 53.69 -21.77 53.58 53.03 -21.45 53.16 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1qmo_p00 MANNOSE BINDING LECTIN, FRIL user 5 2 # 5 A 86 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 104 GLY A 54 GLY.? 9.09 ZN ZN A 119 coo 55.22 -18.55 56.19 54.31 -20.37 56.64 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 53.69 -21.77 53.58 53.03 -21.45 53.16 -21.24 35.01 50.29 -20.80 34.52 50.80 ULMN 2 1qmo_p00 MANNOSE BINDING LECTIN, FRIL user 6 2 # 6 A 86 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 104 GLY A 57 GLY.? 4.30 ZN ZN A 119 coo 55.22 -18.55 56.19 54.31 -20.37 56.64 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 53.69 -21.77 53.58 53.03 -21.45 53.16 -18.19 30.32 43.90 -18.50 30.85 44.43 ULMN 2 1qmo_p00 MANNOSE BINDING LECTIN, FRIL user 7 2 # 7 A 86 ASP A 60 ASP.? -2.37 ZN ZN A 119s A 104 GLY A 59 GLY.? 7.60 ZN ZN A 119 coo 55.22 -18.55 56.19 54.31 -20.37 56.64 -16.84 33.62 48.35 -16.08 32.62 46.63 coo 53.69 -21.77 53.58 53.03 -21.45 53.16 -19.86 36.56 45.91 -19.41 35.88 46.04 ULMN 2 1qmo_p00 MANNOSE BINDING LECTIN, FRIL user 8 2 # 8 A 86 ASP A 61 ASP^? 8.97 ZN ZN A 119 A 104 GLY A 53 GLY.? 9.26 ZN ZN A 119 coo 55.22 -18.55 56.19 54.31 -20.37 56.64 -13.54 37.53 49.98 -14.44 39.37 49.54 coo 53.69 -21.77 53.58 53.03 -21.45 53.16 -18.39 35.86 52.61 -18.29 35.05 52.32 ULMN 2 1qmo_p00 MANNOSE BINDING LECTIN, FRIL user 9 2 # 9 A 86 ASP B 15 ASP~? 8.50 ZN ZN A 119 A 104 GLY B 13 GLY^? 8.33 CH3 ACY B 120